<html>
    <head>
        <meta charset="utf-8">
        
            <script src="lib/bindings/utils.js"></script>
            <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/dist/vis-network.min.css" integrity="sha512-WgxfT5LWjfszlPHXRmBWHkV2eceiWTOBvrKCNbdgDYTHrT2AeLCGbF4sZlZw3UMN3WtL0tGUoIAKsu8mllg/XA==" crossorigin="anonymous" referrerpolicy="no-referrer" />
            <script src="https://cdnjs.cloudflare.com/ajax/libs/vis-network/9.1.2/dist/vis-network.min.js" integrity="sha512-LnvoEWDFrqGHlHmDD2101OrLcbsfkrzoSpvtSQtxK3RMnRV0eOkhhBN2dXHKRrUU8p2DGRTk35n4O8nWSVe1mQ==" crossorigin="anonymous" referrerpolicy="no-referrer"></script>
            
        
<center>
<h1></h1>
</center>

<!-- <link rel="stylesheet" href="../node_modules/vis/dist/vis.min.css" type="text/css" />
<script type="text/javascript" src="../node_modules/vis/dist/vis.js"> </script>-->
        <link
          href="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/css/bootstrap.min.css"
          rel="stylesheet"
          integrity="sha384-eOJMYsd53ii+scO/bJGFsiCZc+5NDVN2yr8+0RDqr0Ql0h+rP48ckxlpbzKgwra6"
          crossorigin="anonymous"
        />
        <script
          src="https://cdn.jsdelivr.net/npm/bootstrap@5.0.0-beta3/dist/js/bootstrap.bundle.min.js"
          integrity="sha384-JEW9xMcG8R+pH31jmWH6WWP0WintQrMb4s7ZOdauHnUtxwoG2vI5DkLtS3qm9Ekf"
          crossorigin="anonymous"
        ></script>


        <center>
          <h1></h1>
        </center>
        <style type="text/css">

             #mynetwork {
                 width: 100%;
                 height: 1000px;
                 background-color: #ffffff;
                 border: 1px solid lightgray;
                 position: relative;
                 float: left;
             }

             
             #loadingBar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width: 100%;
                 height: 1000px;
                 background-color:rgba(200,200,200,0.8);
                 -webkit-transition: all 0.5s ease;
                 -moz-transition: all 0.5s ease;
                 -ms-transition: all 0.5s ease;
                 -o-transition: all 0.5s ease;
                 transition: all 0.5s ease;
                 opacity:1;
             }

             #bar {
                 position:absolute;
                 top:0px;
                 left:0px;
                 width:20px;
                 height:20px;
                 margin:auto auto auto auto;
                 border-radius:11px;
                 border:2px solid rgba(30,30,30,0.05);
                 background: rgb(0, 173, 246); /* Old browsers */
                 box-shadow: 2px 0px 4px rgba(0,0,0,0.4);
             }

             #border {
                 position:absolute;
                 top:10px;
                 left:10px;
                 width:500px;
                 height:23px;
                 margin:auto auto auto auto;
                 box-shadow: 0px 0px 4px rgba(0,0,0,0.2);
                 border-radius:10px;
             }

             #text {
                 position:absolute;
                 top:8px;
                 left:530px;
                 width:30px;
                 height:50px;
                 margin:auto auto auto auto;
                 font-size:22px;
                 color: #000000;
             }

             div.outerBorder {
                 position:relative;
                 top:400px;
                 width:600px;
                 height:44px;
                 margin:auto auto auto auto;
                 border:8px solid rgba(0,0,0,0.1);
                 background: rgb(252,252,252); /* Old browsers */
                 background: -moz-linear-gradient(top,  rgba(252,252,252,1) 0%, rgba(237,237,237,1) 100%); /* FF3.6+ */
                 background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,rgba(252,252,252,1)), color-stop(100%,rgba(237,237,237,1))); /* Chrome,Safari4+ */
                 background: -webkit-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Chrome10+,Safari5.1+ */
                 background: -o-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* Opera 11.10+ */
                 background: -ms-linear-gradient(top,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* IE10+ */
                 background: linear-gradient(to bottom,  rgba(252,252,252,1) 0%,rgba(237,237,237,1) 100%); /* W3C */
                 filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#fcfcfc', endColorstr='#ededed',GradientType=0 ); /* IE6-9 */
                 border-radius:72px;
                 box-shadow: 0px 0px 10px rgba(0,0,0,0.2);
             }
             

             

             
        </style>
    </head>


    <body>
        <div class="card" style="width: 100%">
            
            
            <div id="mynetwork" class="card-body"></div>
        </div>

        
            <div id="loadingBar">
              <div class="outerBorder">
                <div id="text">0%</div>
                <div id="border">
                  <div id="bar"></div>
                </div>
              </div>
            </div>
        
        

        <script type="text/javascript">

              // initialize global variables.
              var edges;
              var nodes;
              var allNodes;
              var allEdges;
              var nodeColors;
              var originalNodes;
              var network;
              var container;
              var options, data;
              var filter = {
                  item : '',
                  property : '',
                  value : []
              };

              

              

              // This method is responsible for drawing the graph, returns the drawn network
              function drawGraph() {
                  var container = document.getElementById('mynetwork');

                  

                  // parsing and collecting nodes and edges from the python
                  nodes = new vis.DataSet([{"group": 37, "id": "(UK brain bank)", "label": "(UK brain bank)", "shape": "dot", "size": 10, "title": "(UK brain bank) | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 1a3720e2622382c1  \n[file]: 36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\n\u003e [evidence]: We thank the UK brain expression consortium (UK brain bank) for the control brain samples and the...", "value": 15.735393346764045}, {"group": 37, "id": "the Edinburgh brain bank", "label": "the Edinburgh brain bank", "shape": "dot", "size": 10, "title": "the Edinburgh brain bank | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 1a3720e2622382c1  \n[file]: 36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\n\u003e [evidence]: We thank the UK brain expression consortium (UK brain bank) for the control brain samples and the...", "value": 15.735393346764045}, {"group": 38, "id": "10 month old Arctic mice", "label": "10 month old Arctic mice", "shape": "dot", "size": 10, "title": "10 month old Arctic mice | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: A decrease in neuronal complexity was seen in hippocampus of 10 month old Arctic mice at the time...", "value": 15.735393346764045}, {"group": 38, "id": "behavior deficit", "label": "behavior deficit", "shape": "dot", "size": 10, "title": "behavior deficit | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: A decrease in neuronal complexity was seen in hippocampus of 10 month old Arctic mice at the time...", "value": 15.735393346764045}, {"group": 39, "id": "10 months of age", "label": "10 months of age", "shape": "dot", "size": 10, "title": "10 months of age | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Moreover, microglial transcriptome analysis revealed increased expression of inflammation related...", "value": 15.735393346764045}, {"group": 39, "id": "Arctic/C5aR1KO", "label": "Arctic/C5aR1KO", "shape": "dot", "size": 10, "title": "Arctic/C5aR1KO | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: These genes showed higher expression in the Arctic/C5aR1KO either early in the disease (TREM2, TY...\n\u003e [evidence]: Moreover, microglial transcriptome analysis revealed increased expression of inflammation related...\n\u003e [evidence]: RNA-seq analysis identified inflammation related genes as differentially expressed, with increase...", "value": 15.735393346764045}, {"group": 40, "id": "18 h", "label": "18 h", "shape": "dot", "size": 10, "title": "18 h | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: Data are presented as mean (SEM). *p \u003c 0.05, **p \u003c 0.01, ***p \u003c 0.001 (one-way ANOVA). (e-g) Seah...", "value": 15.735393346764045}, {"group": 40, "id": "10 nM recombinant mouse C3a", "label": "10 nM recombinant mouse C3a", "shape": "dot", "size": 10, "title": "10 nM recombinant mouse C3a | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: Data are presented as mean (SEM). *p \u003c 0.05, **p \u003c 0.01, ***p \u003c 0.001 (one-way ANOVA). (e-g) Seah...\n\u003e [evidence]: Young microglia (postnatal day 0\u20132) were treated with 10 nM recombinant mouse C3a.", "value": 15.735393346764045}, {"group": 41, "id": "20 genes", "label": "20 genes", "shape": "dot", "size": 10, "title": "20 genes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 92d2fb0bf85a478b  \n[file]: 38036733 - Spatiotemporal characterization of glial cell activation in an Alzheimer\u0027s disease model by spatially resolved transcriptomics.pdf\n\u003e [evidence]: In addition, we identi\ufb01ed 20 genes that were correlated with amyloid deposit patterns and upregul...", "value": 15.735393346764045}, {"group": 41, "id": "amyloid deposit patterns", "label": "amyloid deposit patterns", "shape": "dot", "size": 10, "title": "amyloid deposit patterns | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 92d2fb0bf85a478b  \n[file]: 38036733 - Spatiotemporal characterization of glial cell activation in an Alzheimer\u0027s disease model by spatially resolved transcriptomics.pdf\n\u003e [evidence]: In addition, we identi\ufb01ed 20 genes that were correlated with amyloid deposit patterns and upregul...\n\u003e [evidence]: In addition, we identi\ufb01ed 20 genes that were correlated with amyloid deposit patterns and upregul...\n\u003e [evidence]: Therefore, we concentrated on genes spatially associated with amyloid deposit patterns and invest...", "value": 15.735393346764045}, {"group": 42, "id": "2018", "label": "2018", "shape": "dot", "size": 10, "title": "2018 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 75e9d948abad0bc8  \n[file]: 30558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\n\u003e [evidence]: Molecular Neurodegeneration (2018) 13:65 We also explored the expression changes of genes that ha...", "value": 15.735393346764045}, {"group": 42, "id": "genes that have been linked to AD", "label": "genes that have been linked to AD", "shape": "dot", "size": 10, "title": "genes that have been linked to AD | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 75e9d948abad0bc8  \n[file]: 30558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\n\u003e [evidence]: Molecular Neurodegeneration (2018) 13:65 We also explored the expression changes of genes that ha...", "value": 15.735393346764045}, {"group": 16, "id": "24-h LPS stimulation", "label": "24-h LPS stimulation", "shape": "dot", "size": 10, "title": "24-h LPS stimulation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: c259f1527833acb2  \n[file]: 40301889 - Monoallelic TYROBP deletion is a novel risk factor for Alzheimer\u0027s disease.pdf\n\u003e [evidence]: We found that 24-h LPS stimulation induces upregulation of inflammatory pathways and downregulati...", "value": 15.735393346764045}, {"group": 16, "id": "inflammatory pathways", "label": "inflammatory pathways", "shape": "dot", "size": 10, "title": "inflammatory pathways | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: However, the gene expression profile of the microglia from Arctic/C5aR1KO brain showed a decrease...\n[doc_id]: c259f1527833acb2  \n[file]: 40301889 - Monoallelic TYROBP deletion is a novel risk factor for Alzheimer\u0027s disease.pdf\n\u003e [evidence]: We found that 24-h LPS stimulation induces upregulation of inflammatory pathways and downregulati...", "value": 18.11107105653813}, {"group": 16, "id": "Arctic/C5aR1KO brain", "label": "Arctic/C5aR1KO brain", "shape": "dot", "size": 10, "title": "Arctic/C5aR1KO brain | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: However, the gene expression profile of the microglia from Arctic/C5aR1KO brain showed a decrease...", "value": 15.735393346764045}, {"group": 43, "id": "301 billion dollars", "label": "301 billion dollars", "shape": "dot", "size": 10, "title": "301 billion dollars | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ff5d3a47ea9588d  \n[file]: 35459147 - Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.pdf\n\u003e [evidence]: The estimated cost for health care in the United States is 301 billion dollars and this number is...", "value": 15.735393346764045}, {"group": 43, "id": "1.1 trillion dollars", "label": "1.1 trillion dollars", "shape": "dot", "size": 10, "title": "1.1 trillion dollars | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ff5d3a47ea9588d  \n[file]: 35459147 - Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.pdf\n\u003e [evidence]: The estimated cost for health care in the United States is 301 billion dollars and this number is...", "value": 15.735393346764045}, {"group": 17, "id": "3D MDMi", "label": "3D MDMi", "shape": "dot", "size": 10, "title": "3D MDMi | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: adfef4c28263ade2  \n[file]: 38365833 - Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: We identified that 3D MDMi exhibit enhanced microglia-like features and AD-specific changes in th...\n\u003e [evidence]: We identified that 3D MDMi exhibit enhanced microglia-like features and AD-specific changes in th...", "value": 18.11107105653813}, {"group": 17, "id": "AD-specific changes", "label": "AD-specific changes", "shape": "dot", "size": 10, "title": "AD-specific changes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: adfef4c28263ade2  \n[file]: 38365833 - Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: We identified that 3D MDMi exhibit enhanced microglia-like features and AD-specific changes in th...", "value": 15.735393346764045}, {"group": 17, "id": "microglia-like features", "label": "microglia-like features", "shape": "dot", "size": 10, "title": "microglia-like features | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: adfef4c28263ade2  \n[file]: 38365833 - Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: We identified that 3D MDMi exhibit enhanced microglia-like features and AD-specific changes in th...", "value": 15.735393346764045}, {"group": 1, "id": "3xTg AD mouse models", "label": "3xTg AD mouse models", "shape": "dot", "size": 10, "title": "3xTg AD mouse models | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Our previously published studies using a pharmacological approach to block function of C5aR1 in t...\n\u003e [evidence]: Our previously published studies using a pharmacological approach to block function of C5aR1 in t...", "value": 18.11107105653813}, {"group": 1, "id": "fibrillar plaques", "label": "fibrillar plaques", "shape": "dot", "size": 10, "title": "fibrillar plaques | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Our previously published studies using a pharmacological approach to block function of C5aR1 in t...", "value": 15.735393346764045}, {"group": 1, "id": "gliosis", "label": "gliosis", "shape": "dot", "size": 10, "title": "gliosis | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 882d7b83c983ad03  \n[file]: 31399126 - A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain.pdf\n\u003e [evidence]: AD is also associated with neuronal death and gliosis specifically in the cerebral cortex.\n\u003e [evidence]: This neurodegenerative disorder is associated with neuronal death and gliosis heavily impacting t...\n[doc_id]: adfef4c28263ade2  \n[file]: 38365833 - Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: For example, in post-mortem brain samples an imbalanced distribution of PDGF-AA immunopositive ce...\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Our previously published studies using a pharmacological approach to block function of C5aR1 in t...", "value": 18.11107105653813}, {"group": 1, "id": "AD", "label": "AD", "shape": "dot", "size": 10, "title": "AD | deg=18\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f7ba0f60074958f6  \n[file]: 32271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\n\u003e [evidence]: Because HERV-K RNA can induce CNS injury, blocking functional effects of HERV-K transcripts may a...\n[doc_id]: 17b13a15fc3bdd35  \n[file]: 39415193 - Network dynamics-based subtyping of Alzheimer\u0027s disease with microglial genetic risk factors.pdf\n\u003e [evidence]: Upregulation of MEF2C and downregulation of PICALM, identified through simulations, are also know...\n\u003e [evidence]: Multiple risk alleles are present for a single gene, and each risk allele affects AD differently.\n[doc_id]: 882d7b83c983ad03  \n[file]: 31399126 - A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain.pdf\n\u003e [evidence]: AD is also associated with neuronal death and gliosis specifically in the cerebral cortex.\n\u003e [evidence]: AD is also associated with neuronal death and gliosis specifically in the cerebral cortex.\n[doc_id]: 4d6afb7163e035aa  \n[file]: 40796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\n\u003e [evidence]: AD has lower reproducibility than PD, HD, and COVID-19, but still has hundreds of DEGs.\n\u003e [evidence]: AD has lower reproducibility than PD, HD, and COVID-19, but still has hundreds of DEGs.\n\u003e [evidence]: AD has lower reproducibility than PD, HD, and COVID-19, but still has hundreds of DEGs.\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: This manually curated diagram summarizes transcriptional changes in retromer-associated genes and...\n\u003e [evidence]: The neuronal ryanodine receptor (Ryr2) is overactivated in AD, leading to enhanced receptor-opera...\n\u003e [evidence]: The neuronal ryanodine receptor (Ryr2) is overactivated in AD, leading to enhanced receptor-opera...\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Moreover, Ctsb has been found to be upregulated in the serum of AD patients and is considered a b...\n\u003e [evidence]: These extensive alterations of cell populations by APC treatment demonstrate significant impact t...\n\u003e [evidence]: Additionally, other omics data such as metabolomics and proteomics study of APC treatment on AD w...\n\u003e [evidence]: APC treatment in AD Tg2576 transgenic mice has also been found to inhibit A\u03b2 production by a diff...\n\u003e [evidence]: Using single-cell RNA sequencing and bioinformatic analysis, we analyze the effects of APC treatm...\n\u003e [evidence]: It is unknown if the downregulation of these genes is beneficial in the treatment of AD.", "value": 34.33321316961438}, {"group": 44, "id": "3xTg-D and WT-D", "label": "3xTg-D and WT-D", "shape": "dot", "size": 10, "title": "3xTg-D and WT-D | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3a6969ccf167b6e1  \n[file]: 35443751 - Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Our data shows that MHC-I genes were among the most highly up-regulated genes between 3xTg-D and ...", "value": 15.735393346764045}, {"group": 44, "id": "SCDi", "label": "SCDi", "shape": "dot", "size": 10, "title": "SCDi | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3a6969ccf167b6e1  \n[file]: 35443751 - Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: We used SCDi to reduce levels of these AD-associated triglycerides: in young adult mice this reco...\n\u003e [evidence]: Given the key role of the hippocampus in AD, in this study we focused speci\ufb01cally on understandin...\n\u003e [evidence]: Our data shows that MHC-I genes were among the most highly up-regulated genes between 3xTg-D and ...", "value": 15.735393346764045}, {"group": 45, "id": "4000 genes", "label": "4000 genes", "shape": "dot", "size": 10, "title": "4000 genes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 75e9d948abad0bc8  \n[file]: 30558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\n\u003e [evidence]: Results: Statistical analysis of RNAseq data indicated that more than 4000 genes were differentia...", "value": 15.735393346764045}, {"group": 45, "id": "rTg4510 microglia", "label": "rTg4510 microglia", "shape": "dot", "size": 10, "title": "rTg4510 microglia | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 75e9d948abad0bc8  \n[file]: 30558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\n\u003e [evidence]: Results: Statistical analysis of RNAseq data indicated that more than 4000 genes were differentia...\n\u003e [evidence]: We found that several of them, such as genetic risk factors APOE, PLD3, TREM2, phagocytotic genes...", "value": 15.735393346764045}, {"group": 46, "id": "5 mM", "label": "5 mM", "shape": "dot", "size": 10, "title": "5 mM | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: Rapamycin (50 \u00b5M) or 2-DG (5 mM) were pre- (1 h) and co-treated (18 h) with C3a.", "value": 15.735393346764045}, {"group": 46, "id": "C3a", "label": "C3a", "shape": "dot", "size": 10, "title": "C3a | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: Rapamycin (50 \u00b5M) or 2-DG (5 mM) were pre- (1 h) and co-treated (18 h) with C3a.", "value": 15.735393346764045}, {"group": 3, "id": "5 \u00d7 FAD mice", "label": "5 \u00d7 FAD mice", "shape": "dot", "size": 10, "title": "5 \u00d7 FAD mice | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: Furthermore, our study revealed an age-associated increase of microglia in 5 \u00d7 FAD mice, which co...\n\u003e [evidence]: Results We identified a significant upregulation of COX-1 in 5 \u00d7 FAD mice, with expression specif...", "value": 18.11107105653813}, {"group": 3, "id": "A\u03b2 deposition", "label": "A\u03b2 deposition", "shape": "dot", "size": 10, "title": "A\u03b2 deposition | deg=7\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: In this regard, we and others have demonstrated that antibiotic (ABX)-mediated gut microbiota per...\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Compared to knock-in Hexb mice, Hexb heterozygotic mice showed improved behavior and decrease in ...\n[doc_id]: 608b887729bab05d  \n[file]: 34600516 - Cell type-specific potential pathogenic genes and functional pathways in Alzheimer\u0027s Disease.pdf\n\u003e [evidence]: Moreover, in most AD patients, A\u03b2 deposition has been seen around perivascular, which leads to en...\n[doc_id]: b5d5053cd6fc980b  \n[file]: 40346662 - A single-cell transcriptomic atlas of all cell types in the brain of 5xFAD Alzheimer mice in response to dietary inulin supplementation.pdf\n\u003e [evidence]: Similarly, oral treatment with Akkermansia muciniphila in AD-like rat models reduced A\u03b2 depositio...\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: Furthermore, our study revealed an age-associated increase of microglia in 5 \u00d7 FAD mice, which co...\n[doc_id]: 2ab9e10b4b26b7a7  \n[file]: 40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\n\u003e [evidence]: Our results indicated that ANGPTL8 KO reduced A\u03b2 deposition by suppressing microgliosis and micro...\n\u003e [evidence]: Our data revealed that ANGPTL8 KO improved cognitive function and significantly reduced A\u03b2 deposi...\n\u003e [evidence]: Our results indicated that ANGPTL8 KO reduced A\u03b2 deposition by suppressing microgliosis and micro...\n\u003e [evidence]: Results ANGPTL8 knockout improved cognitive function and reduced A\u03b2 deposition by reducing microg...\n\u003e [evidence]: Our results indicated that ANGPTL8 KO reduced A\u03b2 deposition by suppressing microgliosis and micro...", "value": 25.1744244666721}, {"group": 0, "id": "microglia", "label": "microglia", "shape": "dot", "size": 10, "title": "microglia | deg=19\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: a8e8ae58507d8422  \n[file]: 36805764 - TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation.pdf\n\u003e [evidence]: Moreover, recent studies have reported that sTREM2 activates microglia and rescues long-term pote...\n\u003e [evidence]: In the brain, TREM2 expression is restricted to microglia where it acts to promote microglial sur...\n\u003e [evidence]: In the brain, TREM2 expression is restricted to microglia where it acts to promote microglial sur...\n[doc_id]: bb73bcc13afee4b4  \n[file]: 34465358 - Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: According to a previous study, TREM2-deficiency induces impaired energy metabolism in microglia a...\n\u003e [evidence]: According to a previous study, TREM2-deficiency induces impaired energy metabolism in microglia a...\n\u003e [evidence]: Furthermore, a recent study showed that amyloid beta exposure to microglia induced microglial rep...\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: C5a induces an inflammatory polarization of the microglia, potentially synergizing with TLRs, whi...\n\u003e [evidence]: Amyloid deposited C3b/iC3b should lead to more efficient phagocytosis by microglia/macrophages, w...\n\u003e [evidence]: Microglia also express C5aR1 leading to C5a-induced chemotactic functions [26].\n\u003e [evidence]: In addition, microglia express TLRs.\n\u003e [evidence]: In addition, since C5aR1 is primarily expressed on cells of the myeloid lineage, and only to a le...\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: Results We identified a significant upregulation of COX-1 in 5 \u00d7 FAD mice, with expression specif...\n\u003e [evidence]: COX-1, a target irreversibly inactivated by aspirin, is highly expressed in microglia associated ...\n\u003e [evidence]: By using 5 \u00d7 FAD mice, we found that COX-1 is primarily expressed in microglia, and its level inc...\n\u003e [evidence]: COX-1, a target irreversibly inactivated by aspirin, is highly expressed in microglia associated ...\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Here, we found that IL2R\u03b2 expression was significantly increased in BV2 cells treated with ApoE4 ...\n\u003e [evidence]: Capsaicin reversed ER \u00adCa2+ depletion, cholesterol accumulation, lysosomal dysfunction and immuno...\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The study found that loss of Bin1 did not affect microglia number in Bin1 c-KO mice.", "value": 35.0}, {"group": 3, "id": "cognitive function", "label": "cognitive function", "shape": "dot", "size": 10, "title": "cognitive function | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6e263da311cc2e11  \n[file]: 37340466 - Sex specific molecular networks and key drivers of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Gene perturbation experiments in EFAD mouse models demonstrated that LRP10 differentially affecte...\n[doc_id]: bf000dbd95632554  \n[file]: 40369584 - Transcriptomic signatures of oxytosis ferroptosis are enriched in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: The loss of GSH is associated with impairments in cognitive function, microglial activation, and ...\n[doc_id]: 3a6969ccf167b6e1  \n[file]: 35443751 - Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Synapse loss correlates highly with decline in cognitive function during AD22,23, and microglia a...\n\u003e [evidence]: Moreover, increased fatty acid desaturation was positively correlated with increased reversal lea...\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: Growing evidence demonstrated that thyroid dysfunction was associated with cognitive function and...\n[doc_id]: 2ab9e10b4b26b7a7  \n[file]: 40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\n\u003e [evidence]: Results ANGPTL8 knockout improved cognitive function and reduced A\u03b2 deposition by reducing microg...\n\u003e [evidence]: Our data revealed that ANGPTL8 KO improved cognitive function and significantly reduced A\u03b2 deposi...", "value": 18.11107105653813}, {"group": 3, "id": "AD-like rat models", "label": "AD-like rat models", "shape": "dot", "size": 10, "title": "AD-like rat models | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b5d5053cd6fc980b  \n[file]: 40346662 - A single-cell transcriptomic atlas of all cell types in the brain of 5xFAD Alzheimer mice in response to dietary inulin supplementation.pdf\n\u003e [evidence]: Similarly, oral treatment with Akkermansia muciniphila in AD-like rat models reduced A\u03b2 depositio...", "value": 15.735393346764045}, {"group": 3, "id": "ANGPTL8 KO", "label": "ANGPTL8 KO", "shape": "dot", "size": 10, "title": "ANGPTL8 KO | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ab9e10b4b26b7a7  \n[file]: 40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\n\u003e [evidence]: Our results indicated that ANGPTL8 KO reduced A\u03b2 deposition by suppressing microgliosis and micro...", "value": 15.735393346764045}, {"group": 3, "id": "endothelial cell dysfunction", "label": "endothelial cell dysfunction", "shape": "dot", "size": 10, "title": "endothelial cell dysfunction | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 608b887729bab05d  \n[file]: 34600516 - Cell type-specific potential pathogenic genes and functional pathways in Alzheimer\u0027s Disease.pdf\n\u003e [evidence]: Moreover, in most AD patients, A\u03b2 deposition has been seen around perivascular, which leads to en...\n\u003e [evidence]: Moreover, in most AD patients, A\u03b2 deposition has been seen around perivascular, which leads to en...", "value": 15.735393346764045}, {"group": 3, "id": "microglial activation", "label": "microglial activation", "shape": "dot", "size": 10, "title": "microglial activation | deg=5\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: By contrast, in the hTau model of tauopathy, loss of Cx3cr1 enhances microglial activation, incre...\n[doc_id]: 91d0e406cb470366  \n[file]: 33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\n\u003e [evidence]: Specifically, MCR activation reduces neurotoxic astrocytes and microglial activation in a brain r...\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: The results showed that in the 5xFAD model, ApoeCh led to a decrease in tau pathology and an incr...\n[doc_id]: c51ff7fb94d8674f  \n[file]: 39604588 - Elevated expression of the retrotransposon LINE-1 drives Alzheimer\u0027s disease-associated microglial dysfunction.pdf\n\u003e [evidence]: This hypothesis is supported by the fact that variants protective against AD, such as the P522R p...\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: In the neuroinflammatory domain, retromer stabilization modulated microglial activation, shifting...\n[doc_id]: 4dcab4259d686c0e  \n[file]: 38695952 - Characterisation of premature cell senescence in Alzheimer\u0027s disease using single nuclear transcriptomics.pdf\n\u003e [evidence]: Instead, our data suggest that the overall pathology burden associated with R47H, particularly in...", "value": 22.824729401064424}, {"group": 3, "id": "microgliosis", "label": "microgliosis", "shape": "dot", "size": 10, "title": "microgliosis | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 213b0617682e2ece  \n[file]: 40307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\n\u003e [evidence]: 5 APOE de\ufb01ciency inhibited microgliosis in a model recapitulating ATN pathology.\n[doc_id]: 2ab9e10b4b26b7a7  \n[file]: 40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\n\u003e [evidence]: Our results indicated that ANGPTL8 KO reduced A\u03b2 deposition by suppressing microgliosis and micro...", "value": 18.11107105653813}, {"group": 0, "id": "TREM2", "label": "TREM2", "shape": "dot", "size": 10, "title": "TREM2 | deg=4\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 666910073258515e  \n[file]: 32703241 - Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.pdf\n\u003e [evidence]: Furthermore, we identified sets of genes that were affected in TREM2- and APOE isoform-dependent ...\n\u003e [evidence]: Recent studies showed that APOE binds to TREM2, thus raising the possibility of an APOE-TREM2 int...\n[doc_id]: b77fb099d704992b  \n[file]: 29416036 - A transcriptomic atlas of aged human microglia.pdf\n\u003e [evidence]: In particular, we report the intriguing result that the APOE\u03b52 haplotype is associated with a red...\n[doc_id]: 38639c37ea0f3a09  \n[file]: 33115519 - Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice.pdf\n\u003e [evidence]: Abstract Background: Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed in the...\n[doc_id]: 01ab70cecab4b6e6  \n[file]: 37115208 - Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation.pdf\n\u003e [evidence]: Abstract TREM2 is an innate immune receptor expressed by microglia in the adult brain.\n\u003e [evidence]: Keywords TREM2 \u00b7 Induced pluripotent stem cells \u00b7 Microglia \u00b7 Nasu-Hakola disease \u00b7 Transcriptomi...\n\u003e [evidence]: Keywords TREM2 \u00b7 Induced pluripotent stem cells \u00b7 Microglia \u00b7 Nasu-Hakola disease \u00b7 Transcriptomi...\n[doc_id]: 03b5a3ad723acdbf  \n[file]: 37988169 - Galectin-3 aggravates microglial activation and tau transmission in tauopathy.pdf\n\u003e [evidence]: Our findings indicate that pTau treatment significantly reduces the level of TREM2 in iMGL, and t...\n\u003e [evidence]: Intriguingly, Gal3 inhibition suppressed the abnormal release of EVs triggered by pTau, without a...\n[doc_id]: 0fafd5f17a2c043e  \n[file]: 33097708 - Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Previous studies examining how APOE isoforms interact with TREM2 have been inconsistent.\n\u003e [evidence]: For example, Atagi et al. found that TREM2 binds all APOE isoforms with similar af\ufb01nity, whereas ...", "value": 21.47078669352809}, {"group": 0, "id": "Cst7", "label": "Cst7", "shape": "dot", "size": 10, "title": "Cst7 | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Cst7 expressing microglia tend to surround A\u03b2 in the brain and increase inflammation [56].\n\u003e [evidence]: Though this decreased expression may only prove to be beneficial to males as knockout of Cst7 in ...\n\u003e [evidence]: Expression of Cst7 is notably expressed in microglia of AD pathology and has recently been consid...", "value": 18.11107105653813}, {"group": 0, "id": "excitatory neurons", "label": "excitatory neurons", "shape": "dot", "size": 10, "title": "excitatory neurons | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 608b887729bab05d  \n[file]: 34600516 - Cell type-specific potential pathogenic genes and functional pathways in Alzheimer\u0027s Disease.pdf\n\u003e [evidence]: DEGs were analyzed in microglia, astrocytes, oligodendrocytes, excitatory neurons, inhibitory neu...\n[doc_id]: 72f6a572bc577d36  \n[file]: 38849813 - Altered glia-neuron communication in Alzheimer\u0027s Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq.pdf\n\u003e [evidence]: We inferred differential CCC interactions between astrocytes, microglia, oligodendrocytes, or OPC...\n[doc_id]: 4dcab4259d686c0e  \n[file]: 38695952 - Characterisation of premature cell senescence in Alzheimer\u0027s disease using single nuclear transcriptomics.pdf\n\u003e [evidence]: Dehkordi et al. previously concluded that excitatory neurons uniquely expressed a senescence sign...\n[doc_id]: 882d7b83c983ad03  \n[file]: 31399126 - A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain.pdf\n\u003e [evidence]: Our results showed a reduced percentage of excitatory neurons in the brain carrier of a PSEN1 mut...\n[doc_id]: 1a3720e2622382c1  \n[file]: 36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\n\u003e [evidence]: Y axis: Gene count values of cell type marker genes, x axis: 6 cell type marker gene categories (...\n\u003e [evidence]: UMAP cluster analysis revealed that the proportions of astrocytes, excitatory neurons, inhibitory...\n\u003e [evidence]: By analysis of publicly available Alzheimer\u2019s/neurological control datasets have found significan...\n\u003e [evidence]: Y axis: Gene count values of cell type marker genes, x axis: 6 cell type marker gene categories (...\n\u003e [evidence]: UMAP cluster analysis revealed that the proportions of astrocytes, excitatory neurons, inhibitory...", "value": 18.11107105653813}, {"group": 0, "id": "5\u00d7FAD mice", "label": "5\u00d7FAD mice", "shape": "dot", "size": 10, "title": "5\u00d7FAD mice | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3319f4b14f340c9e  \n[file]: 37989983 - Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5\u00d7FAD Mice.pdf\n\u003e [evidence]: miR-29a sponge significantly reduced hippocampal beta-amyloid deposition in 5\u00d7FAD mice and lowere...\n\u003e [evidence]: miR-29a sponge significantly reduced hippocampal beta-amyloid deposition in 5\u00d7FAD mice and lowere...\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: In addition, we also examined neuropathological changes, especially the amyloid plaque levels in ...", "value": 18.11107105653813}, {"group": 2, "id": "APC", "label": "APC", "shape": "dot", "size": 10, "title": "APC | deg=11\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Our study comprehensively quantified the transcriptomes in different cell types of mouse brains, ...\n\u003e [evidence]: APC treatment shows return to near WT levels of expression of Cd63 and Cd68.\n\u003e [evidence]: Using single-cell RNA sequencing and bioinformatic analysis, we analyze the effects of APC treatm...\n\u003e [evidence]: APC treated microglia.\n\u003e [evidence]: We observed a downregulation of C4b in APC treatment, while further study is needed, the anti-inf...\n\u003e [evidence]: Additionally, other omics data such as metabolomics and proteomics study of APC treatment on AD w...\n\u003e [evidence]: APC treatment in AD Tg2576 transgenic mice has also been found to inhibit A\u03b2 production by a diff...\n\u003e [evidence]: APC treatment in AD Tg2576 transgenic mice has also been found to inhibit A\u03b2 production by a diff...\n\u003e [evidence]: Several microglial genes were also found to be regulated by APC treatment.\n\u003e [evidence]: Further important AD risk genes were also found to be upregulated in 5xFAD mice and later downreg...\n\u003e [evidence]: Using single-cell RNA sequencing and bioinformatic analysis, we analyze the effects of APC treatm...\n\u003e [evidence]: The significant decrease in microglial Cst7 by APC treatment may prove a strong decrease in A\u03b2 pr...\n\u003e [evidence]: The astrocyte population notably expresses two DEGs that are modulated by APC treatment.\n\u003e [evidence]: APC treatment sample uncovers a large decrease in the microglial population suggesting reversal o...\n\u003e [evidence]: These extensive alterations of cell populations by APC treatment demonstrate significant impact t...", "value": 29.022147756317054}, {"group": 0, "id": "Amyloid deposited C3b/iC3b", "label": "Amyloid deposited C3b/iC3b", "shape": "dot", "size": 10, "title": "Amyloid deposited C3b/iC3b | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Amyloid deposited C3b/iC3b should lead to more efficient phagocytosis by microglia/macrophages, w...", "value": 15.735393346764045}, {"group": 0, "id": "A\u03b2 or tau pathologies", "label": "A\u03b2 or tau pathologies", "shape": "dot", "size": 10, "title": "A\u03b2 or tau pathologies | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 1f79b999e0214ae2  \n[file]: 36536457 - Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes.pdf\n\u003e [evidence]: These findings are consistent with a model whereby A\u03b2 or tau pathologies stimulate the activation...", "value": 15.735393346764045}, {"group": 0, "id": "Bin1", "label": "Bin1", "shape": "dot", "size": 10, "title": "Bin1 | deg=3\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The study also found that loss of Bin1 affected neuropathological features in Bin1 c-KO mice, reg...\n\u003e [evidence]: However, the study found that loss of Bin1 affected behavior in Bin1 c-KO mice.\n\u003e [evidence]: The study found that loss of Bin1 did not affect microglia number in Bin1 c-KO mice.", "value": 19.933992677987828}, {"group": 0, "id": "C3a receptor-1 (C3aR1)", "label": "C3a receptor-1 (C3aR1)", "shape": "dot", "size": 10, "title": "C3a receptor-1 (C3aR1) | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: VGF-derived peptide TLQP-21 activates the complement C3a receptor-1 (C3aR1), predominantly expres...\n\u003e [evidence]: VGF-derived peptide TLQP-21 activates the complement C3a receptor-1 (C3aR1), predominantly expres...", "value": 15.735393346764045}, {"group": 0, "id": "C3aR", "label": "C3aR", "shape": "dot", "size": 10, "title": "C3aR | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: In brain, C5aR1 and C3aR are prominently induced in microglia in response to injury (reviewed in ...", "value": 15.735393346764045}, {"group": 0, "id": "C3aR1", "label": "C3aR1", "shape": "dot", "size": 10, "title": "C3aR1 | deg=3\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: C3aR1 is expressed by neurons, astrocytes, and microglia in the brain [26\u201328], but the functional...\n\u003e [evidence]: C3aR1 is expressed by neurons, astrocytes, and microglia in the brain [26\u201328], but the functional...\n\u003e [evidence]: C3aR1 is expressed by neurons, astrocytes, and microglia in the brain [26\u201328], but the functional...", "value": 19.933992677987828}, {"group": 6, "id": "C5a", "label": "C5a", "shape": "dot", "size": 10, "title": "C5a | deg=4\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Abstract Background: Pharmacologic inhibition of C5aR1, a receptor for the complement activation ...\n\u003e [evidence]: C5a induces an inflammatory polarization of the microglia, potentially synergizing with TLRs, whi...\n\u003e [evidence]: C5a may synergistically enhance microglial polarization to a more inflammatory state in response ...\n\u003e [evidence]: In addition, in vitro cultures of C57BL6/J cortical neurons express C5aR1 and, upon binding, C5a ...", "value": 21.47078669352809}, {"group": 0, "id": "COX-1", "label": "COX-1", "shape": "dot", "size": 10, "title": "COX-1 | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: By using 5 \u00d7 FAD mice, we found that COX-1 is primarily expressed in microglia, and its level inc...\n\u003e [evidence]: COX-1, a target irreversibly inactivated by aspirin, is highly expressed in microglia associated ...", "value": 18.11107105653813}, {"group": 2, "id": "FcRs", "label": "FcRs", "shape": "dot", "size": 10, "title": "FcRs | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: The Fc portion of Adu can bind to FcRs expressed in microglia and opsonize A\u03b2 for phagocytosis by...\n\u003e [evidence]: The Fc portion of Adu can bind to FcRs expressed in microglia and opsonize A\u03b2 for phagocytosis by...\n\u003e [evidence]: The Fc portion of Adu can bind to FcRs expressed in microglia and opsonize A\u03b2 for phagocytosis by...\n\u003e [evidence]: The Fc portion of Adu can bind to FcRs expressed in microglia and opsonize A\u03b2 for phagocytosis by...", "value": 18.11107105653813}, {"group": 0, "id": "GWAS", "label": "GWAS", "shape": "dot", "size": 10, "title": "GWAS | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: In addition, a majority of the common AD variants identified by GWAS are preferentially expressed...\n[doc_id]: 4d6afb7163e035aa  \n[file]: 40796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\n\u003e [evidence]: This effect is much more pronounced in single-cell studies relative to GWAS due to the lower stab...", "value": 15.735393346764045}, {"group": 0, "id": "IE2", "label": "IE2", "shape": "dot", "size": 10, "title": "IE2 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: According to the analysis of the single-cell data, the expression of IE2 is accompanied by the ac...\n\u003e [evidence]: IE2, immediately-early protein of HCMV, has been shown to affect brain development and cognition ...\n\u003e [evidence]: Differentially expressed gene analysis and pathway enrichment revealed that IE2 upregulated immun...\n\u003e [evidence]: Single-cell sequencing analysis revealed that IE2 promoted the activation of microglia and upregu...", "value": 15.735393346764045}, {"group": 0, "id": "Insoluble A\u03b21\u201340 and A\u03b21\u201342 levels", "label": "Insoluble A\u03b21\u201340 and A\u03b21\u201342 levels", "shape": "dot", "size": 10, "title": "Insoluble A\u03b21\u201340 and A\u03b21\u201342 levels | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Insoluble A\u03b21\u201340 and A\u03b21\u201342 levels were reduced comparably while more astrocytes and microglia we...\n\u003e [evidence]: Insoluble A\u03b21\u201340 and A\u03b21\u201342 levels were reduced comparably while more astrocytes and microglia we...", "value": 18.11107105653813}, {"group": 0, "id": "Lower panel", "label": "Lower panel", "shape": "dot", "size": 10, "title": "Lower panel | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 1a3720e2622382c1  \n[file]: 36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\n\u003e [evidence]: Lower panel: Inhibitory neurons, microglia and oligodendrocyte marker genes.\n\u003e [evidence]: Lower panel: Inhibitory neurons, microglia and oligodendrocyte marker genes.", "value": 15.735393346764045}, {"group": 47, "id": "53", "label": "53", "shape": "dot", "size": 10, "title": "53 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d3c889662b8907a9  \n[file]: 32238175 - Transcriptomic profiling of microglia and astrocytes throughout aging.pdf\n\u003e [evidence]: Spock3 and Timp4, encode proteins that participate in inhibiting matrix metalloproteinases (MMPs)...", "value": 15.735393346764045}, {"group": 47, "id": "tumor cells", "label": "tumor cells", "shape": "dot", "size": 10, "title": "tumor cells | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d3c889662b8907a9  \n[file]: 32238175 - Transcriptomic profiling of microglia and astrocytes throughout aging.pdf\n\u003e [evidence]: Spock3 and Timp4, encode proteins that participate in inhibiting matrix metalloproteinases (MMPs)...", "value": 15.735393346764045}, {"group": 48, "id": "5X FAD mice", "label": "5X FAD mice", "shape": "dot", "size": 10, "title": "5X FAD mice | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: We have shown that in APPPS1-21 mice treated in the early stage of disease (2\u20133 months of age) an...", "value": 15.735393346764045}, {"group": 48, "id": "late stage of amyloidosis", "label": "late stage of amyloidosis", "shape": "dot", "size": 10, "title": "late stage of amyloidosis | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: We have shown that in APPPS1-21 mice treated in the early stage of disease (2\u20133 months of age) an...", "value": 15.735393346764045}, {"group": 4, "id": "5XFAD mice", "label": "5XFAD mice", "shape": "dot", "size": 10, "title": "5XFAD mice | deg=4\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: db5b60a0a5df0d5b  \n[file]: 40537787 - KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Highlights \u2022 Genetic deletion of potassium channel interacting protein 3 (KChIP3) in 5XFAD mice, ...\n\u003e [evidence]: Our results demonstrate that the absence of KChIP3 in the 5XFAD mice leads to reduced hippocampal...\n\u003e [evidence]: Highlights \u2022 Genetic deletion of potassium channel interacting protein 3 (KChIP3) in 5XFAD mice, ...\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: In parallel, and to corroborate existing published studies and further investigate sex-related di...", "value": 21.47078669352809}, {"group": 4, "id": "hippocampal inflammation", "label": "hippocampal inflammation", "shape": "dot", "size": 10, "title": "hippocampal inflammation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: db5b60a0a5df0d5b  \n[file]: 40537787 - KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Our results demonstrate that the absence of KChIP3 in the 5XFAD mice leads to reduced hippocampal...", "value": 15.735393346764045}, {"group": 4, "id": "neuroinflammation", "label": "neuroinflammation", "shape": "dot", "size": 10, "title": "neuroinflammation | deg=5\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b093f6f0497dd291  \n[file]: 36180898 - Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Conclusions: Ex vivo expanded Tregs with amplified immunomodulatory function, suppressed neuroinf...\n\u003e [evidence]: Following peripheral administration, Tregs were detectable in the central nervous system, suppres...\n\u003e [evidence]: A key question is whether adoptive transfer of ex vivo expanded human Tregs can suppress neuroinf...\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Previous research indicates that the A\u03b2 deposits trigger neuroinflammation and microglial activat...\n\u003e [evidence]: The significant decrease in microglial Cst7 by APC treatment may prove a strong decrease in A\u03b2 pr...\n[doc_id]: 9e637c3659f6dff8  \n[file]: 35859075 - Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration.pdf\n\u003e [evidence]: Genetic deletion of galectin-3 enhances neuroinflammation, affects microglial activation and cont...\n\u003e [evidence]: Genetic deletion of galectin-3 enhances neuroinflammation, affects microglial activation and cont...\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: A previous study showed that COX-1 KO mice exhibit reduced neuroinflammation induced by A\u03b2 and at...\n\u003e [evidence]: A previous study showed that COX-1 KO mice exhibit reduced neuroinflammation induced by A\u03b2 and at...\n\u003e [evidence]: COX-1, a target irreversibly inactivated by aspirin, is highly expressed in microglia associated ...\n\u003e [evidence]: Neuroinflammation associated with reactive microglia promotes AD progression.\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: Microglia M1 phenotype increased the expression of inflammatory factor including TNF\u03b1, iNOS, and ...\n[doc_id]: d3c889662b8907a9  \n[file]: 32238175 - Transcriptomic profiling of microglia and astrocytes throughout aging.pdf\n\u003e [evidence]: Our results suggest that in normal aging, increased production of serine proteases inhibiter/MMPs...\n\u003e [evidence]: Our results suggest that in normal aging, increased production of serine proteases inhibiter/MMPs...", "value": 22.824729401064424}, {"group": 4, "id": "\u03b2A plaque formation", "label": "\u03b2A plaque formation", "shape": "dot", "size": 10, "title": "\u03b2A plaque formation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: db5b60a0a5df0d5b  \n[file]: 40537787 - KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Highlights \u2022 Genetic deletion of potassium channel interacting protein 3 (KChIP3) in 5XFAD mice, ...", "value": 15.735393346764045}, {"group": 4, "id": "GV-971", "label": "GV-971", "shape": "dot", "size": 10, "title": "GV-971 | deg=3\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: Male and female APPPS1-21 mice were treated daily with 40, 80, or 160 mg/ kg of GV-971 from 8, wh...\n\u003e [evidence]: Prior investigations of 5xFAD mice treated with GV-971 revealed that this agent shifted microbiom...\n\u003e [evidence]: In parallel, and to corroborate existing published studies and further investigate sex-related di...\n\u003e [evidence]: We also found that GV-971 significantly reduced GFAP expression in male 5XFAD mice, suggesting a ...\n\u003e [evidence]: Specifically, we demonstrated that GV-971 reduced plaque-associated \u00adClec7a+ activated microglia ...\n\u003e [evidence]: In this regard, we were intrigued by the finding that a marine-derived oligosaccharide, GV-971, w...", "value": 19.933992677987828}, {"group": 4, "id": "APOE binding", "label": "APOE binding", "shape": "dot", "size": 10, "title": "APOE binding | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: Studies indicate that APOE binding is integral to some of these processes [16\u201320] with difference...\n\u003e [evidence]: Studies indicate that APOE binding is integral to some of these processes [16\u201320] with difference...", "value": 18.11107105653813}, {"group": 2, "id": "A\u03b2", "label": "A\u03b2", "shape": "dot", "size": 10, "title": "A\u03b2 | deg=12\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: The significant decrease in microglial Cst7 by APC treatment may prove a strong decrease in A\u03b2 pr...\n\u003e [evidence]: Cst7 expressing microglia tend to surround A\u03b2 in the brain and increase inflammation [56].\n\u003e [evidence]: It was proven that Irf8 is involved in microglial activation in response to A\u03b2 and leads to inter...\n\u003e [evidence]: Previous research indicates that the A\u03b2 deposits trigger neuroinflammation and microglial activat...\n\u003e [evidence]: Previous research indicates that the A\u03b2 deposits trigger neuroinflammation and microglial activat...\n\u003e [evidence]: Deficiency of Cx3cr1 has shown increased A\u03b2 pathology as well as cognitive decline [28]\n\u003e [evidence]: The significant decrease in microglial Cst7 by APC treatment may prove a strong decrease in A\u03b2 pr...\n\u003e [evidence]: APC treatment in AD Tg2576 transgenic mice has also been found to inhibit A\u03b2 production by a diff...\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Single-nuclei RNA sequencing (snRNA-seq) data have indicated that distinct clusters of activated ...\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: A previous study showed that COX-1 KO mice exhibit reduced neuroinflammation induced by A\u03b2 and at...\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: The Fc portion of Adu can bind to FcRs expressed in microglia and opsonize A\u03b2 for phagocytosis by...\n[doc_id]: 7ff5d3a47ea9588d  \n[file]: 35459147 - Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.pdf\n\u003e [evidence]: This evidence has led to the hypothesis that in the Alzheimer\u2019s brain, A\u03b2 triggers an exacerbated...\n[doc_id]: 7ec126941318b941  \n[file]: 39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\n\u003e [evidence]: We showed that STING suppression was effective in AD model mice that expressed both A\u03b2 and human ...", "value": 29.867985355975655}, {"group": 4, "id": "COX-1 KO mice", "label": "COX-1 KO mice", "shape": "dot", "size": 10, "title": "COX-1 KO mice | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: A previous study showed that COX-1 KO mice exhibit reduced neuroinflammation induced by A\u03b2 and at...", "value": 15.735393346764045}, {"group": 4, "id": "IL-1\u03b2", "label": "IL-1\u03b2", "shape": "dot", "size": 10, "title": "IL-1\u03b2 | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: Notably, COX-1 deficiency attenuated the hyperinflammatory microglial state (evidenced by reduced...\n\u003e [evidence]: Increased levels of serum TNF-\u03b1 and IL-1\u03b2 correlate with an accelerated rate of cognitive impairm...\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: Microglia M1 phenotype increased the expression of inflammatory factor including TNF\u03b1, iNOS, and ...\n\u003e [evidence]: Microglia M1 phenotype increased the expression of inflammatory factor including TNF\u03b1, iNOS, and ...\n[doc_id]: 26d4e5b068d5aa0d  \n[file]: 37684405 - Lipid metabolism transcriptomics of murine microglia in Alzheimer\u0027s disease and neuroinflammation.pdf\n\u003e [evidence]: These data suggest therapeutic agents that block activation of the NLRP3 inflammasome and IL-1\u03b2 a...\n\u003e [evidence]: IL-1\u03b2 was highly up-regulated in both our datasets, and is a vital component of lipid metabolism ...", "value": 18.11107105653813}, {"group": 4, "id": "APPPS1-21 mice", "label": "APPPS1-21 mice", "shape": "dot", "size": 10, "title": "APPPS1-21 mice | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: Male and female APPPS1-21 mice were treated daily with 40, 80, or 160 mg/ kg of GV-971 from 8, wh...\n\u003e [evidence]: We have shown that in APPPS1-21 mice treated in the early stage of disease (2\u20133 months of age) an...", "value": 18.11107105653813}, {"group": 4, "id": "A\u03b2 amyloidosis", "label": "A\u03b2 amyloidosis", "shape": "dot", "size": 10, "title": "A\u03b2 amyloidosis | deg=3\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: In this regard, we were intrigued by the finding that a marine-derived oligosaccharide, GV-971, w...\n\u003e [evidence]: In addition, A\u03b2 amyloidosis is significantly reduced in APPPS1-21 and 5xFAD mouse models raised i...\n\u003e [evidence]: We have shown that ABX-mediated gut microbiota perturbations failed to reduce A\u03b2 amyloidosis in m...", "value": 19.933992677987828}, {"group": 2, "id": "5xFAD", "label": "5xFAD", "shape": "dot", "size": 10, "title": "5xFAD | deg=5\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: 5xFAD mice did not show a decrease in Cx3cr1 expression.\n\u003e [evidence]: Further important AD risk genes were also found to be upregulated in 5xFAD mice and later downreg...\n\u003e [evidence]: Alterations in glial cells occurred in 5xFAD versus WT, especially increases in microglia prolife...\n\u003e [evidence]: C4b expression was found to be greater in 5xFAD mice and is considered a biomarker for AD in huma...\n\u003e [evidence]: Previous study of Ctsb in AD and other neurological disorders have proven that Ctsb knockout (KO)...\n\u003e [evidence]: Further important AD risk genes were also found to be upregulated in 5xFAD mice and later downreg...", "value": 22.824729401064424}, {"group": 2, "id": "Cx3cr1", "label": "Cx3cr1", "shape": "dot", "size": 10, "title": "Cx3cr1 | deg=3\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Deficiency of Cx3cr1 has shown increased A\u03b2 pathology as well as cognitive decline [28]\n\u003e [evidence]: 5xFAD mice did not show a decrease in Cx3cr1 expression.\n\u003e [evidence]: Deficiency of Cx3cr1 has shown increased A\u03b2 pathology as well as cognitive decline [28]", "value": 19.933992677987828}, {"group": 2, "id": "microglia proliferation", "label": "microglia proliferation", "shape": "dot", "size": 10, "title": "microglia proliferation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Alterations in glial cells occurred in 5xFAD versus WT, especially increases in microglia prolife...\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: We show direct evidence of microglia proliferation induced by ATV:TREM2, which could help resolve...", "value": 15.735393346764045}, {"group": 2, "id": "C1qc", "label": "C1qc", "shape": "dot", "size": 10, "title": "C1qc | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Previous study of Ctsb in AD and other neurological disorders have proven that Ctsb knockout (KO)...", "value": 15.735393346764045}, {"group": 2, "id": "C4b", "label": "C4b", "shape": "dot", "size": 10, "title": "C4b | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d3c889662b8907a9  \n[file]: 32238175 - Transcriptomic profiling of microglia and astrocytes throughout aging.pdf\n\u003e [evidence]: Our astrocyte gene- expression dataset agrees with the findings of the previous studies, because ...\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: C4b expression was found to be greater in 5xFAD mice and is considered a biomarker for AD in huma...", "value": 15.735393346764045}, {"group": 2, "id": "pathology", "label": "pathology", "shape": "dot", "size": 10, "title": "pathology | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Deficiency of Cx3cr1 has shown increased A\u03b2 pathology as well as cognitive decline [28]", "value": 15.735393346764045}, {"group": 2, "id": "5xFAD mice", "label": "5xFAD mice", "shape": "dot", "size": 10, "title": "5xFAD mice | deg=3\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Additionally, our analysis confirms that 5xFAD mice exhibit extensive gene expression changes in ...\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: To determine the potential mechanisms(s) via which TLQP-21 reduces amyloid plaque burden and micr...\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Our study comprehensively quantified the transcriptomes in different cell types of mouse brains, ...\n[doc_id]: bb73bcc13afee4b4  \n[file]: 34465358 - Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Moreover, a subset of microglia with high GLUTs was increased in 5xFAD mice.", "value": 19.933992677987828}, {"group": 2, "id": "microglial population", "label": "microglial population", "shape": "dot", "size": 10, "title": "microglial population | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: APC treatment sample uncovers a large decrease in the microglial population suggesting reversal o...", "value": 15.735393346764045}, {"group": 2, "id": "Tg2576 transgenic mice", "label": "Tg2576 transgenic mice", "shape": "dot", "size": 10, "title": "Tg2576 transgenic mice | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: APC treatment in AD Tg2576 transgenic mice has also been found to inhibit A\u03b2 production by a diff...\n\u003e [evidence]: APC treatment in AD Tg2576 transgenic mice has also been found to inhibit A\u03b2 production by a diff...\n[doc_id]: 92ff8f2be96289d7  \n[file]: 41077614 - Midbrain degeneration triggers astrocyte reactivity and tau pathology in experimental Alzheimer\u0027s Disease.pdf\n\u003e [evidence]: In a separate set of experiments, we induced experimental midbrain lesion in Tg2576 transgenic mi...", "value": 15.735393346764045}, {"group": 2, "id": "WT", "label": "WT", "shape": "dot", "size": 10, "title": "WT | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3319f4b14f340c9e  \n[file]: 37989983 - Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5\u00d7FAD Mice.pdf\n\u003e [evidence]: We found that beta-amyloid deposition was reduced in FAD mice receiving the miR-29a sponge, and m...\n\u003e [evidence]: By contrast, miR-29a sponge expression in WT mice was associated with changes in genes involved i...\n\u003e [evidence]: By contrast, miR-29a sponge expression in WT mice was associated with changes in genes involved i...\n\u003e [evidence]: Transcriptomic and proteomic profiling designed to identify putative causal genes or sets of gene...\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: APC treatment shows return to near WT levels of expression of Cd63 and Cd68.\n\u003e [evidence]: APC treatment shows return to near WT levels of expression of Cd63 and Cd68.\n\u003e [evidence]: APC treatment shows return to near WT levels of expression of Cd63 and Cd68.", "value": 15.735393346764045}, {"group": 2, "id": "anti-inflammatory properties", "label": "anti-inflammatory properties", "shape": "dot", "size": 10, "title": "anti-inflammatory properties | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: We observed a downregulation of C4b in APC treatment, while further study is needed, the anti-inf...", "value": 15.735393346764045}, {"group": 2, "id": "transgenic mice", "label": "transgenic mice", "shape": "dot", "size": 10, "title": "transgenic mice | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Using single-cell RNA sequencing and bioinformatic analysis, we analyze the effects of APC treatm...\n[doc_id]: 5194787e6776a5c5  \n[file]: 37833764 - Chronic neuroinflammation during aging leads to cholinergic neurodegeneration in the mouse medial septum.pdf\n\u003e [evidence]: Methods To gain further insight into age-related cholinergic decline, we investigated the cumulat...\n[doc_id]: 7cac9416d7d5b236  \n[file]: 22984603 - Organotypic brain slice cultures of adult transgenic P301S mice--a model for tauopathy studies.pdf\n\u003e [evidence]: Deposits of hyperphosphorylated tau, called neurofibrillary tangles (NFTs), surrounded by activat...", "value": 15.735393346764045}, {"group": 2, "id": "DEGs", "label": "DEGs", "shape": "dot", "size": 10, "title": "DEGs | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 121f7cadde31d785  \n[file]: 37923721 - Dissecting the human leptomeninges at single-cell resolution.pdf\n\u003e [evidence]: Furthermore, the DEGs in \ufb01broblasts are related to ECM dynamics, immune response and cytokine sig...\n\u003e [evidence]: Furthermore, the DEGs in \ufb01broblasts are related to ECM dynamics, immune response and cytokine sig...\n[doc_id]: 4d6afb7163e035aa  \n[file]: 40796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\n\u003e [evidence]: This study provides strong evidence that for diseases of high heterogeneity like AD and SCZ, the ...\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: The astrocyte population notably expresses two DEGs that are modulated by APC treatment.\n\u003e [evidence]: The astrocyte population notably expresses two DEGs that are modulated by APC treatment.\n[doc_id]: c95d64dce55527b0  \n[file]: 40826098 - Single-nucleus transcriptomics reveals a distinct microglial state and increased MSR1-mediated phagocytosis as common features across dementia subtypes.pdf\n\u003e [evidence]: Our investigation highlighted MSR1, which encodes a class A macrophage scavenger receptor, as one...\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: Pathway analysis of the DEGs revealed enrichment in several pathways related to immune response, ...", "value": 15.735393346764045}, {"group": 49, "id": "5xFAD animals", "label": "5xFAD animals", "shape": "dot", "size": 10, "title": "5xFAD animals | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Our results indicate that Cx3cr1 deficiency exacerbates neurodegeneration and cognitive impairmen...", "value": 15.735393346764045}, {"group": 49, "id": "neurotoxic oligomeric A\u03b2 (oA\u03b2)", "label": "neurotoxic oligomeric A\u03b2 (oA\u03b2)", "shape": "dot", "size": 10, "title": "neurotoxic oligomeric A\u03b2 (oA\u03b2) | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Our results indicate that Cx3cr1 deficiency exacerbates neurodegeneration and cognitive impairmen...", "value": 15.735393346764045}, {"group": 2, "id": "retromer interactome", "label": "retromer interactome", "shape": "dot", "size": 10, "title": "retromer interactome | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Additionally, our analysis confirms that 5xFAD mice exhibit extensive gene expression changes in ...", "value": 15.735393346764045}, {"group": 2, "id": "aCSF", "label": "aCSF", "shape": "dot", "size": 10, "title": "aCSF | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: To determine the potential mechanisms(s) via which TLQP-21 reduces amyloid plaque burden and micr...", "value": 15.735393346764045}, {"group": 50, "id": "5xFAD model", "label": "5xFAD model", "shape": "dot", "size": 10, "title": "5xFAD model | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: We then assessed the effects of APOE3Ch on amyloid-\u03b2 and tau pathology in two mouse models of AD:...", "value": 15.735393346764045}, {"group": 50, "id": "APP and PSEN1 genes", "label": "APP and PSEN1 genes", "shape": "dot", "size": 10, "title": "APP and PSEN1 genes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: We then assessed the effects of APOE3Ch on amyloid-\u03b2 and tau pathology in two mouse models of AD:...", "value": 15.735393346764045}, {"group": 4, "id": "5xFAD mouse model", "label": "5xFAD mouse model", "shape": "dot", "size": 10, "title": "5xFAD mouse model | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: In addition, A\u03b2 amyloidosis is significantly reduced in APPPS1-21 and 5xFAD mouse models raised i...\n\u003e [evidence]: In addition, A\u03b2 amyloidosis is significantly reduced in APPPS1-21 and 5xFAD mouse models raised i...", "value": 18.11107105653813}, {"group": 4, "id": "germ-free (GF) conditions", "label": "germ-free (GF) conditions", "shape": "dot", "size": 10, "title": "germ-free (GF) conditions | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: In addition, A\u03b2 amyloidosis is significantly reduced in APPPS1-21 and 5xFAD mouse models raised i...", "value": 15.735393346764045}, {"group": 51, "id": "5xFAD transgenic mice", "label": "5xFAD transgenic mice", "shape": "dot", "size": 10, "title": "5xFAD transgenic mice | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: In the future, we plan to obtain this derivative and experiment with not only 5xFAD transgenic mi...", "value": 15.735393346764045}, {"group": 51, "id": "tau physiology", "label": "tau physiology", "shape": "dot", "size": 10, "title": "tau physiology | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: In the future, we plan to obtain this derivative and experiment with not only 5xFAD transgenic mi...", "value": 15.735393346764045}, {"group": 52, "id": "5xFAD;Cx3cr1\u2212/\u2212 mice", "label": "5xFAD;Cx3cr1\u2212/\u2212 mice", "shape": "dot", "size": 10, "title": "5xFAD;Cx3cr1\u2212/\u2212 mice | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Results: Disease progression in 5xFAD;Cx3cr1\u2212/\u2212 mice is characterized by increased deposition of ...", "value": 15.735393346764045}, {"group": 52, "id": "filamentous plaques", "label": "filamentous plaques", "shape": "dot", "size": 10, "title": "filamentous plaques | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Results: Disease progression in 5xFAD;Cx3cr1\u2212/\u2212 mice is characterized by increased deposition of ...", "value": 15.735393346764045}, {"group": 0, "id": "astrocyte", "label": "astrocyte", "shape": "dot", "size": 10, "title": "astrocyte | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3319f4b14f340c9e  \n[file]: 37989983 - Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5\u00d7FAD Mice.pdf\n\u003e [evidence]: miR-29a sponge significantly reduced hippocampal beta-amyloid deposition in 5\u00d7FAD mice and lowere...\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: The astrocyte population notably expresses two DEGs that are modulated by APC treatment.", "value": 15.735393346764045}, {"group": 53, "id": "6-7-month-old PS2APP transgenic mice", "label": "6-7-month-old PS2APP transgenic mice", "shape": "dot", "size": 10, "title": "6-7-month-old PS2APP transgenic mice | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 8cb824110484db3e  \n[file]: 36895556 - The effect of Abi3 locus deletion on the progression of Alzheimer\u0027s disease-related pathologies.pdf\n\u003e [evidence]: For example, while Trem2 de\ufb01ciency increased amyloid plaque load at 6-7-month-old PS2APP transgen...", "value": 15.735393346764045}, {"group": 53, "id": "Alterations in cytokine levels", "label": "Alterations in cytokine levels", "shape": "dot", "size": 10, "title": "Alterations in cytokine levels | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 8cb824110484db3e  \n[file]: 36895556 - The effect of Abi3 locus deletion on the progression of Alzheimer\u0027s disease-related pathologies.pdf\n\u003e [evidence]: For example, while Trem2 de\ufb01ciency increased amyloid plaque load at 6-7-month-old PS2APP transgen...", "value": 15.735393346764045}, {"group": 54, "id": "617 amino acid VGF precursor", "label": "617 amino acid VGF precursor", "shape": "dot", "size": 10, "title": "617 amino acid VGF precursor | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: The C-terminal peptide TLQP-21 (named by its four Nterminal amino acids and length) is processed ...", "value": 15.735393346764045}, {"group": 54, "id": "brain", "label": "brain", "shape": "dot", "size": 10, "title": "brain | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: In addition, since C5aR1 is primarily expressed on cells of the myeloid lineage, and only to a le...\n[doc_id]: f7ba0f60074958f6  \n[file]: 32271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\n\u003e [evidence]: SVA and HERV-K can form active chromatin regions in the brain and thus affect neighbor gene expre...\n[doc_id]: 8c61c58869724761  \n[file]: 31978074 - Accelerated brain aging towards transcriptional inversion in a zebrafish model of the K115fs mutation of human PSEN2.pdf\n\u003e [evidence]: In humans, chronically increased glucocorticoid signalling in the brain can lead to glucocorticoi...\n[doc_id]: 39466bfdd7c95692  \n[file]: 36914812 - The gut microbiome modulates the transformation of microglial subtypes.pdf\n\u003e [evidence]: In recent years, important progress has been made in understanding how the gut microbiome affects...\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: The C-terminal peptide TLQP-21 (named by its four Nterminal amino acids and length) is processed ...\n[doc_id]: 2ab9e10b4b26b7a7  \n[file]: 40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\n\u003e [evidence]: Liver dysfunction contributes to Alzheimer\u2019s disease (AD) pathogenesis, and evidence suggests tha...", "value": 15.735393346764045}, {"group": 55, "id": "65", "label": "65", "shape": "dot", "size": 10, "title": "65 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d3c889662b8907a9  \n[file]: 32238175 - Transcriptomic profiling of microglia and astrocytes throughout aging.pdf\n\u003e [evidence]: Ccl2 is a key mediator of spinal microglial activation, and blocking spinal Ccl2 alleviates heat ...", "value": 15.735393346764045}, {"group": 55, "id": "immunosuppression", "label": "immunosuppression", "shape": "dot", "size": 10, "title": "immunosuppression | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d3c889662b8907a9  \n[file]: 32238175 - Transcriptomic profiling of microglia and astrocytes throughout aging.pdf\n\u003e [evidence]: Ccl2 is a key mediator of spinal microglial activation, and blocking spinal Ccl2 alleviates heat ...", "value": 15.735393346764045}, {"group": 56, "id": "7-transmembrane spanning G-protein coupled receptor", "label": "7-transmembrane spanning G-protein coupled receptor", "shape": "dot", "size": 10, "title": "7-transmembrane spanning G-protein coupled receptor | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: The C3a receptor-1 (C3aR1), a 7-transmembrane spanning G-protein coupled receptor that is activat...", "value": 15.735393346764045}, {"group": 56, "id": "complement activation product C3a", "label": "complement activation product C3a", "shape": "dot", "size": 10, "title": "complement activation product C3a | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: The C3a receptor-1 (C3aR1), a 7-transmembrane spanning G-protein coupled receptor that is activat...", "value": 15.735393346764045}, {"group": 57, "id": "9 significantly enriched gene sets", "label": "9 significantly enriched gene sets", "shape": "dot", "size": 10, "title": "9 significantly enriched gene sets | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: c GSEA enrichment results showed 9 significantly enriched gene sets out of 44 upregulated gene se...", "value": 15.735393346764045}, {"group": 57, "id": "Vehicle- treated male group", "label": "Vehicle- treated male group", "shape": "dot", "size": 10, "title": "Vehicle- treated male group | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: c GSEA enrichment results showed 9 significantly enriched gene sets out of 44 upregulated gene se...", "value": 15.735393346764045}, {"group": 58, "id": "A1 astrocytes", "label": "A1 astrocytes", "shape": "dot", "size": 10, "title": "A1 astrocytes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 91d0e406cb470366  \n[file]: 33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\n\u003e [evidence]: TGF-\u03b2 is a cytokine with potential neuroprotective effects mediated by glial c\u00ad ells57,58, while ...\n\u003e [evidence]: A1 astrocytes are described to mediate synaptic loss and impairment as well as initiating neurona...", "value": 15.735393346764045}, {"group": 58, "id": "synaptic loss and impairment", "label": "synaptic loss and impairment", "shape": "dot", "size": 10, "title": "synaptic loss and impairment | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 91d0e406cb470366  \n[file]: 33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\n\u003e [evidence]: A1 astrocytes are described to mediate synaptic loss and impairment as well as initiating neurona...", "value": 15.735393346764045}, {"group": 3, "id": "A20", "label": "A20", "shape": "dot", "size": 10, "title": "A20 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d0fa5a5a09a4de36  \n[file]: 38352874 - Inflammasome signaling is dispensable for \u00df-amyloid-induced neuropathology in preclinical models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Furthermore, the study suggests that A20 overexpression does not affect microglial activation or ...", "value": 15.735393346764045}, {"group": 3, "id": "HERV-K inhibitor", "label": "HERV-K inhibitor", "shape": "dot", "size": 10, "title": "HERV-K inhibitor | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f7ba0f60074958f6  \n[file]: 32271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\n\u003e [evidence]: The HERV-K inhibitor also prevented neurodegeneration and microglial activation in response to in...\n\u003e [evidence]: Finally, HERV-K inhibitor reduced neurotoxicity of lysates from dying neurons applied to neurons.\n\u003e [evidence]: The HERV-K inhibitor also prevented neurodegeneration and microglial activation in response to in...", "value": 18.11107105653813}, {"group": 3, "id": "MCR activation", "label": "MCR activation", "shape": "dot", "size": 10, "title": "MCR activation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 91d0e406cb470366  \n[file]: 33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\n\u003e [evidence]: Specifically, MCR activation reduces neurotoxic astrocytes and microglial activation in a brain r...\n\u003e [evidence]: Specifically, MCR activation reduces neurotoxic astrocytes and microglial activation in a brain r...\n\u003e [evidence]: Meanwhile, our results show that MCR activation reduces the activation and proliferation of micro...", "value": 15.735393346764045}, {"group": 59, "id": "A3 astrocytes", "label": "A3 astrocytes", "shape": "dot", "size": 10, "title": "A3 astrocytes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Secondly, A3 astrocytes, expressing disease-mitigating genes, were induced in response to the APP...", "value": 15.735393346764045}, {"group": 59, "id": "disease-mitigating genes", "label": "disease-mitigating genes", "shape": "dot", "size": 10, "title": "disease-mitigating genes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Secondly, A3 astrocytes, expressing disease-mitigating genes, were induced in response to the APP...", "value": 15.735393346764045}, {"group": 18, "id": "AAV", "label": "AAV", "shape": "dot", "size": 10, "title": "AAV | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3319f4b14f340c9e  \n[file]: 37989983 - Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5\u00d7FAD Mice.pdf\n\u003e [evidence]: We found that the AAV expressing miR-29a sponge functionally reduced miR-29a levels and improved ...\n\u003e [evidence]: To test this, we generated an adeno-associated virus (AAV) expressing GFP and a miR-29a \u2018sponge\u2019 ...", "value": 18.11107105653813}, {"group": 18, "id": "GFP", "label": "GFP", "shape": "dot", "size": 10, "title": "GFP | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3319f4b14f340c9e  \n[file]: 37989983 - Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5\u00d7FAD Mice.pdf\n\u003e [evidence]: To test this, we generated an adeno-associated virus (AAV) expressing GFP and a miR-29a \u2018sponge\u2019 ...", "value": 15.735393346764045}, {"group": 18, "id": "miR-29a sponge", "label": "miR-29a sponge", "shape": "dot", "size": 10, "title": "miR-29a sponge | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3319f4b14f340c9e  \n[file]: 37989983 - Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5\u00d7FAD Mice.pdf\n\u003e [evidence]: miR-29a sponge significantly reduced hippocampal beta-amyloid deposition in 5\u00d7FAD mice and lowere...\n\u003e [evidence]: We found that beta-amyloid deposition was reduced in FAD mice receiving the miR-29a sponge, and m...\n\u003e [evidence]: By contrast, miR-29a sponge expression in WT mice was associated with changes in genes involved i...\n\u003e [evidence]: We found that the AAV expressing miR-29a sponge functionally reduced miR-29a levels and improved ...\n\u003e [evidence]: Scale bars represent 100 \u03bcm; *p \u003c 0.05, **p \u003c 0.01, compared with the control group In 5\u00d7FAD mice...", "value": 15.735393346764045}, {"group": 8, "id": "ABCB1", "label": "ABCB1", "shape": "dot", "size": 10, "title": "ABCB1 | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: 5 Deletion of Dicer1 in intestinal epithelial cells reduces BACE1 activity and increases LRP1 and...\n\u003e [evidence]: It lowered A\u03b2 load in the brain, possibly by inhibiting \u03b2-secretase activity, and increasing the ...\n\u003e [evidence]: 5 Deletion of Dicer1 in intestinal epithelial cells reduces BACE1 activity and increases LRP1 and...", "value": 18.11107105653813}, {"group": 8, "id": "App-knock-in mice", "label": "App-knock-in mice", "shape": "dot", "size": 10, "title": "App-knock-in mice | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: 5 Deletion of Dicer1 in intestinal epithelial cells reduces BACE1 activity and increases LRP1 and...\n\u003e [evidence]: Results Deletion of Dicer1 in intestinal epithelial cells of App-knock-in mice reduced the absolu...", "value": 18.11107105653813}, {"group": 8, "id": "BACE1 activity", "label": "BACE1 activity", "shape": "dot", "size": 10, "title": "BACE1 activity | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: 5 Deletion of Dicer1 in intestinal epithelial cells reduces BACE1 activity and increases LRP1 and...\n\u003e [evidence]: 5 Deletion of Dicer1 in intestinal epithelial cells reduces BACE1 activity and increases LRP1 and...\n\u003e [evidence]: 5 Deletion of Dicer1 in intestinal epithelial cells reduces BACE1 activity and increases LRP1 and...", "value": 18.11107105653813}, {"group": 8, "id": "absolute number", "label": "absolute number", "shape": "dot", "size": 10, "title": "absolute number | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: Results Deletion of Dicer1 in intestinal epithelial cells of App-knock-in mice reduced the absolu...", "value": 15.735393346764045}, {"group": 4, "id": "ABX-mediated gut microbiota perturbations", "label": "ABX-mediated gut microbiota perturbations", "shape": "dot", "size": 10, "title": "ABX-mediated gut microbiota perturbations | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: We have shown that ABX-mediated gut microbiota perturbations failed to reduce A\u03b2 amyloidosis in m...", "value": 15.735393346764045}, {"group": 60, "id": "ABXinduced perturbations of gut microbiota", "label": "ABXinduced perturbations of gut microbiota", "shape": "dot", "size": 10, "title": "ABXinduced perturbations of gut microbiota | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: Our previous work also established that ABXinduced perturbations of gut microbiota are associated...", "value": 15.735393346764045}, {"group": 60, "id": "sex-specific alterations in microglial phenotypes", "label": "sex-specific alterations in microglial phenotypes", "shape": "dot", "size": 10, "title": "sex-specific alterations in microglial phenotypes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: Our previous work also established that ABXinduced perturbations of gut microbiota are associated...", "value": 15.735393346764045}, {"group": 1, "id": "amyloid plaques", "label": "amyloid plaques", "shape": "dot", "size": 10, "title": "amyloid plaques | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: In addition, the total area of the amyloid plaques was reduced in the hippocampi of the 5\u00d7FAD + F...\n\u003e [evidence]: Due to the combined effect of FUS and Adu, neurogenesis and phagocytosis are increased and amyloi...\n\u003e [evidence]: The combined treatment induced significantly less cognitive decline and decreased the level of am...\n\u003e [evidence]: Combined treatment with FUS and Adu activated phagocytic microglia and increased the number of as...\n\u003e [evidence]: The number of amyloid plaques was decreased in the hippocampi of the 5\u00d7FAD + Adu, 5\u00d7FAD + FUS, an...\n[doc_id]: e3232b24532f5879  \n[file]: 34103079 - CSF1R inhibition rescues tau pathology and neurodegeneration in an A T N model with combined AD pathologies, while preserving plaque associated microglia.pdf\n\u003e [evidence]: Recent work has also shown that amyloid plaques facilitate tau-seeding, thereby enhancing aggrega...\n[doc_id]: 92d2fb0bf85a478b  \n[file]: 38036733 - Spatiotemporal characterization of glial cell activation in an Alzheimer\u0027s disease model by spatially resolved transcriptomics.pdf\n\u003e [evidence]: These results con\ufb01rmed that upregulated genes in AD spatially associated with amyloid plaques wer...\n[doc_id]: 8cb824110484db3e  \n[file]: 36895556 - The effect of Abi3 locus deletion on the progression of Alzheimer\u0027s disease-related pathologies.pdf\n\u003e [evidence]: In that study, we found a signi\ufb01cant increase in Ab levels and amyloid plaques, accompanied by in...\n\u003e [evidence]: In that study, we found a signi\ufb01cant increase in Ab levels and amyloid plaques, accompanied by in...", "value": 15.735393346764045}, {"group": 1, "id": "dietary patterns", "label": "dietary patterns", "shape": "dot", "size": 10, "title": "dietary patterns | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b5d5053cd6fc980b  \n[file]: 40346662 - A single-cell transcriptomic atlas of all cell types in the brain of 5xFAD Alzheimer mice in response to dietary inulin supplementation.pdf\n\u003e [evidence]: Discussion Emerging evidence has suggested that AD onset and progression are associated with diet...", "value": 15.735393346764045}, {"group": 1, "id": "neuronal death", "label": "neuronal death", "shape": "dot", "size": 10, "title": "neuronal death | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 882d7b83c983ad03  \n[file]: 31399126 - A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain.pdf\n\u003e [evidence]: AD is also associated with neuronal death and gliosis specifically in the cerebral cortex.\n\u003e [evidence]: This neurodegenerative disorder is associated with neuronal death and gliosis heavily impacting t...\n[doc_id]: b093f6f0497dd291  \n[file]: 36180898 - Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: The activation of complement cascade and pro-inflammatory microglia can lead to synaptic dysfunct...\n\u003e [evidence]: The activation of complement cascade and pro-inflammatory microglia can lead to synaptic dysfunct...\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: Why GD induces a higher degree of neuronal death in the cortex but not in the hippocampus needs t...", "value": 18.11107105653813}, {"group": 1, "id": "expression of genes", "label": "expression of genes", "shape": "dot", "size": 10, "title": "expression of genes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7e54ca131b151a6f  \n[file]: 35849618 - Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Researchers have found that AD causes changes in the expression of genes within the brain cells.", "value": 15.735393346764045}, {"group": 1, "id": "signaling pathways", "label": "signaling pathways", "shape": "dot", "size": 10, "title": "signaling pathways | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: ce17e594043be4f0  \n[file]: 35247975 - Transcriptional response of murine microglia in Alzheimer\u0027s disease and inflammation.pdf\n\u003e [evidence]: Conclusions: In summary, AD triggered multiple signaling pathways that regulate numerous genes in...\n\u003e [evidence]: Conclusions: In summary, AD triggered multiple signaling pathways that regulate numerous genes in...\n[doc_id]: 17b13a15fc3bdd35  \n[file]: 39415193 - Network dynamics-based subtyping of Alzheimer\u0027s disease with microglial genetic risk factors.pdf\n\u003e [evidence]: The network model incorporated 20 known risk factors and crucial signaling pathways associated wi...", "value": 15.735393346764045}, {"group": 1, "id": "therapeutic strategies", "label": "therapeutic strategies", "shape": "dot", "size": 10, "title": "therapeutic strategies | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: db5b60a0a5df0d5b  \n[file]: 40537787 - KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: However, understanding the mechanisms underlying AD could lead to potential therapeutic strategies.", "value": 15.735393346764045}, {"group": 1, "id": "COVID-19", "label": "COVID-19", "shape": "dot", "size": 10, "title": "COVID-19 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4d6afb7163e035aa  \n[file]: 40796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\n\u003e [evidence]: AD has lower reproducibility than PD, HD, and COVID-19, but still has hundreds of DEGs.", "value": 15.735393346764045}, {"group": 1, "id": "HD", "label": "HD", "shape": "dot", "size": 10, "title": "HD | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4d6afb7163e035aa  \n[file]: 40796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\n\u003e [evidence]: AD has lower reproducibility than PD, HD, and COVID-19, but still has hundreds of DEGs.", "value": 15.735393346764045}, {"group": 1, "id": "PD", "label": "PD", "shape": "dot", "size": 10, "title": "PD | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4d6afb7163e035aa  \n[file]: 40796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\n\u003e [evidence]: AD has lower reproducibility than PD, HD, and COVID-19, but still has hundreds of DEGs.", "value": 15.735393346764045}, {"group": 1, "id": "microglia from AD patients", "label": "microglia from AD patients", "shape": "dot", "size": 10, "title": "microglia from AD patients | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b075ab080a8658ed  \n[file]: 39294270 - Transcriptional profiling in microglia across physiological and pathological states identifies a transcriptional module associated with neurodegeneration.pdf\n\u003e [evidence]: This analysis led to the identi\ufb01cation of human microglial gene modules including core (high expr...", "value": 15.735393346764045}, {"group": 1, "id": "calcium entry", "label": "calcium entry", "shape": "dot", "size": 10, "title": "calcium entry | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: The neuronal ryanodine receptor (Ryr2) is overactivated in AD, leading to enhanced receptor-opera...\n\u003e [evidence]: The neuronal ryanodine receptor (Ryr2) is overactivated in AD, leading to enhanced receptor-opera...", "value": 15.735393346764045}, {"group": 1, "id": "dementia", "label": "dementia", "shape": "dot", "size": 10, "title": "dementia | deg=4\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7e54ca131b151a6f  \n[file]: 35849618 - Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Alzheimer\u2019s Disease (AD) is the leading cause of dementia.\n[doc_id]: 1fbc0757cf45e82a  \n[file]: 41057304 - Fate mapping of peripherally-derived macrophages after traumatic brain injury in mice reveals a long-lasting population with a distinct transcriptomic signature.pdf\n\u003e [evidence]: Given that TBI is a major environmental risk factor for dementia70, these \ufb01ndings offer compellin...\n[doc_id]: 819143bcdc07bcd0  \n[file]: 40607399 - Decoding neuroinflammation in Alzheimer\u0027s disease a multi-omics and AI-driven perspective for precision medicine.pdf\n\u003e [evidence]: 1 Introduction Alzheimer\u2019s disease (AD) is one of the leading causes of dementia and represents a...\n[doc_id]: 72f6a572bc577d36  \n[file]: 38849813 - Altered glia-neuron communication in Alzheimer\u0027s Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq.pdf\n\u003e [evidence]: Abstract Background Alzheimer\u2019s disease is the most common cause of dementia and is characterized...\n[doc_id]: c259f1527833acb2  \n[file]: 40301889 - Monoallelic TYROBP deletion is a novel risk factor for Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Discussion In this study we show that monoallelic 5.2-kb TYROBP deletion is a novel risk factor f...\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: Growing evidence demonstrated that thyroid dysfunction was associated with cognitive function and...\n\u003e [evidence]: Clinical and experimental studies have demonstrated a clear association between overt hypothyroid...\n\u003e [evidence]: Evidence from clinical studies has demonstrated that hypothyroidism is related to an increased ri...\n\u003e [evidence]: Growing evidence demonstrated that thyroid dysfunction was associated with cognitive function and...", "value": 21.47078669352809}, {"group": 1, "id": "R33", "label": "R33", "shape": "dot", "size": 10, "title": "R33 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: This manually curated diagram summarizes transcriptional changes in retromer-associated genes and...", "value": 15.735393346764045}, {"group": 10, "id": "APOE3Ch", "label": "APOE3Ch", "shape": "dot", "size": 10, "title": "APOE3Ch | deg=5\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: Understanding the mechanisms by which APOE3Ch prevents the subsequent development of tau patholog...\n\u003e [evidence]: Together, these findings provide insights into the mechanisms by which APOE3Ch may protect agains...\n\u003e [evidence]: These findings suggest that APOE3Ch may affect synaptic function in the brain, which could contri...\n\u003e [evidence]: These findings suggest that APOE3Ch may affect lipid metabolism in the brain, which could contrib...\n\u003e [evidence]: These findings suggest that APOE3Ch may modulate the immune response to plaques, consistent with ...", "value": 22.824729401064424}, {"group": 1, "id": "Adu", "label": "Adu", "shape": "dot", "size": 10, "title": "Adu | deg=4\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: According to the study, patients who were treated with 10 mg/kg of Adu experienced ARIA-E with he...\n\u003e [evidence]: The Western blotting and immunofluorescence results demonstrated that the delivery of Adu was imp...\n\u003e [evidence]: To understand the underlying mechanisms of action, we investigated the changes in microglia, astr...\n\u003e [evidence]: However, the high dose of Adu (10\u201360 mg /kg) used in clinical studies induced ARIA-E in human cli...\n\u003e [evidence]: Recently, the FDA approved Adu for the treatment of AD based on an evaluation of effects of the d...\n\u003e [evidence]: In this work, we demonstrated that FUS with microbubbles induced BBB opening and increased the de...", "value": 21.47078669352809}, {"group": 9, "id": "Ctsb", "label": "Ctsb", "shape": "dot", "size": 10, "title": "Ctsb | deg=3\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Tre...\n\u003e [evidence]: Moreover, Ctsb has been found to be upregulated in the serum of AD patients and is considered a b...\n\u003e [evidence]: Regarding A\u03b2 production, Ctsb is thought to interact with the \u03b2-secretase site of amyloid precurs...", "value": 19.933992677987828}, {"group": 1, "id": "GD", "label": "GD", "shape": "dot", "size": 10, "title": "GD | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: 6 GD-induced RIPK3 activation affects A\u03b2 levels and increases neuronal loss in the APP/PS1 mice.\n\u003e [evidence]: Why GD induces a higher degree of neuronal death in the cortex but not in the hippocampus needs t...\n\u003e [evidence]: A large-scale registry-based data showed a higher incidence of dementia in individuals with hyper...\n\u003e [evidence]: Evidence indicates that cognitive deficit is associated with GD. [14, 61].\n\u003e [evidence]: In addition, we provide evidence and support that GD activates RIPK3 to induce necroptosis by a R...\n\u003e [evidence]: 5 GD induces the necroptosis activation in the hippocampus of APP/PS1 mice.", "value": 15.735393346764045}, {"group": 1, "id": "Alzheimer\u2019s disease (AD)", "label": "Alzheimer\u2019s disease (AD)", "shape": "dot", "size": 10, "title": "Alzheimer\u2019s disease (AD) | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4e5ef603f6ec87b5  \n[file]: 40787447 - Programmed cell death signatures-driven microglial transformation in Alzheimer\u0027s disease single-cell transcriptomics and functional validation.pdf\n\u003e [evidence]: Conclusion Our study identified a novel PCDS comprising nine genes (CFLAR, FYCO1, HDAC1, ITGB1, N...\n[doc_id]: 37cdae96f6271e07  \n[file]: 35213535 - Mapping the gene network landscape of Alzheimer\u0027s disease through integrating genomics and transcriptomics.pdf\n\u003e [evidence]: Author summary Alzheimer\u2019s disease (AD) is recognized as the leading primary cause of dementia, r...\n[doc_id]: 819143bcdc07bcd0  \n[file]: 40607399 - Decoding neuroinflammation in Alzheimer\u0027s disease a multi-omics and AI-driven perspective for precision medicine.pdf\n\u003e [evidence]: 1 Introduction Alzheimer\u2019s disease (AD) is one of the leading causes of dementia and represents a...\n[doc_id]: 7ff5d3a47ea9588d  \n[file]: 35459147 - Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.pdf\n\u003e [evidence]: Background Alzheimer\u2019s disease (AD) affects about 5.8 million people in the USA and nearly 400 mi...", "value": 18.11107105653813}, {"group": 1, "id": "Alzheimer\u2019s Disease", "label": "Alzheimer\u2019s Disease", "shape": "dot", "size": 10, "title": "Alzheimer\u2019s Disease | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7e54ca131b151a6f  \n[file]: 35849618 - Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Alzheimer\u2019s Disease (AD) is the leading cause of dementia.\n[doc_id]: 92ff8f2be96289d7  \n[file]: 41077614 - Midbrain degeneration triggers astrocyte reactivity and tau pathology in experimental Alzheimer\u0027s Disease.pdf\n\u003e [evidence]: Abstract Background Smaller midbrain volumes predict Alzheimer\u2019s Disease (AD) progression and fas...", "value": 15.735393346764045}, {"group": 1, "id": "Alzheimer\u2019s disease", "label": "Alzheimer\u2019s disease", "shape": "dot", "size": 10, "title": "Alzheimer\u2019s disease | deg=4\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 5700848d1ffe11e1  \n[file]: 39238030 - Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Background Microglial activation constitutes a hallmark in the pathophysiology of Alzheimer\u2019s dis...\n[doc_id]: 5b4711bead6c11ad  \n[file]: 35706029 - Microglial amyloid beta clearance is driven by PIEZO1 channels.pdf\n\u003e [evidence]: Genome-wide association studies (GWAS) implicate dysfunction in several microglial innate immunit...\n[doc_id]: 72f6a572bc577d36  \n[file]: 38849813 - Altered glia-neuron communication in Alzheimer\u0027s Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq.pdf\n\u003e [evidence]: Abstract Background Alzheimer\u2019s disease is the most common cause of dementia and is characterized...\n[doc_id]: 75e9d948abad0bc8  \n[file]: 30558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\n\u003e [evidence]: In neurodegenerative diseases, such as Alzheimer\u2019s disease (AD), activated microglia are detected...\n[doc_id]: 3eb75adf1386e0a9  \n[file]: 40275260 - Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability.pdf\n\u003e [evidence]: Methods We combined a machine learning approach with the analysis of disease-associated miRNA dat...\n[doc_id]: 01ab70cecab4b6e6  \n[file]: 37115208 - Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation.pdf\n\u003e [evidence]: Genetic variation in the TREM2 gene has been implicated in risk for Alzheimer\u2019s disease and front...", "value": 21.47078669352809}, {"group": 61, "id": "AD entorhinal cortex", "label": "AD entorhinal cortex", "shape": "dot", "size": 10, "title": "AD entorhinal cortex | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: bf000dbd95632554  \n[file]: 40369584 - Transcriptomic signatures of oxytosis ferroptosis are enriched in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: The other study identified selectively vulnerable neurons in the AD entorhinal cortex associated ...", "value": 15.735393346764045}, {"group": 61, "id": "neurofibrillary inclusions", "label": "neurofibrillary inclusions", "shape": "dot", "size": 10, "title": "neurofibrillary inclusions | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: bf000dbd95632554  \n[file]: 40369584 - Transcriptomic signatures of oxytosis ferroptosis are enriched in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: The other study identified selectively vulnerable neurons in the AD entorhinal cortex associated ...", "value": 15.735393346764045}, {"group": 62, "id": "AD genes", "label": "AD genes", "shape": "dot", "size": 10, "title": "AD genes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2cd55c3c03739c98  \n[file]: 33257666 - Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u0027s disease.pdf\n\u003e [evidence]: In particular, antigen-presenting cluster 7 stands out amongst the other clusters since it emerge...", "value": 15.735393346764045}, {"group": 62, "id": "cortical tissue level", "label": "cortical tissue level", "shape": "dot", "size": 10, "title": "cortical tissue level | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2cd55c3c03739c98  \n[file]: 33257666 - Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u0027s disease.pdf\n\u003e [evidence]: In particular, antigen-presenting cluster 7 stands out amongst the other clusters since it emerge...", "value": 15.735393346764045}, {"group": 6, "id": "AD mice", "label": "AD mice", "shape": "dot", "size": 10, "title": "AD mice | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b093f6f0497dd291  \n[file]: 36180898 - Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Genetic ablation of T cells, B cells and NK cells in AD mice, further amplified the expression of...\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: Necroptosis is activated in brains of AD human and AD mice, and suppression of necroptosis exerts...\n[doc_id]: 4d7d47f583b6d19c  \n[file]: 40707875 - Mir-199a-3p aggravates neuroinflammation in an Alzheimer\u0027s disease transgenic mouse model by promoting M1-polarization microgliaMir-199a-3p M1.pdf\n\u003e [evidence]: Results Intracerebroventricular administration of miR-199a-3p agomir exacerbated amyloid depositi...\n[doc_id]: d3c889662b8907a9  \n[file]: 32238175 - Transcriptomic profiling of microglia and astrocytes throughout aging.pdf\n\u003e [evidence]: And most age-up genes were more highly expressed in AD mice at the same time points.", "value": 18.11107105653813}, {"group": 6, "id": "pathologic inflammatory genes", "label": "pathologic inflammatory genes", "shape": "dot", "size": 10, "title": "pathologic inflammatory genes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b093f6f0497dd291  \n[file]: 36180898 - Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Genetic ablation of T cells, B cells and NK cells in AD mice, further amplified the expression of...", "value": 15.735393346764045}, {"group": 6, "id": "microglial polarization", "label": "microglial polarization", "shape": "dot", "size": 10, "title": "microglial polarization | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4e5ef603f6ec87b5  \n[file]: 40787447 - Programmed cell death signatures-driven microglial transformation in Alzheimer\u0027s disease single-cell transcriptomics and functional validation.pdf\n\u003e [evidence]: In multiple sclerosis, S100A4 overexpression promotes microglial polarization of pro-in\ufb02ammatory ...\n[doc_id]: 4d7d47f583b6d19c  \n[file]: 40707875 - Mir-199a-3p aggravates neuroinflammation in an Alzheimer\u0027s disease transgenic mouse model by promoting M1-polarization microgliaMir-199a-3p M1.pdf\n\u003e [evidence]: Results Intracerebroventricular administration of miR-199a-3p agomir exacerbated amyloid depositi...\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: C5a may synergistically enhance microglial polarization to a more inflammatory state in response ...", "value": 18.11107105653813}, {"group": 2, "id": "AD model mice", "label": "AD model mice", "shape": "dot", "size": 10, "title": "AD model mice | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 373c2b48d426b2d0  \n[file]: 39592224 - Tau Accumulation Induces Microglial State Alterations in Alzheimer\u0027s Disease Model Mice.pdf\n\u003e [evidence]: Immunohistochemical analyses revealed that Dectin-1-positive disease-associated microglia were in...\n[doc_id]: 7ec126941318b941  \n[file]: 39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\n\u003e [evidence]: We showed that STING suppression was effective in AD model mice that expressed both A\u03b2 and human ...\n\u003e [evidence]: We showed that STING suppression was effective in AD model mice that expressed both A\u03b2 and human ...", "value": 18.11107105653813}, {"group": 2, "id": "human tau", "label": "human tau", "shape": "dot", "size": 10, "title": "human tau | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 373c2b48d426b2d0  \n[file]: 39592224 - Tau Accumulation Induces Microglial State Alterations in Alzheimer\u0027s Disease Model Mice.pdf\n\u003e [evidence]: Combined with \ufb01ndings from existing single-cell RNA-seq datasets and integrative analyses using s...\n[doc_id]: 7ec126941318b941  \n[file]: 39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\n\u003e [evidence]: We showed that STING suppression was effective in AD model mice that expressed both A\u03b2 and human ...", "value": 15.735393346764045}, {"group": 2, "id": "interleukin-1\u03b2 inflammation", "label": "interleukin-1\u03b2 inflammation", "shape": "dot", "size": 10, "title": "interleukin-1\u03b2 inflammation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: It was proven that Irf8 is involved in microglial activation in response to A\u03b2 and leads to inter...", "value": 15.735393346764045}, {"group": 2, "id": "proinflammatory activation", "label": "proinflammatory activation", "shape": "dot", "size": 10, "title": "proinflammatory activation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ff5d3a47ea9588d  \n[file]: 35459147 - Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.pdf\n\u003e [evidence]: This evidence has led to the hypothesis that in the Alzheimer\u2019s brain, A\u03b2 triggers an exacerbated...", "value": 15.735393346764045}, {"group": 2, "id": "hippocampus", "label": "hippocampus", "shape": "dot", "size": 10, "title": "hippocampus | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Conclusion Genetic ablation of C5aR1 in a mouse model of AD resulted in microglial gene expressio...\n[doc_id]: 38639c37ea0f3a09  \n[file]: 33115519 - Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice.pdf\n\u003e [evidence]: We observed regional decreases in synaptic protein levels, with the most affected synapses in the...\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: F Western blotting analysis of BACE1 and A\u03b2 expression in the hippocampus in the indicated mice.\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: In addition, we also examined neuropathological changes, especially the amyloid plaque levels in ...", "value": 15.735393346764045}, {"group": 2, "id": "inflammation", "label": "inflammation", "shape": "dot", "size": 10, "title": "inflammation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Cst7 expressing microglia tend to surround A\u03b2 in the brain and increase inflammation [56].\n[doc_id]: c51ff7fb94d8674f  \n[file]: 39604588 - Elevated expression of the retrotransposon LINE-1 drives Alzheimer\u0027s disease-associated microglial dysfunction.pdf\n\u003e [evidence]: As previous studies in human fibroblasts found that LINE-1 derepression stimulated inflammation [...\n[doc_id]: b093f6f0497dd291  \n[file]: 36180898 - Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Regulatory T cells (Tregs) are a subset of T cells that play a neuroprotective role by suppressin...\n[doc_id]: 3eb75adf1386e0a9  \n[file]: 40275260 - Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability.pdf\n\u003e [evidence]: Toll-like receptors (TLRs) contribute to such central nervous system (CNS) injury by triggering i...", "value": 15.735393346764045}, {"group": 2, "id": "neuronal loss", "label": "neuronal loss", "shape": "dot", "size": 10, "title": "neuronal loss | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Similar results have been reported in the SOD1-G93A model of ALS, where Cx3cr1 deficiency is asso...\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: 6 GD-induced RIPK3 activation affects A\u03b2 levels and increases neuronal loss in the APP/PS1 mice.\n\u003e [evidence]: RIPK3 inhibitor could inhibit GD-mediated A\u03b2 accumulation and neuronal loss.\n\u003e [evidence]: Conclusions Our findings reveal that GD hyperthyroidism aggravates cognitive deficits in AD mice ...", "value": 18.11107105653813}, {"group": 2, "id": "PIEZO1-mediated calcium transients", "label": "PIEZO1-mediated calcium transients", "shape": "dot", "size": 10, "title": "PIEZO1-mediated calcium transients | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 5b4711bead6c11ad  \n[file]: 35706029 - Microglial amyloid beta clearance is driven by PIEZO1 channels.pdf\n\u003e [evidence]: A\u03b2 inhibited PIEZO1-mediated calcium transients, whereas activation of PIEZO1 with a selective ag...", "value": 15.735393346764045}, {"group": 19, "id": "AD mouse model", "label": "AD mouse model", "shape": "dot", "size": 10, "title": "AD mouse model | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: Additionally, knockout of GFAP in an AD mouse model showed a twofold increase in amyloid plaque b...", "value": 15.735393346764045}, {"group": 19, "id": "amyloid plaque burden", "label": "amyloid plaque burden", "shape": "dot", "size": 10, "title": "amyloid plaque burden | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6e263da311cc2e11  \n[file]: 37340466 - Sex specific molecular networks and key drivers of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: The study also found that LRP10 over-expression in male E4FAD mice led to an increase in amyloid ...\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: Additionally, knockout of GFAP in an AD mouse model showed a twofold increase in amyloid plaque b...\n[doc_id]: c51ff7fb94d8674f  \n[file]: 39604588 - Elevated expression of the retrotransposon LINE-1 drives Alzheimer\u0027s disease-associated microglial dysfunction.pdf\n\u003e [evidence]: Our findings suggest that LINE-1 activity at this stage may impair microglial functions, such as ...", "value": 18.11107105653813}, {"group": 19, "id": "A\u03b2 clearance", "label": "A\u03b2 clearance", "shape": "dot", "size": 10, "title": "A\u03b2 clearance | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: c51ff7fb94d8674f  \n[file]: 39604588 - Elevated expression of the retrotransposon LINE-1 drives Alzheimer\u0027s disease-associated microglial dysfunction.pdf\n\u003e [evidence]: Our findings suggest that LINE-1 activity at this stage may impair microglial functions, such as ...", "value": 15.735393346764045}, {"group": 3, "id": "AD pathology", "label": "AD pathology", "shape": "dot", "size": 10, "title": "AD pathology | deg=4\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6e263da311cc2e11  \n[file]: 37340466 - Sex specific molecular networks and key drivers of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Gene perturbation experiments in EFAD mouse models demonstrated that LRP10 differentially affecte...\n[doc_id]: 1f79b999e0214ae2  \n[file]: 36536457 - Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes.pdf\n\u003e [evidence]: The study found that DAM, EADAM, and LADAM have distinct expression profiles associated with AD p...\n[doc_id]: 17b13a15fc3bdd35  \n[file]: 39415193 - Network dynamics-based subtyping of Alzheimer\u0027s disease with microglial genetic risk factors.pdf\n\u003e [evidence]: Interestingly, the core regulators such as MEF2C, PICALM, and LAT2 are known to have the potentia...\n[doc_id]: 4d7d47f583b6d19c  \n[file]: 40707875 - Mir-199a-3p aggravates neuroinflammation in an Alzheimer\u0027s disease transgenic mouse model by promoting M1-polarization microgliaMir-199a-3p M1.pdf\n\u003e [evidence]: Conversely, treatment with miR-199a-3p antagomir attenuated AD pathology and suppressed M1 polari...\n[doc_id]: 03b5a3ad723acdbf  \n[file]: 37988169 - Galectin-3 aggravates microglial activation and tau transmission in tauopathy.pdf\n\u003e [evidence]: Although microglial depletion has been shown to reduce AD pathology (57), microglial activation i...\n[doc_id]: d0fa5a5a09a4de36  \n[file]: 38352874 - Inflammasome signaling is dispensable for \u00df-amyloid-induced neuropathology in preclinical models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: They also discovered that caspase-1 deficiency does not suppress AD pathology in 20-week-old AppN...", "value": 21.47078669352809}, {"group": 3, "id": "sub-types previously defined", "label": "sub-types previously defined", "shape": "dot", "size": 10, "title": "sub-types previously defined | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 98011f49f4ecb3ac  \n[file]: 34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: Our results also highlight a diversity of astrocyte and microglial responses to AD pathology that...", "value": 15.735393346764045}, {"group": 3, "id": "M1 polarization", "label": "M1 polarization", "shape": "dot", "size": 10, "title": "M1 polarization | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4e5ef603f6ec87b5  \n[file]: 40787447 - Programmed cell death signatures-driven microglial transformation in Alzheimer\u0027s disease single-cell transcriptomics and functional validation.pdf\n\u003e [evidence]: Functional analyses revealed that S100A4 knockdown improved microglial viability, reduced apoptos...\n[doc_id]: 4d7d47f583b6d19c  \n[file]: 40707875 - Mir-199a-3p aggravates neuroinflammation in an Alzheimer\u0027s disease transgenic mouse model by promoting M1-polarization microgliaMir-199a-3p M1.pdf\n\u003e [evidence]: In LPS treated BV2 cells, miR-199a-3p mimics promoted M1 polarization, while inhibitors reversed ...\n\u003e [evidence]: Conversely, treatment with miR-199a-3p antagomir attenuated AD pathology and suppressed M1 polari...", "value": 15.735393346764045}, {"group": 3, "id": "DAM", "label": "DAM", "shape": "dot", "size": 10, "title": "DAM | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 373c2b48d426b2d0  \n[file]: 39592224 - Tau Accumulation Induces Microglial State Alterations in Alzheimer\u0027s Disease Model Mice.pdf\n\u003e [evidence]: Combined with \ufb01ndings from existing single-cell RNA-seq datasets and integrative analyses using s...\n\u003e [evidence]: Combined with \ufb01ndings from existing single-cell RNA-seq datasets and integrative analyses using s...\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: A Schematic illustration showing microglia switching from homeostatic to stage 1 (an intermediate...\n\u003e [evidence]: A Schematic illustration showing microglia switching from homeostatic to stage 1 (an intermediate...\n[doc_id]: 1f79b999e0214ae2  \n[file]: 36536457 - Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes.pdf\n\u003e [evidence]: During early-stage disease in 6-month-old Tau4R\u0394K-AP, but not APP;PS1 or Tau4R\u0394K mice, the presen...\n[doc_id]: bb73bcc13afee4b4  \n[file]: 34465358 - Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: However, TSPO-positive microglia are different from DAM activated by the TREM2 pathway [50, 51].\n[doc_id]: c110590ee636ba06  \n[file]: 39753747 - A subcellular sampling instrument allows spatial resolution of amyloid deposit-derived organelle-specific effects in microglia.pdf\n\u003e [evidence]: Concerning nucleic encoded genes that are not fundamentally involved in mitochondrial maintenance...", "value": 15.735393346764045}, {"group": 3, "id": "LRP10", "label": "LRP10", "shape": "dot", "size": 10, "title": "LRP10 | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6e263da311cc2e11  \n[file]: 37340466 - Sex specific molecular networks and key drivers of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: The study also found that LRP10 has binding partners, including CD34, NBR1, and ACBD3, which are ...\n\u003e [evidence]: Gene perturbation experiments in EFAD mouse models demonstrated that LRP10 differentially affecte...\n\u003e [evidence]: The study also found that LRP10 has binding partners, including CD34, NBR1, and ACBD3, which are ...\n\u003e [evidence]: The study also found that LRP10 has binding partners, including CD34, NBR1, and ACBD3, which are ...\n\u003e [evidence]: Gene perturbation experiments in EFAD mouse models demonstrated that LRP10 differentially affecte...\n\u003e [evidence]: The study also found that LRP10 has binding partners, including CD34, NBR1, and ACBD3, which are ...\n\u003e [evidence]: The study also found that LRP10 has binding partners, including CD34, NBR1, and ACBD3, which are ...\n\u003e [evidence]: Eight LRP10 binding partners were identified by the yeast two-hybrid system screening, and LRP10 ...\n\u003e [evidence]: The study also found that LRP10 has binding partners, including CD34, NBR1, and ACBD3, which are ...", "value": 18.11107105653813}, {"group": 5, "id": "AD patients", "label": "AD patients", "shape": "dot", "size": 10, "title": "AD patients | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f7ba0f60074958f6  \n[file]: 32271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\n\u003e [evidence]: Thus, although the observed TLR8 and HERV-K upregulation in patients with AD can be both a cause ...\n[doc_id]: 17b13a15fc3bdd35  \n[file]: 39415193 - Network dynamics-based subtyping of Alzheimer\u0027s disease with microglial genetic risk factors.pdf\n\u003e [evidence]: The three main identified risk factors distinguishing AD patients are highly related to microglia...", "value": 18.11107105653813}, {"group": 5, "id": "microglial functions", "label": "microglial functions", "shape": "dot", "size": 10, "title": "microglial functions | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: Despite the potential for BIN1 to regulate crucial cellular pathways and microglial functions und...\n[doc_id]: 17b13a15fc3bdd35  \n[file]: 39415193 - Network dynamics-based subtyping of Alzheimer\u0027s disease with microglial genetic risk factors.pdf\n\u003e [evidence]: The three main identified risk factors distinguishing AD patients are highly related to microglia...", "value": 18.11107105653813}, {"group": 5, "id": "CSF", "label": "CSF", "shape": "dot", "size": 10, "title": "CSF | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: e1110680be88d477  \n[file]: 36747024 - Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Finally, TGF-\u03b21 has been shown to be increased in CSF and perivascular space of AD patients, wher...\n[doc_id]: f7ba0f60074958f6  \n[file]: 32271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\n\u003e [evidence]: Thus, although the observed TLR8 and HERV-K upregulation in patients with AD can be both a cause ...", "value": 15.735393346764045}, {"group": 5, "id": "BIN1", "label": "BIN1", "shape": "dot", "size": 10, "title": "BIN1 | deg=9\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: Despite the potential for BIN1 to regulate crucial cellular pathways and microglial functions und...\n\u003e [evidence]: Despite the potential for BIN1 to regulate crucial cellular pathways and microglial functions und...\n\u003e [evidence]: We conclude that BIN1 expression is central for appropriate microglial responses to CNS challenge...\n\u003e [evidence]: Additionally, BIN1 can bind to tau and BIN1 overexpression induces tau-dependent network hyperexc...\n\u003e [evidence]: The requirement for BIN1 to regulate Ifitm3 upregulation during inflammation has important implic...\n\u003e [evidence]: We also found that BIN1 regulates the expression of key genes involved in microglial phagocytosis...\n\u003e [evidence]: Additionally, BIN1 can bind to tau and BIN1 overexpression induces tau-dependent network hyperexc...\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: Furthermore, the level of neuronal-specific BIN1 isoform 1 protein is decreased in sporadic AD ca...\n\u003e [evidence]: BIN1 AD-associated SNPs correlate with Tau deposition as well as with brain atrophy.", "value": 27.206180040292132}, {"group": 9, "id": "AD progression", "label": "AD progression", "shape": "dot", "size": 10, "title": "AD progression | deg=6\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Tre...\n\u003e [evidence]: Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Tre...\n\u003e [evidence]: Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Tre...\n\u003e [evidence]: Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Tre...\n[doc_id]: b5d5053cd6fc980b  \n[file]: 40346662 - A single-cell transcriptomic atlas of all cell types in the brain of 5xFAD Alzheimer mice in response to dietary inulin supplementation.pdf\n\u003e [evidence]: Results Here, we show that dietary inulin supplementation synergized with AD progression to speci...\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: Future studies should focus on the identification of AD-specific miRNAs in the gut that can be th...\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: High-resolution proteomics identified VGF El Gaamouch et al. Molecular Neurodegeneration (2020) 1...\n[doc_id]: 8c61c58869724761  \n[file]: 31978074 - Accelerated brain aging towards transcriptional inversion in a zebrafish model of the K115fs mutation of human PSEN2.pdf\n\u003e [evidence]: Evidently, to find strategies for preventing AD progression while patients are still asymptomatic...", "value": 24.048787173725408}, {"group": 9, "id": "Apoe", "label": "Apoe", "shape": "dot", "size": 10, "title": "Apoe | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Tre...\n[doc_id]: 19a9292f563b3f37  \n[file]: 29784049 - Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Pro-inflammatory DAM emerged earlier in mouse models of AD and were characterized by pro-inflamma...\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Attenuated Cx3cr1 expression represents a shift in microglia towards a protective phenotype assoc...", "value": 15.735393346764045}, {"group": 9, "id": "Trem2", "label": "Trem2", "shape": "dot", "size": 10, "title": "Trem2 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: Interestingly, Tsc1 deletion induced expression of Trem2 and other DAM genes (e.g. Clec7a, Cd68, ...\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Tre...\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Attenuated Cx3cr1 expression represents a shift in microglia towards a protective phenotype assoc...", "value": 15.735393346764045}, {"group": 9, "id": "Tyrobp", "label": "Tyrobp", "shape": "dot", "size": 10, "title": "Tyrobp | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ba736b6cce4527e  \n[file]: 28612290 - Deficiency of TYROBP, an adapter protein for TREM2 and CR3 receptors, is neuroprotective in a mouse model of early Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: In accordance with our data, Strittmatter and colleagues [75] recently reported that mouse defici...\n\u003e [evidence]: Thus, the effect of a decreased Tyrobp expression on the stoichiometry of TAU phosphorylation app...\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Tre...", "value": 15.735393346764045}, {"group": 9, "id": "CSF levels of VGF", "label": "CSF levels of VGF", "shape": "dot", "size": 10, "title": "CSF levels of VGF | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: High-resolution proteomics identified VGF El Gaamouch et al. Molecular Neurodegeneration (2020) 1...", "value": 15.735393346764045}, {"group": 9, "id": "Akkermansia muciniphila", "label": "Akkermansia muciniphila", "shape": "dot", "size": 10, "title": "Akkermansia muciniphila | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b5d5053cd6fc980b  \n[file]: 40346662 - A single-cell transcriptomic atlas of all cell types in the brain of 5xFAD Alzheimer mice in response to dietary inulin supplementation.pdf\n\u003e [evidence]: Results Here, we show that dietary inulin supplementation synergized with AD progression to speci...\n\u003e [evidence]: In line with this, daily feeding of APP/PS1 mice with Akkermansia muciniphila for 6 months led to...", "value": 18.11107105653813}, {"group": 9, "id": "\u03b2-secretase site", "label": "\u03b2-secretase site", "shape": "dot", "size": 10, "title": "\u03b2-secretase site | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Regarding A\u03b2 production, Ctsb is thought to interact with the \u03b2-secretase site of amyloid precurs...", "value": 15.735393346764045}, {"group": 9, "id": "A\u03b2 plaque burden", "label": "A\u03b2 plaque burden", "shape": "dot", "size": 10, "title": "A\u03b2 plaque burden | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b5d5053cd6fc980b  \n[file]: 40346662 - A single-cell transcriptomic atlas of all cell types in the brain of 5xFAD Alzheimer mice in response to dietary inulin supplementation.pdf\n\u003e [evidence]: In line with this, daily feeding of APP/PS1 mice with Akkermansia muciniphila for 6 months led to...", "value": 15.735393346764045}, {"group": 15, "id": "AD risk genes", "label": "AD risk genes", "shape": "dot", "size": 10, "title": "AD risk genes | deg=3\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 98011f49f4ecb3ac  \n[file]: 34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: Significant differences in glial gene expression (including AD risk genes expressed in both the a...\n\u003e [evidence]: Significant differences in glial gene expression (including AD risk genes expressed in both the a...\n\u003e [evidence]: Significant differences in glial gene expression (including AD risk genes expressed in both the a...\n[doc_id]: adfef4c28263ade2  \n[file]: 38365833 - Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Microglial function is controlled by variants in AD risk genes (e.g., TREM2, APOE, CLU, CD33, PIL...", "value": 19.933992677987828}, {"group": 15, "id": "CLU", "label": "CLU", "shape": "dot", "size": 10, "title": "CLU | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 98011f49f4ecb3ac  \n[file]: 34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: Significant differences in glial gene expression (including AD risk genes expressed in both the a...", "value": 15.735393346764045}, {"group": 15, "id": "IQCK", "label": "IQCK", "shape": "dot", "size": 10, "title": "IQCK | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 98011f49f4ecb3ac  \n[file]: 34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: Significant differences in glial gene expression (including AD risk genes expressed in both the a...", "value": 15.735393346764045}, {"group": 15, "id": "MEF2C", "label": "MEF2C", "shape": "dot", "size": 10, "title": "MEF2C | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 98011f49f4ecb3ac  \n[file]: 34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: Significant differences in glial gene expression (including AD risk genes expressed in both the a...", "value": 15.735393346764045}, {"group": 63, "id": "AD subtypes", "label": "AD subtypes", "shape": "dot", "size": 10, "title": "AD subtypes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 819143bcdc07bcd0  \n[file]: 40607399 - Decoding neuroinflammation in Alzheimer\u0027s disease a multi-omics and AI-driven perspective for precision medicine.pdf\n\u003e [evidence]: This strategy is expected to achieve accurate classification and early diagnosis of AD subtypes, ...", "value": 15.735393346764045}, {"group": 63, "id": "individualized treatment strategies", "label": "individualized treatment strategies", "shape": "dot", "size": 10, "title": "individualized treatment strategies | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 819143bcdc07bcd0  \n[file]: 40607399 - Decoding neuroinflammation in Alzheimer\u0027s disease a multi-omics and AI-driven perspective for precision medicine.pdf\n\u003e [evidence]: This strategy is expected to achieve accurate classification and early diagnosis of AD subtypes, ...", "value": 15.735393346764045}, {"group": 64, "id": "AD-PRS score", "label": "AD-PRS score", "shape": "dot", "size": 10, "title": "AD-PRS score | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 67093924e7a7a040  \n[file]: 41044568 - Cytokine expression profile in the human brain of older adults.pdf\n\u003e [evidence]: Further supporting the link between AD genetic risk and cytokine expression, we observed that a h...", "value": 15.735393346764045}, {"group": 64, "id": "SPP1 expression in microglia", "label": "SPP1 expression in microglia", "shape": "dot", "size": 10, "title": "SPP1 expression in microglia | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 67093924e7a7a040  \n[file]: 41044568 - Cytokine expression profile in the human brain of older adults.pdf\n\u003e [evidence]: Further supporting the link between AD genetic risk and cytokine expression, we observed that a h...", "value": 15.735393346764045}, {"group": 20, "id": "AD-associated hyperacetylation", "label": "AD-associated hyperacetylation", "shape": "dot", "size": 10, "title": "AD-associated hyperacetylation | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4e7b649fab289523  \n[file]: 34172755 - Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders.pdf\n\u003e [evidence]: It is of note that while AD-associated hyperacetylation was linked to oligodendrocyte genes and a...\n\u003e [evidence]: It is of note that while AD-associated hyperacetylation was linked to oligodendrocyte genes and a...", "value": 18.11107105653813}, {"group": 20, "id": "astrocyte co-expression modules", "label": "astrocyte co-expression modules", "shape": "dot", "size": 10, "title": "astrocyte co-expression modules | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4e7b649fab289523  \n[file]: 34172755 - Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders.pdf\n\u003e [evidence]: It is of note that while AD-associated hyperacetylation was linked to oligodendrocyte genes and a...", "value": 15.735393346764045}, {"group": 20, "id": "oligodendrocyte genes", "label": "oligodendrocyte genes", "shape": "dot", "size": 10, "title": "oligodendrocyte genes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4e7b649fab289523  \n[file]: 34172755 - Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders.pdf\n\u003e [evidence]: It is of note that while AD-associated hyperacetylation was linked to oligodendrocyte genes and a...", "value": 15.735393346764045}, {"group": 65, "id": "AD-like disease", "label": "AD-like disease", "shape": "dot", "size": 10, "title": "AD-like disease | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: Here, we propose a hypothesis that HCMV immediate-early 2 (IE2) protein promotes microglia activa...\n\u003e [evidence]: Taken together, these findings provide useful insights into AD-like disease activated by HCMV IE2.", "value": 15.735393346764045}, {"group": 65, "id": "HCMV IE2", "label": "HCMV IE2", "shape": "dot", "size": 10, "title": "HCMV IE2 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: Taken together, these findings provide useful insights into AD-like disease activated by HCMV IE2.", "value": 15.735393346764045}, {"group": 66, "id": "AD-like phenotypes", "label": "AD-like phenotypes", "shape": "dot", "size": 10, "title": "AD-like phenotypes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: It is also increased by environmental enrichment (EE) [57], which reduces amyloid toxicity and AD...\n\u003e [evidence]: It is also increased by environmental enrichment (EE) [57], which reduces amyloid toxicity and AD...", "value": 15.735393346764045}, {"group": 66, "id": "microglialmediated neuroinflammation", "label": "microglialmediated neuroinflammation", "shape": "dot", "size": 10, "title": "microglialmediated neuroinflammation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: It is also increased by environmental enrichment (EE) [57], which reduces amyloid toxicity and AD...", "value": 15.735393346764045}, {"group": 67, "id": "AD-risk variant", "label": "AD-risk variant", "shape": "dot", "size": 10, "title": "AD-risk variant | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 686e459beba250bc  \n[file]: 40653482 - Multi-omics analysis for identifying cell-type-specific and bulk-level druggable targets in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: The AD-risk variant associated with candidate causal gene PABPC1 is located near or within enhanc...", "value": 15.735393346764045}, {"group": 67, "id": "candidate causal gene PABPC1", "label": "candidate causal gene PABPC1", "shape": "dot", "size": 10, "title": "candidate causal gene PABPC1 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 686e459beba250bc  \n[file]: 40653482 - Multi-omics analysis for identifying cell-type-specific and bulk-level druggable targets in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: The AD-risk variant associated with candidate causal gene PABPC1 is located near or within enhanc...", "value": 15.735393346764045}, {"group": 68, "id": "ANXA1", "label": "ANXA1", "shape": "dot", "size": 10, "title": "ANXA1 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9534686b56278393  \n[file]: 39987247 - Fokker-Planck diffusion maps of microglial transcriptomes reveal radial differentiation into substates associated with Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: In macrophages it has been shown that ANXA1 regulates interferon beta production downstream of TL...", "value": 15.735393346764045}, {"group": 68, "id": "interferon beta production", "label": "interferon beta production", "shape": "dot", "size": 10, "title": "interferon beta production | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9534686b56278393  \n[file]: 39987247 - Fokker-Planck diffusion maps of microglial transcriptomes reveal radial differentiation into substates associated with Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: In macrophages it has been shown that ANXA1 regulates interferon beta production downstream of TL...", "value": 15.735393346764045}, {"group": 0, "id": "APOE", "label": "APOE", "shape": "dot", "size": 10, "title": "APOE | deg=6\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: ce3baf1e3e930d32  \n[file]: 34040149 - NEBULA is a fast negative binomial mixed model for differential or co-expression analysis of large-scale multi-subject single-cell data.pdf\n\u003e [evidence]: c and d Top 10 KEGG pathways in which the genes most correlated with APOE in astrocytes (panel c)...\n[doc_id]: df2d131cac5a5725  \n[file]: 34301296 - Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Notably, TREM2-R47H xMGs also show overall reduced reactivity to plaques, including diminished pl...\n[doc_id]: b77fb099d704992b  \n[file]: 29416036 - A transcriptomic atlas of aged human microglia.pdf\n\u003e [evidence]: In particular, we report the intriguing result that the APOE\u03b52 haplotype is associated with a red...\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: Mechanistically, APOE may modulate the immune response to plaques, preventing aspects that drive ...\n[doc_id]: 666910073258515e  \n[file]: 32703241 - Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.pdf\n\u003e [evidence]: Recent studies showed that APOE binds to TREM2, thus raising the possibility of an APOE-TREM2 int...\n[doc_id]: 213b0617682e2ece  \n[file]: 40307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\n\u003e [evidence]: Conclusion Overall, using a robust model of ATN pathology, we show that APOE de\ufb01ciency decreased ...", "value": 24.048787173725408}, {"group": 0, "id": "late-stage amyloidfacilitated tau pathology", "label": "late-stage amyloidfacilitated tau pathology", "shape": "dot", "size": 10, "title": "late-stage amyloidfacilitated tau pathology | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 213b0617682e2ece  \n[file]: 40307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\n\u003e [evidence]: Conclusion Overall, using a robust model of ATN pathology, we show that APOE de\ufb01ciency decreased ...", "value": 15.735393346764045}, {"group": 0, "id": "astrocytes", "label": "astrocytes", "shape": "dot", "size": 10, "title": "astrocytes | deg=3\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: APOE is the most abundant apolipoprotein in the brain and is normally expressed at highest levels...\n\u003e [evidence]: APOE is the most abundant apolipoprotein in the brain and is normally expressed at highest levels...\n\u003e [evidence]: APOE is the most abundant apolipoprotein in the brain and is normally expressed at highest levels...\n[doc_id]: 98011f49f4ecb3ac  \n[file]: 34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: However, astrocytes also expressed inflammasomes and inflammatory activation pathways commonly fo...\n\u003e [evidence]: However, astrocytes also expressed inflammasomes and inflammatory activation pathways commonly fo...\n\u003e [evidence]: Differentially expressed genes in astrocytes were associated with increased expression of genes f...\n[doc_id]: 1a3720e2622382c1  \n[file]: 36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\n\u003e [evidence]: Right: Another plot of the promotion of cell marker genes (blue/; upregulated in AD vs control, r...\n\u003e [evidence]: We have also discovered an increase in the frequency of microglia, astrocytes and oligodendrocyte...\n[doc_id]: 0daf66358b71ecf2  \n[file]: 27097852 - Untangling the brain\u0027s neuroinflammatory and neurodegenerative transcriptional responses.pdf\n\u003e [evidence]: Our examination of existing data sets from neurodegenerative disease tissues revealed a 12 common...\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Insoluble A\u03b21\u201340 and A\u03b21\u201342 levels were reduced comparably while more astrocytes and microglia we...\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: Combined treatment with FUS and Adu activated phagocytic microglia and increased the number of as...\n\u003e [evidence]: Combined treatment with FUS and Adu activated phagocytic microglia and increased the number of as...", "value": 19.933992677987828}, {"group": 10, "id": "immune response to plaques", "label": "immune response to plaques", "shape": "dot", "size": 10, "title": "immune response to plaques | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: Mechanistically, APOE may modulate the immune response to plaques, preventing aspects that drive ...\n\u003e [evidence]: These findings suggest that APOE3Ch may modulate the immune response to plaques, consistent with ...\n\u003e [evidence]: Mechanistically, APOE may modulate the immune response to plaques, preventing aspects that drive ...", "value": 18.11107105653813}, {"group": 0, "id": "CD9 expression", "label": "CD9 expression", "shape": "dot", "size": 10, "title": "CD9 expression | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: df2d131cac5a5725  \n[file]: 34301296 - Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Notably, TREM2-R47H xMGs also show overall reduced reactivity to plaques, including diminished pl...\n\u003e [evidence]: Notably, TREM2-R47H xMGs also show overall reduced reactivity to plaques, including diminished pl...", "value": 15.735393346764045}, {"group": 0, "id": "FDAMic", "label": "FDAMic", "shape": "dot", "size": 10, "title": "FDAMic | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: ca701e89f5b6c8c9  \n[file]: 38178204 - Identification of female-enriched and disease-associated microglia (FDAMic) contributes to sexual dimorphism in late-onset Alzheimer\u0027s disease.pdf\n\u003e [evidence]: FDAMic are associated with more advanced pathologies and severe trends of cognitive decline.\n\u003e [evidence]: Among other subtypes of microglia, FDAMic exhibit the lowest expression level of ESR1 or ESR2, an...\n\u003e [evidence]: FDAMic are associated with more advanced pathologies and severe trends of cognitive decline.\n\u003e [evidence]: Considering that FDAMic also exhibited the highest expression levels of APOE and TREM2 (Additiona...\n\u003e [evidence]: Among other subtypes of microglia, FDAMic exhibit the lowest expression level of ESR1 or ESR2, an...\n\u003e [evidence]: Quantitatively, the relative cell number ratio of FDAMic is positively associated with more advan...", "value": 15.735393346764045}, {"group": 0, "id": "APOE isoforms", "label": "APOE isoforms", "shape": "dot", "size": 10, "title": "APOE isoforms | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0fafd5f17a2c043e  \n[file]: 33097708 - Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: For example, Atagi et al. found that TREM2 binds all APOE isoforms with similar af\ufb01nity, whereas ...\n\u003e [evidence]: Previous studies examining how APOE isoforms interact with TREM2 have been inconsistent.", "value": 15.735393346764045}, {"group": 0, "id": "Gal-3", "label": "Gal-3", "shape": "dot", "size": 10, "title": "Gal-3 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9e637c3659f6dff8  \n[file]: 35859075 - Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration.pdf\n\u003e [evidence]: MICROGLIA DIVERSITY AND GAL-3 Gal-3 is associated with activated microglia since homeostatic micr...\n\u003e [evidence]: Gal-3 interacts with immune receptors like TREM2 and TLR4.\n\u003e [evidence]: Gal-3 appears upregulated in the transcriptomic pro\ufb01le of microglia in distinct neurodegenerative...\n\u003e [evidence]: Gal-3 interacts with immune receptors like TREM2 and TLR4.", "value": 15.735393346764045}, {"group": 10, "id": "APOE and TREM2", "label": "APOE and TREM2", "shape": "dot", "size": 10, "title": "APOE and TREM2 | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 666910073258515e  \n[file]: 32703241 - Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.pdf\n\u003e [evidence]: While APOE and TREM2 are two major genetic risk factors for LOAD, surprisingly little is known ab...\n[doc_id]: 75e9d948abad0bc8  \n[file]: 30558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\n\u003e [evidence]: Both APOE and TREM2 are associated with lipid metabolism, thus their activation may connect with ...", "value": 18.11107105653813}, {"group": 10, "id": "lipid metabolism", "label": "lipid metabolism", "shape": "dot", "size": 10, "title": "lipid metabolism | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: c51ff7fb94d8674f  \n[file]: 39604588 - Elevated expression of the retrotransposon LINE-1 drives Alzheimer\u0027s disease-associated microglial dysfunction.pdf\n\u003e [evidence]: Using an in vitro model of increased LINE-1 activity in microglia, we determine that retrotranspo...\n\u003e [evidence]: We also find LINE-1 upregulation in iMG induces transcriptomic changes genes associated with anti...\n[doc_id]: 37cdae96f6271e07  \n[file]: 35213535 - Mapping the gene network landscape of Alzheimer\u0027s disease through integrating genomics and transcriptomics.pdf\n\u003e [evidence]: By integrating the AD gene network with transcriptomic data of AD and healthy temporal cortices, ...\n[doc_id]: 75e9d948abad0bc8  \n[file]: 30558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\n\u003e [evidence]: Both APOE and TREM2 are associated with lipid metabolism, thus their activation may connect with ...\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: These findings suggest that APOE3Ch may affect lipid metabolism in the brain, which could contrib...", "value": 18.11107105653813}, {"group": 10, "id": "LOAD", "label": "LOAD", "shape": "dot", "size": 10, "title": "LOAD | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 666910073258515e  \n[file]: 32703241 - Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.pdf\n\u003e [evidence]: While APOE and TREM2 are two major genetic risk factors for LOAD, surprisingly little is known ab...\n[doc_id]: a5271e582a6524a5  \n[file]: 35180881 - PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Recent large-scale genome-wide association studies (GWAS) have identified more than 30 genetic lo...\n\u003e [evidence]: Age, sex, and the apolipoprotein \u03b54 allele (APOE \u03b54) are the three greatest risk factors for LOAD...\n[doc_id]: a8e8ae58507d8422  \n[file]: 36805764 - TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation.pdf\n\u003e [evidence]: The triggering receptor expressed in myeloid cell 2 (TREM2) is among these immune genes, as its g...\n[doc_id]: ca701e89f5b6c8c9  \n[file]: 38178204 - Identification of female-enriched and disease-associated microglia (FDAMic) contributes to sexual dimorphism in late-onset Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Here, we report that the coexistence of APOE4 genetic status\u2014 the strongest genetic risk factor f...", "value": 18.11107105653813}, {"group": 10, "id": "APOE4 genetic status", "label": "APOE4 genetic status", "shape": "dot", "size": 10, "title": "APOE4 genetic status | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: ca701e89f5b6c8c9  \n[file]: 38178204 - Identification of female-enriched and disease-associated microglia (FDAMic) contributes to sexual dimorphism in late-onset Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Here, we report that the coexistence of APOE4 genetic status\u2014 the strongest genetic risk factor f...", "value": 15.735393346764045}, {"group": 4, "id": "tau pathology", "label": "tau pathology", "shape": "dot", "size": 10, "title": "tau pathology | deg=3\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: The results showed that in the 5xFAD model, ApoeCh led to a decrease in tau pathology and an incr...\n\u003e [evidence]: Mechanistically, APOE may modulate the immune response to plaques, preventing aspects that drive ...\n\u003e [evidence]: The results showed that in the 5xFAD model, ApoeCh led to a decrease in tau pathology and an incr...\n\u003e [evidence]: Studies indicate that APOE binding is integral to some of these processes [16\u201320] with difference...\n\u003e [evidence]: In contrast, APOE3Ch expression had no effect on amyloid-\u03b2 plaque burden in the PS19 model, but s...\n[doc_id]: 9534686b56278393  \n[file]: 39987247 - Fokker-Planck diffusion maps of microglial transcriptomes reveal radial differentiation into substates associated with Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: Recent work has shown that T-cell in\ufb01ltration into the brain due to tau pathology can lead to inc...\n\u003e [evidence]: Finally, MS4A6A over expression has been shown to increase with soluble TREM2 in the cerebral spi...\n[doc_id]: 03b5a3ad723acdbf  \n[file]: 37988169 - Galectin-3 aggravates microglial activation and tau transmission in tauopathy.pdf\n\u003e [evidence]: The removal of Gal3 markedly reduced tau pathology in mouse models of tauopathy and AD.", "value": 19.933992677987828}, {"group": 4, "id": "ApoeCh", "label": "ApoeCh", "shape": "dot", "size": 10, "title": "ApoeCh | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: The results showed that in the 5xFAD model, ApoeCh led to a decrease in tau pathology and an incr...", "value": 15.735393346764045}, {"group": 4, "id": "Gal3", "label": "Gal3", "shape": "dot", "size": 10, "title": "Gal3 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 03b5a3ad723acdbf  \n[file]: 37988169 - Galectin-3 aggravates microglial activation and tau transmission in tauopathy.pdf\n\u003e [evidence]: Moreover, the deletion of Gal3 markedly reduced the extent of tauopathy in THY-Tau22 mice (Figure...\n\u003e [evidence]: It is plausible that Gal3 may interact with pTau and serve as an opsonin to enhance the uptake of...\n\u003e [evidence]: Herein, we demonstrated that the exposure of microglia to pathological tau from neurons led to th...\n\u003e [evidence]: The removal of Gal3 markedly reduced tau pathology in mouse models of tauopathy and AD.\n\u003e [evidence]: A recent study showed that HIV infection significantly increases the level of Gal3 in exosomes de...\n\u003e [evidence]: Under the tested conditions, we found that Gal3 directly facilitates the aggregation of pTau into...", "value": 15.735393346764045}, {"group": 3, "id": "APOE de\ufb01ciency", "label": "APOE de\ufb01ciency", "shape": "dot", "size": 10, "title": "APOE de\ufb01ciency | deg=3\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 213b0617682e2ece  \n[file]: 40307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\n\u003e [evidence]: 5 APOE de\ufb01ciency inhibited microgliosis in a model recapitulating ATN pathology.\n\u003e [evidence]: Taken together, our data indicate that APOE de\ufb01ciency inhibits ATN progression by pleiotropic eff...\n\u003e [evidence]: We showed that APOE de\ufb01ciency inhibits progressive amyloid-driven tau pathology and neurodegenera...", "value": 19.933992677987828}, {"group": 3, "id": "ATN progression", "label": "ATN progression", "shape": "dot", "size": 10, "title": "ATN progression | deg=3\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 213b0617682e2ece  \n[file]: 40307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\n\u003e [evidence]: Taken together, our data indicate that APOE de\ufb01ciency inhibits ATN progression by pleiotropic eff...\n\u003e [evidence]: Taken together, our data indicate that APOE de\ufb01ciency inhibits ATN progression by pleiotropic eff...\n\u003e [evidence]: The observed effects of APOE de\ufb01ciency on ATN progression were associated with reduced dense core...", "value": 19.933992677987828}, {"group": 3, "id": "amyloid-driven tau pathology", "label": "amyloid-driven tau pathology", "shape": "dot", "size": 10, "title": "amyloid-driven tau pathology | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 213b0617682e2ece  \n[file]: 40307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\n\u003e [evidence]: We showed that APOE de\ufb01ciency inhibits progressive amyloid-driven tau pathology and neurodegenera...\n\u003e [evidence]: Moreover, microglial elimination signi\ufb01cantly decreased amyloid-driven tau pathology in the prese...", "value": 15.735393346764045}, {"group": 3, "id": "dense core plaque formation", "label": "dense core plaque formation", "shape": "dot", "size": 10, "title": "dense core plaque formation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 213b0617682e2ece  \n[file]: 40307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\n\u003e [evidence]: The observed effects of APOE de\ufb01ciency on ATN progression were associated with reduced dense core...", "value": 15.735393346764045}, {"group": 3, "id": "dense core amyloid plaque formation", "label": "dense core amyloid plaque formation", "shape": "dot", "size": 10, "title": "dense core amyloid plaque formation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 213b0617682e2ece  \n[file]: 40307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\n\u003e [evidence]: Taken together, our data indicate that APOE de\ufb01ciency inhibits ATN progression by pleiotropic eff...\n\u003e [evidence]: Taken together, our data indicate that APOE de\ufb01ciency inhibits ATN progression by pleiotropic eff...", "value": 15.735393346764045}, {"group": 21, "id": "APOE expression in microglia", "label": "APOE expression in microglia", "shape": "dot", "size": 10, "title": "APOE expression in microglia | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: a2b5d2580db67e89  \n[file]: 35436980 - Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer\u0027s disease-associated genetic variants.pdf\n\u003e [evidence]: Compared with astrocytes, the APOE expression in microglia is upregulated in patients with AD [27].\n\u003e [evidence]: Compared with astrocytes, the APOE expression in microglia is upregulated in patients with AD [27].", "value": 18.11107105653813}, {"group": 21, "id": "[27]", "label": "[27]", "shape": "dot", "size": 10, "title": "[27] | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: a2b5d2580db67e89  \n[file]: 35436980 - Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer\u0027s disease-associated genetic variants.pdf\n\u003e [evidence]: Compared with astrocytes, the APOE expression in microglia is upregulated in patients with AD [27].", "value": 15.735393346764045}, {"group": 21, "id": "patients with AD", "label": "patients with AD", "shape": "dot", "size": 10, "title": "patients with AD | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f7ba0f60074958f6  \n[file]: 32271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\n\u003e [evidence]: However, unlike HERV-K, L1_Hs was not differentially upregulated in patients with AD.\n[doc_id]: 7ff5d3a47ea9588d  \n[file]: 35459147 - Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.pdf\n\u003e [evidence]: Resident brain immune cells from patients with AD express more genes associated with immune pathw...\n[doc_id]: a2b5d2580db67e89  \n[file]: 35436980 - Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer\u0027s disease-associated genetic variants.pdf\n\u003e [evidence]: Compared with astrocytes, the APOE expression in microglia is upregulated in patients with AD [27].\n\u003e [evidence]: Due to this eQTL effect, the higher proportion of APOE \u03b54 carriers among the patients with AD can...", "value": 15.735393346764045}, {"group": 22, "id": "APOE \u03b54 allele", "label": "APOE \u03b54 allele", "shape": "dot", "size": 10, "title": "APOE \u03b54 allele | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ec126941318b941  \n[file]: 39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\n\u003e [evidence]: Both A\u03b2 and tau, as well as the APOE \u03b54 allele, were linked to increases in cGAS and STING levels...\n\u003e [evidence]: Both A\u03b2 and tau, as well as the APOE \u03b54 allele, were linked to increases in cGAS and STING levels...", "value": 18.11107105653813}, {"group": 22, "id": "STING", "label": "STING", "shape": "dot", "size": 10, "title": "STING | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ec126941318b941  \n[file]: 39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\n\u003e [evidence]: Both A\u03b2 and tau, as well as the APOE \u03b54 allele, were linked to increases in cGAS and STING levels...", "value": 15.735393346764045}, {"group": 22, "id": "cGAS", "label": "cGAS", "shape": "dot", "size": 10, "title": "cGAS | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ec126941318b941  \n[file]: 39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\n\u003e [evidence]: Both A\u03b2 and tau, as well as the APOE \u03b54 allele, were linked to increases in cGAS and STING levels...", "value": 15.735393346764045}, {"group": 69, "id": "APOE \u03b54 variant", "label": "APOE \u03b54 variant", "shape": "dot", "size": 10, "title": "APOE \u03b54 variant | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: a2b5d2580db67e89  \n[file]: 35436980 - Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer\u0027s disease-associated genetic variants.pdf\n\u003e [evidence]: Interestingly, the APOE \u03b54 variant is associated with attenuated expression of the major transcri...", "value": 15.735393346764045}, {"group": 69, "id": "attenuated expression", "label": "attenuated expression", "shape": "dot", "size": 10, "title": "attenuated expression | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: a2b5d2580db67e89  \n[file]: 35436980 - Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer\u0027s disease-associated genetic variants.pdf\n\u003e [evidence]: Interestingly, the APOE \u03b54 variant is associated with attenuated expression of the major transcri...", "value": 15.735393346764045}, {"group": 10, "id": "synaptic function", "label": "synaptic function", "shape": "dot", "size": 10, "title": "synaptic function | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: These findings suggest that APOE3Ch may affect synaptic function in the brain, which could contri...", "value": 15.735393346764045}, {"group": 10, "id": "subsequent development of tau pathology and neurodegeneration", "label": "subsequent development of tau pathology and neurodegeneration", "shape": "dot", "size": 10, "title": "subsequent development of tau pathology and neurodegeneration | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: Understanding the mechanisms by which APOE3Ch prevents the subsequent development of tau patholog...", "value": 15.735393346764045}, {"group": 70, "id": "APOE3Ch expression", "label": "APOE3Ch expression", "shape": "dot", "size": 10, "title": "APOE3Ch expression | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: We found that APOE3Ch expression significantly reduced amyloid-\u03b2 plaque burden in the 5xFAD model...", "value": 15.735393346764045}, {"group": 70, "id": "amyloid-\u03b2 plaque burden", "label": "amyloid-\u03b2 plaque burden", "shape": "dot", "size": 10, "title": "amyloid-\u03b2 plaque burden | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b5d5053cd6fc980b  \n[file]: 40346662 - A single-cell transcriptomic atlas of all cell types in the brain of 5xFAD Alzheimer mice in response to dietary inulin supplementation.pdf\n\u003e [evidence]: Intriguingly, such dietary change reduces amyloid-\u03b2 plaque burden and alleviates microgliosis in ...\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: We found that APOE3Ch expression significantly reduced amyloid-\u03b2 plaque burden in the 5xFAD model...", "value": 15.735393346764045}, {"group": 12, "id": "APOE4", "label": "APOE4", "shape": "dot", "size": 10, "title": "APOE4 | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: APOE4-induced ER stress, specifically resulting from the ER \u00adCa2+ depletion, promotes the SREBP2 ...\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: APOE4 is the most robust genetic risk factor for sporadic LOAD.", "value": 18.11107105653813}, {"group": 12, "id": "ER stress", "label": "ER stress", "shape": "dot", "size": 10, "title": "ER stress | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: ER stress is also known to stimulate the nuclear translocation of SREBP, which regulates the expr...\n\u003e [evidence]: ER stress can lead to the release of C \u00ad a2+, thus modu2+ lating \u00adCa -dependent functions [56, 57].\n\u003e [evidence]: In conclusion, our study provides evidence that ApoE4 induces ER stress and dysregulation of chol...\n\u003e [evidence]: APOE4-induced ER stress, specifically resulting from the ER \u00adCa2+ depletion, promotes the SREBP2 ...\n[doc_id]: 4dcab4259d686c0e  \n[file]: 38695952 - Characterisation of premature cell senescence in Alzheimer\u0027s disease using single nuclear transcriptomics.pdf\n\u003e [evidence]: Gene set enrichment and pseudotime trajectories described extensive DNA double-strand breaks (DSB...\n\u003e [evidence]: Our data additionally suggest mechanisms that DNA damage, mitochondrial dysfunction and ER stress...", "value": 18.11107105653813}, {"group": 12, "id": "sporadic LOAD", "label": "sporadic LOAD", "shape": "dot", "size": 10, "title": "sporadic LOAD | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: APOE4 is the most robust genetic risk factor for sporadic LOAD.", "value": 15.735393346764045}, {"group": 12, "id": "ApoE4", "label": "ApoE4", "shape": "dot", "size": 10, "title": "ApoE4 | deg=3\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Our observations indicated that MHC II molecules strongly clustered with lipid rafts in BV2 cells...\n\u003e [evidence]: In conclusion, our study provides evidence that ApoE4 induces ER stress and dysregulation of chol...\n\u003e [evidence]: In conclusion, our study provides evidence that ApoE4 induces ER stress and dysregulation of chol...", "value": 19.933992677987828}, {"group": 71, "id": "APOE4 microglia derived from hiPSCs of AD", "label": "APOE4 microglia derived from hiPSCs of AD", "shape": "dot", "size": 10, "title": "APOE4 microglia derived from hiPSCs of AD | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Consistently, we observed significant enrichment of genes associated with unfolded protein respon...", "value": 15.735393346764045}, {"group": 71, "id": "SREBP2", "label": "SREBP2", "shape": "dot", "size": 10, "title": "SREBP2 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Consistently, we observed significant enrichment of genes associated with unfolded protein respon...", "value": 15.735393346764045}, {"group": 72, "id": "APOE\u03b52 haplotype", "label": "APOE\u03b52 haplotype", "shape": "dot", "size": 10, "title": "APOE\u03b52 haplotype | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b77fb099d704992b  \n[file]: 29416036 - A transcriptomic atlas of aged human microglia.pdf\n\u003e [evidence]: In particular, we report the intriguing result that the APOE\u03b52 haplotype is associated with a red...", "value": 15.735393346764045}, {"group": 72, "id": "reduced HuMi_Aged signature", "label": "reduced HuMi_Aged signature", "shape": "dot", "size": 10, "title": "reduced HuMi_Aged signature | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b77fb099d704992b  \n[file]: 29416036 - A transcriptomic atlas of aged human microglia.pdf\n\u003e [evidence]: In particular, we report the intriguing result that the APOE\u03b52 haplotype is associated with a red...", "value": 15.735393346764045}, {"group": 23, "id": "APOE\u03b54 carriers", "label": "APOE\u03b54 carriers", "shape": "dot", "size": 10, "title": "APOE\u03b54 carriers | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: ee0279144e802df8  \n[file]: 37085492 - Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers.pdf\n\u003e [evidence]: APOE\u03b54 carriers had decreased proportions of nuclei in Mic-PNN and IN-axonogenesis, expression st...\n\u003e [evidence]: APOE\u03b54 carriers had decreased proportions of nuclei in Mic-PNN and IN-axonogenesis, expression st...", "value": 18.11107105653813}, {"group": 23, "id": "IN-axonogenesis", "label": "IN-axonogenesis", "shape": "dot", "size": 10, "title": "IN-axonogenesis | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: ee0279144e802df8  \n[file]: 37085492 - Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers.pdf\n\u003e [evidence]: APOE\u03b54 carriers had decreased proportions of nuclei in Mic-PNN and IN-axonogenesis, expression st...", "value": 15.735393346764045}, {"group": 23, "id": "Mic-PNN", "label": "Mic-PNN", "shape": "dot", "size": 10, "title": "Mic-PNN | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: ee0279144e802df8  \n[file]: 37085492 - Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers.pdf\n\u003e [evidence]: APOE\u03b54 carriers had decreased proportions of nuclei in Mic-PNN and IN-axonogenesis, expression st...", "value": 15.735393346764045}, {"group": 73, "id": "APP", "label": "APP", "shape": "dot", "size": 10, "title": "APP | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: This was confirmed in isolated O4 + oligodendrocytes which, showed a significant reduction in BAC...\n[doc_id]: 402f6e14750c9ef2  \n[file]: 35690868 - Novel App knock-in mouse model shows key features of amyloid pathology and reveals profound metabolic dysregulation of microglia.pdf\n\u003e [evidence]: Discussion This study demonstrates that a mouse model expressing physiologically relevant levels ...", "value": 15.735393346764045}, {"group": 73, "id": "APP cleavage", "label": "APP cleavage", "shape": "dot", "size": 10, "title": "APP cleavage | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: This was confirmed in isolated O4 + oligodendrocytes which, showed a significant reduction in BAC...", "value": 15.735393346764045}, {"group": 11, "id": "APP/PS1 mice", "label": "APP/PS1 mice", "shape": "dot", "size": 10, "title": "APP/PS1 mice | deg=6\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: I APP/PS1 mice were treated with Ad-TSHR289 or Ad-Control in the presence of either vehicle or GS...\n\u003e [evidence]: C Schematic drawing of the experimental schedule: APP/PS1 mice were treated with Ad-TSHR289 or Ad...\n\u003e [evidence]: G Primary microglia from APP/PS1 mice were treated with oligomeric A\u03b21\u201342 and then treated with T...\n\u003e [evidence]: I APP/PS1 mice were treated with Ad-TSHR289 or Ad-Control in the presence of either vehicle or GS...\n\u003e [evidence]: C Schematic drawing of the experimental schedule: APP/PS1 mice were treated with Ad-TSHR289 or Ad...\n[doc_id]: 9538f215b7d18baa  \n[file]: 40450296 - Early transcriptional and cellular abnormalities in choroid plexus of a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Additionally, a novel proliferative immune cell type was increased in APP/PS1 mice, suggesting th...\n[doc_id]: 91d0e406cb470366  \n[file]: 33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\n\u003e [evidence]: Representative immunostaining (E) and quantification of the density (F) of microglia (labeled wit...\n\u003e [evidence]: Representative immunostaining (A) and quantification of the density (B) of microglia (labeled wit...\n\u003e [evidence]: Representative immunostaining (A) and quantification of the density (B) of microglia (labeled wit...\n\u003e [evidence]: Representative immunostaining (E) and quantification of the density (F) of microglia (labeled wit...", "value": 24.048787173725408}, {"group": 11, "id": "Ad-Control", "label": "Ad-Control", "shape": "dot", "size": 10, "title": "Ad-Control | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: I APP/PS1 mice were treated with Ad-TSHR289 or Ad-Control in the presence of either vehicle or GS...\n\u003e [evidence]: C Schematic drawing of the experimental schedule: APP/PS1 mice were treated with Ad-TSHR289 or Ad...", "value": 15.735393346764045}, {"group": 11, "id": "Ad-TSHR289", "label": "Ad-TSHR289", "shape": "dot", "size": 10, "title": "Ad-TSHR289 | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: I APP/PS1 mice were treated with Ad-TSHR289 or Ad-Control in the presence of either vehicle or GS...\n\u003e [evidence]: C Schematic drawing of the experimental schedule: APP/PS1 mice were treated with Ad-TSHR289 or Ad...\n\u003e [evidence]: To fulfil the purpose, the 3-month-old female APP/PS1 transgenic mice were immunized and injected...", "value": 18.11107105653813}, {"group": 11, "id": "M1 macrophages", "label": "M1 macrophages", "shape": "dot", "size": 10, "title": "M1 macrophages | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9538f215b7d18baa  \n[file]: 40450296 - Early transcriptional and cellular abnormalities in choroid plexus of a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Additionally, a novel proliferative immune cell type was increased in APP/PS1 mice, suggesting th...", "value": 15.735393346764045}, {"group": 11, "id": "chronic D-Tyr", "label": "chronic D-Tyr", "shape": "dot", "size": 10, "title": "chronic D-Tyr | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 91d0e406cb470366  \n[file]: 33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\n\u003e [evidence]: Representative immunostaining (E) and quantification of the density (F) of microglia (labeled wit...", "value": 15.735393346764045}, {"group": 11, "id": "chronic d-Tyr", "label": "chronic d-Tyr", "shape": "dot", "size": 10, "title": "chronic d-Tyr | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 91d0e406cb470366  \n[file]: 33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\n\u003e [evidence]: Representative immunostaining (A) and quantification of the density (B) of microglia (labeled wit...", "value": 15.735393346764045}, {"group": 11, "id": "oligomeric A\u03b21\u201342", "label": "oligomeric A\u03b21\u201342", "shape": "dot", "size": 10, "title": "oligomeric A\u03b21\u201342 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: G Primary microglia from APP/PS1 mice were treated with oligomeric A\u03b21\u201342 and then treated with T...\n\u003e [evidence]: G Primary microglia from APP/PS1 mice were treated with oligomeric A\u03b21\u201342 and then treated with T...\n\u003e [evidence]: G Primary microglia from APP/PS1 mice were treated with oligomeric A\u03b21\u201342 and then treated with T...", "value": 15.735393346764045}, {"group": 11, "id": "GD phenotype", "label": "GD phenotype", "shape": "dot", "size": 10, "title": "GD phenotype | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: To fulfil the purpose, the 3-month-old female APP/PS1 transgenic mice were immunized and injected...", "value": 15.735393346764045}, {"group": 74, "id": "APP/PSEN1dE9", "label": "APP/PSEN1dE9", "shape": "dot", "size": 10, "title": "APP/PSEN1dE9 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 666910073258515e  \n[file]: 32703241 - Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.pdf\n\u003e [evidence]: The aim of this study was to investigate this interaction using complex AD model mice - a crossbr...", "value": 15.735393346764045}, {"group": 74, "id": "human APOE3", "label": "human APOE3", "shape": "dot", "size": 10, "title": "human APOE3 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 666910073258515e  \n[file]: 32703241 - Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.pdf\n\u003e [evidence]: The aim of this study was to investigate this interaction using complex AD model mice - a crossbr...", "value": 15.735393346764045}, {"group": 4, "id": "early stage of disease", "label": "early stage of disease", "shape": "dot", "size": 10, "title": "early stage of disease | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: We have shown that in APPPS1-21 mice treated in the early stage of disease (2\u20133 months of age) an...", "value": 15.735393346764045}, {"group": 75, "id": "ATN pathology", "label": "ATN pathology", "shape": "dot", "size": 10, "title": "ATN pathology | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: e3232b24532f5879  \n[file]: 34103079 - CSF1R inhibition rescues tau pathology and neurodegeneration in an A T N model with combined AD pathologies, while preserving plaque associated microglia.pdf\n\u003e [evidence]: v Additional file 6: Fig. S6. ATN pathology increases general and microgliarelated expression of ...", "value": 15.735393346764045}, {"group": 75, "id": "general and microgliarelated expression of ApoE", "label": "general and microgliarelated expression of ApoE", "shape": "dot", "size": 10, "title": "general and microgliarelated expression of ApoE | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: e3232b24532f5879  \n[file]: 34103079 - CSF1R inhibition rescues tau pathology and neurodegeneration in an A T N model with combined AD pathologies, while preserving plaque associated microglia.pdf\n\u003e [evidence]: v Additional file 6: Fig. S6. ATN pathology increases general and microgliarelated expression of ...", "value": 15.735393346764045}, {"group": 76, "id": "ATP6AP2", "label": "ATP6AP2", "shape": "dot", "size": 10, "title": "ATP6AP2 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 01ab70cecab4b6e6  \n[file]: 37115208 - Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation.pdf\n\u003e [evidence]: Alteration in lysosomal gene expression, such as decreased expression of genes implicated in lyso...\n\u003e [evidence]: Alteration in lysosomal gene expression, such as decreased expression of genes implicated in lyso...", "value": 15.735393346764045}, {"group": 76, "id": "LAMP2", "label": "LAMP2", "shape": "dot", "size": 10, "title": "LAMP2 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 01ab70cecab4b6e6  \n[file]: 37115208 - Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation.pdf\n\u003e [evidence]: Alteration in lysosomal gene expression, such as decreased expression of genes implicated in lyso...", "value": 15.735393346764045}, {"group": 5, "id": "ATV:4D9", "label": "ATV:4D9", "shape": "dot", "size": 10, "title": "ATV:4D9 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: ATV:4D9 induced durable yet reversible microglial responses by single-cell transcriptional profil...", "value": 15.735393346764045}, {"group": 5, "id": "microglial responses", "label": "microglial responses", "shape": "dot", "size": 10, "title": "microglial responses | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: ATV:4D9 induced durable yet reversible microglial responses by single-cell transcriptional profil...\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: We conclude that BIN1 expression is central for appropriate microglial responses to CNS challenge...", "value": 18.11107105653813}, {"group": 7, "id": "ATV:TREM2", "label": "ATV:TREM2", "shape": "dot", "size": 10, "title": "ATV:TREM2 | deg=8\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: Whether ATV:TREM2 induces glucose uptake cell autonomously in microglia or influences other CNS c...\n\u003e [evidence]: We discovered that ATV:TREM2 promotes energetic capacity via specific metabolic pathways.\n\u003e [evidence]: Namely, ATV:TREM2 promoted mitochondrial fatty acid oxidization, in which TGs stored in lipid dro...\n\u003e [evidence]: ATV:TREM2 also promoted glucose oxidation, demonstrating flexibility in substrate utilization.\n\u003e [evidence]: We found that ATV:TREM2 activates mTOR signaling, which is required for microglia proliferation.\n\u003e [evidence]: ATV:TREM2 increased FDG-PET in an amyloid mouse model, thereby improving brain metabolism in a di...\n\u003e [evidence]: We show direct evidence of microglia proliferation induced by ATV:TREM2, which could help resolve...\n\u003e [evidence]: We also demonstrate that ATV:TREM2 increased microglial activity and glucose metabolism in an amy...\n\u003e [evidence]: Because ATV:TREM2 resulted in enhanced microglia responses compared to anti-TREM2 with equivalent...", "value": 26.222142113076256}, {"group": 7, "id": "mTOR signaling", "label": "mTOR signaling", "shape": "dot", "size": 10, "title": "mTOR signaling | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: We found that ATV:TREM2 activates mTOR signaling, which is required for microglia proliferation.", "value": 15.735393346764045}, {"group": 7, "id": "glucose uptake", "label": "glucose uptake", "shape": "dot", "size": 10, "title": "glucose uptake | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: bb73bcc13afee4b4  \n[file]: 34465358 - Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Notably, while both glycolysis and OXPHOS were decreased, glucose uptake of hippocampal microglia...\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: Whether ATV:TREM2 induces glucose uptake cell autonomously in microglia or influences other CNS c...", "value": 15.735393346764045}, {"group": 7, "id": "FDG-PET", "label": "FDG-PET", "shape": "dot", "size": 10, "title": "FDG-PET | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: ATV:TREM2 increased FDG-PET in an amyloid mouse model, thereby improving brain metabolism in a di...", "value": 15.735393346764045}, {"group": 7, "id": "microglia responses", "label": "microglia responses", "shape": "dot", "size": 10, "title": "microglia responses | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: Because ATV:TREM2 resulted in enhanced microglia responses compared to anti-TREM2 with equivalent...", "value": 15.735393346764045}, {"group": 7, "id": "microglial activity", "label": "microglial activity", "shape": "dot", "size": 10, "title": "microglial activity | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 58164633001be033  \n[file]: 33081847 - Identification of a dysfunctional microglial population in human Alzheimer\u0027s disease cortex using novel single-cell histology image analysis.pdf\n\u003e [evidence]: With two disparate hypotheses, it is unclear whether microglial activity should be enhanced or re...\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: We also demonstrate that ATV:TREM2 increased microglial activity and glucose metabolism in an amy...", "value": 15.735393346764045}, {"group": 7, "id": "energetic capacity", "label": "energetic capacity", "shape": "dot", "size": 10, "title": "energetic capacity | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: We discovered that ATV:TREM2 promotes energetic capacity via specific metabolic pathways.", "value": 15.735393346764045}, {"group": 7, "id": "glucose oxidation", "label": "glucose oxidation", "shape": "dot", "size": 10, "title": "glucose oxidation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: ATV:TREM2 also promoted glucose oxidation, demonstrating flexibility in substrate utilization.\n\u003e [evidence]: We show that a key physiological effect of ATV:TREM2 is to improve the energetic capacity of micr...", "value": 15.735393346764045}, {"group": 7, "id": "mitochondrial fatty acid oxidization", "label": "mitochondrial fatty acid oxidization", "shape": "dot", "size": 10, "title": "mitochondrial fatty acid oxidization | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: Namely, ATV:TREM2 promoted mitochondrial fatty acid oxidization, in which TGs stored in lipid dro...", "value": 15.735393346764045}, {"group": 77, "id": "Ab", "label": "Ab", "shape": "dot", "size": 10, "title": "Ab | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2d3528df6d21428a  \n[file]: 18800168 - Abeta mediated diminution of MTT reduction--an artefact of single cell culture.pdf\n\u003e [evidence]: * E-mail: roenicke@zenit-magdeburg.de other hand, indicated that Ab decreases cellular MTT reduct...", "value": 15.735393346764045}, {"group": 77, "id": "cellular MTT reduction", "label": "cellular MTT reduction", "shape": "dot", "size": 10, "title": "cellular MTT reduction | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2d3528df6d21428a  \n[file]: 18800168 - Abeta mediated diminution of MTT reduction--an artefact of single cell culture.pdf\n\u003e [evidence]: * E-mail: roenicke@zenit-magdeburg.de other hand, indicated that Ab decreases cellular MTT reduct...", "value": 15.735393346764045}, {"group": 78, "id": "Ab (25-35)", "label": "Ab (25-35)", "shape": "dot", "size": 10, "title": "Ab (25-35) | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2d3528df6d21428a  \n[file]: 18800168 - Abeta mediated diminution of MTT reduction--an artefact of single cell culture.pdf\n\u003e [evidence]: Ab (25-35) did not affect LTP in the present study, although a diminution in LTP was found by oth...", "value": 15.735393346764045}, {"group": 78, "id": "LTP", "label": "LTP", "shape": "dot", "size": 10, "title": "LTP | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2d3528df6d21428a  \n[file]: 18800168 - Abeta mediated diminution of MTT reduction--an artefact of single cell culture.pdf\n\u003e [evidence]: Ab (25-35) did not affect LTP in the present study, although a diminution in LTP was found by oth...\n\u003e [evidence]: Oligomeric Ab (1-40) significantly reduced the LTP, compared to control potentiation.", "value": 15.735393346764045}, {"group": 79, "id": "Ab aggregates", "label": "Ab aggregates", "shape": "dot", "size": 10, "title": "Ab aggregates | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4e5ef603f6ec87b5  \n[file]: 40787447 - Programmed cell death signatures-driven microglial transformation in Alzheimer\u0027s disease single-cell transcriptomics and functional validation.pdf\n\u003e [evidence]: Ab aggregates promote neuronal necroptosis via the RIPK1-MLKL axis, forming a cascade effect (47).", "value": 15.735393346764045}, {"group": 79, "id": "RIPK1-MLKL axis", "label": "RIPK1-MLKL axis", "shape": "dot", "size": 10, "title": "RIPK1-MLKL axis | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4e5ef603f6ec87b5  \n[file]: 40787447 - Programmed cell death signatures-driven microglial transformation in Alzheimer\u0027s disease single-cell transcriptomics and functional validation.pdf\n\u003e [evidence]: Ab aggregates promote neuronal necroptosis via the RIPK1-MLKL axis, forming a cascade effect (47).", "value": 15.735393346764045}, {"group": 24, "id": "Ab species", "label": "Ab species", "shape": "dot", "size": 10, "title": "Ab species | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2d3528df6d21428a  \n[file]: 18800168 - Abeta mediated diminution of MTT reduction--an artefact of single cell culture.pdf\n\u003e [evidence]: In addition, we demonstrated that Ab mediated LTP disruption depends on the Ab species and does n...\n\u003e [evidence]: In contrast to our findings in the single cell cultures none of the Ab species affected cellular ...", "value": 18.11107105653813}, {"group": 24, "id": "cellular viability", "label": "cellular viability", "shape": "dot", "size": 10, "title": "cellular viability | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2d3528df6d21428a  \n[file]: 18800168 - Abeta mediated diminution of MTT reduction--an artefact of single cell culture.pdf\n\u003e [evidence]: In contrast to our findings in the single cell cultures none of the Ab species affected cellular ...", "value": 15.735393346764045}, {"group": 24, "id": "MTT reduction", "label": "MTT reduction", "shape": "dot", "size": 10, "title": "MTT reduction | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2d3528df6d21428a  \n[file]: 18800168 - Abeta mediated diminution of MTT reduction--an artefact of single cell culture.pdf\n\u003e [evidence]: In addition, we demonstrated that Ab mediated LTP disruption depends on the Ab species and does n...", "value": 15.735393346764045}, {"group": 80, "id": "AbetaO", "label": "AbetaO", "shape": "dot", "size": 10, "title": "AbetaO | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4e5ef603f6ec87b5  \n[file]: 40787447 - Programmed cell death signatures-driven microglial transformation in Alzheimer\u0027s disease single-cell transcriptomics and functional validation.pdf\n\u003e [evidence]: FIGURE 11 S100A4 knockdown inhibits AbetaO-triggered redox imbalance. (A\u2013C) Inhibition of S100A4 ...\n\u003e [evidence]: FIGURE 11 S100A4 knockdown inhibits AbetaO-triggered redox imbalance. (A\u2013C) Inhibition of S100A4 ...\n\u003e [evidence]: FIGURE 10 S100A4 knockdown modulates AbetaO-induced microglial activation. (A\u2013F) Quantitative RT-...", "value": 15.735393346764045}, {"group": 80, "id": "MDA concentrations", "label": "MDA concentrations", "shape": "dot", "size": 10, "title": "MDA concentrations | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4e5ef603f6ec87b5  \n[file]: 40787447 - Programmed cell death signatures-driven microglial transformation in Alzheimer\u0027s disease single-cell transcriptomics and functional validation.pdf\n\u003e [evidence]: FIGURE 11 S100A4 knockdown inhibits AbetaO-triggered redox imbalance. (A\u2013C) Inhibition of S100A4 ...\n\u003e [evidence]: FIGURE 11 S100A4 knockdown inhibits AbetaO-triggered redox imbalance. (A\u2013C) Inhibition of S100A4 ...", "value": 15.735393346764045}, {"group": 81, "id": "Abi3 de\ufb01ciency", "label": "Abi3 de\ufb01ciency", "shape": "dot", "size": 10, "title": "Abi3 de\ufb01ciency | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 8cb824110484db3e  \n[file]: 36895556 - The effect of Abi3 locus deletion on the progression of Alzheimer\u0027s disease-related pathologies.pdf\n\u003e [evidence]: In summary, Abi3 de\ufb01ciency affects key signaling pathways in microglia function and immune respon...", "value": 15.735393346764045}, {"group": 81, "id": "key signaling pathways", "label": "key signaling pathways", "shape": "dot", "size": 10, "title": "key signaling pathways | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 8cb824110484db3e  \n[file]: 36895556 - The effect of Abi3 locus deletion on the progression of Alzheimer\u0027s disease-related pathologies.pdf\n\u003e [evidence]: In summary, Abi3 de\ufb01ciency affects key signaling pathways in microglia function and immune respon...", "value": 15.735393346764045}, {"group": 82, "id": "Acta Neuropathologica (2022) 143:75\u201391", "label": "Acta Neuropathologica (2022) 143:75\u201391", "shape": "dot", "size": 10, "title": "Acta Neuropathologica (2022) 143:75\u201391 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 98011f49f4ecb3ac  \n[file]: 34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: While 50\u201360% of the significantly up-regulated genes were Acta Neuropathologica (2022) 143:75\u201391 ...", "value": 15.735393346764045}, {"group": 82, "id": "pathological proteins", "label": "pathological proteins", "shape": "dot", "size": 10, "title": "pathological proteins | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 98011f49f4ecb3ac  \n[file]: 34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: While 50\u201360% of the significantly up-regulated genes were Acta Neuropathologica (2022) 143:75\u201391 ...", "value": 15.735393346764045}, {"group": 1, "id": "ARIA-E", "label": "ARIA-E", "shape": "dot", "size": 10, "title": "ARIA-E | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: However, the high dose of Adu (10\u201360 mg /kg) used in clinical studies induced ARIA-E in human cli...", "value": 15.735393346764045}, {"group": 1, "id": "Fig. 1d\u2013f", "label": "Fig. 1d\u2013f", "shape": "dot", "size": 10, "title": "Fig. 1d\u2013f | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: The Western blotting and immunofluorescence results demonstrated that the delivery of Adu was imp...", "value": 15.735393346764045}, {"group": 1, "id": "BBB", "label": "BBB", "shape": "dot", "size": 10, "title": "BBB | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: As neurogenesis is induced only when the BBB is opened, it is assumed that changes in the intrava...\n\u003e [evidence]: In this work, we demonstrated that FUS with microbubbles induced BBB opening and increased the de...\n\u003e [evidence]: In this work, we demonstrated that FUS with microbubbles induced BBB opening and increased the de...\n[doc_id]: 0dda4f28de06d22f  \n[file]: 37907966 - Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer disease.pdf\n\u003e [evidence]: A leaky and dysfunctional BBB is linked to many neurodegenerative diseases, including LOAD [5, 37].", "value": 18.11107105653813}, {"group": 83, "id": "Age-related cognitive decline", "label": "Age-related cognitive decline", "shape": "dot", "size": 10, "title": "Age-related cognitive decline | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: Thus, it is important to understand the mechanisms underlying microglial activation, plasticity a...\n\u003e [evidence]: Thus, it is important to understand the mechanisms underlying microglial activation, plasticity a...", "value": 15.735393346764045}, {"group": 83, "id": "Neurodegenerative disease risk", "label": "Neurodegenerative disease risk", "shape": "dot", "size": 10, "title": "Neurodegenerative disease risk | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: Thus, it is important to understand the mechanisms underlying microglial activation, plasticity a...", "value": 15.735393346764045}, {"group": 84, "id": "Aging", "label": "Aging", "shape": "dot", "size": 10, "title": "Aging | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4dcab4259d686c0e  \n[file]: 38695952 - Characterisation of premature cell senescence in Alzheimer\u0027s disease using single nuclear transcriptomics.pdf\n\u003e [evidence]: Abstract Aging is associated with cell senescence and is the major risk factor for AD.", "value": 15.735393346764045}, {"group": 84, "id": "cell senescence", "label": "cell senescence", "shape": "dot", "size": 10, "title": "cell senescence | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4dcab4259d686c0e  \n[file]: 38695952 - Characterisation of premature cell senescence in Alzheimer\u0027s disease using single nuclear transcriptomics.pdf\n\u003e [evidence]: Abstract Aging is associated with cell senescence and is the major risk factor for AD.\n\u003e [evidence]: Cell senescence also is related to aging, as we showed for the non-diseased control brains.\n\u003e [evidence]: Abstract Aging is associated with cell senescence and is the major risk factor for AD.", "value": 15.735393346764045}, {"group": 1, "id": "histological analyses", "label": "histological analyses", "shape": "dot", "size": 10, "title": "histological analyses | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 75e9d948abad0bc8  \n[file]: 30558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\n\u003e [evidence]: In neurodegenerative diseases, such as Alzheimer\u2019s disease (AD), activated microglia are detected...", "value": 15.735393346764045}, {"group": 1, "id": "aggregation of misfolded \u03b2-amyloid", "label": "aggregation of misfolded \u03b2-amyloid", "shape": "dot", "size": 10, "title": "aggregation of misfolded \u03b2-amyloid | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 5700848d1ffe11e1  \n[file]: 39238030 - Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Background Microglial activation constitutes a hallmark in the pathophysiology of Alzheimer\u2019s dis...", "value": 15.735393346764045}, {"group": 1, "id": "A\u00df", "label": "A\u00df", "shape": "dot", "size": 10, "title": "A\u00df | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Cathepsin S is known to play a role in the degradation of A\u00df and other proteins associated with A...", "value": 15.735393346764045}, {"group": 1, "id": "about 5.8 million people", "label": "about 5.8 million people", "shape": "dot", "size": 10, "title": "about 5.8 million people | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ff5d3a47ea9588d  \n[file]: 35459147 - Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.pdf\n\u003e [evidence]: Background Alzheimer\u2019s disease (AD) affects about 5.8 million people in the USA and nearly 400 mi...", "value": 15.735393346764045}, {"group": 85, "id": "Alzheimer\u2019s disease amyloid precursor protein", "label": "Alzheimer\u2019s disease amyloid precursor protein", "shape": "dot", "size": 10, "title": "Alzheimer\u2019s disease amyloid precursor protein | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0d8fbabff4218d22  \n[file]: 33712570 - Integration of Alzheimer\u0027s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.pdf\n\u003e [evidence]: Burgos, P. et al. Sorting of the Alzheimer\u2019s disease amyloid precursor protein mediated by the AP...", "value": 15.735393346764045}, {"group": 85, "id": "AP-4 complex", "label": "AP-4 complex", "shape": "dot", "size": 10, "title": "AP-4 complex | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0d8fbabff4218d22  \n[file]: 33712570 - Integration of Alzheimer\u0027s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.pdf\n\u003e [evidence]: Burgos, P. et al. Sorting of the Alzheimer\u2019s disease amyloid precursor protein mediated by the AP...", "value": 15.735393346764045}, {"group": 86, "id": "Angiopoietin-like protein 8 (ANGPTL8)", "label": "Angiopoietin-like protein 8 (ANGPTL8)", "shape": "dot", "size": 10, "title": "Angiopoietin-like protein 8 (ANGPTL8) | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ab9e10b4b26b7a7  \n[file]: 40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\n\u003e [evidence]: Objectives Angiopoietin-like protein 8 (ANGPTL8), a high expression of liver-specific secreted pr...", "value": 15.735393346764045}, {"group": 86, "id": "liver-specific secreted proinflammatory factor", "label": "liver-specific secreted proinflammatory factor", "shape": "dot", "size": 10, "title": "liver-specific secreted proinflammatory factor | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ab9e10b4b26b7a7  \n[file]: 40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\n\u003e [evidence]: Objectives Angiopoietin-like protein 8 (ANGPTL8), a high expression of liver-specific secreted pr...", "value": 15.735393346764045}, {"group": 87, "id": "ApoE3", "label": "ApoE3", "shape": "dot", "size": 10, "title": "ApoE3 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Interestingly, compared with ApoE3, ApoE4 is associated with greater dysregulation of cholesterol...", "value": 15.735393346764045}, {"group": 87, "id": "dysregulation of cholesterol and lipid metabolism in glia", "label": "dysregulation of cholesterol and lipid metabolism in glia", "shape": "dot", "size": 10, "title": "dysregulation of cholesterol and lipid metabolism in glia | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Interestingly, compared with ApoE3, ApoE4 is associated with greater dysregulation of cholesterol...", "value": 15.735393346764045}, {"group": 12, "id": "dysregulation of cholesterol metabolism", "label": "dysregulation of cholesterol metabolism", "shape": "dot", "size": 10, "title": "dysregulation of cholesterol metabolism | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: In conclusion, our study provides evidence that ApoE4 induces ER stress and dysregulation of chol...\n\u003e [evidence]: In conclusion, our study provides evidence that ApoE4 induces ER stress and dysregulation of chol...", "value": 15.735393346764045}, {"group": 12, "id": "BV2 cells", "label": "BV2 cells", "shape": "dot", "size": 10, "title": "BV2 cells | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Our observations indicated that MHC II molecules strongly clustered with lipid rafts in BV2 cells...", "value": 15.735393346764045}, {"group": 88, "id": "Apolipoprotein E \u03b54", "label": "Apolipoprotein E \u03b54", "shape": "dot", "size": 10, "title": "Apolipoprotein E \u03b54 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: Abstract Background Apolipoprotein E \u03b54 (APOE4) is the strongest genetic risk factor for late-ons...", "value": 15.735393346764045}, {"group": 88, "id": "late-onset Alzheimer\u2019s disease", "label": "late-onset Alzheimer\u2019s disease", "shape": "dot", "size": 10, "title": "late-onset Alzheimer\u2019s disease | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: Abstract Background Apolipoprotein E \u03b54 (APOE4) is the strongest genetic risk factor for late-ons...\n[doc_id]: 666910073258515e  \n[file]: 32703241 - Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.pdf\n\u003e [evidence]: Background The inheritance of \u03b54 allele of apolipoprotein E (APOE) is the major genetic risk fact...", "value": 15.735393346764045}, {"group": 25, "id": "Arc mice", "label": "Arc mice", "shape": "dot", "size": 10, "title": "Arc mice | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: In a smaller pilot experiment, Arc mice were treated with PMX205 via drinking water for 2, 6, or ...\n\u003e [evidence]: These \ufb01ndings, that C5aR1 antagonism in Arc mice enhances pathways associated with synaptic plast...", "value": 18.11107105653813}, {"group": 25, "id": "synaptic plasticity and learning", "label": "synaptic plasticity and learning", "shape": "dot", "size": 10, "title": "synaptic plasticity and learning | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: These \ufb01ndings, that C5aR1 antagonism in Arc mice enhances pathways associated with synaptic plast...", "value": 15.735393346764045}, {"group": 25, "id": "PMX205", "label": "PMX205", "shape": "dot", "size": 10, "title": "PMX205 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Previous studies in our lab have demonstrated that treatment of mouse models of AD with a specifi...\n\u003e [evidence]: Previous studies in our lab have demonstrated that treatment of mouse models of AD with a specifi...\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: In a smaller pilot experiment, Arc mice were treated with PMX205 via drinking water for 2, 6, or ...", "value": 15.735393346764045}, {"group": 26, "id": "Arctic model of AD", "label": "Arctic model of AD", "shape": "dot", "size": 10, "title": "Arctic model of AD | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: In contrast, the genetic approach to eliminate C5aR1 function used in this Arctic model of AD did...\n\u003e [evidence]: In contrast, the genetic approach to eliminate C5aR1 function used in this Arctic model of AD did...", "value": 18.11107105653813}, {"group": 26, "id": "fibrillar plaque", "label": "fibrillar plaque", "shape": "dot", "size": 10, "title": "fibrillar plaque | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: In contrast, the genetic approach to eliminate C5aR1 function used in this Arctic model of AD did...", "value": 15.735393346764045}, {"group": 26, "id": "microglial accumulation", "label": "microglial accumulation", "shape": "dot", "size": 10, "title": "microglial accumulation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: In contrast, the genetic approach to eliminate C5aR1 function used in this Arctic model of AD did...", "value": 15.735393346764045}, {"group": 89, "id": "Arctic mutation", "label": "Arctic mutation", "shape": "dot", "size": 10, "title": "Arctic mutation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: The Arctic mutation results in the increased rate of fibrillar amyloid plaque deposition, initiat...", "value": 15.735393346764045}, {"group": 89, "id": "fibrillar amyloid plaque deposition", "label": "fibrillar amyloid plaque deposition", "shape": "dot", "size": 10, "title": "fibrillar amyloid plaque deposition | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: The Arctic mutation results in the increased rate of fibrillar amyloid plaque deposition, initiat...", "value": 15.735393346764045}, {"group": 2, "id": "Cx3cr1 deficiency", "label": "Cx3cr1 deficiency", "shape": "dot", "size": 10, "title": "Cx3cr1 deficiency | deg=4\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: In the APPPS1 and R1.40 mouse models of amyloidosis, Cx3cr1 deficiency results in a gene-dose dep...\n\u003e [evidence]: Interestingly, Cx3cr1 deficiency results in heightened accumulation of neurotoxic, oligomeric A\u03b2,...\n\u003e [evidence]: Similar results have been reported in the SOD1-G93A model of ALS, where Cx3cr1 deficiency is asso...\n\u003e [evidence]: Cx3cr1 deficiency is associated with a transient deficit in microglial abundance during early pos...\n\u003e [evidence]: Similar results have been reported in the SOD1-G93A model of ALS, where Cx3cr1 deficiency is asso...", "value": 21.47078669352809}, {"group": 4, "id": "A\u03b2 burden", "label": "A\u03b2 burden", "shape": "dot", "size": 10, "title": "A\u03b2 burden | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: The studies by Wang and colleagues [17] show that GV-971 reconditioned gut microbiota dysbiosis, ...\n\u003e [evidence]: The studies by Wang and colleagues [17] show that GV-971 reconditioned gut microbiota dysbiosis, ...", "value": 15.735393346764045}, {"group": 4, "id": "cognitive impairment", "label": "cognitive impairment", "shape": "dot", "size": 10, "title": "cognitive impairment | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: Furthermore, COX-1 KO in AD mice restored cognitive impairment, accompanied by reduced accumulati...\n\u003e [evidence]: Increased levels of serum TNF-\u03b1 and IL-1\u03b2 correlate with an accelerated rate of cognitive impairm...\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: The studies by Wang and colleagues [17] show that GV-971 reconditioned gut microbiota dysbiosis, ...", "value": 18.11107105653813}, {"group": 90, "id": "A\u03b2 deposition along the vasculature", "label": "A\u03b2 deposition along the vasculature", "shape": "dot", "size": 10, "title": "A\u03b2 deposition along the vasculature | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: e1110680be88d477  \n[file]: 36747024 - Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Altogether, these and our studies highlight A\u03b2 deposition along the vasculature as a possible tri...", "value": 15.735393346764045}, {"group": 90, "id": "PVMs and PVFs", "label": "PVMs and PVFs", "shape": "dot", "size": 10, "title": "PVMs and PVFs | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: e1110680be88d477  \n[file]: 36747024 - Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Altogether, these and our studies highlight A\u03b2 deposition along the vasculature as a possible tri...", "value": 15.735393346764045}, {"group": 91, "id": "A\u03b2 fibrils", "label": "A\u03b2 fibrils", "shape": "dot", "size": 10, "title": "A\u03b2 fibrils | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: A\u03b2 fibrils activate complement resulting in cleavage of C3 and C5.", "value": 15.735393346764045}, {"group": 91, "id": "complement", "label": "complement", "shape": "dot", "size": 10, "title": "complement | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: A\u03b2 fibrils activate complement resulting in cleavage of C3 and C5.\n[doc_id]: 98011f49f4ecb3ac  \n[file]: 34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: Moreover, co-expression networks suggest cell-specific functional roles for genes associated with...\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: If complement is activated and C5 is present locally to enable production of C5a, C5aR1 signaling...", "value": 15.735393346764045}, {"group": 8, "id": "A\u03b2 load", "label": "A\u03b2 load", "shape": "dot", "size": 10, "title": "A\u03b2 load | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: It lowered A\u03b2 load in the brain, possibly by inhibiting \u03b2-secretase activity, and increasing the ...", "value": 15.735393346764045}, {"group": 8, "id": "\u03b2-secretase activity", "label": "\u03b2-secretase activity", "shape": "dot", "size": 10, "title": "\u03b2-secretase activity | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: It lowered A\u03b2 load in the brain, possibly by inhibiting \u03b2-secretase activity, and increasing the ...\n\u003e [evidence]: It lowered A\u03b2 load in the brain, possibly by inhibiting \u03b2-secretase activity, and increasing the ...\n\u003e [evidence]: It lowered A\u03b2 load in the brain, possibly by inhibiting \u03b2-secretase activity, and increasing the ...\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: Even though we did not replicate the previously reported effects of THs on APP gene expression, w...", "value": 18.11107105653813}, {"group": 8, "id": "BACE1", "label": "BACE1", "shape": "dot", "size": 10, "title": "BACE1 | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: Even though we did not replicate the previously reported effects of THs on APP gene expression, w...\n\u003e [evidence]: Even though we did not replicate the previously reported effects of THs on APP gene expression, w...\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: Deletion of Dicer1 slightly but significantly reduced the activity of BACE1, but not \u03b3-secretase ...", "value": 18.11107105653813}, {"group": 92, "id": "A\u03b2 oligomers", "label": "A\u03b2 oligomers", "shape": "dot", "size": 10, "title": "A\u03b2 oligomers | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: For example, A\u03b2 oligomers increase cholesterol concentration at synapses, Ramonet et al.", "value": 15.735393346764045}, {"group": 92, "id": "Ramonet et al.", "label": "Ramonet et al.", "shape": "dot", "size": 10, "title": "Ramonet et al. | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: For example, A\u03b2 oligomers increase cholesterol concentration at synapses, Ramonet et al.", "value": 15.735393346764045}, {"group": 27, "id": "A\u03b2 pathology", "label": "A\u03b2 pathology", "shape": "dot", "size": 10, "title": "A\u03b2 pathology | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: Deletion of Dicer1 in the gut ameliorates A\u03b2 pathology but may also inhibit mitochondrial respira...\n[doc_id]: 1f79b999e0214ae2  \n[file]: 36536457 - Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes.pdf\n\u003e [evidence]: For example, Siglec-F is upregulated in response to A\u03b2 pathology and is selectively expressed in ...\n\u003e [evidence]: For example, Siglec-F is upregulated in response to A\u03b2 pathology and is selectively expressed in ...", "value": 18.11107105653813}, {"group": 27, "id": "A\u03b2-associated DAMs", "label": "A\u03b2-associated DAMs", "shape": "dot", "size": 10, "title": "A\u03b2-associated DAMs | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 1f79b999e0214ae2  \n[file]: 36536457 - Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes.pdf\n\u003e [evidence]: For example, Siglec-F is upregulated in response to A\u03b2 pathology and is selectively expressed in ...", "value": 15.735393346764045}, {"group": 27, "id": "mitochondrial respiration in the brain", "label": "mitochondrial respiration in the brain", "shape": "dot", "size": 10, "title": "mitochondrial respiration in the brain | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: Deletion of Dicer1 in the gut ameliorates A\u03b2 pathology but may also inhibit mitochondrial respira...\n\u003e [evidence]: Deletion of Dicer1 in the gut ameliorates A\u03b2 pathology but may also inhibit mitochondrial respira...", "value": 15.735393346764045}, {"group": 93, "id": "A\u03b2 plagues", "label": "A\u03b2 plagues", "shape": "dot", "size": 10, "title": "A\u03b2 plagues | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 5b4711bead6c11ad  \n[file]: 35706029 - Microglial amyloid beta clearance is driven by PIEZO1 channels.pdf\n\u003e [evidence]: Moreover, treatment of the 5xFAD mouse model of AD with Yoda1 recruits microglia towards A\u03b2 plagu...", "value": 15.735393346764045}, {"group": 93, "id": "hippocampus and cortex", "label": "hippocampus and cortex", "shape": "dot", "size": 10, "title": "hippocampus and cortex | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 5b4711bead6c11ad  \n[file]: 35706029 - Microglial amyloid beta clearance is driven by PIEZO1 channels.pdf\n\u003e [evidence]: Moreover, treatment of the 5xFAD mouse model of AD with Yoda1 recruits microglia towards A\u03b2 plagu...", "value": 15.735393346764045}, {"group": 13, "id": "A\u03b2 plaques", "label": "A\u03b2 plaques", "shape": "dot", "size": 10, "title": "A\u03b2 plaques | deg=3\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: Our immunochemical results showed that A\u03b2 plaques and the expression of p-Tau were markedly incre...\n[doc_id]: b21810daf417fcbe  \n[file]: 39102080 - Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: In a mouse model of amyloidosis, it has been observed that A\u03b2 plaques create a unique environment...\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: These results indicate that COX-1 deletion reduces A\u03b2 plaques by reprogramming microglia toward a...", "value": 19.933992677987828}, {"group": 13, "id": "tau phosphorylation", "label": "tau phosphorylation", "shape": "dot", "size": 10, "title": "tau phosphorylation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b21810daf417fcbe  \n[file]: 39102080 - Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: In a mouse model of amyloidosis, it has been observed that A\u03b2 plaques create a unique environment...", "value": 15.735393346764045}, {"group": 13, "id": "p-Tau", "label": "p-Tau", "shape": "dot", "size": 10, "title": "p-Tau | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: Our immunochemical results showed that A\u03b2 plaques and the expression of p-Tau were markedly incre...\n\u003e [evidence]: Our immunochemical results showed that A\u03b2 plaques and the expression of p-Tau were markedly incre...\n\u003e [evidence]: Immunohistochemical analysis showed that the expressions of both amyloid precursor protein (APP) ...", "value": 15.735393346764045}, {"group": 13, "id": "COX-1 deletion", "label": "COX-1 deletion", "shape": "dot", "size": 10, "title": "COX-1 deletion | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: COX-1 deletion preferentially enhances microglial clearance of A\u03b242.\n\u003e [evidence]: These results indicate that COX-1 deletion reduces A\u03b2 plaques by reprogramming microglia toward a...", "value": 18.11107105653813}, {"group": 94, "id": "A\u03b2-exposed microglia", "label": "A\u03b2-exposed microglia", "shape": "dot", "size": 10, "title": "A\u03b2-exposed microglia | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ec126941318b941  \n[file]: 39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\n\u003e [evidence]: d Representative immunoblots showing changes in iNOS levels in A\u03b2-exposed microglia pretreated wi...", "value": 15.735393346764045}, {"group": 94, "id": "STING agonist or antagonist", "label": "STING agonist or antagonist", "shape": "dot", "size": 10, "title": "STING agonist or antagonist | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ec126941318b941  \n[file]: 39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\n\u003e [evidence]: d Representative immunoblots showing changes in iNOS levels in A\u03b2-exposed microglia pretreated wi...", "value": 15.735393346764045}, {"group": 95, "id": "B cell development", "label": "B cell development", "shape": "dot", "size": 10, "title": "B cell development | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0d8fbabff4218d22  \n[file]: 33712570 - Integration of Alzheimer\u0027s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.pdf\n\u003e [evidence]: Schneppenheim, J. et al. The intramembrane protease SPPL2a promotes B cell development and contro...\n\u003e [evidence]: Schneppenheim, J. et al. The intramembrane protease SPPL2a promotes B cell development and contro...", "value": 15.735393346764045}, {"group": 95, "id": "endosomal traf\ufb01c", "label": "endosomal traf\ufb01c", "shape": "dot", "size": 10, "title": "endosomal traf\ufb01c | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0d8fbabff4218d22  \n[file]: 33712570 - Integration of Alzheimer\u0027s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.pdf\n\u003e [evidence]: Schneppenheim, J. et al. The intramembrane protease SPPL2a promotes B cell development and contro...", "value": 15.735393346764045}, {"group": 8, "id": "Dicer1", "label": "Dicer1", "shape": "dot", "size": 10, "title": "Dicer1 | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: Conclusions Deletion of Dicer1 in intestinal epithelial cells modulates the microbiome in both th...\n\u003e [evidence]: Deletion of Dicer1 slightly but significantly reduced the activity of BACE1, but not \u03b3-secretase ...\n\u003e [evidence]: Quantitative Western blot of vessel lysates showed that deletion of Dicer1 significantly increase...", "value": 18.11107105653813}, {"group": 8, "id": "LRP1", "label": "LRP1", "shape": "dot", "size": 10, "title": "LRP1 | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: 5 Deletion of Dicer1 in intestinal epithelial cells reduces BACE1 activity and increases LRP1 and...\n\u003e [evidence]: Quantitative Western blot of vessel lysates showed that deletion of Dicer1 significantly increase...\n\u003e [evidence]: It lowered A\u03b2 load in the brain, possibly by inhibiting \u03b2-secretase activity, and increasing the ...", "value": 18.11107105653813}, {"group": 96, "id": "BACE1 inhibitors", "label": "BACE1 inhibitors", "shape": "dot", "size": 10, "title": "BACE1 inhibitors | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: While BACE1 inhibitors have been shown to reduce A\u03b2 levels in people with AD, clinical trials tar...", "value": 15.735393346764045}, {"group": 96, "id": "A\u03b2 levels", "label": "A\u03b2 levels", "shape": "dot", "size": 10, "title": "A\u03b2 levels | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: While BACE1 inhibitors have been shown to reduce A\u03b2 levels in people with AD, clinical trials tar...", "value": 15.735393346764045}, {"group": 28, "id": "BAMs", "label": "BAMs", "shape": "dot", "size": 10, "title": "BAMs | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 121f7cadde31d785  \n[file]: 37923721 - Dissecting the human leptomeninges at single-cell resolution.pdf\n\u003e [evidence]: Notably, BAMs display 780 differentially expressed genes from parenchymal microglia, indicating t...\n\u003e [evidence]: In addition, BAMs and microglia both express more AD GWAS genes than other cell types, highlighti...", "value": 18.11107105653813}, {"group": 28, "id": "AD GWAS genes", "label": "AD GWAS genes", "shape": "dot", "size": 10, "title": "AD GWAS genes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 121f7cadde31d785  \n[file]: 37923721 - Dissecting the human leptomeninges at single-cell resolution.pdf\n\u003e [evidence]: In addition, BAMs and microglia both express more AD GWAS genes than other cell types, highlighti...", "value": 15.735393346764045}, {"group": 28, "id": "parenchymal microglia", "label": "parenchymal microglia", "shape": "dot", "size": 10, "title": "parenchymal microglia | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 121f7cadde31d785  \n[file]: 37923721 - Dissecting the human leptomeninges at single-cell resolution.pdf\n\u003e [evidence]: Notably, BAMs display 780 differentially expressed genes from parenchymal microglia, indicating t...", "value": 15.735393346764045}, {"group": 1, "id": "neurodegenerative diseases", "label": "neurodegenerative diseases", "shape": "dot", "size": 10, "title": "neurodegenerative diseases | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Our results supports previous reports that dysfunctional retromer linked to neurodegenerative dis...\n\u003e [evidence]: Our results supports previous reports that dysfunctional retromer linked to neurodegenerative dis...\n[doc_id]: 239a1b3e2f1dfa15  \n[file]: 37803069 - Deconvolution reveals cell-type-specific transcriptomic changes in the aging mouse brain.pdf\n\u003e [evidence]: These immune changes contribute to cognitive decline and increase the risk of neurodegenerative d...\n[doc_id]: 0dda4f28de06d22f  \n[file]: 37907966 - Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer disease.pdf\n\u003e [evidence]: A leaky and dysfunctional BBB is linked to many neurodegenerative diseases, including LOAD [5, 37].\n[doc_id]: c259f1527833acb2  \n[file]: 40301889 - Monoallelic TYROBP deletion is a novel risk factor for Alzheimer\u0027s disease.pdf\n\u003e [evidence]: One previous study has explored the possibility that the Finnish TYROBP deletion might be a risk ...\n[doc_id]: 3eb75adf1386e0a9  \n[file]: 40275260 - Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability.pdf\n\u003e [evidence]: MiRNAs are differentially expressed in neurodegenerative diseases [12\u201315].\n[doc_id]: 38639c37ea0f3a09  \n[file]: 33115519 - Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice.pdf\n\u003e [evidence]: Recent genome-wide association studies have identified variants of microglial genes that are asso...", "value": 15.735393346764045}, {"group": 0, "id": "BCAT1 gene", "label": "BCAT1 gene", "shape": "dot", "size": 10, "title": "BCAT1 gene | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4d6afb7163e035aa  \n[file]: 40796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\n\u003e [evidence]: We validate the BCAT1 gene as downregulated in oligodendrocytes of humans and mice with AD.", "value": 15.735393346764045}, {"group": 0, "id": "oligodendrocytes", "label": "oligodendrocytes", "shape": "dot", "size": 10, "title": "oligodendrocytes | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: APOE is the most abundant apolipoprotein in the brain and is normally expressed at highest levels...\n[doc_id]: 1a3720e2622382c1  \n[file]: 36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\n\u003e [evidence]: Y axis: Gene count values of cell type marker genes, x axis: 6 cell type marker gene categories (...\n\u003e [evidence]: UMAP cluster analysis revealed that the proportions of astrocytes, excitatory neurons, inhibitory...\n\u003e [evidence]: By analysis of publicly available Alzheimer\u2019s/neurological control datasets have found significan...\n[doc_id]: c95d64dce55527b0  \n[file]: 40826098 - Single-nucleus transcriptomics reveals a distinct microglial state and increased MSR1-mediated phagocytosis as common features across dementia subtypes.pdf\n\u003e [evidence]: In response, injury or dysfunction of oligodendrocytes triggers the release of immune mediators t...\n[doc_id]: 92d2fb0bf85a478b  \n[file]: 38036733 - Spatiotemporal characterization of glial cell activation in an Alzheimer\u0027s disease model by spatially resolved transcriptomics.pdf\n\u003e [evidence]: The generally upregulated genes related to oligodendrocytes were consistent with our \ufb01ndings.\n[doc_id]: 686e459beba250bc  \n[file]: 40653482 - Multi-omics analysis for identifying cell-type-specific and bulk-level druggable targets in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Among the 19 cell-type level candidate causal genes, microglia contributed the highest number of ...\n[doc_id]: 4d6afb7163e035aa  \n[file]: 40796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\n\u003e [evidence]: We validate the BCAT1 gene as downregulated in oligodendrocytes of humans and mice with AD.", "value": 18.11107105653813}, {"group": 97, "id": "BDNF signaling pathway", "label": "BDNF signaling pathway", "shape": "dot", "size": 10, "title": "BDNF signaling pathway | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 187cefb34d98d25f  \n[file]: 39103533 - Single-cell spatial transcriptomics reveals distinct patterns of dysregulation in non-neuronal and neuronal cells induced by the Trem2(R47H) Alzheimer\u0027s risk gene mutati.pdf\n\u003e [evidence]: Nr2f2 and Bdnf are both critical to the BDNF signaling pathway, which activates ERK and Akt pathw...", "value": 15.735393346764045}, {"group": 97, "id": "ERK and Akt pathways", "label": "ERK and Akt pathways", "shape": "dot", "size": 10, "title": "ERK and Akt pathways | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 187cefb34d98d25f  \n[file]: 39103533 - Single-cell spatial transcriptomics reveals distinct patterns of dysregulation in non-neuronal and neuronal cells induced by the Trem2(R47H) Alzheimer\u0027s risk gene mutati.pdf\n\u003e [evidence]: Nr2f2 and Bdnf are both critical to the BDNF signaling pathway, which activates ERK and Akt pathw...", "value": 15.735393346764045}, {"group": 5, "id": "BIN1 overexpression", "label": "BIN1 overexpression", "shape": "dot", "size": 10, "title": "BIN1 overexpression | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: Additionally, BIN1 can bind to tau and BIN1 overexpression induces tau-dependent network hyperexc...\n\u003e [evidence]: Additionally, BIN1 can bind to tau and BIN1 overexpression induces tau-dependent network hyperexc...", "value": 18.11107105653813}, {"group": 5, "id": "tau", "label": "tau", "shape": "dot", "size": 10, "title": "tau | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 58164633001be033  \n[file]: 33081847 - Identification of a dysfunctional microglial population in human Alzheimer\u0027s disease cortex using novel single-cell histology image analysis.pdf\n\u003e [evidence]: Further investigation of the I\u00adba1low population revealed that their abundances correlated with t...\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: Additionally, BIN1 can bind to tau and BIN1 overexpression induces tau-dependent network hyperexc...\n[doc_id]: 1f79b999e0214ae2  \n[file]: 36536457 - Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes.pdf\n\u003e [evidence]: Yet, how canonical amyloid-\u03b2 (A\u03b2) and tau pathologies regulate microglia subtypes during the prog...\n\u003e [evidence]: We identify novel microglia subtypes that are induced in response to both A\u03b2 and tau pathologies ...\n[doc_id]: 03b5a3ad723acdbf  \n[file]: 37988169 - Galectin-3 aggravates microglial activation and tau transmission in tauopathy.pdf\n\u003e [evidence]: In addition, GAM may also increase the phosphorylation of tau via the secretion of proinflammator...\n\u003e [evidence]: A previous study demonstrated that the deletion of Trem2 enhances the transmission of tau via exo...", "value": 15.735393346764045}, {"group": 5, "id": "Tau deposition", "label": "Tau deposition", "shape": "dot", "size": 10, "title": "Tau deposition | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: BIN1 AD-associated SNPs correlate with Tau deposition as well as with brain atrophy.", "value": 15.735393346764045}, {"group": 5, "id": "sporadic AD cases", "label": "sporadic AD cases", "shape": "dot", "size": 10, "title": "sporadic AD cases | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: Furthermore, the level of neuronal-specific BIN1 isoform 1 protein is decreased in sporadic AD ca...", "value": 15.735393346764045}, {"group": 5, "id": "Ifitm3", "label": "Ifitm3", "shape": "dot", "size": 10, "title": "Ifitm3 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: The requirement for BIN1 to regulate Ifitm3 upregulation during inflammation has important implic...\n\u003e [evidence]: Importantly, key characteristics of microglial phenotypic transition, including the upregulation ...", "value": 15.735393346764045}, {"group": 5, "id": "cellular pathways", "label": "cellular pathways", "shape": "dot", "size": 10, "title": "cellular pathways | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: Despite the potential for BIN1 to regulate crucial cellular pathways and microglial functions und...", "value": 15.735393346764045}, {"group": 5, "id": "microglial phagocytosis and inflammatory response", "label": "microglial phagocytosis and inflammatory response", "shape": "dot", "size": 10, "title": "microglial phagocytosis and inflammatory response | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: We also found that BIN1 regulates the expression of key genes involved in microglial phagocytosis...", "value": 15.735393346764045}, {"group": 5, "id": "cultured neurons", "label": "cultured neurons", "shape": "dot", "size": 10, "title": "cultured neurons | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: Additionally, BIN1 can bind to tau and BIN1 overexpression induces tau-dependent network hyperexc...", "value": 15.735393346764045}, {"group": 98, "id": "BIN1\u2019s ability", "label": "BIN1\u2019s ability", "shape": "dot", "size": 10, "title": "BIN1\u2019s ability | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: A central Clathrin-Associated Protein binding region (CLAP domain), present only in neuronal isof...", "value": 15.735393346764045}, {"group": 98, "id": "endocytic protein clathrin", "label": "endocytic protein clathrin", "shape": "dot", "size": 10, "title": "endocytic protein clathrin | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: A central Clathrin-Associated Protein binding region (CLAP domain), present only in neuronal isof...", "value": 15.735393346764045}, {"group": 99, "id": "BV2 cell pyroptosis", "label": "BV2 cell pyroptosis", "shape": "dot", "size": 10, "title": "BV2 cell pyroptosis | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ab9e10b4b26b7a7  \n[file]: 40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\n\u003e [evidence]: A. To analyse the role of NLRP3 in BV2 cell pyroptosis after treatment with ANGPLT8 and/or A\u03b21-42...", "value": 15.735393346764045}, {"group": 99, "id": "siRNA strategy", "label": "siRNA strategy", "shape": "dot", "size": 10, "title": "siRNA strategy | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ab9e10b4b26b7a7  \n[file]: 40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\n\u003e [evidence]: A. To analyse the role of NLRP3 in BV2 cell pyroptosis after treatment with ANGPLT8 and/or A\u03b21-42...", "value": 15.735393346764045}, {"group": 100, "id": "Bace1", "label": "Bace1", "shape": "dot", "size": 10, "title": "Bace1 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Our most important finding is that oligodendrocyte Bace1 deletion significantly reduces A\u03b2 plaque...", "value": 15.735393346764045}, {"group": 100, "id": "A\u03b2 plaque", "label": "A\u03b2 plaque", "shape": "dot", "size": 10, "title": "A\u03b2 plaque | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Our most important finding is that oligodendrocyte Bace1 deletion significantly reduces A\u03b2 plaque...", "value": 15.735393346764045}, {"group": 0, "id": "Bace1fl/fl controls", "label": "Bace1fl/fl controls", "shape": "dot", "size": 10, "title": "Bace1fl/fl controls | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: We found that overall BACE1 and APP-fl protein levels in Bace1fl/fl;Olig2-Cre hippocampal tissues...", "value": 15.735393346764045}, {"group": 0, "id": "neurons", "label": "neurons", "shape": "dot", "size": 10, "title": "neurons | deg=4\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: We found that overall BACE1 and APP-fl protein levels in Bace1fl/fl;Olig2-Cre hippocampal tissues...\n[doc_id]: 3eb75adf1386e0a9  \n[file]: 40275260 - Neurodegenerative disease-associated microRNAs acting as signaling molecules modulate CNS neuron structure and viability.pdf\n\u003e [evidence]: Most of the observed miRNA-induced effects on neurons required TLR7/8 signaling.\n[doc_id]: 0daf66358b71ecf2  \n[file]: 27097852 - Untangling the brain\u0027s neuroinflammatory and neurodegenerative transcriptional responses.pdf\n\u003e [evidence]: Our examination of existing data sets from neurodegenerative disease tissues revealed a 12 common...\n[doc_id]: a8e8ae58507d8422  \n[file]: 36805764 - TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation.pdf\n\u003e [evidence]: Analysis of stroke and AD mouse models revealed that sTREM2 proteins bind to neurons, which sugge...\n\u003e [evidence]: sTREM2 has been shown to directly bind to neurons in mouse models of stroke and AD [27, 28], whic...\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: In the CNS, ubiquitous BIN1 isoforms lacking the CLAP domain are expressed in neurons and non-neu...\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: To understand the underlying mechanisms of action, we investigated the changes in microglia, astr...", "value": 21.47078669352809}, {"group": 0, "id": "CLAP domain", "label": "CLAP domain", "shape": "dot", "size": 10, "title": "CLAP domain | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: In the CNS, ubiquitous BIN1 isoforms lacking the CLAP domain are expressed in neurons and non-neu...\n\u003e [evidence]: In the CNS, ubiquitous BIN1 isoforms lacking the CLAP domain are expressed in neurons and non-neu...", "value": 18.11107105653813}, {"group": 0, "id": "IE2 gene", "label": "IE2 gene", "shape": "dot", "size": 10, "title": "IE2 gene | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: Previous experiments have demonstrated that overexpression of the IE2 gene can lead to loss of sy...\n\u003e [evidence]: Previous experiments have demonstrated that overexpression of the IE2 gene can lead to loss of sy...\n\u003e [evidence]: Previous experiments have demonstrated that overexpression of the IE2 gene can lead to loss of sy...", "value": 15.735393346764045}, {"group": 101, "id": "Bayesian approach", "label": "Bayesian approach", "shape": "dot", "size": 10, "title": "Bayesian approach | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: ab2593c0e43503e8  \n[file]: 40074951 - Spotiphy enables single-cell spatial whole transcriptomics across an entire section.pdf\n\u003e [evidence]: Spotiphy uses a Bayesian approach to dissect the expression of individual genes and assign them t...", "value": 15.735393346764045}, {"group": 101, "id": "individual genes", "label": "individual genes", "shape": "dot", "size": 10, "title": "individual genes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: ab2593c0e43503e8  \n[file]: 40074951 - Spotiphy enables single-cell spatial whole transcriptomics across an entire section.pdf\n\u003e [evidence]: Spotiphy uses a Bayesian approach to dissect the expression of individual genes and assign them t...", "value": 15.735393346764045}, {"group": 0, "id": "behavior", "label": "behavior", "shape": "dot", "size": 10, "title": "behavior | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: However, the study found that loss of Bin1 affected behavior in Bin1 c-KO mice.\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Compared to knock-in Hexb mice, Hexb heterozygotic mice showed improved behavior and decrease in ...", "value": 15.735393346764045}, {"group": 0, "id": "neuropathological features", "label": "neuropathological features", "shape": "dot", "size": 10, "title": "neuropathological features | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The study also found that loss of Bin1 affected neuropathological features in Bin1 c-KO mice, reg...", "value": 15.735393346764045}, {"group": 14, "id": "Bin1 c-KO mice", "label": "Bin1 c-KO mice", "shape": "dot", "size": 10, "title": "Bin1 c-KO mice | deg=4\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The study also found that Bin1 c-KO mice showed reduced freezing time during fear conditioning.\n\u003e [evidence]: The study found that Bin1 c-KO mice showed reduced open field exploration and auditory startle re...\n\u003e [evidence]: The study also found that loss of Bin1 affected neuropathological features in Bin1 c-KO mice, reg...\n\u003e [evidence]: The study found that Bin1 c-KO mice showed reduced open field exploration and auditory startle re...", "value": 21.47078669352809}, {"group": 14, "id": "auditory startle response", "label": "auditory startle response", "shape": "dot", "size": 10, "title": "auditory startle response | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The study found that Bin1 c-KO mice showed reduced open field exploration and auditory startle re...", "value": 15.735393346764045}, {"group": 14, "id": "fear conditioning", "label": "fear conditioning", "shape": "dot", "size": 10, "title": "fear conditioning | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The study also found that Bin1 c-KO mice showed reduced freezing time during fear conditioning.", "value": 15.735393346764045}, {"group": 14, "id": "open field exploration", "label": "open field exploration", "shape": "dot", "size": 10, "title": "open field exploration | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The study found that Bin1 c-KO mice showed reduced open field exploration and auditory startle re...", "value": 15.735393346764045}, {"group": 14, "id": "human Tau P301S", "label": "human Tau P301S", "shape": "dot", "size": 10, "title": "human Tau P301S | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The study also found that loss of Bin1 affected neuropathological features in Bin1 c-KO mice, reg...", "value": 15.735393346764045}, {"group": 102, "id": "Bin1 isoform 1", "label": "Bin1 isoform 1", "shape": "dot", "size": 10, "title": "Bin1 isoform 1 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The loss of Bin1 isoform 1 resulted in reduced excitability in primary neurons in vitro, reduced ...", "value": 15.735393346764045}, {"group": 102, "id": "primary neurons", "label": "primary neurons", "shape": "dot", "size": 10, "title": "primary neurons | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The loss of Bin1 isoform 1 resulted in reduced excitability in primary neurons in vitro, reduced ...\n\u003e [evidence]: The loss of Bin1 isoform 1 resulted in reduced excitability in primary neurons in vitro, reduced ...", "value": 15.735393346764045}, {"group": 29, "id": "Black", "label": "Black", "shape": "dot", "size": 10, "title": "Black | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 19a9292f563b3f37  \n[file]: 29784049 - Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Colors represent module membership (Blue: Homeostatic module, Red and Midnightblue: M1-like modul...\n\u003e [evidence]: Colors represent module membership (Blue: Homeostatic module, Red and Midnightblue: M1-like modul...", "value": 18.11107105653813}, {"group": 29, "id": "Yellow", "label": "Yellow", "shape": "dot", "size": 10, "title": "Yellow | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 19a9292f563b3f37  \n[file]: 29784049 - Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Colors represent module membership (Blue: Homeostatic module, Red and Midnightblue: M1-like modul...\n\u003e [evidence]: Colors represent module membership (Blue: Homeostatic module, Red and Midnightblue: M1-like modul...", "value": 15.735393346764045}, {"group": 29, "id": "Cyan", "label": "Cyan", "shape": "dot", "size": 10, "title": "Cyan | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 19a9292f563b3f37  \n[file]: 29784049 - Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Colors represent module membership (Blue: Homeostatic module, Red and Midnightblue: M1-like modul...\n\u003e [evidence]: Colors represent module membership (Blue: Homeostatic module, Red and Midnightblue: M1-like modul...\n\u003e [evidence]: e Overlap of mouse modules [Blue/homeostatic, Yellow/anti-inflammatory DAM, Magenta/pro-inflammat...", "value": 15.735393346764045}, {"group": 103, "id": "Bone-marrow derived Macrophages", "label": "Bone-marrow derived Macrophages", "shape": "dot", "size": 10, "title": "Bone-marrow derived Macrophages | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 83604f00c2934caf  \n[file]: 34294785 - Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Bone-marrow derived Macrophages overexpressing PU.1 increased GM-CSF and M-CSF dependent prolifer...", "value": 15.735393346764045}, {"group": 103, "id": "GM-CSF", "label": "GM-CSF", "shape": "dot", "size": 10, "title": "GM-CSF | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 83604f00c2934caf  \n[file]: 34294785 - Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Bone-marrow derived Macrophages overexpressing PU.1 increased GM-CSF and M-CSF dependent prolifer...", "value": 15.735393346764045}, {"group": 104, "id": "Brain", "label": "Brain", "shape": "dot", "size": 10, "title": "Brain | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: However, aging-associated chronic, low-grade inflammation in the brain can result in dysfunctiona...", "value": 15.735393346764045}, {"group": 104, "id": "Microglial phagocytosis", "label": "Microglial phagocytosis", "shape": "dot", "size": 10, "title": "Microglial phagocytosis | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: However, aging-associated chronic, low-grade inflammation in the brain can result in dysfunctiona...", "value": 15.735393346764045}, {"group": 105, "id": "Brown", "label": "Brown", "shape": "dot", "size": 10, "title": "Brown | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4531a8781d26732c  \n[file]: 29954413 - Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer\u0027s disease-related proteins.pdf\n\u003e [evidence]: g Immunohistochemistry micrographs from AD and non-disease control post-mortem human brains (fron...", "value": 15.735393346764045}, {"group": 105, "id": "representative images", "label": "representative images", "shape": "dot", "size": 10, "title": "representative images | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4531a8781d26732c  \n[file]: 29954413 - Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer\u0027s disease-related proteins.pdf\n\u003e [evidence]: g Immunohistochemistry micrographs from AD and non-disease control post-mortem human brains (fron...", "value": 15.735393346764045}, {"group": 106, "id": "C \u00ad D68+/Iba-1+ area", "label": "C \u00ad D68+/Iba-1+ area", "shape": "dot", "size": 10, "title": "C \u00ad D68+/Iba-1+ area | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: Interestingly, a quantitative assessment of the C \u00ad D68+/Iba-1+ area revealed a significant incre...", "value": 15.735393346764045}, {"group": 106, "id": "5\u00d7FAD + FUS + Adu group", "label": "5\u00d7FAD + FUS + Adu group", "shape": "dot", "size": 10, "title": "5\u00d7FAD + FUS + Adu group | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: Interestingly, a quantitative assessment of the C \u00ad D68+/Iba-1+ area revealed a significant incre...", "value": 15.735393346764045}, {"group": 107, "id": "C1q depletion", "label": "C1q depletion", "shape": "dot", "size": 10, "title": "C1q depletion | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3a6969ccf167b6e1  \n[file]: 35443751 - Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: In AD, C1q depletion is associated with reduced microglia/macrophage activation and AD mice lacki...", "value": 15.735393346764045}, {"group": 107, "id": "microglia/macrophage activation", "label": "microglia/macrophage activation", "shape": "dot", "size": 10, "title": "microglia/macrophage activation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3a6969ccf167b6e1  \n[file]: 35443751 - Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: In AD, C1q depletion is associated with reduced microglia/macrophage activation and AD mice lacki...\n\u003e [evidence]: In AD, C1q depletion is associated with reduced microglia/macrophage activation and AD mice lacki...", "value": 15.735393346764045}, {"group": 30, "id": "C2C", "label": "C2C", "shape": "dot", "size": 10, "title": "C2C | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9f6a04c9a2b37f2c  \n[file]: 38741048 - Characterizing dysregulations via cell-cell communications in Alzheimer\u0027s brains using single-cell transcriptomes.pdf\n\u003e [evidence]: Abbreviations AD Alzheimer\u2019s Disease Astro Astrocytes BICCN BRAIN Initiative Cell Census Network ...\n\u003e [evidence]: Abbreviations AD Alzheimer\u2019s Disease Astro Astrocytes BICCN BRAIN Initiative Cell Census Network ...", "value": 18.11107105653813}, {"group": 30, "id": "CT", "label": "CT", "shape": "dot", "size": 10, "title": "CT | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9f6a04c9a2b37f2c  \n[file]: 38741048 - Characterizing dysregulations via cell-cell communications in Alzheimer\u0027s brains using single-cell transcriptomes.pdf\n\u003e [evidence]: Abbreviations AD Alzheimer\u2019s Disease Astro Astrocytes BICCN BRAIN Initiative Cell Census Network ...", "value": 15.735393346764045}, {"group": 30, "id": "Cortico-thalamic Endo", "label": "Cortico-thalamic Endo", "shape": "dot", "size": 10, "title": "Cortico-thalamic Endo | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9f6a04c9a2b37f2c  \n[file]: 38741048 - Characterizing dysregulations via cell-cell communications in Alzheimer\u0027s brains using single-cell transcriptomes.pdf\n\u003e [evidence]: Abbreviations AD Alzheimer\u2019s Disease Astro Astrocytes BICCN BRAIN Initiative Cell Census Network ...", "value": 15.735393346764045}, {"group": 108, "id": "C3 depletion", "label": "C3 depletion", "shape": "dot", "size": 10, "title": "C3 depletion | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3a6969ccf167b6e1  \n[file]: 35443751 - Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Moreover, C3 depletion in a mouse model of AD signi\ufb01cantly reduces synapse loss and promotes cogn...", "value": 15.735393346764045}, {"group": 108, "id": "synapse loss", "label": "synapse loss", "shape": "dot", "size": 10, "title": "synapse loss | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3a6969ccf167b6e1  \n[file]: 35443751 - Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Moreover, C3 depletion in a mouse model of AD signi\ufb01cantly reduces synapse loss and promotes cogn...\n\u003e [evidence]: In AD, C1q depletion is associated with reduced microglia/macrophage activation and AD mice lacki...\n\u003e [evidence]: Moreover, C3 depletion in a mouse model of AD signi\ufb01cantly reduces synapse loss and promotes cogn...\n\u003e [evidence]: Synapse loss correlates highly with decline in cognitive function during AD22,23, and microglia a...", "value": 15.735393346764045}, {"group": 31, "id": "C3a \u2013 C3aR signaling", "label": "C3a \u2013 C3aR signaling", "shape": "dot", "size": 10, "title": "C3a \u2013 C3aR signaling | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: 5 Microglial C3a \u2013 C3aR signaling promotes glycolysis and phagocytosis.\n\u003e [evidence]: 5 Microglial C3a \u2013 C3aR signaling promotes glycolysis and phagocytosis.", "value": 18.11107105653813}, {"group": 31, "id": "glycolysis", "label": "glycolysis", "shape": "dot", "size": 10, "title": "glycolysis | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: 5 Microglial C3a \u2013 C3aR signaling promotes glycolysis and phagocytosis.", "value": 15.735393346764045}, {"group": 31, "id": "phagocytosis", "label": "phagocytosis", "shape": "dot", "size": 10, "title": "phagocytosis | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ff5d3a47ea9588d  \n[file]: 35459147 - Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.pdf\n\u003e [evidence]: Resident brain immune cells from patients with AD express more genes associated with immune pathw...\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: Due to the combined effect of FUS and Adu, neurogenesis and phagocytosis are increased and amyloi...\n\u003e [evidence]: FcR activates phagocytosis, clearance of myelin debris and the inflammatory response.\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: C5a induces an inflammatory polarization of the microglia, potentially synergizing with TLRs, whi...\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: 5 Microglial C3a \u2013 C3aR signaling promotes glycolysis and phagocytosis.", "value": 15.735393346764045}, {"group": 32, "id": "C3aR1-null mice", "label": "C3aR1-null mice", "shape": "dot", "size": 10, "title": "C3aR1-null mice | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: Methods: We performed phagocytic/migration assays and RNA sequencing on BV2 microglial cells and ...\n\u003e [evidence]: Methods: We performed phagocytic/migration assays and RNA sequencing on BV2 microglial cells and ...", "value": 18.11107105653813}, {"group": 32, "id": "C3a super agonist (C3aSA)", "label": "C3a super agonist (C3aSA)", "shape": "dot", "size": 10, "title": "C3a super agonist (C3aSA) | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: Methods: We performed phagocytic/migration assays and RNA sequencing on BV2 microglial cells and ...", "value": 15.735393346764045}, {"group": 32, "id": "TLQP-21", "label": "TLQP-21", "shape": "dot", "size": 10, "title": "TLQP-21 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: Methods: We performed phagocytic/migration assays and RNA sequencing on BV2 microglial cells and ...\n\u003e [evidence]: We first showed that TLQP-21 activates microglia via C3aR1.\n\u003e [evidence]: Results: We demonstrate that TLQP-21 increases motility and phagocytic capacity in murine BV2 mic...", "value": 15.735393346764045}, {"group": 6, "id": "Alzheimer\u0027s disease (AD)", "label": "Alzheimer\u0027s disease (AD)", "shape": "dot", "size": 10, "title": "Alzheimer\u0027s disease (AD) | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Abstract Background: Pharmacologic inhibition of C5aR1, a receptor for the complement activation ...", "value": 15.735393346764045}, {"group": 6, "id": "C5aR1", "label": "C5aR1", "shape": "dot", "size": 10, "title": "C5aR1 | deg=4\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: In addition, in vitro cultures of C57BL6/J cortical neurons express C5aR1 and, upon binding, C5a ...\n\u003e [evidence]: Results: A lack of C5aR1 prevented behavior deficits at 10 months, although amyloid plaque load w...\n\u003e [evidence]: In addition, since C5aR1 is primarily expressed on cells of the myeloid lineage, and only to a le...\n\u003e [evidence]: To validate that the effect of the antagonist was specifically via C5aR1 inhibition, mice lacking...\n\u003e [evidence]: Microglia also express C5aR1 leading to C5a-induced chemotactic functions [26].\n\u003e [evidence]: In addition, in vitro cultures of C57BL6/J cortical neurons express C5aR1 and, upon binding, C5a ...", "value": 21.47078669352809}, {"group": 6, "id": "myeloid lineage", "label": "myeloid lineage", "shape": "dot", "size": 10, "title": "myeloid lineage | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: In addition, since C5aR1 is primarily expressed on cells of the myeloid lineage, and only to a le...", "value": 15.735393346764045}, {"group": 6, "id": "mice", "label": "mice", "shape": "dot", "size": 10, "title": "mice | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3319f4b14f340c9e  \n[file]: 37989983 - Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5\u00d7FAD Mice.pdf\n\u003e [evidence]: Abstract microRNA-29a (miR-29a) increases with age in humans and mice, and, in the brain, it has ...\n[doc_id]: c110590ee636ba06  \n[file]: 39753747 - A subcellular sampling instrument allows spatial resolution of amyloid deposit-derived organelle-specific effects in microglia.pdf\n\u003e [evidence]: Cox-2 de\ufb01ciency has been found recently to in\ufb02uence microglial density and morphology in mice40 a...\n\u003e [evidence]: d Cox-2 de\ufb01ciency has been found recently to in\ufb02uence microglial density and morphology in mice40...\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: To validate that the effect of the antagonist was specifically via C5aR1 inhibition, mice lacking...", "value": 15.735393346764045}, {"group": 6, "id": "behavior deficits", "label": "behavior deficits", "shape": "dot", "size": 10, "title": "behavior deficits | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Results: A lack of C5aR1 prevented behavior deficits at 10 months, although amyloid plaque load w...", "value": 15.735393346764045}, {"group": 109, "id": "C5aR1 inhibition", "label": "C5aR1 inhibition", "shape": "dot", "size": 10, "title": "C5aR1 inhibition | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: However, in those models C5aR1 inhibition decreased amyloid plaque accumulation by 50%.", "value": 15.735393346764045}, {"group": 109, "id": "amyloid plaque accumulation", "label": "amyloid plaque accumulation", "shape": "dot", "size": 10, "title": "amyloid plaque accumulation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: However, in those models C5aR1 inhibition decreased amyloid plaque accumulation by 50%.", "value": 15.735393346764045}, {"group": 33, "id": "C5aR1 signaling", "label": "C5aR1 signaling", "shape": "dot", "size": 10, "title": "C5aR1 signaling | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Further studies are needed to determine the specific mechanisms by which C5aR1 signaling regulate...\n\u003e [evidence]: These results provide links between microglial responses and loss of cognitive performance and, c...\n\u003e [evidence]: Conclusions: These data are consistent with microglial polarization in the absence of C5aR1 signa...", "value": 18.11107105653813}, {"group": 33, "id": "inflammatory genes", "label": "inflammatory genes", "shape": "dot", "size": 10, "title": "inflammatory genes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Conclusions: These data are consistent with microglial polarization in the absence of C5aR1 signa...\n\u003e [evidence]: Conclusions: These data are consistent with microglial polarization in the absence of C5aR1 signa...", "value": 15.735393346764045}, {"group": 33, "id": "potential of C5aR1 antagonists", "label": "potential of C5aR1 antagonists", "shape": "dot", "size": 10, "title": "potential of C5aR1 antagonists | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Further studies are needed to determine the specific mechanisms by which C5aR1 signaling regulate...", "value": 15.735393346764045}, {"group": 110, "id": "C5aR1-dependent", "label": "C5aR1-dependent", "shape": "dot", "size": 10, "title": "C5aR1-dependent | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Microglia clusters M4 and M9 were C5aR1-dependent and expressed genes that detrimentally modulate...", "value": 15.735393346764045}, {"group": 110, "id": "synapse pruning", "label": "synapse pruning", "shape": "dot", "size": 10, "title": "synapse pruning | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Microglia clusters M4 and M9 were C5aR1-dependent and expressed genes that detrimentally modulate...", "value": 15.735393346764045}, {"group": 111, "id": "CA1 neurons", "label": "CA1 neurons", "shape": "dot", "size": 10, "title": "CA1 neurons | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Discussion Genetic deletion of C5aR1 in the Arctic Alzheimer\u2019s disease mouse model resulted in pr...", "value": 15.735393346764045}, {"group": 111, "id": "hippocampal dependent spatial memory task", "label": "hippocampal dependent spatial memory task", "shape": "dot", "size": 10, "title": "hippocampal dependent spatial memory task | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Discussion Genetic deletion of C5aR1 in the Arctic Alzheimer\u2019s disease mouse model resulted in pr...", "value": 15.735393346764045}, {"group": 112, "id": "CD33 and TREM2", "label": "CD33 and TREM2", "shape": "dot", "size": 10, "title": "CD33 and TREM2 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 58164633001be033  \n[file]: 33081847 - Identification of a dysfunctional microglial population in human Alzheimer\u0027s disease cortex using novel single-cell histology image analysis.pdf\n\u003e [evidence]: Genetic risk factors for AD include loss-offunction mutations in microglia-specific genes, includ...", "value": 15.735393346764045}, {"group": 112, "id": "reduced microglial phagocytic capacity", "label": "reduced microglial phagocytic capacity", "shape": "dot", "size": 10, "title": "reduced microglial phagocytic capacity | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 58164633001be033  \n[file]: 33081847 - Identification of a dysfunctional microglial population in human Alzheimer\u0027s disease cortex using novel single-cell histology image analysis.pdf\n\u003e [evidence]: Genetic risk factors for AD include loss-offunction mutations in microglia-specific genes, includ...", "value": 15.735393346764045}, {"group": 113, "id": "CD8+ cells", "label": "CD8+ cells", "shape": "dot", "size": 10, "title": "CD8+ cells | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 121f7cadde31d785  \n[file]: 37923721 - Dissecting the human leptomeninges at single-cell resolution.pdf\n\u003e [evidence]: For immune cells, we detect diverse T cell subtypes in the leptomeninges, primarily CD8+ cells, e...", "value": 15.735393346764045}, {"group": 113, "id": "TRM core genes", "label": "TRM core genes", "shape": "dot", "size": 10, "title": "TRM core genes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 121f7cadde31d785  \n[file]: 37923721 - Dissecting the human leptomeninges at single-cell resolution.pdf\n\u003e [evidence]: For immune cells, we detect diverse T cell subtypes in the leptomeninges, primarily CD8+ cells, e...", "value": 15.735393346764045}, {"group": 34, "id": "CD83", "label": "CD83", "shape": "dot", "size": 10, "title": "CD83 | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: 13 1342 Molecular Neurobiology (2024) 61:1331\u20131345 upregulated genes (ApoE, ISG15, CD83) and down...\n\u003e [evidence]: 13 1342 Molecular Neurobiology (2024) 61:1331\u20131345 upregulated genes (ApoE, ISG15, CD83) and down...", "value": 18.11107105653813}, {"group": 34, "id": "P2ry12", "label": "P2ry12", "shape": "dot", "size": 10, "title": "P2ry12 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: 13 1342 Molecular Neurobiology (2024) 61:1331\u20131345 upregulated genes (ApoE, ISG15, CD83) and down...", "value": 15.735393346764045}, {"group": 34, "id": "Tmem119", "label": "Tmem119", "shape": "dot", "size": 10, "title": "Tmem119 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: 13 1342 Molecular Neurobiology (2024) 61:1331\u20131345 upregulated genes (ApoE, ISG15, CD83) and down...", "value": 15.735393346764045}, {"group": 0, "id": "non-neuronal cells", "label": "non-neuronal cells", "shape": "dot", "size": 10, "title": "non-neuronal cells | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9f6a04c9a2b37f2c  \n[file]: 38741048 - Characterizing dysregulations via cell-cell communications in Alzheimer\u0027s brains using single-cell transcriptomes.pdf\n\u003e [evidence]: Secondly, we performed a more focused cell-type-centric analysis and found that excitatory neuron...\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: In the CNS, ubiquitous BIN1 isoforms lacking the CLAP domain are expressed in neurons and non-neu...", "value": 15.735393346764045}, {"group": 114, "id": "COVID-19-related anosmia", "label": "COVID-19-related anosmia", "shape": "dot", "size": 10, "title": "COVID-19-related anosmia | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d6b219e5033d7585  \n[file]: 37620562 - Animal models to study the neurological manifestations of the post-COVID-19 condition.pdf\n\u003e [evidence]: COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory...", "value": 15.735393346764045}, {"group": 114, "id": "viral persistence", "label": "viral persistence", "shape": "dot", "size": 10, "title": "viral persistence | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d6b219e5033d7585  \n[file]: 37620562 - Animal models to study the neurological manifestations of the post-COVID-19 condition.pdf\n\u003e [evidence]: COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory...", "value": 15.735393346764045}, {"group": 0, "id": "aspirin", "label": "aspirin", "shape": "dot", "size": 10, "title": "aspirin | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: COX-1, a target irreversibly inactivated by aspirin, is highly expressed in microglia associated ...\n\u003e [evidence]: COX-1, a target irreversibly inactivated by aspirin, is highly expressed in microglia associated ...", "value": 15.735393346764045}, {"group": 13, "id": "microglial clearance", "label": "microglial clearance", "shape": "dot", "size": 10, "title": "microglial clearance | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: COX-1 deletion preferentially enhances microglial clearance of A\u03b242.", "value": 15.735393346764045}, {"group": 115, "id": "CRISPR-ON/OFF system", "label": "CRISPR-ON/OFF system", "shape": "dot", "size": 10, "title": "CRISPR-ON/OFF system | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 55563c4d6648408c  \n[file]: 38600587 - An integrated toolkit for human microglia functional genomics.pdf\n\u003e [evidence]: The optimized CRISPR-ON/OFF system modulates gene expression with temporal control, and important...", "value": 15.735393346764045}, {"group": 115, "id": "temporal control", "label": "temporal control", "shape": "dot", "size": 10, "title": "temporal control | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 55563c4d6648408c  \n[file]: 38600587 - An integrated toolkit for human microglia functional genomics.pdf\n\u003e [evidence]: The optimized CRISPR-ON/OFF system modulates gene expression with temporal control, and important...", "value": 15.735393346764045}, {"group": 116, "id": "CSF sTREM2", "label": "CSF sTREM2", "shape": "dot", "size": 10, "title": "CSF sTREM2 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: bb73bcc13afee4b4  \n[file]: 34465358 - Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Another emerging biomarker for assessing DAM is CSF sTREM2, which can induce DAM to protect again...", "value": 15.735393346764045}, {"group": 116, "id": "amyloid beta-induced neuronal damage", "label": "amyloid beta-induced neuronal damage", "shape": "dot", "size": 10, "title": "amyloid beta-induced neuronal damage | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: bb73bcc13afee4b4  \n[file]: 34465358 - Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Another emerging biomarker for assessing DAM is CSF sTREM2, which can induce DAM to protect again...", "value": 15.735393346764045}, {"group": 35, "id": "CSF1R", "label": "CSF1R", "shape": "dot", "size": 10, "title": "CSF1R | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b075ab080a8658ed  \n[file]: 39294270 - Transcriptional profiling in microglia across physiological and pathological states identifies a transcriptional module associated with neurodegeneration.pdf\n\u003e [evidence]: Genes that were previously identi\ufb01ed as microglial markers, such as TREM2, TYROBP, P2RY12, CSF1R,...\n\u003e [evidence]: Genes that were previously identi\ufb01ed as microglial markers, such as TREM2, TYROBP, P2RY12, CSF1R,...", "value": 18.11107105653813}, {"group": 35, "id": "human microglial set", "label": "human microglial set", "shape": "dot", "size": 10, "title": "human microglial set | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b075ab080a8658ed  \n[file]: 39294270 - Transcriptional profiling in microglia across physiological and pathological states identifies a transcriptional module associated with neurodegeneration.pdf\n\u003e [evidence]: Genes that were previously identi\ufb01ed as microglial markers, such as TREM2, TYROBP, P2RY12, CSF1R,...", "value": 15.735393346764045}, {"group": 35, "id": "microglia vs other cells", "label": "microglia vs other cells", "shape": "dot", "size": 10, "title": "microglia vs other cells | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b075ab080a8658ed  \n[file]: 39294270 - Transcriptional profiling in microglia across physiological and pathological states identifies a transcriptional module associated with neurodegeneration.pdf\n\u003e [evidence]: Genes that were previously identi\ufb01ed as microglial markers, such as TREM2, TYROBP, P2RY12, CSF1R,...", "value": 15.735393346764045}, {"group": 117, "id": "CXCR4", "label": "CXCR4", "shape": "dot", "size": 10, "title": "CXCR4 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 19a9292f563b3f37  \n[file]: 29784049 - Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: While pro-inflammatory DAM are characterized by higher expression of CD44, CD45 and Kv1.3 channel...", "value": 15.735393346764045}, {"group": 117, "id": "LXR\u03b1/\u03b2", "label": "LXR\u03b1/\u03b2", "shape": "dot", "size": 10, "title": "LXR\u03b1/\u03b2 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 19a9292f563b3f37  \n[file]: 29784049 - Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: While pro-inflammatory DAM are characterized by higher expression of CD44, CD45 and Kv1.3 channel...", "value": 15.735393346764045}, {"group": 118, "id": "CXCR4 expression", "label": "CXCR4 expression", "shape": "dot", "size": 10, "title": "CXCR4 expression | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0fafd5f17a2c043e  \n[file]: 33097708 - Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: However, we do see CXCR4 expression highly expressed in the human DAM population and decreased in...", "value": 15.735393346764045}, {"group": 118, "id": "human DAM population", "label": "human DAM population", "shape": "dot", "size": 10, "title": "human DAM population | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0fafd5f17a2c043e  \n[file]: 33097708 - Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: However, we do see CXCR4 expression highly expressed in the human DAM population and decreased in...\n\u003e [evidence]: However, we do see CXCR4 expression highly expressed in the human DAM population and decreased in...\n\u003e [evidence]: However, we do see CXCR4 expression highly expressed in the human DAM population and decreased in...", "value": 15.735393346764045}, {"group": 119, "id": "CXCR4 signaling", "label": "CXCR4 signaling", "shape": "dot", "size": 10, "title": "CXCR4 signaling | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0fafd5f17a2c043e  \n[file]: 33097708 - Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: To corroborate these data, we show that blocking CXCR4 signaling with AMD3100 is suf\ufb01cient to pre...", "value": 15.735393346764045}, {"group": 119, "id": "WT microglia", "label": "WT microglia", "shape": "dot", "size": 10, "title": "WT microglia | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0fafd5f17a2c043e  \n[file]: 33097708 - Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: To corroborate these data, we show that blocking CXCR4 signaling with AMD3100 is suf\ufb01cient to pre...", "value": 15.735393346764045}, {"group": 120, "id": "Cellular debris", "label": "Cellular debris", "shape": "dot", "size": 10, "title": "Cellular debris | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: However, aging-associated chronic, low-grade inflammation in the brain can result in dysfunctiona...", "value": 15.735393346764045}, {"group": 120, "id": "Amyloid beta deposition", "label": "Amyloid beta deposition", "shape": "dot", "size": 10, "title": "Amyloid beta deposition | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: However, aging-associated chronic, low-grade inflammation in the brain can result in dysfunctiona...", "value": 15.735393346764045}, {"group": 121, "id": "ChP", "label": "ChP", "shape": "dot", "size": 10, "title": "ChP | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9538f215b7d18baa  \n[file]: 40450296 - Early transcriptional and cellular abnormalities in choroid plexus of a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: The ChP also mediates the entry of A\u03b2-activated peripheral monocytes into the brain parenchyma [3...", "value": 15.735393346764045}, {"group": 121, "id": "A\u03b2-activated peripheral monocytes", "label": "A\u03b2-activated peripheral monocytes", "shape": "dot", "size": 10, "title": "A\u03b2-activated peripheral monocytes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9538f215b7d18baa  \n[file]: 40450296 - Early transcriptional and cellular abnormalities in choroid plexus of a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: The ChP also mediates the entry of A\u03b2-activated peripheral monocytes into the brain parenchyma [3...", "value": 15.735393346764045}, {"group": 122, "id": "Chen et al.", "label": "Chen et al.", "shape": "dot", "size": 10, "title": "Chen et al. | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 55563c4d6648408c  \n[file]: 38600587 - An integrated toolkit for human microglia functional genomics.pdf\n\u003e [evidence]: Chen et al. induced hiPSCs into iMG in \u003c 20 days with SPI1/CEPBA overexpression.", "value": 15.735393346764045}, {"group": 122, "id": "SPI1/CEPBA overexpression", "label": "SPI1/CEPBA overexpression", "shape": "dot", "size": 10, "title": "SPI1/CEPBA overexpression | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 55563c4d6648408c  \n[file]: 38600587 - An integrated toolkit for human microglia functional genomics.pdf\n\u003e [evidence]: Chen et al. induced hiPSCs into iMG in \u003c 20 days with SPI1/CEPBA overexpression.", "value": 15.735393346764045}, {"group": 123, "id": "Choi et al.", "label": "Choi et al.", "shape": "dot", "size": 10, "title": "Choi et al. | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: However, a study by Park et al. [81] in APP/PS1 mice showed no A\u03b2 reduction with COX-1 deletion, ...", "value": 15.735393346764045}, {"group": 123, "id": "3 \u00d7 Tg-AD mice", "label": "3 \u00d7 Tg-AD mice", "shape": "dot", "size": 10, "title": "3 \u00d7 Tg-AD mice | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: However, a study by Park et al. [81] in APP/PS1 mice showed no A\u03b2 reduction with COX-1 deletion, ...", "value": 15.735393346764045}, {"group": 124, "id": "Chronic-low level inflammation", "label": "Chronic-low level inflammation", "shape": "dot", "size": 10, "title": "Chronic-low level inflammation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ede31c1d54bcb30  \n[file]: 36199077 - Alzheimer\u0027s disease-related transcriptional sex differences in myeloid cells.pdf\n\u003e [evidence]: For example, the transcriptome of peripheral monocytes isolated from individuals with evidence fo...", "value": 15.735393346764045}, {"group": 124, "id": "Pro-inflammatory genes", "label": "Pro-inflammatory genes", "shape": "dot", "size": 10, "title": "Pro-inflammatory genes | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ede31c1d54bcb30  \n[file]: 36199077 - Alzheimer\u0027s disease-related transcriptional sex differences in myeloid cells.pdf\n\u003e [evidence]: For example, the transcriptome of peripheral monocytes isolated from individuals with evidence fo...", "value": 15.735393346764045}, {"group": 125, "id": "Col25a1", "label": "Col25a1", "shape": "dot", "size": 10, "title": "Col25a1 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Col25a1 encodes a collagenlike amyloid plaque component, known for forming protease-resistant agg...", "value": 15.735393346764045}, {"group": 125, "id": "collagenlike amyloid plaque component", "label": "collagenlike amyloid plaque component", "shape": "dot", "size": 10, "title": "collagenlike amyloid plaque component | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Col25a1 encodes a collagenlike amyloid plaque component, known for forming protease-resistant agg...", "value": 15.735393346764045}, {"group": 126, "id": "Combined drop of DA and 5-HT", "label": "Combined drop of DA and 5-HT", "shape": "dot", "size": 10, "title": "Combined drop of DA and 5-HT | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 92ff8f2be96289d7  \n[file]: 41077614 - Midbrain degeneration triggers astrocyte reactivity and tau pathology in experimental Alzheimer\u0027s Disease.pdf\n\u003e [evidence]: We provide evidence that the combined drop of DA and 5-HT induces significant hippocampal neuroin...", "value": 15.735393346764045}, {"group": 126, "id": "Hippocampal neuroinflammation in C57BL/6N mice", "label": "Hippocampal neuroinflammation in C57BL/6N mice", "shape": "dot", "size": 10, "title": "Hippocampal neuroinflammation in C57BL/6N mice | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 92ff8f2be96289d7  \n[file]: 41077614 - Midbrain degeneration triggers astrocyte reactivity and tau pathology in experimental Alzheimer\u0027s Disease.pdf\n\u003e [evidence]: We provide evidence that the combined drop of DA and 5-HT induces significant hippocampal neuroin...", "value": 15.735393346764045}, {"group": 127, "id": "Computational cell mapping techniques", "label": "Computational cell mapping techniques", "shape": "dot", "size": 10, "title": "Computational cell mapping techniques | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ede31c1d54bcb30  \n[file]: 36199077 - Alzheimer\u0027s disease-related transcriptional sex differences in myeloid cells.pdf\n\u003e [evidence]: Using computational cell mapping techniques to predict microglial gene expression from bulk trans...", "value": 15.735393346764045}, {"group": 127, "id": "Microglial gene expression", "label": "Microglial gene expression", "shape": "dot", "size": 10, "title": "Microglial gene expression | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ede31c1d54bcb30  \n[file]: 36199077 - Alzheimer\u0027s disease-related transcriptional sex differences in myeloid cells.pdf\n\u003e [evidence]: Using computational cell mapping techniques to predict microglial gene expression from bulk trans...", "value": 15.735393346764045}, {"group": 128, "id": "Csf1r inhibitors", "label": "Csf1r inhibitors", "shape": "dot", "size": 10, "title": "Csf1r inhibitors | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 83604f00c2934caf  \n[file]: 34294785 - Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Given that Csf1r inhibitors have been shown to prevent AD-related microgliosis and partially amel...", "value": 15.735393346764045}, {"group": 128, "id": "AD-related microgliosis", "label": "AD-related microgliosis", "shape": "dot", "size": 10, "title": "AD-related microgliosis | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 83604f00c2934caf  \n[file]: 34294785 - Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Given that Csf1r inhibitors have been shown to prevent AD-related microgliosis and partially amel...", "value": 15.735393346764045}, {"group": 0, "id": "pro-inflammatory mediators", "label": "pro-inflammatory mediators", "shape": "dot", "size": 10, "title": "pro-inflammatory mediators | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Though this decreased expression may only prove to be beneficial to males as knockout of Cst7 in ...\n[doc_id]: bf000dbd95632554  \n[file]: 40369584 - Transcriptomic signatures of oxytosis ferroptosis are enriched in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Finally, it has been shown that intracellular accumulation of amyloid beta (A\u03b2) can induce oxytos...", "value": 15.735393346764045}, {"group": 129, "id": "Ctsl expression", "label": "Ctsl expression", "shape": "dot", "size": 10, "title": "Ctsl expression | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: We observed increased Ctsl expression by old microglia, but also decreased expression of Cd55, wh...\n\u003e [evidence]: We observed increased Ctsl expression by old microglia, but also decreased expression of Cd55, wh...", "value": 15.735393346764045}, {"group": 129, "id": "Cd55", "label": "Cd55", "shape": "dot", "size": 10, "title": "Cd55 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: We observed increased Ctsl expression by old microglia, but also decreased expression of Cd55, wh...", "value": 15.735393346764045}, {"group": 2, "id": "SOD1 aggregation", "label": "SOD1 aggregation", "shape": "dot", "size": 10, "title": "SOD1 aggregation | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Similar results have been reported in the SOD1-G93A model of ALS, where Cx3cr1 deficiency is asso...", "value": 15.735393346764045}, {"group": 2, "id": "microglial abundance", "label": "microglial abundance", "shape": "dot", "size": 10, "title": "microglial abundance | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Cx3cr1 deficiency is associated with a transient deficit in microglial abundance during early pos...", "value": 15.735393346764045}, {"group": 2, "id": "gene-dose dependent reduction", "label": "gene-dose dependent reduction", "shape": "dot", "size": 10, "title": "gene-dose dependent reduction | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: In the APPPS1 and R1.40 mouse models of amyloidosis, Cx3cr1 deficiency results in a gene-dose dep...", "value": 15.735393346764045}, {"group": 130, "id": "EGFP", "label": "EGFP", "shape": "dot", "size": 10, "title": "EGFP | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 5194787e6776a5c5  \n[file]: 37833764 - Chronic neuroinflammation during aging leads to cholinergic neurodegeneration in the mouse medial septum.pdf\n\u003e [evidence]: Abbreviations AD Alzheimer\u2019s disease BFCN Basal forebrain cholinergic neuron MS Medial septum BF ...\n\u003e [evidence]: Abbreviations AD Alzheimer\u2019s disease BFCN Basal forebrain cholinergic neuron MS Medial septum BF ...", "value": 15.735393346764045}, {"group": 130, "id": "LPS", "label": "LPS", "shape": "dot", "size": 10, "title": "LPS | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b075ab080a8658ed  \n[file]: 39294270 - Transcriptional profiling in microglia across physiological and pathological states identifies a transcriptional module associated with neurodegeneration.pdf\n\u003e [evidence]: This analysis led to the identi\ufb01cation of human microglial gene modules including core (high expr...\n\u003e [evidence]: This analysis led to the identi\ufb01cation of human microglial gene modules including core (high expr...\n\u003e [evidence]: This analysis led to the identi\ufb01cation of human microglial gene modules including core (high expr...\n[doc_id]: 0fafd5f17a2c043e  \n[file]: 33097708 - Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Previous studies have shown that activation of microglia with a strong pro-in\ufb02ammatory stimuli (e...\n[doc_id]: 5194787e6776a5c5  \n[file]: 37833764 - Chronic neuroinflammation during aging leads to cholinergic neurodegeneration in the mouse medial septum.pdf\n\u003e [evidence]: Abbreviations AD Alzheimer\u2019s disease BFCN Basal forebrain cholinergic neuron MS Medial septum BF ...", "value": 15.735393346764045}, {"group": 131, "id": "P2RY12", "label": "P2RY12", "shape": "dot", "size": 10, "title": "P2RY12 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f240478c77c09355  \n[file]: 37248328 - Human microglia show unique transcriptional changes in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Trajectory analysis also showed that the autophagic stress and inflammatory clusters Nature Aging...\n\u003e [evidence]: Dystrophic (cluster 4) and senescent (cluster 9) clusters Nature Aging | Volume 3 | July 2023 | 8...\n[doc_id]: 128568d9c3e2b7e2  \n[file]: 39820004 - The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions.pdf\n\u003e [evidence]: Special attention must also be given to Homeos2, which expresses high levels of P2RY12 and CX3CR1...", "value": 15.735393346764045}, {"group": 131, "id": "Homeos2", "label": "Homeos2", "shape": "dot", "size": 10, "title": "Homeos2 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 128568d9c3e2b7e2  \n[file]: 39820004 - The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions.pdf\n\u003e [evidence]: Special attention must also be given to Homeos2, which expresses high levels of P2RY12 and CX3CR1...\n\u003e [evidence]: Special attention must also be given to Homeos2, which expresses high levels of P2RY12 and CX3CR1...", "value": 15.735393346764045}, {"group": 3, "id": "HERV-K RNA", "label": "HERV-K RNA", "shape": "dot", "size": 10, "title": "HERV-K RNA | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f7ba0f60074958f6  \n[file]: 32271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\n\u003e [evidence]: Because HERV-K RNA can induce CNS injury, blocking functional effects of HERV-K transcripts may a...\n\u003e [evidence]: Although microglia released inflammatory molecules in response to HERV-K RNA and enhanced HERV-K ...\n\u003e [evidence]: Considering the sequence specificity of the LNA-based RNA inhibitor, our data strongly indicate t...\n\u003e [evidence]: Because HERV-K RNA can induce CNS injury, blocking functional effects of HERV-K transcripts may a...\n\u003e [evidence]: Accordingly, we found that HERV-K RNA does not induce NF-\u03baB activation in neurons, and MyD88 is n...\n\u003e [evidence]: These results indicate that HERV-K RNA activates an intrinsic cell death pathway in neurons.", "value": 15.735393346764045}, {"group": 3, "id": "neurodegeneration", "label": "neurodegeneration", "shape": "dot", "size": 10, "title": "neurodegeneration | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 1b6ef9c18a4f3801  \n[file]: 39154174 - Deterioration of neuroimmune homeostasis in Alzheimer\u0027s Disease patients who survive a COVID-19 infection.pdf\n\u003e [evidence]: The IHC analysis involved the use of various primary antibodies to detect specific proteins in fi...\n[doc_id]: f7ba0f60074958f6  \n[file]: 32271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\n\u003e [evidence]: Further, neuronal injury induced by HERV-K RNA required SARM1, an established regulator of neurod...\n\u003e [evidence]: Although microglia released inflammatory molecules in response to HERV-K RNA and enhanced HERV-K ...\n\u003e [evidence]: Considering the sequence specificity of the LNA-based RNA inhibitor, our data strongly indicate t...\n\u003e [evidence]: Further research including more differentiated patient cohorts will be required to investigate th...\n\u003e [evidence]: The HERV-K inhibitor also prevented neurodegeneration and microglial activation in response to in...\n[doc_id]: ca701e89f5b6c8c9  \n[file]: 38178204 - Identification of female-enriched and disease-associated microglia (FDAMic) contributes to sexual dimorphism in late-onset Alzheimer\u0027s disease.pdf\n\u003e [evidence]: In the same way, losses in homeostatic phenotype, phagocytic activities and activation response o...\n[doc_id]: 9534686b56278393  \n[file]: 39987247 - Fokker-Planck diffusion maps of microglial transcriptomes reveal radial differentiation into substates associated with Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: Recent work has shown that T-cell in\ufb01ltration into the brain due to tau pathology can lead to inc...\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: These findings suggest that CX3CR1 signaling plays a critical role in maintaining microglial home...", "value": 18.11107105653813}, {"group": 36, "id": "plaque density", "label": "plaque density", "shape": "dot", "size": 10, "title": "plaque density | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: c110590ee636ba06  \n[file]: 39753747 - A subcellular sampling instrument allows spatial resolution of amyloid deposit-derived organelle-specific effects in microglia.pdf\n\u003e [evidence]: c Inpp5d was found to correlate with plaque density in human brain and expressed in plaque-associ...\n\u003e [evidence]: Inpp5d was found to correlate with plaque density in human brain and expressed in plaque-associat...\n[doc_id]: a5271e582a6524a5  \n[file]: 35180881 - PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: PLCG2 expression was increased in LOAD patients and was associated with plaque density.", "value": 15.735393346764045}, {"group": 36, "id": "LOAD patients", "label": "LOAD patients", "shape": "dot", "size": 10, "title": "LOAD patients | deg=2\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: a5271e582a6524a5  \n[file]: 35180881 - PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Methods: Using bulk RNA-Seq (N=1249) data from the Accelerating Medicines Partnership-Alzheimer\u2019s...\n\u003e [evidence]: PLCG2 expression was increased in LOAD patients and was associated with plaque density.\n\u003e [evidence]: PLCG2 expression was increased in LOAD patients and was associated with plaque density.", "value": 18.11107105653813}, {"group": 36, "id": "PLCG2", "label": "PLCG2", "shape": "dot", "size": 10, "title": "PLCG2 | deg=1\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: a5271e582a6524a5  \n[file]: 35180881 - PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Moreover, investigating how PLCG2 modulates microglia phenotypes in AD may identify novel therape...\n\u003e [evidence]: Methods: Using bulk RNA-Seq (N=1249) data from the Accelerating Medicines Partnership-Alzheimer\u2019s...\n\u003e [evidence]: Table S2: Levels of plaque mean density, and the expression levels of PLCG2, AIF1, and TMEM119 in...\n\u003e [evidence]: The UMAP plot shows the expression of PLCG2, and each dot represents a cell (a).\n\u003e [evidence]: Here, we report that PLCG2 expression is increased in several brain regions of LOAD patients and ...\n\u003e [evidence]: PLCG2 expression was increased in LOAD patients and was associated with plaque density.\n\u003e [evidence]: PLCG2 was increased exclusively in microglia in the AD mouse model.\n\u003e [evidence]: PLCG2 co-expression network analysis of microglial single-cell RNA-Seq data identified inflammato...\n\u003e [evidence]: Conclusions In conclusion, PLCG2 expression is increased in several brain regions in LOAD patient...", "value": 15.735393346764045}, {"group": 132, "id": "Cybb", "label": "Cybb", "shape": "dot", "size": 10, "title": "Cybb | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Lastly, microglia in 6 month-old 5xFAD;Cx3cr1\u2212/\u2212 mice express a \u2018degenerative\u2019 phenotype charac\u2011 ...\n\u003e [evidence]: Lastly, microglia in 6 month-old 5xFAD;Cx3cr1\u2212/\u2212 mice express a \u2018degenerative\u2019 phenotype charac\u2011 ...", "value": 10.0}, {"group": 133, "id": "DEP", "label": "DEP", "shape": "dot", "size": 10, "title": "DEP | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: c259f1527833acb2  \n[file]: 40301889 - Monoallelic TYROBP deletion is a novel risk factor for Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Abbreviations AD Alzheimer\u2019s disease AUC\u200b Area under the curve CSF Cerebrospinal fluid CT Compute...\n\u003e [evidence]: Abbreviations AD Alzheimer\u2019s disease AUC\u200b Area under the curve CSF Cerebrospinal fluid CT Compute...", "value": 10.0}, {"group": 134, "id": "DNA hypomethylation", "label": "DNA hypomethylation", "shape": "dot", "size": 10, "title": "DNA hypomethylation | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7f3199195341cd0e  \n[file]: 37789414 - Identification of methylation-regulated genes modulating microglial phagocytosis in hyperhomocysteinemia-exacerbated Alzheimer\u0027s disease.pdf\n\u003e [evidence]: We described that HHcy induces DNA hypomethylation on the promoters of cyclin A and CD40 [19, 30]...\n\u003e [evidence]: We described that HHcy induces DNA hypomethylation on the promoters of cyclin A and CD40 [19, 30]...", "value": 10.0}, {"group": 135, "id": "GS", "label": "GS", "shape": "dot", "size": 10, "title": "GS | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 22db2a1ca12d1172  \n[file]: 35109872 - Cyclic multiplex fluorescent immunohistochemistry and machine learning reveal distinct states of astrocytes and microglia in normal aging and Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Intermediate astrocytes had markedly increased EAAT2, moderately increased GS, and intermediate G...\n\u003e [evidence]: Intermediate astrocytes had markedly increased EAAT2, moderately increased GS, and intermediate G...\n\u003e [evidence]: Intermediate astrocytes had markedly increased EAAT2, moderately increased GS, and intermediate G...\n\u003e [evidence]: Compared to homeostatic, reactive astrocytes contained substantially higher GFAP and YKL-40, mode...", "value": 10.0}, {"group": 136, "id": "ER translocation genes", "label": "ER translocation genes", "shape": "dot", "size": 10, "title": "ER translocation genes | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d26adf176db8b9fd  \n[file]: 33234543 - Donor-Specific Transcriptomic Analysis of Alzheimer\u0027s Disease-Associated Hypometabolism Highlights a Unique Donor, Ribosomal Proteins and Microglia.pdf\n\u003e [evidence]: By performing neuroanatomical analyses, this study also discovered that the ER translocation gene...\n\u003e [evidence]: By performing neuroanatomical analyses, this study also discovered that the ER translocation gene...\n\u003e [evidence]: ER translocation genes, which encode proteins of the cytosolic ribosome and target protein transl...\n\u003e [evidence]: In a recent postmortem study of two cohorts, the ER translocation genes were strongly downregulat...\n\u003e [evidence]: A second study supports this connection by showing that the ER translocation genes are upregulate...", "value": 10.0}, {"group": 137, "id": "FAK", "label": "FAK", "shape": "dot", "size": 10, "title": "FAK | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 17b13a15fc3bdd35  \n[file]: 39415193 - Network dynamics-based subtyping of Alzheimer\u0027s disease with microglial genetic risk factors.pdf\n\u003e [evidence]: CASS4, while little investigated, is known to interact with FAK, affecting cellular adhesion, mig...\n\u003e [evidence]: CASS4, while little investigated, is known to interact with FAK, affecting cellular adhesion, mig...\n\u003e [evidence]: CASS4, while little investigated, is known to interact with FAK, affecting cellular adhesion, mig...", "value": 10.0}, {"group": 138, "id": "FUS", "label": "FUS", "shape": "dot", "size": 10, "title": "FUS | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: In this study, the enhanced delivery of a low dose of Adu (3 mg/kg) via FUS reduced amyloid depos...\n\u003e [evidence]: Additionally, FUS induced localized BBB opening and the opening was closed within 24 h (data not ...", "value": 10.0}, {"group": 139, "id": "FUS-mediated BBB opening", "label": "FUS-mediated BBB opening", "shape": "dot", "size": 10, "title": "FUS-mediated BBB opening | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: Previous studies have reported that FUS-mediated BBB opening induces hippocampal neurogenesis [17...\n\u003e [evidence]: FUS-mediated BBB opening increases adult hippocampal neurogenesis\n\u003e [evidence]: Results: The FUS-mediated BBB opening markedly increased the delivery of Adu into the brain by ap...", "value": 10.0}, {"group": 140, "id": "MDMi", "label": "MDMi", "shape": "dot", "size": 10, "title": "MDMi | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: c259f1527833acb2  \n[file]: 40301889 - Monoallelic TYROBP deletion is a novel risk factor for Alzheimer\u0027s disease.pdf\n\u003e [evidence]: MDMi express microglial markers and have gene expression signature (See figure on next page.) Fig.\n[doc_id]: adfef4c28263ade2  \n[file]: 38365833 - Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Importantly, microglia-enriched markers such as C1QA, TREM2, PROS1, GPR34, TMEM119 and GAS6 were ...", "value": 10.0}, {"group": 141, "id": "GD model mice", "label": "GD model mice", "shape": "dot", "size": 10, "title": "GD model mice | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: Previous study has demonstrated that GD model mice exhibited a significant increase in TRAb and T...\n\u003e [evidence]: Previous study has demonstrated that GD model mice exhibited a significant increase in TRAb and T...", "value": 10.0}, {"group": 142, "id": "GFAP-IL6 mice", "label": "GFAP-IL6 mice", "shape": "dot", "size": 10, "title": "GFAP-IL6 mice | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 5194787e6776a5c5  \n[file]: 37833764 - Chronic neuroinflammation during aging leads to cholinergic neurodegeneration in the mouse medial septum.pdf\n\u003e [evidence]: These findings could also be extended to access the behavioural phenotype in GFAP-IL6 mice relate...\n\u003e [evidence]: These findings could also be extended to access the behavioural phenotype in GFAP-IL6 mice relate...", "value": 10.0}, {"group": 143, "id": "INPP5D", "label": "INPP5D", "shape": "dot", "size": 10, "title": "INPP5D | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 17b13a15fc3bdd35  \n[file]: 39415193 - Network dynamics-based subtyping of Alzheimer\u0027s disease with microglial genetic risk factors.pdf\n\u003e [evidence]: Alzheimer\u2019s Research \u0026 Therapy (2024) 16:229 Table 2 Optimal single and double targets to restore...\n\u003e [evidence]: Furthermore, we clarified the reasons for the previous contradictory experimental results that su...\n\u003e [evidence]: Alzheimer\u2019s Research \u0026 Therapy (2024) 16:229 Table 2 Optimal single and double targets to restore...", "value": 10.0}, {"group": 144, "id": "IQGAP2", "label": "IQGAP2", "shape": "dot", "size": 10, "title": "IQGAP2 | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 819143bcdc07bcd0  \n[file]: 40607399 - Decoding neuroinflammation in Alzheimer\u0027s disease a multi-omics and AI-driven perspective for precision medicine.pdf\n\u003e [evidence]: IQGAP2 regulates blood-brain barrier immune dynamics.\n\u003e [evidence]: IQGAP2 regulates blood-brain barrier immune dynamics.", "value": 10.0}, {"group": 145, "id": "Iba1", "label": "Iba1", "shape": "dot", "size": 10, "title": "Iba1 | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 1fbc0757cf45e82a  \n[file]: 41057304 - Fate mapping of peripherally-derived macrophages after traumatic brain injury in mice reveals a long-lasting population with a distinct transcriptomic signature.pdf\n\u003e [evidence]: b Moreover, the % of tdTomato+ MDMs expressing the macrophage/ microglia marker Iba1 increases ov...\n[doc_id]: 58164633001be033  \n[file]: 33081847 - Identification of a dysfunctional microglial population in human Alzheimer\u0027s disease cortex using novel single-cell histology image analysis.pdf\n\u003e [evidence]: Abbreviations AD: Alzheimer\u2019s disease; MTG: Middle temporal gyrus; MOI: Marker of interest; CD: C...\n[doc_id]: 91d0e406cb470366  \n[file]: 33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\n\u003e [evidence]: Interestingly, Iba1 is reported to induce IL-6 secretion in mononuclear \u00adcells55, while IL-6 is r...", "value": 10.0}, {"group": 146, "id": "Inhibition", "label": "Inhibition", "shape": "dot", "size": 10, "title": "Inhibition | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 17b13a15fc3bdd35  \n[file]: 39415193 - Network dynamics-based subtyping of Alzheimer\u0027s disease with microglial genetic risk factors.pdf\n\u003e [evidence]: Alzheimer\u2019s Research \u0026 Therapy (2024) 16:229 Table 2 Optimal single and double targets to restore...\n\u003e [evidence]: Alzheimer\u2019s Research \u0026 Therapy (2024) 16:229 Table 2 Optimal single and double targets to restore...", "value": 10.0}, {"group": 147, "id": "KChIP3 deletion", "label": "KChIP3 deletion", "shape": "dot", "size": 10, "title": "KChIP3 deletion | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: db5b60a0a5df0d5b  \n[file]: 40537787 - KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Consistently, KChIP3 deletion enhanced dendritic complexity, synaptic plasticity, and cognitive p...\n\u003e [evidence]: Consistently, KChIP3 deletion enhanced dendritic complexity, synaptic plasticity, and cognitive p...", "value": 10.0}, {"group": 148, "id": "Kv1.3", "label": "Kv1.3", "shape": "dot", "size": 10, "title": "Kv1.3 | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 19a9292f563b3f37  \n[file]: 29784049 - Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: While pro-inflammatory DAM are characterized by higher expression of CD44, CD45 and Kv1.3 channel...\n\u003e [evidence]: While pro-inflammatory DAM are characterized by higher expression of CD44, CD45 and Kv1.3 channel...\n\u003e [evidence]: While pro-inflammatory DAM are characterized by higher expression of CD44, CD45 and Kv1.3 channel...", "value": 10.0}, {"group": 149, "id": "anti-inflammatory DAM", "label": "anti-inflammatory DAM", "shape": "dot", "size": 10, "title": "anti-inflammatory DAM | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 19a9292f563b3f37  \n[file]: 29784049 - Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Pro-inflammatory DAM emerged earlier in mouse models of AD and were characterized by pro-inflamma...\n\u003e [evidence]: As neuro-immunomodulatory strategies, we validated LXR\u03b1/\u03b2 agonism and Kv1.3 blockade by ShK-223 p...\n\u003e [evidence]: In addition to Kv1.3 channels, we also found that an agonist of LXR:RXR nuclear receptormediated ...\n\u003e [evidence]: By targeting decreased pro-inflammatory DAM and increased anti-inflammatory DAM as the desired ef...\n\u003e [evidence]: As neuro-immunomodulatory strategies, we validated LXR\u03b1/\u03b2 agonism and Kv1.3 blockade by ShK-223 p...\n\u003e [evidence]: Pro-inflammatory DAM emerged earlier in mouse models of AD and were characterized by pro-inflamma...\n\u003e [evidence]: Pro-inflammatory DAM emerged earlier in mouse models of AD and were characterized by pro-inflamma...\n\u003e [evidence]: In addition to Kv1.3 channels, we also found that an agonist of LXR:RXR nuclear receptormediated ...", "value": 10.0}, {"group": 150, "id": "LINE-1 mobilization", "label": "LINE-1 mobilization", "shape": "dot", "size": 10, "title": "LINE-1 mobilization | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: c51ff7fb94d8674f  \n[file]: 39604588 - Elevated expression of the retrotransposon LINE-1 drives Alzheimer\u0027s disease-associated microglial dysfunction.pdf\n\u003e [evidence]: LINE-1 mobilization, by nature, causes endogenous mutagenesis and genome instability.\n\u003e [evidence]: LINE-1 mobilization, by nature, causes endogenous mutagenesis and genome instability.", "value": 10.0}, {"group": 151, "id": "Lactobacillus strain ingestion", "label": "Lactobacillus strain ingestion", "shape": "dot", "size": 10, "title": "Lactobacillus strain ingestion | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 39466bfdd7c95692  \n[file]: 36914812 - The gut microbiome modulates the transformation of microglial subtypes.pdf\n\u003e [evidence]: Cryan et al. reported that Lactobacillus strain ingestion regulates emotional behaviors and centr...\n\u003e [evidence]: Cryan et al. reported that Lactobacillus strain ingestion regulates emotional behaviors and centr...", "value": 10.0}, {"group": 152, "id": "Late-stage AD-Associated Microglia", "label": "Late-stage AD-Associated Microglia", "shape": "dot", "size": 10, "title": "Late-stage AD-Associated Microglia | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 1f79b999e0214ae2  \n[file]: 36536457 - Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes.pdf\n\u003e [evidence]: In late-stage disease (12-month-old Tau4R\u0394K-AP mice), we found that another novel microglia subty...\n\u003e [evidence]: In late-stage disease (12-month-old Tau4R\u0394K-AP mice), we found that another novel microglia subty...", "value": 10.0}, {"group": 153, "id": "MSR1", "label": "MSR1", "shape": "dot", "size": 10, "title": "MSR1 | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: c95d64dce55527b0  \n[file]: 40826098 - Single-nucleus transcriptomics reveals a distinct microglial state and increased MSR1-mediated phagocytosis as common features across dementia subtypes.pdf\n\u003e [evidence]: Lastly, overexpression of microglial MSR1 promoted myelin uptake, and reciprocally, myelin treatm...\n\u003e [evidence]: In parallel, microglia isolated from PD mouse models exhibited increased expression of both MSR1 ...\n\u003e [evidence]: Our investigation highlighted MSR1, which encodes a class A macrophage scavenger receptor, as one...", "value": 10.0}, {"group": 154, "id": "heatmap", "label": "heatmap", "shape": "dot", "size": 10, "title": "heatmap | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4d7d47f583b6d19c  \n[file]: 40707875 - Mir-199a-3p aggravates neuroinflammation in an Alzheimer\u0027s disease transgenic mouse model by promoting M1-polarization microgliaMir-199a-3p M1.pdf\n\u003e [evidence]: B The heatmap of expression levels of CD151, WDR76, Fam199x, Tgif2, and Lin28b in bV2 transfected...\n\u003e [evidence]: C The heatmap showing expression of CD151, WDR76, Fam199x, Tgif2, and Lin28b in integrated expres...\n\u003e [evidence]: C The heatmap showing expression of CD151, WDR76, Fam199x, Tgif2, and Lin28b in integrated expres...\n\u003e [evidence]: C The heatmap showing expression of CD151, WDR76, Fam199x, Tgif2, and Lin28b in integrated expres...\n\u003e [evidence]: B The heatmap of expression levels of CD151, WDR76, Fam199x, Tgif2, and Lin28b in bV2 transfected...\n\u003e [evidence]: C The heatmap showing expression of CD151, WDR76, Fam199x, Tgif2, and Lin28b in integrated expres...\n\u003e [evidence]: B The heatmap of expression levels of CD151, WDR76, Fam199x, Tgif2, and Lin28b in bV2 transfected...\n\u003e [evidence]: B The heatmap of expression levels of CD151, WDR76, Fam199x, Tgif2, and Lin28b in bV2 transfected...\n[doc_id]: a5271e582a6524a5  \n[file]: 35180881 - PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: The heatmap shows gene expression levels of the top 20 genes identified as co-expressed with PLCG...", "value": 10.0}, {"group": 155, "id": "impaired efferocytosis", "label": "impaired efferocytosis", "shape": "dot", "size": 10, "title": "impaired efferocytosis | deg=0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 1a3720e2622382c1  \n[file]: 36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\n\u003e [evidence]: Conversely, impaired efferocytosis has been linked to autoimmune disease and tissue damage.\n\u003e [evidence]: Conversely, impaired efferocytosis has been linked to autoimmune disease and tissue damage.\n\u003e [evidence]: Conversely, impaired efferocytosis has been linked to autoimmune disease and tissue damage.\n\u003e [evidence]: Conversely, impaired efferocytosis has been linked to autoimmune disease and tissue damage.", "value": 10.0}]);
                  edges = new vis.DataSet([{"from": "(UK brain bank)", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u00271a3720e2622382c1\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 61, \u0027page\u0027: None, \u0027char_span\u0027: [44, 118], \u0027evidence\u0027: \u0027We thank the UK brain expression consortium (UK brain bank) for the control brain samples and the Edinburgh brain bank for the collaboration and Alzheimer\u2019s post-mortem brain samples.\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 1a3720e2622382c1  \n[file]: 36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\n\u003e [evidence]: We thank the UK brain expression consortium (UK brain bank) for the control brain samples and the...", "to": "the Edinburgh brain bank", "value": 1.0, "width": 1.6931471805599454}, {"from": "10 month old Arctic mice", "label": "correlates with", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 10, \u0027page\u0027: None, \u0027char_span\u0027: [61, 139], \u0027evidence\u0027: \u0027A decrease in neuronal complexity was seen in hippocampus of 10 month old Arctic mice at the time that correlates with the behavior deficit, both of which were rescued in the Arctic/C5aR1KO.\u0027, \u0027confidence\u0027: 1.0}"], "title": "correlates with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: A decrease in neuronal complexity was seen in hippocampus of 10 month old Arctic mice at the time...", "to": "behavior deficit", "value": 1.0, "width": 1.6931471805599454}, {"from": "10 months of age", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 46, \u0027page\u0027: None, \u0027char_span\u0027: [183, 249], \u0027evidence\u0027: \u0027Moreover, microglial transcriptome analysis revealed increased expression of inflammation related genes in the Arctic mouse as early as 5 months of age that remained elevated through 10 months of age but were not so upregulated in the Arctic/C5aR1KO.\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Moreover, microglial transcriptome analysis revealed increased expression of inflammation related...", "to": "Arctic/C5aR1KO", "value": 1.0, "width": 1.6931471805599454}, {"from": "18 h", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u0027f08e8a515e81d795\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [226, 282], \u0027evidence\u0027: \u0027Data are presented as mean (SEM). *p \u003c 0.05, **p \u003c 0.01, ***p \u003c 0.001 (one-way ANOVA). (e-g) Seahorse assays were used to evaluate real-time glycolytic rate in young microglia (postnatal day 0\u20132, pooled male and female) after 18 h in vitro treatment with 10 nM recombinant mouse C3a.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: Data are presented as mean (SEM). *p \u003c 0.05, **p \u003c 0.01, ***p \u003c 0.001 (one-way ANOVA). (e-g) Seah...", "to": "10 nM recombinant mouse C3a", "value": 1.0, "width": 1.6931471805599454}, {"from": "20 genes", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u002792d2fb0bf85a478b\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38036733 - Spatiotemporal characterization of glial cell activation in an Alzheimer\u0027s disease model by spatially resolved transcriptomics.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 10, \u0027page\u0027: None, \u0027char_span\u0027: [26, 85], \u0027evidence\u0027: \u0027In addition, we identi\ufb01ed 20 genes that were correlated with amyloid deposit patterns and upregulated in GM at 7 months in 5XFAD mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 92d2fb0bf85a478b  \n[file]: 38036733 - Spatiotemporal characterization of glial cell activation in an Alzheimer\u0027s disease model by spatially resolved transcriptomics.pdf\n\u003e [evidence]: In addition, we identi\ufb01ed 20 genes that were correlated with amyloid deposit patterns and upregul...", "to": "amyloid deposit patterns", "value": 1.0, "width": 1.6931471805599454}, {"from": "2018", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u002775e9d948abad0bc8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002730558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 40, \u0027page\u0027: None, \u0027char_span\u0027: [29, 117], \u0027evidence\u0027: \u0027Molecular Neurodegeneration (2018) 13:65 We also explored the expression changes of genes that have been linked to AD previously to help understand their functions in AD pathogenesis.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 75e9d948abad0bc8  \n[file]: 30558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\n\u003e [evidence]: Molecular Neurodegeneration (2018) 13:65 We also explored the expression changes of genes that ha...", "to": "genes that have been linked to AD", "value": 1.0, "width": 1.6931471805599454}, {"from": "24-h LPS stimulation", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027c259f1527833acb2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40301889 - Monoallelic TYROBP deletion is a novel risk factor for Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 33, \u0027page\u0027: None, \u0027char_span\u0027: [14, 80], \u0027evidence\u0027: \u0027We found that 24-h LPS stimulation induces upregulation of inflammatory pathways and downregulation of MYC and UPR pathways in the monoallelic TYROBP deletion carrier MDMi as compared to MDMi derived from control individuals.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: c259f1527833acb2  \n[file]: 40301889 - Monoallelic TYROBP deletion is a novel risk factor for Alzheimer\u0027s disease.pdf\n\u003e [evidence]: We found that 24-h LPS stimulation induces upregulation of inflammatory pathways and downregulati...", "to": "inflammatory pathways", "value": 1.0, "width": 1.6931471805599454}, {"from": "inflammatory pathways", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [59, 122], \u0027evidence\u0027: \u0027However, the gene expression profile of the microglia from Arctic/C5aR1KO brain showed a decrease in inflammatory pathways and greater induction of clearance and degradation pathways relative to the Arctic as early as 2\u20135 months of age.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: However, the gene expression profile of the microglia from Arctic/C5aR1KO brain showed a decrease...", "to": "Arctic/C5aR1KO brain", "value": 1.0, "width": 1.6931471805599454}, {"from": "301 billion dollars", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u00277ff5d3a47ea9588d\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735459147 - Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 17, \u0027page\u0027: None, \u0027char_span\u0027: [59, 142], \u0027evidence\u0027: \u0027The estimated cost for health care in the United States is 301 billion dollars and this number is expected to increase to 1.1 trillion dollars by 2050 when AD is projected to \u00a9 The Author(s) 2022.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ff5d3a47ea9588d  \n[file]: 35459147 - Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.pdf\n\u003e [evidence]: The estimated cost for health care in the United States is 301 billion dollars and this number is...", "to": "1.1 trillion dollars", "value": 1.0, "width": 1.6931471805599454}, {"from": "3D MDMi", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027adfef4c28263ade2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38365833 - Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 39, \u0027page\u0027: None, \u0027char_span\u0027: [19, 91], \u0027evidence\u0027: \u0027We identified that 3D MDMi exhibit enhanced microglia-like features and AD-specific changes in the patient-derived models.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: adfef4c28263ade2  \n[file]: 38365833 - Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: We identified that 3D MDMi exhibit enhanced microglia-like features and AD-specific changes in th...", "to": "AD-specific changes", "value": 1.0, "width": 1.6931471805599454}, {"from": "3D MDMi", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027adfef4c28263ade2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38365833 - Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 39, \u0027page\u0027: None, \u0027char_span\u0027: [19, 67], \u0027evidence\u0027: \u0027We identified that 3D MDMi exhibit enhanced microglia-like features and AD-specific changes in the patient-derived models.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: adfef4c28263ade2  \n[file]: 38365833 - Advanced patient-specific microglia cell models for pre-clinical studies in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: We identified that 3D MDMi exhibit enhanced microglia-like features and AD-specific changes in th...", "to": "microglia-like features", "value": 1.0, "width": 1.6931471805599454}, {"from": "3xTg AD mouse models", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 17, \u0027page\u0027: None, \u0027char_span\u0027: [111, 173], \u0027evidence\u0027: \u0027Our previously published studies using a pharmacological approach to block function of C5aR1 in the Tg2576 and 3xTg AD mouse models [7] resulted in reduced fibrillar plaques and gliosis surrounding the plaques.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Our previously published studies using a pharmacological approach to block function of C5aR1 in t...", "to": "fibrillar plaques", "value": 1.0, "width": 1.6931471805599454}, {"from": "3xTg AD mouse models", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 17, \u0027page\u0027: None, \u0027char_span\u0027: [111, 185], \u0027evidence\u0027: \u0027Our previously published studies using a pharmacological approach to block function of C5aR1 in the Tg2576 and 3xTg AD mouse models [7] resulted in reduced fibrillar plaques and gliosis surrounding the plaques.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Our previously published studies using a pharmacological approach to block function of C5aR1 in t...", "to": "gliosis", "value": 1.0, "width": 1.6931471805599454}, {"from": "gliosis", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u0027882d7b83c983ad03\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731399126 - A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 19, \u0027page\u0027: None, \u0027char_span\u0027: [0, 53], \u0027evidence\u0027: \u0027AD is also associated with neuronal death and gliosis specifically in the cerebral cortex.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 882d7b83c983ad03  \n[file]: 31399126 - A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain.pdf\n\u003e [evidence]: AD is also associated with neuronal death and gliosis specifically in the cerebral cortex.", "to": "AD", "value": 1.0, "width": 1.6931471805599454}, {"from": "3xTg-D and WT-D", "label": "suppresses", "sources": ["{\u0027doc_id\u0027: \u00273a6969ccf167b6e1\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35443751 - Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer\u0027s disease mouse model.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 22, \u0027page\u0027: None, \u0027char_span\u0027: [86, 145], \u0027evidence\u0027: \u0027Our data shows that MHC-I genes were among the most highly up-regulated genes between 3xTg-D and WT-D, most strongly down-regulated genes by SCDi, and were expressed\u0027, \u0027confidence\u0027: 1.0}"], "title": "suppresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3a6969ccf167b6e1  \n[file]: 35443751 - Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Our data shows that MHC-I genes were among the most highly up-regulated genes between 3xTg-D and ...", "to": "SCDi", "value": 1.0, "width": 1.6931471805599454}, {"from": "4000 genes", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u002775e9d948abad0bc8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002730558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [70, 131], \u0027evidence\u0027: \u0027Results: Statistical analysis of RNAseq data indicated that more than 4000 genes were differentially expressed in rTg4510 microglia compared to wild type microglia, with the majority of gene expression changes occurring between 2- and 4-months of age.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 75e9d948abad0bc8  \n[file]: 30558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\n\u003e [evidence]: Results: Statistical analysis of RNAseq data indicated that more than 4000 genes were differentia...", "to": "rTg4510 microglia", "value": 1.0, "width": 1.6931471805599454}, {"from": "5 mM", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u0027f08e8a515e81d795\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 6, \u0027page\u0027: None, \u0027char_span\u0027: [27, 79], \u0027evidence\u0027: \u0027Rapamycin (50 \u00b5M) or 2-DG (5 mM) were pre- (1 h) and co-treated (18 h) with C3a.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: Rapamycin (50 \u00b5M) or 2-DG (5 mM) were pre- (1 h) and co-treated (18 h) with C3a.", "to": "C3a", "value": 1.0, "width": 1.6931471805599454}, {"from": "5 \u00d7 FAD mice", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u00270e0d3b8ebe88e7d8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 8, \u0027page\u0027: None, \u0027char_span\u0027: [75, 124], \u0027evidence\u0027: \u0027Furthermore, our study revealed an age-associated increase of microglia in 5 \u00d7 FAD mice, which correlated with A\u03b2 deposition.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: Furthermore, our study revealed an age-associated increase of microglia in 5 \u00d7 FAD mice, which co...", "to": "A\u03b2 deposition", "value": 1.0, "width": 1.6931471805599454}, {"from": "5 \u00d7 FAD mice", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00270e0d3b8ebe88e7d8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 6, \u0027page\u0027: None, \u0027char_span\u0027: [61, 126], \u0027evidence\u0027: \u0027Results We identified a significant upregulation of COX-1 in 5 \u00d7 FAD mice, with expression specifically localized to microglia in an age-dependent manner.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: Results We identified a significant upregulation of COX-1 in 5 \u00d7 FAD mice, with expression specif...", "to": "microglia", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 deposition", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00272ab9e10b4b26b7a7\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [34, 78], \u0027evidence\u0027: \u0027Results ANGPTL8 knockout improved cognitive function and reduced A\u03b2 deposition by reducing microgliosis and microglial activation in 5xFAD mice.\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u00272ab9e10b4b26b7a7\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 3, \u0027page\u0027: None, \u0027char_span\u0027: [43, 101], \u0027evidence\u0027: \u0027Our data revealed that ANGPTL8 KO improved cognitive function and significantly reduced A\u03b2 deposition in 5xFAD mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=2.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ab9e10b4b26b7a7  \n[file]: 40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\n\u003e [evidence]: Results ANGPTL8 knockout improved cognitive function and reduced A\u03b2 deposition by reducing microg...\n\u003e [evidence]: Our data revealed that ANGPTL8 KO improved cognitive function and significantly reduced A\u03b2 deposi...", "to": "cognitive function", "value": 2.0, "width": 2.09861228866811}, {"from": "A\u03b2 deposition", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027b5d5053cd6fc980b\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740346662 - A single-cell transcriptomic atlas of all cell types in the brain of 5xFAD Alzheimer mice in response to dietary inulin supplementation.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 42, \u0027page\u0027: None, \u0027char_span\u0027: [58, 98], \u0027evidence\u0027: \u0027Similarly, oral treatment with Akkermansia muciniphila in AD-like rat models reduced A\u03b2 deposition in cortex and alleviated cognitive impairment in the Morris water maze test [40].\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b5d5053cd6fc980b  \n[file]: 40346662 - A single-cell transcriptomic atlas of all cell types in the brain of 5xFAD Alzheimer mice in response to dietary inulin supplementation.pdf\n\u003e [evidence]: Similarly, oral treatment with Akkermansia muciniphila in AD-like rat models reduced A\u03b2 depositio...", "to": "AD-like rat models", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 deposition", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00272ab9e10b4b26b7a7\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 15, \u0027page\u0027: None, \u0027char_span\u0027: [27, 59], \u0027evidence\u0027: \u0027Our results indicated that ANGPTL8 KO reduced A\u03b2 deposition by suppressing microgliosis and microglial activation.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ab9e10b4b26b7a7  \n[file]: 40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\n\u003e [evidence]: Our results indicated that ANGPTL8 KO reduced A\u03b2 deposition by suppressing microgliosis and micro...", "to": "ANGPTL8 KO", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 deposition", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027608b887729bab05d\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"34600516 - Cell type-specific potential pathogenic genes and functional pathways in Alzheimer\u0027s Disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 14, \u0027page\u0027: None, \u0027char_span\u0027: [31, 123], \u0027evidence\u0027: \u0027Moreover, in most AD patients, A\u03b2 deposition has been seen around perivascular, which leads to endothelial cell dysfunction and death, increases the permeability of the blood-brain barrier (BBB) and neuroinflammation, and further contributes to AD progression [7, 25, 26].\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 608b887729bab05d  \n[file]: 34600516 - Cell type-specific potential pathogenic genes and functional pathways in Alzheimer\u0027s Disease.pdf\n\u003e [evidence]: Moreover, in most AD patients, A\u03b2 deposition has been seen around perivascular, which leads to en...", "to": "endothelial cell dysfunction", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 deposition", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u00272ab9e10b4b26b7a7\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 15, \u0027page\u0027: None, \u0027char_span\u0027: [46, 113], \u0027evidence\u0027: \u0027Our results indicated that ANGPTL8 KO reduced A\u03b2 deposition by suppressing microgliosis and microglial activation.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ab9e10b4b26b7a7  \n[file]: 40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\n\u003e [evidence]: Our results indicated that ANGPTL8 KO reduced A\u03b2 deposition by suppressing microgliosis and micro...", "to": "microglial activation", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 deposition", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u00272ab9e10b4b26b7a7\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 15, \u0027page\u0027: None, \u0027char_span\u0027: [46, 87], \u0027evidence\u0027: \u0027Our results indicated that ANGPTL8 KO reduced A\u03b2 deposition by suppressing microgliosis and microglial activation.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ab9e10b4b26b7a7  \n[file]: 40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\n\u003e [evidence]: Our results indicated that ANGPTL8 KO reduced A\u03b2 deposition by suppressing microgliosis and micro...", "to": "microgliosis", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglia", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027c95d64dce55527b0\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740826098 - Single-nucleus transcriptomics reveals a distinct microglial state and increased MSR1-mediated phagocytosis as common features across dementia subtypes.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 28, \u0027page\u0027: None, \u0027char_span\u0027: [7, 68], \u0027evidence\u0027: \u0027In AD, TREM2 is a well-characterised receptor expressed on microglia, which activates a disease-associated microglia phenotype that limits the propagation of A\u03b2 and tau via a phagocytic mechanism [23, 24].\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u002738639c37ea0f3a09\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002733115519 - Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 0, \u0027page\u0027: None, \u0027char_span\u0027: [71, 128], \u0027evidence\u0027: \u0027Abstract Background: Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed in the brain exclusively on microglia and genetic variants are linked to neurodegenerative diseases including Alzheimer\u2019s disease (AD), frontotemporal dementia (FTD) and Nasu Hakola Disease (NHD).\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u002701ab70cecab4b6e6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737115208 - Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 0, \u0027page\u0027: None, \u0027char_span\u0027: [9, 66], \u0027evidence\u0027: \u0027Abstract TREM2 is an innate immune receptor expressed by microglia in the adult brain.\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u0027a8e8ae58507d8422\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002736805764 - TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [14, 57], \u0027evidence\u0027: \u0027In the brain, TREM2 expression is restricted to microglia where it acts to promote microglial survival and proliferation, as well as it stimulates microglial engagement and uptake of amyloid plaques in AD models [9, 10].\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=4.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: c95d64dce55527b0  \n[file]: 40826098 - Single-nucleus transcriptomics reveals a distinct microglial state and increased MSR1-mediated phagocytosis as common features across dementia subtypes.pdf\n\u003e [evidence]: In AD, TREM2 is a well-characterised receptor expressed on microglia, which activates a disease-a...\n[doc_id]: 38639c37ea0f3a09  \n[file]: 33115519 - Trem2 Y38C mutation and loss of Trem2 impairs neuronal synapses in adult mice.pdf\n\u003e [evidence]: Abstract Background: Triggering receptor expressed on myeloid cells 2 (TREM2) is expressed in the...\n[doc_id]: 01ab70cecab4b6e6  \n[file]: 37115208 - Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation.pdf\n\u003e [evidence]: Abstract TREM2 is an innate immune receptor expressed by microglia in the adult brain.\n[doc_id]: a8e8ae58507d8422  \n[file]: 36805764 - TREM2 splice isoforms generate soluble TREM2 species that disrupt long-term potentiation.pdf\n\u003e [evidence]: In the brain, TREM2 expression is restricted to microglia where it acts to promote microglial sur...", "to": "TREM2", "value": 4.0, "width": 2.6094379124341005}, {"from": "microglia", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 61, \u0027page\u0027: None, \u0027char_span\u0027: [0, 25], \u0027evidence\u0027: \u0027Cst7 expressing microglia tend to surround A\u03b2 in the brain and increase inflammation [56].\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 60, \u0027page\u0027: None, \u0027char_span\u0027: [14, 52], \u0027evidence\u0027: \u0027Expression of Cst7 is notably expressed in microglia of AD pathology and has recently been considered a sex-dependent indicator for AD [58, 59].\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=2.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Cst7 expressing microglia tend to surround A\u03b2 in the brain and increase inflammation [56].\n\u003e [evidence]: Expression of Cst7 is notably expressed in microglia of AD pathology and has recently been consid...", "to": "Cst7", "value": 2.0, "width": 2.09861228866811}, {"from": "microglia", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u00271a3720e2622382c1\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [140, 188], \u0027evidence\u0027: \u0027Y axis: Gene count values of cell type marker genes, x axis: 6 cell type marker gene categories (left\u2014astrocytes, endothelial cell markers, excitatory neurons, inhibitory neurons microglia and oligodendrocytes).\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u00271a3720e2622382c1\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 46, \u0027page\u0027: None, \u0027char_span\u0027: [67, 116], \u0027evidence\u0027: \u0027UMAP cluster analysis revealed that the proportions of astrocytes, excitatory neurons, inhibitory neurons, microglia, and oligodendrocytes were similar between the Alzheimer\u2019s and neurological controls brain samples.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=2.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 1a3720e2622382c1  \n[file]: 36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\n\u003e [evidence]: Y axis: Gene count values of cell type marker genes, x axis: 6 cell type marker gene categories (...\n\u003e [evidence]: UMAP cluster analysis revealed that the proportions of astrocytes, excitatory neurons, inhibitory...", "to": "excitatory neurons", "value": 2.0, "width": 2.09861228866811}, {"from": "microglia", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00273319f4b14f340c9e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737989983 - Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5\u00d7FAD Mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [76, 122], \u0027evidence\u0027: \u0027miR-29a sponge significantly reduced hippocampal beta-amyloid deposition in 5\u00d7FAD mice and lowered astrocyte and microglia activation in both 5\u00d7FAD and WT mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3319f4b14f340c9e  \n[file]: 37989983 - Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5\u00d7FAD Mice.pdf\n\u003e [evidence]: miR-29a sponge significantly reduced hippocampal beta-amyloid deposition in 5\u00d7FAD mice and lowere...", "to": "5\u00d7FAD mice", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglia", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 8, \u0027page\u0027: None, \u0027char_span\u0027: [0, 21], \u0027evidence\u0027: \u0027APC treated microglia.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: APC treated microglia.", "to": "APC", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglia", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 2, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [0, 82], \u0027evidence\u0027: \u0027Amyloid deposited C3b/iC3b should lead to more efficient phagocytosis by microglia/macrophages, while generated C5a recruits and alters the function of microglia.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Amyloid deposited C3b/iC3b should lead to more efficient phagocytosis by microglia/macrophages, w...", "to": "Amyloid deposited C3b/iC3b", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglia", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u00271f79b999e0214ae2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002736536457 - Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 50, \u0027page\u0027: None, \u0027char_span\u0027: [51, 110], \u0027evidence\u0027: \u0027These findings are consistent with a model whereby A\u03b2 or tau pathologies stimulate the activation of microglia in different patterns.\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 1f79b999e0214ae2  \n[file]: 36536457 - Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes.pdf\n\u003e [evidence]: These findings are consistent with a model whereby A\u03b2 or tau pathologies stimulate the activation...", "to": "A\u03b2 or tau pathologies", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglia", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027331a8d1a696c0aa5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [29, 58], \u0027evidence\u0027: \u0027The study found that loss of Bin1 did not affect microglia number in Bin1 c-KO mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The study found that loss of Bin1 did not affect microglia number in Bin1 c-KO mice.", "to": "Bin1", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglia", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00279b64c3dd721bd44f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 1, \u0027page\u0027: None, \u0027char_span\u0027: [53, 126], \u0027evidence\u0027: \u0027VGF-derived peptide TLQP-21 activates the complement C3a receptor-1 (C3aR1), predominantly expressed in the brain on microglia.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: VGF-derived peptide TLQP-21 activates the complement C3a receptor-1 (C3aR1), predominantly expres...", "to": "C3a receptor-1 (C3aR1)", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglia", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00276ba9bb6b943017d2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 9, \u0027page\u0027: None, \u0027char_span\u0027: [20, 61], \u0027evidence\u0027: \u0027In brain, C5aR1 and C3aR are prominently induced in microglia in response to injury (reviewed in ref. 50).\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: In brain, C5aR1 and C3aR are prominently induced in microglia in response to injury (reviewed in ...", "to": "C3aR", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglia", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00279b64c3dd721bd44f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [0, 56], \u0027evidence\u0027: \u0027C3aR1 is expressed by neurons, astrocytes, and microglia in the brain [26\u201328], but the functional consequences of TLQP-21 activation of C3aR1 on microglia are poorly understood [29].\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: C3aR1 is expressed by neurons, astrocytes, and microglia in the brain [26\u201328], but the functional...", "to": "C3aR1", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglia", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 2, \u0027sentence_id\u0027: 5, \u0027page\u0027: None, \u0027char_span\u0027: [0, 57], \u0027evidence\u0027: \u0027C5a induces an inflammatory polarization of the microglia, potentially synergizing with TLRs, which results in production of neurotoxic inflammatory products while suppressing beneficial phagocytosis and degradation pathways thereby contributing to neuronal damage and cognitive deficits.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: C5a induces an inflammatory polarization of the microglia, potentially synergizing with TLRs, whi...", "to": "C5a", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglia", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00270e0d3b8ebe88e7d8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [37, 78], \u0027evidence\u0027: \u0027By using 5 \u00d7 FAD mice, we found that COX-1 is primarily expressed in microglia, and its level increases in an age-dependent manner in 5 \u00d7 FAD mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: By using 5 \u00d7 FAD mice, we found that COX-1 is primarily expressed in microglia, and its level inc...", "to": "COX-1", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglia", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027efbf7bba620cd8fe\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002736575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 27, \u0027page\u0027: None, \u0027char_span\u0027: [34, 61], \u0027evidence\u0027: \u0027The Fc portion of Adu can bind to FcRs expressed in microglia and opsonize A\u03b2 for phagocytosis by microglia.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: The Fc portion of Adu can bind to FcRs expressed in microglia and opsonize A\u03b2 for phagocytosis by...", "to": "FcRs", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglia", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00279b64c3dd721bd44f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 29, \u0027page\u0027: None, \u0027char_span\u0027: [64, 110], \u0027evidence\u0027: \u0027In addition, a majority of the common AD variants identified by GWAS are preferentially expressed in microglia compared to neurons or astrocytes [32, 33], consistent with a substantial role for microglia in AD progression.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: In addition, a majority of the common AD variants identified by GWAS are preferentially expressed...", "to": "GWAS", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglia", "label": "promotes", "sources": ["{\u0027doc_id\u0027: \u00279b1a0347efe392c6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 3, \u0027page\u0027: None, \u0027char_span\u0027: [46, 86], \u0027evidence\u0027: \u0027Single-cell sequencing analysis revealed that IE2 promoted the activation of microglia and upregulated the expression of disease-associated microglia genes.\u0027, \u0027confidence\u0027: 1.0}"], "title": "promotes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: Single-cell sequencing analysis revealed that IE2 promoted the activation of microglia and upregu...", "to": "IE2", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglia", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00273012894074386645\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 13, \u0027page\u0027: None, \u0027char_span\u0027: [0, 94], \u0027evidence\u0027: \u0027Insoluble A\u03b21\u201340 and A\u03b21\u201342 levels were reduced comparably while more astrocytes and microglia were observed in surrounding amyloid plaques.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Insoluble A\u03b21\u201340 and A\u03b21\u201342 levels were reduced comparably while more astrocytes and microglia we...", "to": "Insoluble A\u03b21\u201340 and A\u03b21\u201342 levels", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglia", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u00271a3720e2622382c1\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 21, \u0027page\u0027: None, \u0027char_span\u0027: [0, 42], \u0027evidence\u0027: \u0027Lower panel: Inhibitory neurons, microglia and oligodendrocyte marker genes.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 1a3720e2622382c1  \n[file]: 36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\n\u003e [evidence]: Lower panel: Inhibitory neurons, microglia and oligodendrocyte marker genes.", "to": "Lower panel", "value": 1.0, "width": 1.6931471805599454}, {"from": "53", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027d3c889662b8907a9\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002732238175 - Transcriptomic profiling of microglia and astrocytes throughout aging.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 13, \u0027page\u0027: None, \u0027char_span\u0027: [274, 333], \u0027evidence\u0027: \u0027Spock3 and Timp4, encode proteins that participate in inhibiting matrix metalloproteinases (MMPs) involved in the degradation of the extracellular matrix [52], and the other genes encode proteins that inhibit lipoteichoic acid-induced NF-\u03baB, MAP kinase, and Akt activities [53] and decrease the invasion and metastasis of tumor cells in the brain [54].\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d3c889662b8907a9  \n[file]: 32238175 - Transcriptomic profiling of microglia and astrocytes throughout aging.pdf\n\u003e [evidence]: Spock3 and Timp4, encode proteins that participate in inhibiting matrix metalloproteinases (MMPs)...", "to": "tumor cells", "value": 1.0, "width": 1.6931471805599454}, {"from": "5X FAD mice", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u0027215ff893f0c683e8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 32, \u0027page\u0027: None, \u0027char_span\u0027: [99, 149], \u0027evidence\u0027: \u0027We have shown that in APPPS1-21 mice treated in the early stage of disease (2\u20133 months of age) and 5X FAD mice treated at a late stage of amyloidosis (7\u20139 months of age), GV-971 alters the gut microbiota and attenuates A\u03b2 deposition in brains of the two models.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: We have shown that in APPPS1-21 mice treated in the early stage of disease (2\u20133 months of age) an...", "to": "late stage of amyloidosis", "value": 1.0, "width": 1.6931471805599454}, {"from": "5XFAD mice", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027db5b60a0a5df0d5b\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40537787 - KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 14, \u0027page\u0027: None, \u0027char_span\u0027: [58, 110], \u0027evidence\u0027: \u0027Our results demonstrate that the absence of KChIP3 in the 5XFAD mice leads to reduced hippocampal inflammation and improved cognitive function.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: db5b60a0a5df0d5b  \n[file]: 40537787 - KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Our results demonstrate that the absence of KChIP3 in the 5XFAD mice leads to reduced hippocampal...", "to": "hippocampal inflammation", "value": 1.0, "width": 1.6931471805599454}, {"from": "5XFAD mice", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027db5b60a0a5df0d5b\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40537787 - KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 9, \u0027page\u0027: None, \u0027char_span\u0027: [85, 160], \u0027evidence\u0027: \u0027Highlights \u2022 Genetic deletion of potassium channel interacting protein 3 (KChIP3) in 5XFAD mice, significantly reduced \u03b2A plaque formation and neuroinflammation in the hippocampus.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: db5b60a0a5df0d5b  \n[file]: 40537787 - KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Highlights \u2022 Genetic deletion of potassium channel interacting protein 3 (KChIP3) in 5XFAD mice, ...", "to": "neuroinflammation", "value": 1.0, "width": 1.6931471805599454}, {"from": "5XFAD mice", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027db5b60a0a5df0d5b\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40537787 - KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 9, \u0027page\u0027: None, \u0027char_span\u0027: [85, 138], \u0027evidence\u0027: \u0027Highlights \u2022 Genetic deletion of potassium channel interacting protein 3 (KChIP3) in 5XFAD mice, significantly reduced \u03b2A plaque formation and neuroinflammation in the hippocampus.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: db5b60a0a5df0d5b  \n[file]: 40537787 - KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Highlights \u2022 Genetic deletion of potassium channel interacting protein 3 (KChIP3) in 5XFAD mice, ...", "to": "\u03b2A plaque formation", "value": 1.0, "width": 1.6931471805599454}, {"from": "5XFAD mice", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u0027215ff893f0c683e8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 6, \u0027page\u0027: None, \u0027char_span\u0027: [124, 178], \u0027evidence\u0027: \u0027In parallel, and to corroborate existing published studies and further investigate sex-related differences, male and female 5XFAD mice were treated daily with 100 mg/kg of GV-971 from 7 to 9 months of age when A\u03b2 burden was near peak levels.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: In parallel, and to corroborate existing published studies and further investigate sex-related di...", "to": "GV-971", "value": 1.0, "width": 1.6931471805599454}, {"from": "neuroinflammation", "label": "binds", "sources": ["{\u0027doc_id\u0027: \u00279dd895f2425df710\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 36, \u0027page\u0027: None, \u0027char_span\u0027: [22, 200], \u0027evidence\u0027: \u0027Studies indicate that APOE binding is integral to some of these processes [16\u201320] with differences in APOE isoform-specific receptor binding affinity and lipid interactions affecting neuroinflammation, tau pathology, and amyloid plaque dynamics [21\u201324].\u0027, \u0027confidence\u0027: 1.0}"], "title": "binds | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: Studies indicate that APOE binding is integral to some of these processes [16\u201320] with difference...", "to": "APOE binding", "value": 1.0, "width": 1.6931471805599454}, {"from": "neuroinflammation", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 22, \u0027page\u0027: None, \u0027char_span\u0027: [37, 74], \u0027evidence\u0027: \u0027Previous research indicates that the A\u03b2 deposits trigger neuroinflammation and microglial activation leading to eventual metabolic reprogramming [26].\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 62, \u0027page\u0027: None, \u0027char_span\u0027: [92, 197], \u0027evidence\u0027: \u0027The significant decrease in microglial Cst7 by APC treatment may prove a strong decrease in A\u03b2 presence in the brain and consequently a decrease in the population of microglia and neuroinflammation.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Previous research indicates that the A\u03b2 deposits trigger neuroinflammation and microglial activat...\n\u003e [evidence]: The significant decrease in microglial Cst7 by APC treatment may prove a strong decrease in A\u03b2 pr...", "to": "A\u03b2", "value": 1.0, "width": 1.6931471805599454}, {"from": "neuroinflammation", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00270e0d3b8ebe88e7d8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 13, \u0027page\u0027: None, \u0027char_span\u0027: [29, 76], \u0027evidence\u0027: \u0027A previous study showed that COX-1 KO mice exhibit reduced neuroinflammation induced by A\u03b2 and attenuated plaque-associated microgliosis [19].\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: A previous study showed that COX-1 KO mice exhibit reduced neuroinflammation induced by A\u03b2 and at...", "to": "COX-1 KO mice", "value": 1.0, "width": 1.6931471805599454}, {"from": "neuroinflammation", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00272f3cd755c1b95f07\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 45, \u0027page\u0027: None, \u0027char_span\u0027: [97, 140], \u0027evidence\u0027: \u0027Microglia M1 phenotype increased the expression of inflammatory factor including TNF\u03b1, iNOS, and IL-1\u03b2, which could induce neuroinflammation and neuronal damage [70].\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: Microglia M1 phenotype increased the expression of inflammatory factor including TNF\u03b1, iNOS, and ...", "to": "IL-1\u03b2", "value": 1.0, "width": 1.6931471805599454}, {"from": "GV-971", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u0027215ff893f0c683e8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 5, \u0027page\u0027: None, \u0027char_span\u0027: [16, 86], \u0027evidence\u0027: \u0027Male and female APPPS1-21 mice were treated daily with 40, 80, or 160 mg/ kg of GV-971 from 8, when A\u03b2 burden was detectable upto 12 weeks of age when A\u03b2 burden was near maximal levels.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: Male and female APPPS1-21 mice were treated daily with 40, 80, or 160 mg/ kg of GV-971 from 8, wh...", "to": "APPPS1-21 mice", "value": 1.0, "width": 1.6931471805599454}, {"from": "GV-971", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027215ff893f0c683e8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [88, 158], \u0027evidence\u0027: \u0027In this regard, we were intrigued by the finding that a marine-derived oligosaccharide, GV-971, was reported to alter gut microbiota and reduce A\u03b2 amyloidosis in the 5XFAD mouse model that were treated at a point when A\u03b2 burden was near plateau levels.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: In this regard, we were intrigued by the finding that a marine-derived oligosaccharide, GV-971, w...", "to": "A\u03b2 amyloidosis", "value": 1.0, "width": 1.6931471805599454}, {"from": "5xFAD", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 27, \u0027page\u0027: None, \u0027char_span\u0027: [0, 44], \u0027evidence\u0027: \u00275xFAD mice did not show a decrease in Cx3cr1 expression.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: 5xFAD mice did not show a decrease in Cx3cr1 expression.", "to": "Cx3cr1", "value": 1.0, "width": 1.6931471805599454}, {"from": "5xFAD", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [39, 103], \u0027evidence\u0027: \u0027Alterations in glial cells occurred in 5xFAD versus WT, especially increases in microglia proliferation were profound in 5xFAD.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Alterations in glial cells occurred in 5xFAD versus WT, especially increases in microglia prolife...", "to": "microglia proliferation", "value": 1.0, "width": 1.6931471805599454}, {"from": "5xFAD", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 64, \u0027page\u0027: None, \u0027char_span\u0027: [69, 110], \u0027evidence\u0027: \u0027Further important AD risk genes were also found to be upregulated in 5xFAD mice and later downregulated by APC treatment.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Further important AD risk genes were also found to be upregulated in 5xFAD mice and later downreg...", "to": "APC", "value": 1.0, "width": 1.6931471805599454}, {"from": "5xFAD", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 43, \u0027page\u0027: None, \u0027char_span\u0027: [191, 227], \u0027evidence\u0027: \u0027Previous study of Ctsb in AD and other neurological disorders have proven that Ctsb knockout (KO) transgenic mice as well as The differential expression testing revealed that C1qa, C1qb, and C1qc are widely upregulated in 5xFAD.\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Previous study of Ctsb in AD and other neurological disorders have proven that Ctsb knockout (KO)...", "to": "C1qc", "value": 1.0, "width": 1.6931471805599454}, {"from": "5xFAD", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 11, \u0027page\u0027: None, \u0027char_span\u0027: [0, 47], \u0027evidence\u0027: \u0027C4b expression was found to be greater in 5xFAD mice and is considered a biomarker for AD in humans [33].\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: C4b expression was found to be greater in 5xFAD mice and is considered a biomarker for AD in huma...", "to": "C4b", "value": 1.0, "width": 1.6931471805599454}, {"from": "Cx3cr1", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 26, \u0027page\u0027: None, \u0027char_span\u0027: [14, 43], \u0027evidence\u0027: \u0027Deficiency of Cx3cr1 has shown increased A\u03b2 pathology as well as cognitive decline [28]\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Deficiency of Cx3cr1 has shown increased A\u03b2 pathology as well as cognitive decline [28]", "to": "A\u03b2", "value": 1.0, "width": 1.6931471805599454}, {"from": "Cx3cr1", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 26, \u0027page\u0027: None, \u0027char_span\u0027: [14, 53], \u0027evidence\u0027: \u0027Deficiency of Cx3cr1 has shown increased A\u03b2 pathology as well as cognitive decline [28]\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Deficiency of Cx3cr1 has shown increased A\u03b2 pathology as well as cognitive decline [28]", "to": "pathology", "value": 1.0, "width": 1.6931471805599454}, {"from": "APC", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 52, \u0027page\u0027: None, \u0027char_span\u0027: [0, 79], \u0027evidence\u0027: \u0027Additionally, other omics data such as metabolomics and proteomics study of APC treatment on AD would be able to provide further observation of the physiological changes occurring.\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 56, \u0027page\u0027: None, \u0027char_span\u0027: [0, 19], \u0027evidence\u0027: \u0027APC treatment in AD Tg2576 transgenic mice has also been found to inhibit A\u03b2 production by a different mechanism and improve memory deficits through promotion of \u03b1-secretase [24].\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 31, \u0027page\u0027: None, \u0027char_span\u0027: [51, 106], \u0027evidence\u0027: \u0027These extensive alterations of cell populations by APC treatment demonstrate significant impact towards AD progression.\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 5, \u0027page\u0027: None, \u0027char_span\u0027: [87, 106], \u0027evidence\u0027: \u0027Using single-cell RNA sequencing and bioinformatic analysis, we analyze the effects of APC treatment on AD transgenic mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=4.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Additionally, other omics data such as metabolomics and proteomics study of APC treatment on AD w...\n\u003e [evidence]: APC treatment in AD Tg2576 transgenic mice has also been found to inhibit A\u03b2 production by a diff...\n\u003e [evidence]: These extensive alterations of cell populations by APC treatment demonstrate significant impact t...\n\u003e [evidence]: Using single-cell RNA sequencing and bioinformatic analysis, we analyze the effects of APC treatm...", "to": "AD", "value": 4.0, "width": 2.6094379124341005}, {"from": "APC", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 48, \u0027page\u0027: None, \u0027char_span\u0027: [123, 166], \u0027evidence\u0027: \u0027Our study comprehensively quantified the transcriptomes in different cell types of mouse brains, including wild-type mice, 5xFAD mice, and 5xFAD mice treated with APC.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Our study comprehensively quantified the transcriptomes in different cell types of mouse brains, ...", "to": "5xFAD mice", "value": 1.0, "width": 1.6931471805599454}, {"from": "APC", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 62, \u0027page\u0027: None, \u0027char_span\u0027: [47, 94], \u0027evidence\u0027: \u0027The significant decrease in microglial Cst7 by APC treatment may prove a strong decrease in A\u03b2 presence in the brain and consequently a decrease in the population of microglia and neuroinflammation.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: The significant decrease in microglial Cst7 by APC treatment may prove a strong decrease in A\u03b2 pr...", "to": "A\u03b2", "value": 1.0, "width": 1.6931471805599454}, {"from": "APC", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [0, 75], \u0027evidence\u0027: \u0027APC treatment sample uncovers a large decrease in the microglial population suggesting reversal of the immune response towards A\u03b2.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: APC treatment sample uncovers a large decrease in the microglial population suggesting reversal o...", "to": "microglial population", "value": 1.0, "width": 1.6931471805599454}, {"from": "APC", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 56, \u0027page\u0027: None, \u0027char_span\u0027: [0, 42], \u0027evidence\u0027: \u0027APC treatment in AD Tg2576 transgenic mice has also been found to inhibit A\u03b2 production by a different mechanism and improve memory deficits through promotion of \u03b1-secretase [24].\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: APC treatment in AD Tg2576 transgenic mice has also been found to inhibit A\u03b2 production by a diff...", "to": "Tg2576 transgenic mice", "value": 1.0, "width": 1.6931471805599454}, {"from": "APC", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 32, \u0027page\u0027: None, \u0027char_span\u0027: [0, 37], \u0027evidence\u0027: \u0027APC treatment shows return to near WT levels of expression of Cd63 and Cd68.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: APC treatment shows return to near WT levels of expression of Cd63 and Cd68.", "to": "WT", "value": 1.0, "width": 1.6931471805599454}, {"from": "APC", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 13, \u0027page\u0027: None, \u0027char_span\u0027: [39, 117], \u0027evidence\u0027: \u0027We observed a downregulation of C4b in APC treatment, while further study is needed, the anti-inflammatory properties of APC seem to mediate C4b levels in the brain.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: We observed a downregulation of C4b in APC treatment, while further study is needed, the anti-inf...", "to": "anti-inflammatory properties", "value": 1.0, "width": 1.6931471805599454}, {"from": "APC", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 5, \u0027page\u0027: None, \u0027char_span\u0027: [87, 122], \u0027evidence\u0027: \u0027Using single-cell RNA sequencing and bioinformatic analysis, we analyze the effects of APC treatment on AD transgenic mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Using single-cell RNA sequencing and bioinformatic analysis, we analyze the effects of APC treatm...", "to": "transgenic mice", "value": 1.0, "width": 1.6931471805599454}, {"from": "APC", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 10, \u0027page\u0027: None, \u0027char_span\u0027: [47, 77], \u0027evidence\u0027: \u0027The astrocyte population notably expresses two DEGs that are modulated by APC treatment.\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: The astrocyte population notably expresses two DEGs that are modulated by APC treatment.", "to": "DEGs", "value": 1.0, "width": 1.6931471805599454}, {"from": "5xFAD animals", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u00273b13fd318d8fea14\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 38, \u0027page\u0027: None, \u0027char_span\u0027: [127, 208], \u0027evidence\u0027: \u0027Our results indicate that Cx3cr1 deficiency exacerbates neurodegeneration and cognitive impairment with disease progression in 5xFAD animals by driving increased accumulation of neurotoxic oligomeric A\u03b2 (oA\u03b2), fibrillar A\u03b2 (fA\u03b2) plaques, intraneuronal A\u03b2, intraneuronal tau, and synaptic loss.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Our results indicate that Cx3cr1 deficiency exacerbates neurodegeneration and cognitive impairmen...", "to": "neurotoxic oligomeric A\u03b2 (oA\u03b2)", "value": 1.0, "width": 1.6931471805599454}, {"from": "5xFAD mice", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u002779fca66073e8bfa0\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [41, 121], \u0027evidence\u0027: \u0027Additionally, our analysis confirms that 5xFAD mice exhibit extensive gene expression changes in the retromer interactome and its cargo, resembling patterns seen in human AD cohorts \u2014 a degree of alteration not observed in other transgenic AD models.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Additionally, our analysis confirms that 5xFAD mice exhibit extensive gene expression changes in ...", "to": "retromer interactome", "value": 1.0, "width": 1.6931471805599454}, {"from": "5xFAD mice", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u00279b64c3dd721bd44f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 13, \u0027page\u0027: None, \u0027char_span\u0027: [176, 211], \u0027evidence\u0027: \u0027To determine the potential mechanisms(s) via which TLQP-21 reduces amyloid plaque burden and microgliosis, we performed RNA sequencing on microglia isolated from the brains of 5xFAD mice treated with either aCSF or TLQP-21.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: To determine the potential mechanisms(s) via which TLQP-21 reduces amyloid plaque burden and micr...", "to": "aCSF", "value": 1.0, "width": 1.6931471805599454}, {"from": "5xFAD model", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00279dd895f2425df710\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 44, \u0027page\u0027: None, \u0027char_span\u0027: [102, 163], \u0027evidence\u0027: \u0027We then assessed the effects of APOE3Ch on amyloid-\u03b2 and tau pathology in two mouse models of AD: the 5xFAD model, which expresses mutant human APP and PSEN1 genes, and the PS19 model, which expresses mutant human tau.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: We then assessed the effects of APOE3Ch on amyloid-\u03b2 and tau pathology in two mouse models of AD:...", "to": "APP and PSEN1 genes", "value": 1.0, "width": 1.6931471805599454}, {"from": "5xFAD mouse model", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027215ff893f0c683e8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 27, \u0027page\u0027: None, \u0027char_span\u0027: [70, 124], \u0027evidence\u0027: \u0027In addition, A\u03b2 amyloidosis is significantly reduced in APPPS1-21 and 5xFAD mouse models raised in germ-free (GF) conditions, thus strengthening the role of gut microbiota in A\u03b2 amyloidosis [22, 23].\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: In addition, A\u03b2 amyloidosis is significantly reduced in APPPS1-21 and 5xFAD mouse models raised i...", "to": "germ-free (GF) conditions", "value": 1.0, "width": 1.6931471805599454}, {"from": "5xFAD mouse model", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027215ff893f0c683e8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 27, \u0027page\u0027: None, \u0027char_span\u0027: [13, 87], \u0027evidence\u0027: \u0027In addition, A\u03b2 amyloidosis is significantly reduced in APPPS1-21 and 5xFAD mouse models raised in germ-free (GF) conditions, thus strengthening the role of gut microbiota in A\u03b2 amyloidosis [22, 23].\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: In addition, A\u03b2 amyloidosis is significantly reduced in APPPS1-21 and 5xFAD mouse models raised i...", "to": "A\u03b2 amyloidosis", "value": 1.0, "width": 1.6931471805599454}, {"from": "5xFAD transgenic mice", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 55, \u0027page\u0027: None, \u0027char_span\u0027: [78, 157], \u0027evidence\u0027: \u0027In the future, we plan to obtain this derivative and experiment with not only 5xFAD transgenic mice but other strains such as those expressing tau physiology.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: In the future, we plan to obtain this derivative and experiment with not only 5xFAD transgenic mi...", "to": "tau physiology", "value": 1.0, "width": 1.6931471805599454}, {"from": "5xFAD;Cx3cr1\u2212/\u2212 mice", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u00273b13fd318d8fea14\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [32, 116], \u0027evidence\u0027: \u0027Results: Disease progression in 5xFAD;Cx3cr1\u2212/\u2212 mice is characterized by increased deposition of filamentous plaques that display defective microglial plaque engagement.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Results: Disease progression in 5xFAD;Cx3cr1\u2212/\u2212 mice is characterized by increased deposition of ...", "to": "filamentous plaques", "value": 1.0, "width": 1.6931471805599454}, {"from": "5\u00d7FAD mice", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00273319f4b14f340c9e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737989983 - Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5\u00d7FAD Mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [76, 108], \u0027evidence\u0027: \u0027miR-29a sponge significantly reduced hippocampal beta-amyloid deposition in 5\u00d7FAD mice and lowered astrocyte and microglia activation in both 5\u00d7FAD and WT mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3319f4b14f340c9e  \n[file]: 37989983 - Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5\u00d7FAD Mice.pdf\n\u003e [evidence]: miR-29a sponge significantly reduced hippocampal beta-amyloid deposition in 5\u00d7FAD mice and lowere...", "to": "astrocyte", "value": 1.0, "width": 1.6931471805599454}, {"from": "6-7-month-old PS2APP transgenic mice", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00278cb824110484db3e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36895556 - The effect of Abi3 locus deletion on the progression of Alzheimer\u0027s disease-related pathologies.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [68, 149], \u0027evidence\u0027: \u0027For example, while Trem2 de\ufb01ciency increased amyloid plaque load at 6-7-month-old PS2APP transgenic mice, it decreased Alterations in cytokine levels in Abi3 knock-out mice\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 8cb824110484db3e  \n[file]: 36895556 - The effect of Abi3 locus deletion on the progression of Alzheimer\u0027s disease-related pathologies.pdf\n\u003e [evidence]: For example, while Trem2 de\ufb01ciency increased amyloid plaque load at 6-7-month-old PS2APP transgen...", "to": "Alterations in cytokine levels", "value": 1.0, "width": 1.6931471805599454}, {"from": "617 amino acid VGF precursor", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00279b64c3dd721bd44f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 21, \u0027page\u0027: None, \u0027char_span\u0027: [106, 161], \u0027evidence\u0027: \u0027The C-terminal peptide TLQP-21 (named by its four Nterminal amino acids and length) is processed from the 617 amino acid VGF precursor, is expressed in the brain [17], and plays a role in the central and peripheral nervous system (CNS and PNS) to regulate feeding, reproductive and circadian behaviors, body weight, neuropathic pain and peripheral adiposity [17\u201323].\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: The C-terminal peptide TLQP-21 (named by its four Nterminal amino acids and length) is processed ...", "to": "brain", "value": 1.0, "width": 1.6931471805599454}, {"from": "65", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027d3c889662b8907a9\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002732238175 - Transcriptomic profiling of microglia and astrocytes throughout aging.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 24, \u0027page\u0027: None, \u0027char_span\u0027: [184, 214], \u0027evidence\u0027: \u0027Ccl2 is a key mediator of spinal microglial activation, and blocking spinal Ccl2 alleviates heat hyperalgesia and augments glutamatergic transmission in substantia gelatinosa neurons [65], reduces immunosuppression, and Page 16 of 19 augments vaccine immunotherapy [66].\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d3c889662b8907a9  \n[file]: 32238175 - Transcriptomic profiling of microglia and astrocytes throughout aging.pdf\n\u003e [evidence]: Ccl2 is a key mediator of spinal microglial activation, and blocking spinal Ccl2 alleviates heat ...", "to": "immunosuppression", "value": 1.0, "width": 1.6931471805599454}, {"from": "7-transmembrane spanning G-protein coupled receptor", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u00279b64c3dd721bd44f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 22, \u0027page\u0027: None, \u0027char_span\u0027: [30, 140], \u0027evidence\u0027: \u0027The C3a receptor-1 (C3aR1), a 7-transmembrane spanning G-protein coupled receptor that is activated by the complement activation product C3a (traditionally considered a component of innate immunity), was identified as a target for TLQP-21 [24, 25].\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: The C3a receptor-1 (C3aR1), a 7-transmembrane spanning G-protein coupled receptor that is activat...", "to": "complement activation product C3a", "value": 1.0, "width": 1.6931471805599454}, {"from": "9 significantly enriched gene sets", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u0027215ff893f0c683e8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 12, \u0027page\u0027: None, \u0027char_span\u0027: [33, 130], \u0027evidence\u0027: \u0027c GSEA enrichment results showed 9 significantly enriched gene sets out of 44 upregulated gene sets in Vehicle- treated male group compared with GV-971-treated male group Bosch et al.\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: c GSEA enrichment results showed 9 significantly enriched gene sets out of 44 upregulated gene se...", "to": "Vehicle- treated male group", "value": 1.0, "width": 1.6931471805599454}, {"from": "A1 astrocytes", "label": "mediates", "sources": ["{\u0027doc_id\u0027: \u002791d0e406cb470366\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [0, 67], \u0027evidence\u0027: \u0027A1 astrocytes are described to mediate synaptic loss and impairment as well as initiating neuronal cell death, whereas loss of C3-expressing astrocyte signaling alleviates synaptic failure and AD \\xadpathology51,52.\u0027, \u0027confidence\u0027: 1.0}"], "title": "mediates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 91d0e406cb470366  \n[file]: 33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\n\u003e [evidence]: A1 astrocytes are described to mediate synaptic loss and impairment as well as initiating neurona...", "to": "synaptic loss and impairment", "value": 1.0, "width": 1.6931471805599454}, {"from": "A20", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027d0fa5a5a09a4de36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38352874 - Inflammasome signaling is dispensable for \u00df-amyloid-induced neuropathology in preclinical models of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [37, 93], \u0027evidence\u0027: \u0027Furthermore, the study suggests that A20 overexpression does not affect microglial activation or neuronal loss in APP/PS1 mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d0fa5a5a09a4de36  \n[file]: 38352874 - Inflammasome signaling is dispensable for \u00df-amyloid-induced neuropathology in preclinical models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Furthermore, the study suggests that A20 overexpression does not affect microglial activation or ...", "to": "microglial activation", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglial activation", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 22, \u0027page\u0027: None, \u0027char_span\u0027: [37, 100], \u0027evidence\u0027: \u0027Previous research indicates that the A\u03b2 deposits trigger neuroinflammation and microglial activation leading to eventual metabolic reprogramming [26].\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Previous research indicates that the A\u03b2 deposits trigger neuroinflammation and microglial activat...", "to": "A\u03b2", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglial activation", "label": "prevents", "sources": ["{\u0027doc_id\u0027: \u0027f7ba0f60074958f6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002732271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 47, \u0027page\u0027: None, \u0027char_span\u0027: [4, 79], \u0027evidence\u0027: \u0027The HERV-K inhibitor also prevented neurodegeneration and microglial activation in response to intrathecal HERV-K in APPPS1 mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "prevents | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f7ba0f60074958f6  \n[file]: 32271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\n\u003e [evidence]: The HERV-K inhibitor also prevented neurodegeneration and microglial activation in response to in...", "to": "HERV-K inhibitor", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglial activation", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u002791d0e406cb470366\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [14, 84], \u0027evidence\u0027: \u0027Specifically, MCR activation reduces neurotoxic astrocytes and microglial activation in a brain region-specific manner.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 91d0e406cb470366  \n[file]: 33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\n\u003e [evidence]: Specifically, MCR activation reduces neurotoxic astrocytes and microglial activation in a brain r...", "to": "MCR activation", "value": 1.0, "width": 1.6931471805599454}, {"from": "A3 astrocytes", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00276ba9bb6b943017d2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [10, 60], \u0027evidence\u0027: \u0027Secondly, A3 astrocytes, expressing disease-mitigating genes, were induced in response to the APP transgene regardless of C5aR1 function (C5aR1-independent and therefore not negatively affected by PMX205).\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Secondly, A3 astrocytes, expressing disease-mitigating genes, were induced in response to the APP...", "to": "disease-mitigating genes", "value": 1.0, "width": 1.6931471805599454}, {"from": "AAV", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00273319f4b14f340c9e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737989983 - Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5\u00d7FAD Mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [54, 73], \u0027evidence\u0027: \u0027To test this, we generated an adeno-associated virus (AAV) expressing GFP and a miR-29a \u2018sponge\u2019 or empty vector.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3319f4b14f340c9e  \n[file]: 37989983 - Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5\u00d7FAD Mice.pdf\n\u003e [evidence]: To test this, we generated an adeno-associated virus (AAV) expressing GFP and a miR-29a \u2018sponge\u2019 ...", "to": "GFP", "value": 1.0, "width": 1.6931471805599454}, {"from": "AAV", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00273319f4b14f340c9e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737989983 - Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5\u00d7FAD Mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 3, \u0027page\u0027: None, \u0027char_span\u0027: [18, 47], \u0027evidence\u0027: \u0027We found that the AAV expressing miR-29a sponge functionally reduced miR-29a levels and improved measures of memory in the Morris water maze and fear condition paradigms when delivered to the hippocampi of 5\u00d7FAD and WT mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3319f4b14f340c9e  \n[file]: 37989983 - Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5\u00d7FAD Mice.pdf\n\u003e [evidence]: We found that the AAV expressing miR-29a sponge functionally reduced miR-29a levels and improved ...", "to": "miR-29a sponge", "value": 1.0, "width": 1.6931471805599454}, {"from": "ABCB1", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027af1d54ba089df752\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [98, 148], \u0027evidence\u0027: \u00275 Deletion of Dicer1 in intestinal epithelial cells reduces BACE1 activity and increases LRP1 and ABCB1 expression in the brain of App-knock-in mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: 5 Deletion of Dicer1 in intestinal epithelial cells reduces BACE1 activity and increases LRP1 and...", "to": "App-knock-in mice", "value": 1.0, "width": 1.6931471805599454}, {"from": "ABCB1", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027af1d54ba089df752\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [60, 103], \u0027evidence\u0027: \u00275 Deletion of Dicer1 in intestinal epithelial cells reduces BACE1 activity and increases LRP1 and ABCB1 expression in the brain of App-knock-in mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: 5 Deletion of Dicer1 in intestinal epithelial cells reduces BACE1 activity and increases LRP1 and...", "to": "BACE1 activity", "value": 1.0, "width": 1.6931471805599454}, {"from": "App-knock-in mice", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027af1d54ba089df752\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 8, \u0027page\u0027: None, \u0027char_span\u0027: [61, 106], \u0027evidence\u0027: \u0027Results Deletion of Dicer1 in intestinal epithelial cells of App-knock-in mice reduced the absolute number and altered the composition of bacteria in both the gut and brain, and inhibited inflammatory activation in the gut, but had no effect on the differentiation of CD4-positive T lymphocytes.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: Results Deletion of Dicer1 in intestinal epithelial cells of App-knock-in mice reduced the absolu...", "to": "absolute number", "value": 1.0, "width": 1.6931471805599454}, {"from": "ABX-mediated gut microbiota perturbations", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027215ff893f0c683e8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 30, \u0027page\u0027: None, \u0027char_span\u0027: [19, 92], \u0027evidence\u0027: \u0027We have shown that ABX-mediated gut microbiota perturbations failed to reduce A\u03b2 amyloidosis in mice fed with a colony-stimulating factor-1 receptor (CSF-1R) antagonist that depletes microglia [20], indicating an essential role for microglia in the microbiota-amyloid axis.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: We have shown that ABX-mediated gut microbiota perturbations failed to reduce A\u03b2 amyloidosis in m...", "to": "A\u03b2 amyloidosis", "value": 1.0, "width": 1.6931471805599454}, {"from": "ABXinduced perturbations of gut microbiota", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u0027215ff893f0c683e8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 24, \u0027page\u0027: None, \u0027char_span\u0027: [40, 152], \u0027evidence\u0027: \u0027Our previous work also established that ABXinduced perturbations of gut microbiota are associated with sex-specific alterations in microglial phenotypes [15, 19, 58].\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: Our previous work also established that ABXinduced perturbations of gut microbiota are associated...", "to": "sex-specific alterations in microglial phenotypes", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u002792d2fb0bf85a478b\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38036733 - Spatiotemporal characterization of glial cell activation in an Alzheimer\u0027s disease model by spatially resolved transcriptomics.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 16, \u0027page\u0027: None, \u0027char_span\u0027: [49, 93], \u0027evidence\u0027: \u0027These results con\ufb01rmed that upregulated genes in AD spatially associated with amyloid plaques were consistent with previously identi\ufb01ed markers functionally related to A\u03b2.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 92d2fb0bf85a478b  \n[file]: 38036733 - Spatiotemporal characterization of glial cell activation in an Alzheimer\u0027s disease model by spatially resolved transcriptomics.pdf\n\u003e [evidence]: These results con\ufb01rmed that upregulated genes in AD spatially associated with amyloid plaques wer...", "to": "amyloid plaques", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u0027b5d5053cd6fc980b\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740346662 - A single-cell transcriptomic atlas of all cell types in the brain of 5xFAD Alzheimer mice in response to dietary inulin supplementation.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 0, \u0027page\u0027: None, \u0027char_span\u0027: [48, 109], \u0027evidence\u0027: \u0027Discussion Emerging evidence has suggested that AD onset and progression are associated with dietary patterns [23].\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b5d5053cd6fc980b  \n[file]: 40346662 - A single-cell transcriptomic atlas of all cell types in the brain of 5xFAD Alzheimer mice in response to dietary inulin supplementation.pdf\n\u003e [evidence]: Discussion Emerging evidence has suggested that AD onset and progression are associated with diet...", "to": "dietary patterns", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u0027882d7b83c983ad03\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731399126 - A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 19, \u0027page\u0027: None, \u0027char_span\u0027: [0, 41], \u0027evidence\u0027: \u0027AD is also associated with neuronal death and gliosis specifically in the cerebral cortex.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 882d7b83c983ad03  \n[file]: 31399126 - A single-nuclei RNA sequencing study of Mendelian and sporadic AD in the human brain.pdf\n\u003e [evidence]: AD is also associated with neuronal death and gliosis specifically in the cerebral cortex.", "to": "neuronal death", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00277e54ca131b151a6f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35849618 - Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 21, \u0027page\u0027: None, \u0027char_span\u0027: [28, 72], \u0027evidence\u0027: \u0027Researchers have found that AD causes changes in the expression of genes within the brain cells.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7e54ca131b151a6f  \n[file]: 35849618 - Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Researchers have found that AD causes changes in the expression of genes within the brain cells.", "to": "expression of genes", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027ce17e594043be4f0\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35247975 - Transcriptional response of murine microglia in Alzheimer\u0027s disease and inflammation.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 8, \u0027page\u0027: None, \u0027char_span\u0027: [25, 65], \u0027evidence\u0027: \u0027Conclusions: In summary, AD triggered multiple signaling pathways that regulate numerous genes in microglia, contributing to A\u03b2 phagocytosis and neuroinflammation.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: ce17e594043be4f0  \n[file]: 35247975 - Transcriptional response of murine microglia in Alzheimer\u0027s disease and inflammation.pdf\n\u003e [evidence]: Conclusions: In summary, AD triggered multiple signaling pathways that regulate numerous genes in...", "to": "signaling pathways", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027db5b60a0a5df0d5b\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40537787 - KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 10, \u0027page\u0027: None, \u0027char_span\u0027: [49, 98], \u0027evidence\u0027: \u0027However, understanding the mechanisms underlying AD could lead to potential therapeutic strategies.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: db5b60a0a5df0d5b  \n[file]: 40537787 - KChIP3 fosters neuroinflammation and synaptic dysfunction in the 5XFAD mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: However, understanding the mechanisms underlying AD could lead to potential therapeutic strategies.", "to": "therapeutic strategies", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00274d6afb7163e035aa\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 22, \u0027page\u0027: None, \u0027char_span\u0027: [0, 54], \u0027evidence\u0027: \u0027AD has lower reproducibility than PD, HD, and COVID-19, but still has hundreds of DEGs.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4d6afb7163e035aa  \n[file]: 40796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\n\u003e [evidence]: AD has lower reproducibility than PD, HD, and COVID-19, but still has hundreds of DEGs.", "to": "COVID-19", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00274d6afb7163e035aa\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 22, \u0027page\u0027: None, \u0027char_span\u0027: [0, 40], \u0027evidence\u0027: \u0027AD has lower reproducibility than PD, HD, and COVID-19, but still has hundreds of DEGs.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4d6afb7163e035aa  \n[file]: 40796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\n\u003e [evidence]: AD has lower reproducibility than PD, HD, and COVID-19, but still has hundreds of DEGs.", "to": "HD", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00274d6afb7163e035aa\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 22, \u0027page\u0027: None, \u0027char_span\u0027: [0, 36], \u0027evidence\u0027: \u0027AD has lower reproducibility than PD, HD, and COVID-19, but still has hundreds of DEGs.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4d6afb7163e035aa  \n[file]: 40796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\n\u003e [evidence]: AD has lower reproducibility than PD, HD, and COVID-19, but still has hundreds of DEGs.", "to": "PD", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027b075ab080a8658ed\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739294270 - Transcriptional profiling in microglia across physiological and pathological states identifies a transcriptional module associated with neurodegeneration.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 1, \u0027page\u0027: None, \u0027char_span\u0027: [312, 361], \u0027evidence\u0027: \u0027This analysis led to the identi\ufb01cation of human microglial gene modules including core (high expression in human microglia (compared to other cells, but not in disease state), differentiation (high expression in differentiating human microglia), LPS (high expression in LPS-induced, IPSC-derived microglia), and AD (high expression in microglia from AD patients) modules.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b075ab080a8658ed  \n[file]: 39294270 - Transcriptional profiling in microglia across physiological and pathological states identifies a transcriptional module associated with neurodegeneration.pdf\n\u003e [evidence]: This analysis led to the identi\ufb01cation of human microglial gene modules including core (high expr...", "to": "microglia from AD patients", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u002779fca66073e8bfa0\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 24, \u0027page\u0027: None, \u0027char_span\u0027: [59, 114], \u0027evidence\u0027: \u0027The neuronal ryanodine receptor (Ryr2) is overactivated in AD, leading to enhanced receptor-operated calcium entry and decreased buffering capacity [18, 21].\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: The neuronal ryanodine receptor (Ryr2) is overactivated in AD, leading to enhanced receptor-opera...", "to": "calcium entry", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027c259f1527833acb2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40301889 - Monoallelic TYROBP deletion is a novel risk factor for Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 0, \u0027page\u0027: None, \u0027char_span\u0027: [100, 156], \u0027evidence\u0027: \u0027Discussion In this study we show that monoallelic 5.2-kb TYROBP deletion is a novel risk factor for AD, leading to twofold increased risk of AD and dementia with an earlier onset age in the monoallelic carriers when compared to non-carriers.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: c259f1527833acb2  \n[file]: 40301889 - Monoallelic TYROBP deletion is a novel risk factor for Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Discussion In this study we show that monoallelic 5.2-kb TYROBP deletion is a novel risk factor f...", "to": "dementia", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u002779fca66073e8bfa0\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 8, \u0027page\u0027: None, \u0027char_span\u0027: [129, 160], \u0027evidence\u0027: \u0027This manually curated diagram summarizes transcriptional changes in retromer-associated genes and related proteins implicated in AD following treatment with R33 (left area in the box for each gene) and R55 (right area).\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: This manually curated diagram summarizes transcriptional changes in retromer-associated genes and...", "to": "R33", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "prevents", "sources": ["{\u0027doc_id\u0027: \u00279dd895f2425df710\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 56, \u0027page\u0027: None, \u0027char_span\u0027: [71, 101], \u0027evidence\u0027: \u0027Together, these findings provide insights into the mechanisms by which APOE3Ch may protect against AD, and suggest that it may be a promising target for therapeutic intervention.\u0027, \u0027confidence\u0027: 1.0}"], "title": "prevents | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: Together, these findings provide insights into the mechanisms by which APOE3Ch may protect agains...", "to": "APOE3Ch", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u0027efbf7bba620cd8fe\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002736575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [27, 30], \u0027evidence\u0027: \u0027Recently, the FDA approved Adu for the treatment of AD based on an evaluation of effects of the drug in clinical stages [5, 40].\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: Recently, the FDA approved Adu for the treatment of AD based on an evaluation of effects of the d...", "to": "Adu", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 38, \u0027page\u0027: None, \u0027char_span\u0027: [10, 66], \u0027evidence\u0027: \u0027Moreover, Ctsb has been found to be upregulated in the serum of AD patients and is considered a biomarker of AD [48].\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Moreover, Ctsb has been found to be upregulated in the serum of AD patients and is considered a b...", "to": "Ctsb", "value": 1.0, "width": 1.6931471805599454}, {"from": "neuronal death", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00272f3cd755c1b95f07\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 40, \u0027page\u0027: None, \u0027char_span\u0027: [4, 48], \u0027evidence\u0027: \u0027Why GD induces a higher degree of neuronal death in the cortex but not in the hippocampus needs to be further studied.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: Why GD induces a higher degree of neuronal death in the cortex but not in the hippocampus needs t...", "to": "GD", "value": 1.0, "width": 1.6931471805599454}, {"from": "dementia", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u002737cdae96f6271e07\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35213535 - Mapping the gene network landscape of Alzheimer\u0027s disease through integrating genomics and transcriptomics.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [15, 94], \u0027evidence\u0027: \u0027Author summary Alzheimer\u2019s disease (AD) is recognized as the leading primary cause of dementia, resulting in a high socioeconomic burden.\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u0027819143bcdc07bcd0\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40607399 - Decoding neuroinflammation in Alzheimer\u0027s disease a multi-omics and AI-driven perspective for precision medicine.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 11, \u0027page\u0027: None, \u0027char_span\u0027: [15, 80], \u0027evidence\u0027: \u00271 Introduction Alzheimer\u2019s disease (AD) is one of the leading causes of dementia and represents a major public health challenge in the 21st century (1, 2).\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=2.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 37cdae96f6271e07  \n[file]: 35213535 - Mapping the gene network landscape of Alzheimer\u0027s disease through integrating genomics and transcriptomics.pdf\n\u003e [evidence]: Author summary Alzheimer\u2019s disease (AD) is recognized as the leading primary cause of dementia, r...\n[doc_id]: 819143bcdc07bcd0  \n[file]: 40607399 - Decoding neuroinflammation in Alzheimer\u0027s disease a multi-omics and AI-driven perspective for precision medicine.pdf\n\u003e [evidence]: 1 Introduction Alzheimer\u2019s disease (AD) is one of the leading causes of dementia and represents a...", "to": "Alzheimer\u2019s disease (AD)", "value": 2.0, "width": 2.09861228866811}, {"from": "dementia", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00277e54ca131b151a6f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35849618 - Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 18, \u0027page\u0027: None, \u0027char_span\u0027: [0, 57], \u0027evidence\u0027: \u0027Alzheimer\u2019s Disease (AD) is the leading cause of dementia.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7e54ca131b151a6f  \n[file]: 35849618 - Single-cell network biology characterizes cell type gene regulation for drug repurposing and phenotype prediction in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Alzheimer\u2019s Disease (AD) is the leading cause of dementia.", "to": "Alzheimer\u2019s Disease", "value": 1.0, "width": 1.6931471805599454}, {"from": "dementia", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u002772f6a572bc577d36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38849813 - Altered glia-neuron communication in Alzheimer\u0027s Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 0, \u0027page\u0027: None, \u0027char_span\u0027: [20, 76], \u0027evidence\u0027: \u0027Abstract Background Alzheimer\u2019s disease is the most common cause of dementia and is characterized by amyloid-\u03b2 plaques, tau neurofibrillary tangles, and neuronal loss.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 72f6a572bc577d36  \n[file]: 38849813 - Altered glia-neuron communication in Alzheimer\u0027s Disease affects WNT, p53, and NFkB Signaling determined by snRNA-seq.pdf\n\u003e [evidence]: Abstract Background Alzheimer\u2019s disease is the most common cause of dementia and is characterized...", "to": "Alzheimer\u2019s disease", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD entorhinal cortex", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u0027bf000dbd95632554\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40369584 - Transcriptomic signatures of oxytosis ferroptosis are enriched in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 26, \u0027page\u0027: None, \u0027char_span\u0027: [65, 128], \u0027evidence\u0027: \u0027The other study identified selectively vulnerable neurons in the AD entorhinal cortex associated with neurofibrillary inclusions during disease progression and discovered a subpopulation of reactive astrocytes [61].\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: bf000dbd95632554  \n[file]: 40369584 - Transcriptomic signatures of oxytosis ferroptosis are enriched in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: The other study identified selectively vulnerable neurons in the AD entorhinal cortex associated ...", "to": "neurofibrillary inclusions", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD genes", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00272cd55c3c03739c98\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"33257666 - Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 18, \u0027page\u0027: None, \u0027char_span\u0027: [115, 186], \u0027evidence\u0027: \u0027In particular, antigen-presenting cluster 7 stands out amongst the other clusters since it emerges as enriched for AD genes that are diminished in expression at the cortical tissue level in both pathologically de\ufb01ned AD and AD dementia (Fig. 8c and Supplementary Fig. 14b, c).\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2cd55c3c03739c98  \n[file]: 33257666 - Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer\u0027s disease.pdf\n\u003e [evidence]: In particular, antigen-presenting cluster 7 stands out amongst the other clusters since it emerge...", "to": "cortical tissue level", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD mice", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027b093f6f0497dd291\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36180898 - Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 6, \u0027page\u0027: None, \u0027char_span\u0027: [53, 127], \u0027evidence\u0027: \u0027Genetic ablation of T cells, B cells and NK cells in AD mice, further amplified the expression of pathologic inflammatory genes involved in complement cascade and microglial activation.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b093f6f0497dd291  \n[file]: 36180898 - Ex vivo expanded human regulatory T cells modify neuroinflammation in a preclinical model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Genetic ablation of T cells, B cells and NK cells in AD mice, further amplified the expression of...", "to": "pathologic inflammatory genes", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD mice", "label": "promotes", "sources": ["{\u0027doc_id\u0027: \u00274d7d47f583b6d19c\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40707875 - Mir-199a-3p aggravates neuroinflammation in an Alzheimer\u0027s disease transgenic mouse model by promoting M1-polarization microgliaMir-199a-3p M1.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [135, 180], \u0027evidence\u0027: \u0027Results Intracerebroventricular administration of miR-199a-3p agomir exacerbated amyloid deposition and impaired cognitive function in AD mice, and promoted microglial polarization toward the M1 phenotype.\u0027, \u0027confidence\u0027: 1.0}"], "title": "promotes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4d7d47f583b6d19c  \n[file]: 40707875 - Mir-199a-3p aggravates neuroinflammation in an Alzheimer\u0027s disease transgenic mouse model by promoting M1-polarization microgliaMir-199a-3p M1.pdf\n\u003e [evidence]: Results Intracerebroventricular administration of miR-199a-3p agomir exacerbated amyloid depositi...", "to": "microglial polarization", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglial polarization", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 25, \u0027page\u0027: None, \u0027char_span\u0027: [0, 55], \u0027evidence\u0027: \u0027C5a may synergistically enhance microglial polarization to a more inflammatory state in response to A\u00df interactions (or other danger-associated signals) with Hernandez et al.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: C5a may synergistically enhance microglial polarization to a more inflammatory state in response ...", "to": "C5a", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD model mice", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00277ec126941318b941\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [50, 86], \u0027evidence\u0027: \u0027We showed that STING suppression was effective in AD model mice that expressed both A\u03b2 and human tau.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ec126941318b941  \n[file]: 39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\n\u003e [evidence]: We showed that STING suppression was effective in AD model mice that expressed both A\u03b2 and human ...", "to": "A\u03b2", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD model mice", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00277ec126941318b941\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [50, 100], \u0027evidence\u0027: \u0027We showed that STING suppression was effective in AD model mice that expressed both A\u03b2 and human tau.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ec126941318b941  \n[file]: 39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\n\u003e [evidence]: We showed that STING suppression was effective in AD model mice that expressed both A\u03b2 and human ...", "to": "human tau", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 66, \u0027page\u0027: None, \u0027char_span\u0027: [76, 119], \u0027evidence\u0027: \u0027It was proven that Irf8 is involved in microglial activation in response to A\u03b2 and leads to interleukin-1\u03b2 inflammation [61].\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: It was proven that Irf8 is involved in microglial activation in response to A\u03b2 and leads to inter...", "to": "interleukin-1\u03b2 inflammation", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00277ff5d3a47ea9588d\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735459147 - Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 34, \u0027page\u0027: None, \u0027char_span\u0027: [71, 124], \u0027evidence\u0027: \u0027This evidence has led to the hypothesis that in the Alzheimer\u2019s brain, A\u03b2 triggers an exacerbated proinflammatory activation of brain innate immune cells, particularly microglia and to a lesser extent astrocytes, resulting in a chronic neuroinflammatory state that causes neuronal damage and cognitive decline.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ff5d3a47ea9588d  \n[file]: 35459147 - Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.pdf\n\u003e [evidence]: This evidence has led to the hypothesis that in the Alzheimer\u2019s brain, A\u03b2 triggers an exacerbated...", "to": "proinflammatory activation", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00272f3cd755c1b95f07\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [41, 73], \u0027evidence\u0027: \u0027F Western blotting analysis of BACE1 and A\u03b2 expression in the hippocampus in the indicated mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: F Western blotting analysis of BACE1 and A\u03b2 expression in the hippocampus in the indicated mice.", "to": "hippocampus", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 61, \u0027page\u0027: None, \u0027char_span\u0027: [43, 84], \u0027evidence\u0027: \u0027Cst7 expressing microglia tend to surround A\u03b2 in the brain and increase inflammation [56].\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Cst7 expressing microglia tend to surround A\u03b2 in the brain and increase inflammation [56].", "to": "inflammation", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u00272f3cd755c1b95f07\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 20, \u0027page\u0027: None, \u0027char_span\u0027: [38, 75], \u0027evidence\u0027: \u00276 GD-induced RIPK3 activation affects A\u03b2 levels and increases neuronal loss in the APP/PS1 mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: 6 GD-induced RIPK3 activation affects A\u03b2 levels and increases neuronal loss in the APP/PS1 mice.", "to": "neuronal loss", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u00275b4711bead6c11ad\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735706029 - Microglial amyloid beta clearance is driven by PIEZO1 channels.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 12, \u0027page\u0027: None, \u0027char_span\u0027: [0, 47], \u0027evidence\u0027: \u0027A\u03b2 inhibited PIEZO1-mediated calcium transients, whereas activation of PIEZO1 with a selective agonist, Yoda1, improved microglial phagocytosis resulting in A\u03b2 clearance both in human and mouse models of AD.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 5b4711bead6c11ad  \n[file]: 35706029 - Microglial amyloid beta clearance is driven by PIEZO1 channels.pdf\n\u003e [evidence]: A\u03b2 inhibited PIEZO1-mediated calcium transients, whereas activation of PIEZO1 with a selective ag...", "to": "PIEZO1-mediated calcium transients", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027efbf7bba620cd8fe\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002736575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 27, \u0027page\u0027: None, \u0027char_span\u0027: [34, 77], \u0027evidence\u0027: \u0027The Fc portion of Adu can bind to FcRs expressed in microglia and opsonize A\u03b2 for phagocytosis by microglia.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: The Fc portion of Adu can bind to FcRs expressed in microglia and opsonize A\u03b2 for phagocytosis by...", "to": "FcRs", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD mouse model", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027efbf7bba620cd8fe\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002736575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 38, \u0027page\u0027: None, \u0027char_span\u0027: [37, 102], \u0027evidence\u0027: \u0027Additionally, knockout of GFAP in an AD mouse model showed a twofold increase in amyloid plaque burden and twice the amounts of dystrophic neurites [51].\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: Additionally, knockout of GFAP in an AD mouse model showed a twofold increase in amyloid plaque b...", "to": "amyloid plaque burden", "value": 1.0, "width": 1.6931471805599454}, {"from": "amyloid plaque burden", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027c51ff7fb94d8674f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39604588 - Elevated expression of the retrotransposon LINE-1 drives Alzheimer\u0027s disease-associated microglial dysfunction.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 35, \u0027page\u0027: None, \u0027char_span\u0027: [97, 162], \u0027evidence\u0027: \u0027Our findings suggest that LINE-1 activity at this stage may impair microglial functions, such as A\u03b2 clearance, potentially driving increased amyloid plaque burden.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: c51ff7fb94d8674f  \n[file]: 39604588 - Elevated expression of the retrotransposon LINE-1 drives Alzheimer\u0027s disease-associated microglial dysfunction.pdf\n\u003e [evidence]: Our findings suggest that LINE-1 activity at this stage may impair microglial functions, such as ...", "to": "A\u03b2 clearance", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD pathology", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u002798011f49f4ecb3ac\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 27, \u0027page\u0027: None, \u0027char_span\u0027: [80, 144], \u0027evidence\u0027: \u0027Our results also highlight a diversity of astrocyte and microglial responses to AD pathology that, while related to sub-types previously defined in preclinical models, also had distinct features.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 98011f49f4ecb3ac  \n[file]: 34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: Our results also highlight a diversity of astrocyte and microglial responses to AD pathology that...", "to": "sub-types previously defined", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD pathology", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u00274d7d47f583b6d19c\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40707875 - Mir-199a-3p aggravates neuroinflammation in an Alzheimer\u0027s disease transgenic mouse model by promoting M1-polarization microgliaMir-199a-3p M1.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 8, \u0027page\u0027: None, \u0027char_span\u0027: [60, 103], \u0027evidence\u0027: \u0027Conversely, treatment with miR-199a-3p antagomir attenuated AD pathology and suppressed M1 polarization.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4d7d47f583b6d19c  \n[file]: 40707875 - Mir-199a-3p aggravates neuroinflammation in an Alzheimer\u0027s disease transgenic mouse model by promoting M1-polarization microgliaMir-199a-3p M1.pdf\n\u003e [evidence]: Conversely, treatment with miR-199a-3p antagomir attenuated AD pathology and suppressed M1 polari...", "to": "M1 polarization", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD pathology", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u00279b1a0347efe392c6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [117, 181], \u0027evidence\u0027: \u0027A Schematic illustration showing microglia switching from homeostatic to stage 1 (an intermediate state) and stage 2 DAM following signals such as those associated with AD pathology and aging.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: A Schematic illustration showing microglia switching from homeostatic to stage 1 (an intermediate...", "to": "DAM", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD pathology", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00276e263da311cc2e11\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"37340466 - Sex specific molecular networks and key drivers of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 10, \u0027page\u0027: None, \u0027char_span\u0027: [69, 134], \u0027evidence\u0027: \u0027Gene perturbation experiments in EFAD mouse models demonstrated that LRP10 differentially affected cognitive function and AD pathology in sex- and APOE genotype-specific manners.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6e263da311cc2e11  \n[file]: 37340466 - Sex specific molecular networks and key drivers of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Gene perturbation experiments in EFAD mouse models demonstrated that LRP10 differentially affecte...", "to": "LRP10", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD patients", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u002717b13a15fc3bdd35\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39415193 - Network dynamics-based subtyping of Alzheimer\u0027s disease with microglial genetic risk factors.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 31, \u0027page\u0027: None, \u0027char_span\u0027: [54, 108], \u0027evidence\u0027: \u0027The three main identified risk factors distinguishing AD patients are highly related to microglial functions, with MEF2C and SPI1 being transcriptional factors.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 17b13a15fc3bdd35  \n[file]: 39415193 - Network dynamics-based subtyping of Alzheimer\u0027s disease with microglial genetic risk factors.pdf\n\u003e [evidence]: The three main identified risk factors distinguishing AD patients are highly related to microglia...", "to": "microglial functions", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD patients", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027f7ba0f60074958f6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002732271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 44, \u0027page\u0027: None, \u0027char_span\u0027: [166, 213], \u0027evidence\u0027: \u0027Thus, although the observed TLR8 and HERV-K upregulation in patients with AD can be both a cause and a consequence of the disease, our data may have implications for AD patients with increased HERV-K levels in CSF.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f7ba0f60074958f6  \n[file]: 32271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\n\u003e [evidence]: Thus, although the observed TLR8 and HERV-K upregulation in patients with AD can be both a cause ...", "to": "CSF", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglial functions", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u0027749f183524779851\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 48, \u0027page\u0027: None, \u0027char_span\u0027: [26, 93], \u0027evidence\u0027: \u0027Despite the potential for BIN1 to regulate crucial cellular pathways and microglial functions under homeostatic and pathological conditions, studies to date have largely neglected to characterize microglial BIN1 expression.\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: Despite the potential for BIN1 to regulate crucial cellular pathways and microglial functions und...", "to": "BIN1", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD progression", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [43, 86], \u0027evidence\u0027: \u0027Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Trem2, and Tyrobp.\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Tre...", "to": "Apoe", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD progression", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [43, 92], \u0027evidence\u0027: \u0027Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Trem2, and Tyrobp.\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Tre...", "to": "Ctsb", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD progression", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [43, 99], \u0027evidence\u0027: \u0027Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Trem2, and Tyrobp.\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Tre...", "to": "Trem2", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD progression", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [43, 111], \u0027evidence\u0027: \u0027Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Trem2, and Tyrobp.\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Globally, the critical genes implicated in AD progression are upregulated such as Apoe, Ctsb, Tre...", "to": "Tyrobp", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD progression", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00279b64c3dd721bd44f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [136, 203], \u0027evidence\u0027: \u0027High-resolution proteomics identified VGF El Gaamouch et al. Molecular Neurodegeneration (2020) 15:4 as a strong candidate biomarker of AD progression, with an estimated 10% decrease in CSF levels of VGF per year in diseased patients but not in age-matched controls [10].\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: High-resolution proteomics identified VGF El Gaamouch et al. Molecular Neurodegeneration (2020) 1...", "to": "CSF levels of VGF", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD progression", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027b5d5053cd6fc980b\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740346662 - A single-cell transcriptomic atlas of all cell types in the brain of 5xFAD Alzheimer mice in response to dietary inulin supplementation.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [74, 154], \u0027evidence\u0027: \u0027Results Here, we show that dietary inulin supplementation synergized with AD progression to specifically increase the abundance of Akkermansia muciniphila in gut microbiome of 5 \u00d7 Familial AD (FAD) mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b5d5053cd6fc980b  \n[file]: 40346662 - A single-cell transcriptomic atlas of all cell types in the brain of 5xFAD Alzheimer mice in response to dietary inulin supplementation.pdf\n\u003e [evidence]: Results Here, we show that dietary inulin supplementation synergized with AD progression to speci...", "to": "Akkermansia muciniphila", "value": 1.0, "width": 1.6931471805599454}, {"from": "Ctsb", "label": "interacts with", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 42, \u0027page\u0027: None, \u0027char_span\u0027: [25, 78], \u0027evidence\u0027: \u0027Regarding A\u03b2 production, Ctsb is thought to interact with the \u03b2-secretase site of amyloid precursor protein (APP) [53].\u0027, \u0027confidence\u0027: 1.0}"], "title": "interacts with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Regarding A\u03b2 production, Ctsb is thought to interact with the \u03b2-secretase site of amyloid precurs...", "to": "\u03b2-secretase site", "value": 1.0, "width": 1.6931471805599454}, {"from": "Akkermansia muciniphila", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027b5d5053cd6fc980b\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740346662 - A single-cell transcriptomic atlas of all cell types in the brain of 5xFAD Alzheimer mice in response to dietary inulin supplementation.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 41, \u0027page\u0027: None, \u0027char_span\u0027: [54, 124], \u0027evidence\u0027: \u0027In line with this, daily feeding of APP/PS1 mice with Akkermansia muciniphila for 6 months led to decreased A\u03b2 plaque burden in cerebral cortex and improved performance in the Y-maze test [39].\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b5d5053cd6fc980b  \n[file]: 40346662 - A single-cell transcriptomic atlas of all cell types in the brain of 5xFAD Alzheimer mice in response to dietary inulin supplementation.pdf\n\u003e [evidence]: In line with this, daily feeding of APP/PS1 mice with Akkermansia muciniphila for 6 months led to...", "to": "A\u03b2 plaque burden", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD risk genes", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u002798011f49f4ecb3ac\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 1, \u0027page\u0027: None, \u0027char_span\u0027: [52, 73], \u0027evidence\u0027: \u0027Significant differences in glial gene expression (including AD risk genes expressed in both the astrocytes [CLU, MEF2C, IQCK] and microglia [APOE, MS4A6A, PILRA]) were correlated with tissue amyloid or pTau expression.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 98011f49f4ecb3ac  \n[file]: 34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: Significant differences in glial gene expression (including AD risk genes expressed in both the a...", "to": "CLU", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD risk genes", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u002798011f49f4ecb3ac\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 1, \u0027page\u0027: None, \u0027char_span\u0027: [60, 124], \u0027evidence\u0027: \u0027Significant differences in glial gene expression (including AD risk genes expressed in both the astrocytes [CLU, MEF2C, IQCK] and microglia [APOE, MS4A6A, PILRA]) were correlated with tissue amyloid or pTau expression.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 98011f49f4ecb3ac  \n[file]: 34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: Significant differences in glial gene expression (including AD risk genes expressed in both the a...", "to": "IQCK", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD risk genes", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u002798011f49f4ecb3ac\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 1, \u0027page\u0027: None, \u0027char_span\u0027: [60, 118], \u0027evidence\u0027: \u0027Significant differences in glial gene expression (including AD risk genes expressed in both the astrocytes [CLU, MEF2C, IQCK] and microglia [APOE, MS4A6A, PILRA]) were correlated with tissue amyloid or pTau expression.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 98011f49f4ecb3ac  \n[file]: 34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: Significant differences in glial gene expression (including AD risk genes expressed in both the a...", "to": "MEF2C", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD subtypes", "label": "promotes", "sources": ["{\u0027doc_id\u0027: \u0027819143bcdc07bcd0\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40607399 - Decoding neuroinflammation in Alzheimer\u0027s disease a multi-omics and AI-driven perspective for precision medicine.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 9, \u0027page\u0027: None, \u0027char_span\u0027: [84, 163], \u0027evidence\u0027: \u0027This strategy is expected to achieve accurate classification and early diagnosis of AD subtypes, and promote the development of individualized treatment strategies based on individual molecular and immune characteristics.\u0027, \u0027confidence\u0027: 1.0}"], "title": "promotes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 819143bcdc07bcd0  \n[file]: 40607399 - Decoding neuroinflammation in Alzheimer\u0027s disease a multi-omics and AI-driven perspective for precision medicine.pdf\n\u003e [evidence]: This strategy is expected to achieve accurate classification and early diagnosis of AD subtypes, ...", "to": "individualized treatment strategies", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD-PRS score", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u002767093924e7a7a040\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002741044568 - Cytokine expression profile in the human brain of older adults.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 32, \u0027page\u0027: None, \u0027char_span\u0027: [103, 170], \u0027evidence\u0027: \u0027Further supporting the link between AD genetic risk and cytokine expression, we observed that a higher AD-PRS score correlated with increased SPP1 expression in microglia (Fig. 5).\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 67093924e7a7a040  \n[file]: 41044568 - Cytokine expression profile in the human brain of older adults.pdf\n\u003e [evidence]: Further supporting the link between AD genetic risk and cytokine expression, we observed that a h...", "to": "SPP1 expression in microglia", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD-associated hyperacetylation", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u00274e7b649fab289523\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002734172755 - Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 13, \u0027page\u0027: None, \u0027char_span\u0027: [25, 127], \u0027evidence\u0027: \u0027It is of note that while AD-associated hyperacetylation was linked to oligodendrocyte genes and astrocyte co-expression modules, genetic risk factors for AD were mapped onto a different glial cell type, microglia.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4e7b649fab289523  \n[file]: 34172755 - Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders.pdf\n\u003e [evidence]: It is of note that while AD-associated hyperacetylation was linked to oligodendrocyte genes and a...", "to": "astrocyte co-expression modules", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD-associated hyperacetylation", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u00274e7b649fab289523\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002734172755 - Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 13, \u0027page\u0027: None, \u0027char_span\u0027: [25, 91], \u0027evidence\u0027: \u0027It is of note that while AD-associated hyperacetylation was linked to oligodendrocyte genes and astrocyte co-expression modules, genetic risk factors for AD were mapped onto a different glial cell type, microglia.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4e7b649fab289523  \n[file]: 34172755 - Neuronal and glial 3D chromatin architecture informs the cellular etiology of brain disorders.pdf\n\u003e [evidence]: It is of note that while AD-associated hyperacetylation was linked to oligodendrocyte genes and a...", "to": "oligodendrocyte genes", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD-like disease", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u00279b1a0347efe392c6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 6, \u0027page\u0027: None, \u0027char_span\u0027: [60, 97], \u0027evidence\u0027: \u0027Taken together, these findings provide useful insights into AD-like disease activated by HCMV IE2.\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: Taken together, these findings provide useful insights into AD-like disease activated by HCMV IE2.", "to": "HCMV IE2", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD-like phenotypes", "label": "prevents", "sources": ["{\u0027doc_id\u0027: \u00279b64c3dd721bd44f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 5, \u0027page\u0027: None, \u0027char_span\u0027: [95, 163], \u0027evidence\u0027: \u0027It is also increased by environmental enrichment (EE) [57], which reduces amyloid toxicity and AD-like phenotypes and prevents microglialmediated neuroinflammation [58\u201362].\u0027, \u0027confidence\u0027: 1.0}"], "title": "prevents | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: It is also increased by environmental enrichment (EE) [57], which reduces amyloid toxicity and AD...", "to": "microglialmediated neuroinflammation", "value": 1.0, "width": 1.6931471805599454}, {"from": "AD-risk variant", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u0027686e459beba250bc\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40653482 - Multi-omics analysis for identifying cell-type-specific and bulk-level druggable targets in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 11, \u0027page\u0027: None, \u0027char_span\u0027: [4, 64], \u0027evidence\u0027: \u0027The AD-risk variant associated with candidate causal gene PABPC1 is located near or within enhancers only active in astrocytes.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 686e459beba250bc  \n[file]: 40653482 - Multi-omics analysis for identifying cell-type-specific and bulk-level druggable targets in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: The AD-risk variant associated with candidate causal gene PABPC1 is located near or within enhanc...", "to": "candidate causal gene PABPC1", "value": 1.0, "width": 1.6931471805599454}, {"from": "ANXA1", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u00279534686b56278393\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39987247 - Fokker-Planck diffusion maps of microglial transcriptomes reveal radial differentiation into substates associated with Alzheimer\u0027s pathology.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 21, \u0027page\u0027: None, \u0027char_span\u0027: [38, 80], \u0027evidence\u0027: \u0027In macrophages it has been shown that ANXA1 regulates interferon beta production downstream of TLR4 by interacting with TBK1 via the C-terminal domain50.\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9534686b56278393  \n[file]: 39987247 - Fokker-Planck diffusion maps of microglial transcriptomes reveal radial differentiation into substates associated with Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: In macrophages it has been shown that ANXA1 regulates interferon beta production downstream of TL...", "to": "interferon beta production", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE", "label": "binds", "sources": ["{\u0027doc_id\u0027: \u0027666910073258515e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002732703241 - Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [27, 46], \u0027evidence\u0027: \u0027Recent studies showed that APOE binds to TREM2, thus raising the possibility of an APOE-TREM2 interaction that can modulate AD pathology.\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u0027b77fb099d704992b\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002729416036 - A transcriptomic atlas of aged human microglia.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 9, \u0027page\u0027: None, \u0027char_span\u0027: [56, 284], \u0027evidence\u0027: \u0027In particular, we report the intriguing result that the APOE\u03b52 haplotype is associated with a reduced HuMi_Aged signature, consistent with its role as a protective factor in AD, and this observation aligns with recent reports that APOE may interact with microglial genes such as TREM215\u201317.\u0027, \u0027confidence\u0027: 1.0}"], "title": "binds | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 666910073258515e  \n[file]: 32703241 - Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.pdf\n\u003e [evidence]: Recent studies showed that APOE binds to TREM2, thus raising the possibility of an APOE-TREM2 int...\n[doc_id]: b77fb099d704992b  \n[file]: 29416036 - A transcriptomic atlas of aged human microglia.pdf\n\u003e [evidence]: In particular, we report the intriguing result that the APOE\u03b52 haplotype is associated with a red...", "to": "TREM2", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027213b0617682e2ece\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 0, \u0027page\u0027: None, \u0027char_span\u0027: [72, 155], \u0027evidence\u0027: \u0027Conclusion Overall, using a robust model of ATN pathology, we show that APOE de\ufb01ciency decreased progression of late-stage amyloidfacilitated tau pathology and consequent neurodegeneration, despite high A\u03b2 load.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 213b0617682e2ece  \n[file]: 40307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\n\u003e [evidence]: Conclusion Overall, using a robust model of ATN pathology, we show that APOE de\ufb01ciency decreased ...", "to": "late-stage amyloidfacilitated tau pathology", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027a2b5d2580db67e89\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35436980 - Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer\u0027s disease-associated genetic variants.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 15, \u0027page\u0027: None, \u0027char_span\u0027: [8, 52], \u0027evidence\u0027: \u0027Because APOE expresses most abundantly in astrocytes among these neural cell types, astrocytes might be the primary cell type contributing to this effect.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: a2b5d2580db67e89  \n[file]: 35436980 - Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer\u0027s disease-associated genetic variants.pdf\n\u003e [evidence]: Because APOE expresses most abundantly in astrocytes among these neural cell types, astrocytes mi...", "to": "astrocytes", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u00279dd895f2425df710\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 39, \u0027page\u0027: None, \u0027char_span\u0027: [17, 65], \u0027evidence\u0027: \u0027Mechanistically, APOE may modulate the immune response to plaques, preventing aspects that drive tau pathology, or it may play a pivotal role in inducing and spreading tau pathology and subsequent neurodegeneration.\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: Mechanistically, APOE may modulate the immune response to plaques, preventing aspects that drive ...", "to": "immune response to plaques", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027df2d131cac5a5725\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"34301296 - Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 9, \u0027page\u0027: None, \u0027char_span\u0027: [121, 182], \u0027evidence\u0027: \u0027Notably, TREM2-R47H xMGs also show overall reduced reactivity to plaques, including diminished plaque-proximity, reduced CD9 expression, and lower secretion of plaque-associated APOE.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: df2d131cac5a5725  \n[file]: 34301296 - Plaque-associated human microglia accumulate lipid droplets in a chimeric model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Notably, TREM2-R47H xMGs also show overall reduced reactivity to plaques, including diminished pl...", "to": "CD9 expression", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027ca701e89f5b6c8c9\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38178204 - Identification of female-enriched and disease-associated microglia (FDAMic) contributes to sexual dimorphism in late-onset Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 37, \u0027page\u0027: None, \u0027char_span\u0027: [17, 76], \u0027evidence\u0027: \u0027Considering that FDAMic also exhibited the highest expression levels of APOE and TREM2 (Additional file 13: Fig. S4A) but the lowest expression level of CXCR31 (Fig. 2C) among other subtypes of microglia, it is therefore speculated that FDAMic resembles the activated state of DAM, while their predominant APOE4 and female sex status (Fig. 6) might have hindered the activation of phagocytic activities through the Rac and Rho GTPase signaling network [125\u2013128] and associated autophagy pathways [129] (Additional file 12: Fig. S3A).\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: ca701e89f5b6c8c9  \n[file]: 38178204 - Identification of female-enriched and disease-associated microglia (FDAMic) contributes to sexual dimorphism in late-onset Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Considering that FDAMic also exhibited the highest expression levels of APOE and TREM2 (Additiona...", "to": "FDAMic", "value": 1.0, "width": 1.6931471805599454}, {"from": "TREM2", "label": "interacts with", "sources": ["{\u0027doc_id\u0027: \u00270fafd5f17a2c043e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"33097708 - Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 8, \u0027page\u0027: None, \u0027char_span\u0027: [31, 64], \u0027evidence\u0027: \u0027Previous studies examining how APOE isoforms interact with TREM2 have been inconsistent.\u0027, \u0027confidence\u0027: 1.0}"], "title": "interacts with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0fafd5f17a2c043e  \n[file]: 33097708 - Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Previous studies examining how APOE isoforms interact with TREM2 have been inconsistent.", "to": "APOE isoforms", "value": 1.0, "width": 1.6931471805599454}, {"from": "TREM2", "label": "interacts with", "sources": ["{\u0027doc_id\u0027: \u00279e637c3659f6dff8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735859075 - Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [0, 48], \u0027evidence\u0027: \u0027Gal-3 interacts with immune receptors like TREM2 and TLR4.\u0027, \u0027confidence\u0027: 1.0}"], "title": "interacts with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9e637c3659f6dff8  \n[file]: 35859075 - Galectin-3, a rising star in modulating microglia activation under conditions of neurodegeneration.pdf\n\u003e [evidence]: Gal-3 interacts with immune receptors like TREM2 and TLR4.", "to": "Gal-3", "value": 1.0, "width": 1.6931471805599454}, {"from": "astrocytes", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00279b64c3dd721bd44f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [0, 41], \u0027evidence\u0027: \u0027C3aR1 is expressed by neurons, astrocytes, and microglia in the brain [26\u201328], but the functional consequences of TLQP-21 activation of C3aR1 on microglia are poorly understood [29].\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: C3aR1 is expressed by neurons, astrocytes, and microglia in the brain [26\u201328], but the functional...", "to": "C3aR1", "value": 1.0, "width": 1.6931471805599454}, {"from": "astrocytes", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00273012894074386645\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 13, \u0027page\u0027: None, \u0027char_span\u0027: [0, 80], \u0027evidence\u0027: \u0027Insoluble A\u03b21\u201340 and A\u03b21\u201342 levels were reduced comparably while more astrocytes and microglia were observed in surrounding amyloid plaques.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Insoluble A\u03b21\u201340 and A\u03b21\u201342 levels were reduced comparably while more astrocytes and microglia we...", "to": "Insoluble A\u03b21\u201340 and A\u03b21\u201342 levels", "value": 1.0, "width": 1.6931471805599454}, {"from": "immune response to plaques", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u00279dd895f2425df710\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 51, \u0027page\u0027: None, \u0027char_span\u0027: [28, 79], \u0027evidence\u0027: \u0027These findings suggest that APOE3Ch may modulate the immune response to plaques, consistent with our hypothesis.\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: These findings suggest that APOE3Ch may modulate the immune response to plaques, consistent with ...", "to": "APOE3Ch", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE and TREM2", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u002775e9d948abad0bc8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002730558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 46, \u0027page\u0027: None, \u0027char_span\u0027: [5, 56], \u0027evidence\u0027: \u0027Both APOE and TREM2 are associated with lipid metabolism, thus their activation may connect with altered lipidomic homeostasis caused by AD pathology [28].\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 75e9d948abad0bc8  \n[file]: 30558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\n\u003e [evidence]: Both APOE and TREM2 are associated with lipid metabolism, thus their activation may connect with ...", "to": "lipid metabolism", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE and TREM2", "label": "risk for", "sources": ["{\u0027doc_id\u0027: \u0027666910073258515e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002732703241 - Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 29, \u0027page\u0027: None, \u0027char_span\u0027: [6, 64], \u0027evidence\u0027: \u0027While APOE and TREM2 are two major genetic risk factors for LOAD, surprisingly little is known about the interplay between these two, regarding amyloid deposition, microglial phenotype or transcriptomic profile.\u0027, \u0027confidence\u0027: 1.0}"], "title": "risk for | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 666910073258515e  \n[file]: 32703241 - Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.pdf\n\u003e [evidence]: While APOE and TREM2 are two major genetic risk factors for LOAD, surprisingly little is known ab...", "to": "LOAD", "value": 1.0, "width": 1.6931471805599454}, {"from": "lipid metabolism", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00279dd895f2425df710\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 53, \u0027page\u0027: None, \u0027char_span\u0027: [28, 63], \u0027evidence\u0027: \u0027These findings suggest that APOE3Ch may affect lipid metabolism in the brain, which could contribute to its effects on amyloid-\u03b2 and tau pathology.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: These findings suggest that APOE3Ch may affect lipid metabolism in the brain, which could contrib...", "to": "APOE3Ch", "value": 1.0, "width": 1.6931471805599454}, {"from": "LOAD", "label": "risk for", "sources": ["{\u0027doc_id\u0027: \u0027ca701e89f5b6c8c9\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38178204 - Identification of female-enriched and disease-associated microglia (FDAMic) contributes to sexual dimorphism in late-onset Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [40, 104], \u0027evidence\u0027: \u0027Here, we report that the coexistence of APOE4 genetic status\u2014 the strongest genetic risk factor for LOAD [123]\u2014with female sex formulates a set of strong risk factors favoring the emergence of FDAMic.\u0027, \u0027confidence\u0027: 1.0}"], "title": "risk for | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: ca701e89f5b6c8c9  \n[file]: 38178204 - Identification of female-enriched and disease-associated microglia (FDAMic) contributes to sexual dimorphism in late-onset Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Here, we report that the coexistence of APOE4 genetic status\u2014 the strongest genetic risk factor f...", "to": "APOE4 genetic status", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE binding", "label": "binds", "sources": ["{\u0027doc_id\u0027: \u00279dd895f2425df710\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 36, \u0027page\u0027: None, \u0027char_span\u0027: [22, 215], \u0027evidence\u0027: \u0027Studies indicate that APOE binding is integral to some of these processes [16\u201320] with differences in APOE isoform-specific receptor binding affinity and lipid interactions affecting neuroinflammation, tau pathology, and amyloid plaque dynamics [21\u201324].\u0027, \u0027confidence\u0027: 1.0}"], "title": "binds | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: Studies indicate that APOE binding is integral to some of these processes [16\u201320] with difference...", "to": "tau pathology", "value": 1.0, "width": 1.6931471805599454}, {"from": "tau pathology", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00279dd895f2425df710\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 1, \u0027page\u0027: None, \u0027char_span\u0027: [44, 85], \u0027evidence\u0027: \u0027The results showed that in the 5xFAD model, ApoeCh led to a decrease in tau pathology and an increase in microglial activation, while in the PS19 model, ApoeCh had the opposite effect.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: The results showed that in the 5xFAD model, ApoeCh led to a decrease in tau pathology and an incr...", "to": "ApoeCh", "value": 1.0, "width": 1.6931471805599454}, {"from": "tau pathology", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u002703b5a3ad723acdbf\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737988169 - Galectin-3 aggravates microglial activation and tau transmission in tauopathy.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 55, \u0027page\u0027: None, \u0027char_span\u0027: [15, 50], \u0027evidence\u0027: \u0027The removal of Gal3 markedly reduced tau pathology in mouse models of tauopathy and AD.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 03b5a3ad723acdbf  \n[file]: 37988169 - Galectin-3 aggravates microglial activation and tau transmission in tauopathy.pdf\n\u003e [evidence]: The removal of Gal3 markedly reduced tau pathology in mouse models of tauopathy and AD.", "to": "Gal3", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE de\ufb01ciency", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u0027213b0617682e2ece\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [39, 78], \u0027evidence\u0027: \u0027Taken together, our data indicate that APOE de\ufb01ciency inhibits ATN progression by pleiotropic effects, including inhibition of dense core amyloid plaque formation, and inhibition of microglial conversion beyond homeostatic microglia, while our \ufb01ndings also lend support to the validation of protective APOE mutations.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 213b0617682e2ece  \n[file]: 40307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\n\u003e [evidence]: Taken together, our data indicate that APOE de\ufb01ciency inhibits ATN progression by pleiotropic eff...", "to": "ATN progression", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE de\ufb01ciency", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u0027213b0617682e2ece\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [15, 79], \u0027evidence\u0027: \u0027We showed that APOE de\ufb01ciency inhibits progressive amyloid-driven tau pathology and neurodegeneration, despite high A\u03b2 load.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 213b0617682e2ece  \n[file]: 40307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\n\u003e [evidence]: We showed that APOE de\ufb01ciency inhibits progressive amyloid-driven tau pathology and neurodegenera...", "to": "amyloid-driven tau pathology", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE de\ufb01ciency", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u0027213b0617682e2ece\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 8, \u0027page\u0027: None, \u0027char_span\u0027: [2, 39], \u0027evidence\u0027: \u00275 APOE de\ufb01ciency inhibited microgliosis in a model recapitulating ATN pathology.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 213b0617682e2ece  \n[file]: 40307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\n\u003e [evidence]: 5 APOE de\ufb01ciency inhibited microgliosis in a model recapitulating ATN pathology.", "to": "microgliosis", "value": 1.0, "width": 1.6931471805599454}, {"from": "ATN progression", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u0027213b0617682e2ece\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [42, 114], \u0027evidence\u0027: \u0027The observed effects of APOE de\ufb01ciency on ATN progression were associated with reduced dense core plaque formation, favoring large diffuse A\u03b2 deposits, and blocked transition of homeostatic microglia to the reactive and DAM phenotype.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 213b0617682e2ece  \n[file]: 40307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\n\u003e [evidence]: The observed effects of APOE de\ufb01ciency on ATN progression were associated with reduced dense core...", "to": "dense core plaque formation", "value": 1.0, "width": 1.6931471805599454}, {"from": "ATN progression", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u0027213b0617682e2ece\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [63, 162], \u0027evidence\u0027: \u0027Taken together, our data indicate that APOE de\ufb01ciency inhibits ATN progression by pleiotropic effects, including inhibition of dense core amyloid plaque formation, and inhibition of microglial conversion beyond homeostatic microglia, while our \ufb01ndings also lend support to the validation of protective APOE mutations.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 213b0617682e2ece  \n[file]: 40307424 - APOE deficiency inhibits amyloid-facilitated (A) tau pathology (T) and neurodegeneration (N), halting progressive ATN pathology in a preclinical model.pdf\n\u003e [evidence]: Taken together, our data indicate that APOE de\ufb01ciency inhibits ATN progression by pleiotropic eff...", "to": "dense core amyloid plaque formation", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE expression in microglia", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u0027a2b5d2580db67e89\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35436980 - Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer\u0027s disease-associated genetic variants.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 17, \u0027page\u0027: None, \u0027char_span\u0027: [30, 98], \u0027evidence\u0027: \u0027Compared with astrocytes, the APOE expression in microglia is upregulated in patients with AD [27].\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: a2b5d2580db67e89  \n[file]: 35436980 - Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer\u0027s disease-associated genetic variants.pdf\n\u003e [evidence]: Compared with astrocytes, the APOE expression in microglia is upregulated in patients with AD [27].", "to": "[27]", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE expression in microglia", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u0027a2b5d2580db67e89\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35436980 - Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer\u0027s disease-associated genetic variants.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 17, \u0027page\u0027: None, \u0027char_span\u0027: [30, 93], \u0027evidence\u0027: \u0027Compared with astrocytes, the APOE expression in microglia is upregulated in patients with AD [27].\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: a2b5d2580db67e89  \n[file]: 35436980 - Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer\u0027s disease-associated genetic variants.pdf\n\u003e [evidence]: Compared with astrocytes, the APOE expression in microglia is upregulated in patients with AD [27].", "to": "patients with AD", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE \u03b54 allele", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u00277ec126941318b941\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 3, \u0027page\u0027: None, \u0027char_span\u0027: [32, 90], \u0027evidence\u0027: \u0027Both A\u03b2 and tau, as well as the APOE \u03b54 allele, were linked to increases in cGAS and STING levels in human microglia.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ec126941318b941  \n[file]: 39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\n\u003e [evidence]: Both A\u03b2 and tau, as well as the APOE \u03b54 allele, were linked to increases in cGAS and STING levels...", "to": "STING", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE \u03b54 allele", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u00277ec126941318b941\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 3, \u0027page\u0027: None, \u0027char_span\u0027: [32, 80], \u0027evidence\u0027: \u0027Both A\u03b2 and tau, as well as the APOE \u03b54 allele, were linked to increases in cGAS and STING levels in human microglia.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ec126941318b941  \n[file]: 39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\n\u003e [evidence]: Both A\u03b2 and tau, as well as the APOE \u03b54 allele, were linked to increases in cGAS and STING levels...", "to": "cGAS", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE \u03b54 variant", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u0027a2b5d2580db67e89\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35436980 - Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer\u0027s disease-associated genetic variants.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 11, \u0027page\u0027: None, \u0027char_span\u0027: [19, 75], \u0027evidence\u0027: \u0027Interestingly, the APOE \u03b54 variant is associated with attenuated expression of the major transcript of APOE based on the evidence from both allelic imbalance and gene-level expression.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: a2b5d2580db67e89  \n[file]: 35436980 - Allele-specific analysis reveals exon- and cell-type-specific regulatory effects of Alzheimer\u0027s disease-associated genetic variants.pdf\n\u003e [evidence]: Interestingly, the APOE \u03b54 variant is associated with attenuated expression of the major transcri...", "to": "attenuated expression", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE3Ch", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00279dd895f2425df710\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 55, \u0027page\u0027: None, \u0027char_span\u0027: [28, 64], \u0027evidence\u0027: \u0027These findings suggest that APOE3Ch may affect synaptic function in the brain, which could contribute to its effects on cognitive function.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: These findings suggest that APOE3Ch may affect synaptic function in the brain, which could contri...", "to": "synaptic function", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE3Ch", "label": "prevents", "sources": ["{\u0027doc_id\u0027: \u00279dd895f2425df710\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 34, \u0027page\u0027: None, \u0027char_span\u0027: [38, 120], \u0027evidence\u0027: \u0027Understanding the mechanisms by which APOE3Ch prevents the subsequent development of tau pathology and neurodegeneration is essential to stop dementia during the long plaque-laden prodromal phase of AD.\u0027, \u0027confidence\u0027: 1.0}"], "title": "prevents | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: Understanding the mechanisms by which APOE3Ch prevents the subsequent development of tau patholog...", "to": "subsequent development of tau pathology and neurodegeneration", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE3Ch expression", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00279dd895f2425df710\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 45, \u0027page\u0027: None, \u0027char_span\u0027: [14, 78], \u0027evidence\u0027: \u0027We found that APOE3Ch expression significantly reduced amyloid-\u03b2 plaque burden in the 5xFAD model, but had no effect on tau pathology.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: We found that APOE3Ch expression significantly reduced amyloid-\u03b2 plaque burden in the 5xFAD model...", "to": "amyloid-\u03b2 plaque burden", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE4", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u002797bab3151172289e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 1, \u0027page\u0027: None, \u0027char_span\u0027: [0, 23], \u0027evidence\u0027: \u0027APOE4-induced ER stress, specifically resulting from the ER \\xadCa2+ depletion, promotes the SREBP2 transcriptional activation of the cholesterol biosynthesis pathway in microglia.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: APOE4-induced ER stress, specifically resulting from the ER \u00adCa2+ depletion, promotes the SREBP2 ...", "to": "ER stress", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE4", "label": "risk for", "sources": ["{\u0027doc_id\u0027: \u00279dd895f2425df710\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [0, 62], \u0027evidence\u0027: \u0027APOE4 is the most robust genetic risk factor for sporadic LOAD.\u0027, \u0027confidence\u0027: 1.0}"], "title": "risk for | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: APOE4 is the most robust genetic risk factor for sporadic LOAD.", "to": "sporadic LOAD", "value": 1.0, "width": 1.6931471805599454}, {"from": "ER stress", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u002797bab3151172289e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 41, \u0027page\u0027: None, \u0027char_span\u0027: [48, 71], \u0027evidence\u0027: \u0027In conclusion, our study provides evidence that ApoE4 induces ER stress and dysregulation of cholesterol metabolism in microglia, leading to increased SREBP2 expression and activation, which in turn promotes neuroinflammation and neurodegeneration in AD.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: In conclusion, our study provides evidence that ApoE4 induces ER stress and dysregulation of chol...", "to": "ApoE4", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE4 microglia derived from hiPSCs of AD", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u002797bab3151172289e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 34, \u0027page\u0027: None, \u0027char_span\u0027: [155, 247], \u0027evidence\u0027: \u0027Consistently, we observed significant enrichment of genes associated with unfolded protein response and regulation of cholesterol biosynthesis by SREBP in APOE4 microglia derived from hiPSCs of AD, with significantly increased expression of SREBP2 (Fig. 1b\u2013e).\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Consistently, we observed significant enrichment of genes associated with unfolded protein respon...", "to": "SREBP2", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE\u03b52 haplotype", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u0027b77fb099d704992b\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002729416036 - A transcriptomic atlas of aged human microglia.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 9, \u0027page\u0027: None, \u0027char_span\u0027: [56, 121], \u0027evidence\u0027: \u0027In particular, we report the intriguing result that the APOE\u03b52 haplotype is associated with a reduced HuMi_Aged signature, consistent with its role as a protective factor in AD, and this observation aligns with recent reports that APOE may interact with microglial genes such as TREM215\u201317.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b77fb099d704992b  \n[file]: 29416036 - A transcriptomic atlas of aged human microglia.pdf\n\u003e [evidence]: In particular, we report the intriguing result that the APOE\u03b52 haplotype is associated with a red...", "to": "reduced HuMi_Aged signature", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE\u03b54 carriers", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027ee0279144e802df8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737085492 - Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 18, \u0027page\u0027: None, \u0027char_span\u0027: [0, 82], \u0027evidence\u0027: \u0027APOE\u03b54 carriers had decreased proportions of nuclei in Mic-PNN and IN-axonogenesis, expression states that both in\ufb02uence axon regeneration and brain plasticity.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: ee0279144e802df8  \n[file]: 37085492 - Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers.pdf\n\u003e [evidence]: APOE\u03b54 carriers had decreased proportions of nuclei in Mic-PNN and IN-axonogenesis, expression st...", "to": "IN-axonogenesis", "value": 1.0, "width": 1.6931471805599454}, {"from": "APOE\u03b54 carriers", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027ee0279144e802df8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737085492 - Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 18, \u0027page\u0027: None, \u0027char_span\u0027: [0, 62], \u0027evidence\u0027: \u0027APOE\u03b54 carriers had decreased proportions of nuclei in Mic-PNN and IN-axonogenesis, expression states that both in\ufb02uence axon regeneration and brain plasticity.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: ee0279144e802df8  \n[file]: 37085492 - Single-nucleus RNA-sequencing of autosomal dominant Alzheimer disease and risk variant carriers.pdf\n\u003e [evidence]: APOE\u03b54 carriers had decreased proportions of nuclei in Mic-PNN and IN-axonogenesis, expression st...", "to": "Mic-PNN", "value": 1.0, "width": 1.6931471805599454}, {"from": "APP", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00273012894074386645\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 13, \u0027page\u0027: None, \u0027char_span\u0027: [142, 183], \u0027evidence\u0027: \u0027This was confirmed in isolated O4 + oligodendrocytes which, showed a significant reduction in BACE1 levels and elevated levels of full-length APP, indicative of decreased APP cleavage and consistent with loss of function of BACE limited to oligodendrocytes.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: This was confirmed in isolated O4 + oligodendrocytes which, showed a significant reduction in BAC...", "to": "APP cleavage", "value": 1.0, "width": 1.6931471805599454}, {"from": "APP/PS1 mice", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u00272f3cd755c1b95f07\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 27, \u0027page\u0027: None, \u0027char_span\u0027: [2, 57], \u0027evidence\u0027: \u0027I APP/PS1 mice were treated with Ad-TSHR289 or Ad-Control in the presence of either vehicle or GSK872.\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u00272f3cd755c1b95f07\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 10, \u0027page\u0027: None, \u0027char_span\u0027: [50, 105], \u0027evidence\u0027: \u0027C Schematic drawing of the experimental schedule: APP/PS1 mice were treated with Ad-TSHR289 or Ad-Control in the presence of either vehicle or GSK872.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=2.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: I APP/PS1 mice were treated with Ad-TSHR289 or Ad-Control in the presence of either vehicle or GS...\n\u003e [evidence]: C Schematic drawing of the experimental schedule: APP/PS1 mice were treated with Ad-TSHR289 or Ad...", "to": "Ad-Control", "value": 2.0, "width": 2.09861228866811}, {"from": "APP/PS1 mice", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u00272f3cd755c1b95f07\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 27, \u0027page\u0027: None, \u0027char_span\u0027: [2, 43], \u0027evidence\u0027: \u0027I APP/PS1 mice were treated with Ad-TSHR289 or Ad-Control in the presence of either vehicle or GSK872.\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u00272f3cd755c1b95f07\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 10, \u0027page\u0027: None, \u0027char_span\u0027: [50, 91], \u0027evidence\u0027: \u0027C Schematic drawing of the experimental schedule: APP/PS1 mice were treated with Ad-TSHR289 or Ad-Control in the presence of either vehicle or GSK872.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=2.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: I APP/PS1 mice were treated with Ad-TSHR289 or Ad-Control in the presence of either vehicle or GS...\n\u003e [evidence]: C Schematic drawing of the experimental schedule: APP/PS1 mice were treated with Ad-TSHR289 or Ad...", "to": "Ad-TSHR289", "value": 2.0, "width": 2.09861228866811}, {"from": "APP/PS1 mice", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u00279538f215b7d18baa\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40450296 - Early transcriptional and cellular abnormalities in choroid plexus of a mouse model of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 14, \u0027page\u0027: None, \u0027char_span\u0027: [70, 130], \u0027evidence\u0027: \u0027Additionally, a novel proliferative immune cell type was increased in APP/PS1 mice, suggesting that the increase of M1 macrophages may be driven primarily by resident clonal proliferation rather than peripheral recruitment [85].\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9538f215b7d18baa  \n[file]: 40450296 - Early transcriptional and cellular abnormalities in choroid plexus of a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Additionally, a novel proliferative immune cell type was increased in APP/PS1 mice, suggesting th...", "to": "M1 macrophages", "value": 1.0, "width": 1.6931471805599454}, {"from": "APP/PS1 mice", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u002791d0e406cb470366\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 11, \u0027page\u0027: None, \u0027char_span\u0027: [193, 232], \u0027evidence\u0027: \u0027Representative immunostaining (E) and quantification of the density (F) of microglia (labeled with Iba1) in the hippocampal CA3 region on coronal brain sections of WT mice treated with Veh and APP/PS1 mice treated with chronic D-Tyr versus Veh.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 91d0e406cb470366  \n[file]: 33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\n\u003e [evidence]: Representative immunostaining (E) and quantification of the density (F) of microglia (labeled wit...", "to": "chronic D-Tyr", "value": 1.0, "width": 1.6931471805599454}, {"from": "APP/PS1 mice", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u002791d0e406cb470366\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 6, \u0027page\u0027: None, \u0027char_span\u0027: [203, 242], \u0027evidence\u0027: \u0027Representative immunostaining (A) and quantification of the density (B) of microglia (labeled with Iba1) in the hippocampal CA1 region on coronal brain sections of WT mice treated with control (Veh) and APP/PS1 mice treated with chronic d-Tyr versus Veh.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 91d0e406cb470366  \n[file]: 33623128 - Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer\u0027s disease transgenic mouse model.pdf\n\u003e [evidence]: Representative immunostaining (A) and quantification of the density (B) of microglia (labeled wit...", "to": "chronic d-Tyr", "value": 1.0, "width": 1.6931471805599454}, {"from": "APP/PS1 mice", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u00272f3cd755c1b95f07\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 24, \u0027page\u0027: None, \u0027char_span\u0027: [25, 73], \u0027evidence\u0027: \u0027G Primary microglia from APP/PS1 mice were treated with oligomeric A\u03b21\u201342 and then treated with T3 or GSK872.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: G Primary microglia from APP/PS1 mice were treated with oligomeric A\u03b21\u201342 and then treated with T...", "to": "oligomeric A\u03b21\u201342", "value": 1.0, "width": 1.6931471805599454}, {"from": "Ad-TSHR289", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00272f3cd755c1b95f07\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 5, \u0027page\u0027: None, \u0027char_span\u0027: [103, 140], \u0027evidence\u0027: \u0027To fulfil the purpose, the 3-month-old female APP/PS1 transgenic mice were immunized and injected with Ad-TSHR289 to induce the GD phenotype, which was a well-established (See figure on next page.) Fig.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: To fulfil the purpose, the 3-month-old female APP/PS1 transgenic mice were immunized and injected...", "to": "GD phenotype", "value": 1.0, "width": 1.6931471805599454}, {"from": "APP/PSEN1dE9", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027666910073258515e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002732703241 - Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 3, \u0027page\u0027: None, \u0027char_span\u0027: [116, 156], \u0027evidence\u0027: \u0027The aim of this study was to investigate this interaction using complex AD model mice - a crossbreed of Trem2ko and APP/PSEN1dE9 mice expressing human APOE3 or APOE4 isoforms (APP/E3 and APP/E4 respectively), and their WT littermates (E3 and E4)\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 666910073258515e  \n[file]: 32703241 - Trem2 deficiency differentially affects phenotype and transcriptome of human APOE3 and APOE4 mice.pdf\n\u003e [evidence]: The aim of this study was to investigate this interaction using complex AD model mice - a crossbr...", "to": "human APOE3", "value": 1.0, "width": 1.6931471805599454}, {"from": "APPPS1-21 mice", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u0027215ff893f0c683e8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 32, \u0027page\u0027: None, \u0027char_span\u0027: [22, 74], \u0027evidence\u0027: \u0027We have shown that in APPPS1-21 mice treated in the early stage of disease (2\u20133 months of age) and 5X FAD mice treated at a late stage of amyloidosis (7\u20139 months of age), GV-971 alters the gut microbiota and attenuates A\u03b2 deposition in brains of the two models.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: We have shown that in APPPS1-21 mice treated in the early stage of disease (2\u20133 months of age) an...", "to": "early stage of disease", "value": 1.0, "width": 1.6931471805599454}, {"from": "ATN pathology", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027e3232b24532f5879\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002734103079 - CSF1R inhibition rescues tau pathology and neurodegeneration in an A T N model with combined AD pathologies, while preserving plaque associated microglia.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 39, \u0027page\u0027: None, \u0027char_span\u0027: [30, 101], \u0027evidence\u0027: \u0027v Additional file 6: Fig. S6. ATN pathology increases general and microgliarelated expression of ApoE.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: e3232b24532f5879  \n[file]: 34103079 - CSF1R inhibition rescues tau pathology and neurodegeneration in an A T N model with combined AD pathologies, while preserving plaque associated microglia.pdf\n\u003e [evidence]: v Additional file 6: Fig. S6. ATN pathology increases general and microgliarelated expression of ...", "to": "general and microgliarelated expression of ApoE", "value": 1.0, "width": 1.6931471805599454}, {"from": "ATP6AP2", "label": "mediates", "sources": ["{\u0027doc_id\u0027: \u002701ab70cecab4b6e6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737115208 - Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 8, \u0027page\u0027: None, \u0027char_span\u0027: [118, 166], \u0027evidence\u0027: \u0027Alteration in lysosomal gene expression, such as decreased expression of genes implicated in lysosomal acidification (ATP6AP2) and chaperone mediated autophagy (LAMP2), together with reduction in lipid droplets were also observed in post-mortem brain tissues from NHD patients, thus closely recapitulating in vivo the phenotype observed in iMGLs in vitro.\u0027, \u0027confidence\u0027: 1.0}"], "title": "mediates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 01ab70cecab4b6e6  \n[file]: 37115208 - Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation.pdf\n\u003e [evidence]: Alteration in lysosomal gene expression, such as decreased expression of genes implicated in lyso...", "to": "LAMP2", "value": 1.0, "width": 1.6931471805599454}, {"from": "ATV:4D9", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027d18f63b3303469c2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 27, \u0027page\u0027: None, \u0027char_span\u0027: [0, 59], \u0027evidence\u0027: \u0027ATV:4D9 induced durable yet reversible microglial responses by single-cell transcriptional profiling and morphometry.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: ATV:4D9 induced durable yet reversible microglial responses by single-cell transcriptional profil...", "to": "microglial responses", "value": 1.0, "width": 1.6931471805599454}, {"from": "microglial responses", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027749f183524779851\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [17, 80], \u0027evidence\u0027: \u0027We conclude that BIN1 expression is central for appropriate microglial responses to CNS challenge, and that AD risk may arise through impaired BIN1 functionality in microglia.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: We conclude that BIN1 expression is central for appropriate microglial responses to CNS challenge...", "to": "BIN1", "value": 1.0, "width": 1.6931471805599454}, {"from": "ATV:TREM2", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u0027d18f63b3303469c2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 13, \u0027page\u0027: None, \u0027char_span\u0027: [14, 48], \u0027evidence\u0027: \u0027We found that ATV:TREM2 activates mTOR signaling, which is required for microglia proliferation.\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: We found that ATV:TREM2 activates mTOR signaling, which is required for microglia proliferation.", "to": "mTOR signaling", "value": 1.0, "width": 1.6931471805599454}, {"from": "ATV:TREM2", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027d18f63b3303469c2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 36, \u0027page\u0027: None, \u0027char_span\u0027: [8, 40], \u0027evidence\u0027: \u0027Whether ATV:TREM2 induces glucose uptake cell autonomously in microglia or influences other CNS cell types remains an open question.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: Whether ATV:TREM2 induces glucose uptake cell autonomously in microglia or influences other CNS c...", "to": "glucose uptake", "value": 1.0, "width": 1.6931471805599454}, {"from": "ATV:TREM2", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027d18f63b3303469c2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 35, \u0027page\u0027: None, \u0027char_span\u0027: [0, 27], \u0027evidence\u0027: \u0027ATV:TREM2 increased FDG-PET in an amyloid mouse model, thereby improving brain metabolism in a disease context.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: ATV:TREM2 increased FDG-PET in an amyloid mouse model, thereby improving brain metabolism in a di...", "to": "FDG-PET", "value": 1.0, "width": 1.6931471805599454}, {"from": "ATV:TREM2", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027d18f63b3303469c2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 10, \u0027page\u0027: None, \u0027char_span\u0027: [8, 58], \u0027evidence\u0027: \u0027Because ATV:TREM2 resulted in enhanced microglia responses compared to anti-TREM2 with equivalent brain IgG concentrations, the molecular and cellular mechanisms identified in vitro are likely engaged in vivo.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: Because ATV:TREM2 resulted in enhanced microglia responses compared to anti-TREM2 with equivalent...", "to": "microglia responses", "value": 1.0, "width": 1.6931471805599454}, {"from": "ATV:TREM2", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027d18f63b3303469c2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 6, \u0027page\u0027: None, \u0027char_span\u0027: [25, 64], \u0027evidence\u0027: \u0027We also demonstrate that ATV:TREM2 increased microglial activity and glucose metabolism in an amyloid mouse model via TSPO-PET and FDG-PET imaging, respectively.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: We also demonstrate that ATV:TREM2 increased microglial activity and glucose metabolism in an amy...", "to": "microglial activity", "value": 1.0, "width": 1.6931471805599454}, {"from": "ATV:TREM2", "label": "promotes", "sources": ["{\u0027doc_id\u0027: \u0027d18f63b3303469c2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 31, \u0027page\u0027: None, \u0027char_span\u0027: [19, 56], \u0027evidence\u0027: \u0027We discovered that ATV:TREM2 promotes energetic capacity via specific metabolic pathways.\u0027, \u0027confidence\u0027: 1.0}"], "title": "promotes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: We discovered that ATV:TREM2 promotes energetic capacity via specific metabolic pathways.", "to": "energetic capacity", "value": 1.0, "width": 1.6931471805599454}, {"from": "ATV:TREM2", "label": "promotes", "sources": ["{\u0027doc_id\u0027: \u0027d18f63b3303469c2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 33, \u0027page\u0027: None, \u0027char_span\u0027: [0, 41], \u0027evidence\u0027: \u0027ATV:TREM2 also promoted glucose oxidation, demonstrating flexibility in substrate utilization.\u0027, \u0027confidence\u0027: 1.0}"], "title": "promotes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: ATV:TREM2 also promoted glucose oxidation, demonstrating flexibility in substrate utilization.", "to": "glucose oxidation", "value": 1.0, "width": 1.6931471805599454}, {"from": "ATV:TREM2", "label": "promotes", "sources": ["{\u0027doc_id\u0027: \u0027d18f63b3303469c2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 32, \u0027page\u0027: None, \u0027char_span\u0027: [8, 63], \u0027evidence\u0027: \u0027Namely, ATV:TREM2 promoted mitochondrial fatty acid oxidization, in which TGs stored in lipid droplets are catabolized to increase microglial respiration.\u0027, \u0027confidence\u0027: 1.0}"], "title": "promotes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d18f63b3303469c2  \n[file]: 36635496 - A TREM2-activating antibody with a blood-brain barrier transport vehicle enhances microglial metabolism in Alzheimer\u0027s disease models.pdf\n\u003e [evidence]: Namely, ATV:TREM2 promoted mitochondrial fatty acid oxidization, in which TGs stored in lipid dro...", "to": "mitochondrial fatty acid oxidization", "value": 1.0, "width": 1.6931471805599454}, {"from": "Ab", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00272d3528df6d21428a\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002718800168 - Abeta mediated diminution of MTT reduction--an artefact of single cell culture.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 14, \u0027page\u0027: None, \u0027char_span\u0027: [65, 100], \u0027evidence\u0027: \u0027* E-mail: roenicke@zenit-magdeburg.de other hand, indicated that Ab decreases cellular MTT reduction by accelerating the exocytosis of MTT formazan.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2d3528df6d21428a  \n[file]: 18800168 - Abeta mediated diminution of MTT reduction--an artefact of single cell culture.pdf\n\u003e [evidence]: * E-mail: roenicke@zenit-magdeburg.de other hand, indicated that Ab decreases cellular MTT reduct...", "to": "cellular MTT reduction", "value": 1.0, "width": 1.6931471805599454}, {"from": "Ab (25-35)", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00272d3528df6d21428a\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002718800168 - Abeta mediated diminution of MTT reduction--an artefact of single cell culture.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 29, \u0027page\u0027: None, \u0027char_span\u0027: [0, 29], \u0027evidence\u0027: \u0027Ab (25-35) did not affect LTP in the present study, although a diminution in LTP was found by others [54].\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2d3528df6d21428a  \n[file]: 18800168 - Abeta mediated diminution of MTT reduction--an artefact of single cell culture.pdf\n\u003e [evidence]: Ab (25-35) did not affect LTP in the present study, although a diminution in LTP was found by oth...", "to": "LTP", "value": 1.0, "width": 1.6931471805599454}, {"from": "Ab aggregates", "label": "promotes", "sources": ["{\u0027doc_id\u0027: \u00274e5ef603f6ec87b5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40787447 - Programmed cell death signatures-driven microglial transformation in Alzheimer\u0027s disease single-cell transcriptomics and functional validation.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 10, \u0027page\u0027: None, \u0027char_span\u0027: [0, 66], \u0027evidence\u0027: \u0027Ab aggregates promote neuronal necroptosis via the RIPK1-MLKL axis, forming a cascade effect (47).\u0027, \u0027confidence\u0027: 1.0}"], "title": "promotes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4e5ef603f6ec87b5  \n[file]: 40787447 - Programmed cell death signatures-driven microglial transformation in Alzheimer\u0027s disease single-cell transcriptomics and functional validation.pdf\n\u003e [evidence]: Ab aggregates promote neuronal necroptosis via the RIPK1-MLKL axis, forming a cascade effect (47).", "to": "RIPK1-MLKL axis", "value": 1.0, "width": 1.6931471805599454}, {"from": "Ab species", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00272d3528df6d21428a\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002718800168 - Abeta mediated diminution of MTT reduction--an artefact of single cell culture.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 3, \u0027page\u0027: None, \u0027char_span\u0027: [68, 106], \u0027evidence\u0027: \u0027In contrast to our findings in the single cell cultures none of the Ab species affected cellular viability in OHCs, although we could confirm the presence of Ab in the slices by immunostaining and GFAP upregulation.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2d3528df6d21428a  \n[file]: 18800168 - Abeta mediated diminution of MTT reduction--an artefact of single cell culture.pdf\n\u003e [evidence]: In contrast to our findings in the single cell cultures none of the Ab species affected cellular ...", "to": "cellular viability", "value": 1.0, "width": 1.6931471805599454}, {"from": "Ab species", "label": "correlates with", "sources": ["{\u0027doc_id\u0027: \u00272d3528df6d21428a\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002718800168 - Abeta mediated diminution of MTT reduction--an artefact of single cell culture.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 32, \u0027page\u0027: None, \u0027char_span\u0027: [76, 128], \u0027evidence\u0027: \u0027In addition, we demonstrated that Ab mediated LTP disruption depends on the Ab species and does not correlate with MTT reduction in acute isolated slices, relativizing the MTT assay as a reporter of early physiological disruption and drug testing.\u0027, \u0027confidence\u0027: 1.0}"], "title": "correlates with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2d3528df6d21428a  \n[file]: 18800168 - Abeta mediated diminution of MTT reduction--an artefact of single cell culture.pdf\n\u003e [evidence]: In addition, we demonstrated that Ab mediated LTP disruption depends on the Ab species and does n...", "to": "MTT reduction", "value": 1.0, "width": 1.6931471805599454}, {"from": "AbetaO", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u00274e5ef603f6ec87b5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40787447 - Programmed cell death signatures-driven microglial transformation in Alzheimer\u0027s disease single-cell transcriptomics and functional validation.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 16, \u0027page\u0027: None, \u0027char_span\u0027: [36, 211], \u0027evidence\u0027: \u0027FIGURE 11 S100A4 knockdown inhibits AbetaO-triggered redox imbalance. (A\u2013C) Inhibition of S100A4 signi\ufb01cantly modulated redox homeostasis in AbetaO\\xad exposed BV2 microglia, evidenced by reduced MDA concentrations (A), enhanced SOD activity (B), and elevated GSH-Px enzymatic function (C) (n = 3) (D, E) The effects of S100A4 knockdown on the MMP of BV2 microglia with AbetaO stimulation were assessed using the Immuno\ufb02uorescence microscopy.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4e5ef603f6ec87b5  \n[file]: 40787447 - Programmed cell death signatures-driven microglial transformation in Alzheimer\u0027s disease single-cell transcriptomics and functional validation.pdf\n\u003e [evidence]: FIGURE 11 S100A4 knockdown inhibits AbetaO-triggered redox imbalance. (A\u2013C) Inhibition of S100A4 ...", "to": "MDA concentrations", "value": 1.0, "width": 1.6931471805599454}, {"from": "Abi3 de\ufb01ciency", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00278cb824110484db3e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36895556 - The effect of Abi3 locus deletion on the progression of Alzheimer\u0027s disease-related pathologies.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 33, \u0027page\u0027: None, \u0027char_span\u0027: [12, 57], \u0027evidence\u0027: \u0027In summary, Abi3 de\ufb01ciency affects key signaling pathways in microglia function and immune response in the young cohort.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 8cb824110484db3e  \n[file]: 36895556 - The effect of Abi3 locus deletion on the progression of Alzheimer\u0027s disease-related pathologies.pdf\n\u003e [evidence]: In summary, Abi3 de\ufb01ciency affects key signaling pathways in microglia function and immune respon...", "to": "key signaling pathways", "value": 1.0, "width": 1.6931471805599454}, {"from": "Acta Neuropathologica (2022) 143:75\u201391", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u002798011f49f4ecb3ac\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 1, \u0027page\u0027: None, \u0027char_span\u0027: [58, 139], \u0027evidence\u0027: \u0027While 50\u201360% of the significantly up-regulated genes were Acta Neuropathologica (2022) 143:75\u201391 associated with both pathological proteins, a 3\u20134-fold greater number of genes were uniquely differentially expressed with amyloid-beta relative to pTau, mirroring observations with microglia in preclinical transgenic models overexpressing the two proteins [55].\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 98011f49f4ecb3ac  \n[file]: 34767070 - Diverse human astrocyte and microglial transcriptional responses to Alzheimer\u0027s pathology.pdf\n\u003e [evidence]: While 50\u201360% of the significantly up-regulated genes were Acta Neuropathologica (2022) 143:75\u201391 ...", "to": "pathological proteins", "value": 1.0, "width": 1.6931471805599454}, {"from": "Adu", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027efbf7bba620cd8fe\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002736575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 5, \u0027page\u0027: None, \u0027char_span\u0027: [26, 84], \u0027evidence\u0027: \u0027However, the high dose of Adu (10\u201360 mg /kg) used in clinical studies induced ARIA-E in human clinical phases [41].\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: However, the high dose of Adu (10\u201360 mg /kg) used in clinical studies induced ARIA-E in human cli...", "to": "ARIA-E", "value": 1.0, "width": 1.6931471805599454}, {"from": "Adu", "label": "mediates", "sources": ["{\u0027doc_id\u0027: \u0027efbf7bba620cd8fe\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002736575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 10, \u0027page\u0027: None, \u0027char_span\u0027: [86, 141], \u0027evidence\u0027: \u0027The Western blotting and immunofluorescence results demonstrated that the delivery of Adu was improved by FUS-mediated BBB opening (Fig. 1d\u2013f, Additional file 1: Fig. S2).\u0027, \u0027confidence\u0027: 1.0}"], "title": "mediates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: The Western blotting and immunofluorescence results demonstrated that the delivery of Adu was imp...", "to": "Fig. 1d\u2013f", "value": 1.0, "width": 1.6931471805599454}, {"from": "Adu", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027efbf7bba620cd8fe\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002736575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\u0027}, \u0027chunk_id\u0027: 2, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [65, 110], \u0027evidence\u0027: \u0027In this work, we demonstrated that FUS with microbubbles induced BBB opening and increased the delivery of Adu into the brain.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: In this work, we demonstrated that FUS with microbubbles induced BBB opening and increased the de...", "to": "BBB", "value": 1.0, "width": 1.6931471805599454}, {"from": "Age-related cognitive decline", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027f08e8a515e81d795\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 20, \u0027page\u0027: None, \u0027char_span\u0027: [173, 244], \u0027evidence\u0027: \u0027Thus, it is important to understand the mechanisms underlying microglial activation, plasticity and heterogeneity in both sexes throughout life in order to prevent or delay age-related cognitive decline and reduce neurodegenerative disease risk.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: Thus, it is important to understand the mechanisms underlying microglial activation, plasticity a...", "to": "Neurodegenerative disease risk", "value": 1.0, "width": 1.6931471805599454}, {"from": "Aging", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u00274dcab4259d686c0e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38695952 - Characterisation of premature cell senescence in Alzheimer\u0027s disease using single nuclear transcriptomics.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 0, \u0027page\u0027: None, \u0027char_span\u0027: [9, 49], \u0027evidence\u0027: \u0027Abstract Aging is associated with cell senescence and is the major risk factor for AD.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4dcab4259d686c0e  \n[file]: 38695952 - Characterisation of premature cell senescence in Alzheimer\u0027s disease using single nuclear transcriptomics.pdf\n\u003e [evidence]: Abstract Aging is associated with cell senescence and is the major risk factor for AD.", "to": "cell senescence", "value": 1.0, "width": 1.6931471805599454}, {"from": "Alzheimer\u2019s disease", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u002775e9d948abad0bc8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002730558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 20, \u0027page\u0027: None, \u0027char_span\u0027: [39, 122], \u0027evidence\u0027: \u0027In neurodegenerative diseases, such as Alzheimer\u2019s disease (AD), activated microglia are detected by histological analyses of postmortem human brains [9, 10] and positron emission tomography (PET) imaging using TSPO (Translocator protein) ligands in living patients [11\u201313].\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 75e9d948abad0bc8  \n[file]: 30558641 - Genome-wide RNAseq study of the molecular mechanisms underlying microglia activation in response to pathological tau perturbation in the rTg4510 tau transgenic animal mo.pdf\n\u003e [evidence]: In neurodegenerative diseases, such as Alzheimer\u2019s disease (AD), activated microglia are detected...", "to": "histological analyses", "value": 1.0, "width": 1.6931471805599454}, {"from": "Alzheimer\u2019s disease", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u00275700848d1ffe11e1\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39238030 - Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 16, \u0027page\u0027: None, \u0027char_span\u0027: [82, 174], \u0027evidence\u0027: \u0027Background Microglial activation constitutes a hallmark in the pathophysiology of Alzheimer\u2019s disease (AD) [1] and has been associated with aggregation of misfolded \u03b2-amyloid (A\u03b2) and tau accumulation in patients with AD and in mouse models of AD [2].\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 5700848d1ffe11e1  \n[file]: 39238030 - Regional desynchronization of microglial activity is associated with cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Background Microglial activation constitutes a hallmark in the pathophysiology of Alzheimer\u2019s dis...", "to": "aggregation of misfolded \u03b2-amyloid", "value": 1.0, "width": 1.6931471805599454}, {"from": "Alzheimer\u2019s disease", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 43, \u0027page\u0027: None, \u0027char_span\u0027: [58, 115], \u0027evidence\u0027: \u0027Cathepsin S is known to play a role in the degradation of A\u00df and other proteins associated with Alzheimer\u2019s disease.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Cathepsin S is known to play a role in the degradation of A\u00df and other proteins associated with A...", "to": "A\u00df", "value": 1.0, "width": 1.6931471805599454}, {"from": "Alzheimer\u2019s disease (AD)", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00277ff5d3a47ea9588d\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735459147 - Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 16, \u0027page\u0027: None, \u0027char_span\u0027: [11, 68], \u0027evidence\u0027: \u0027Background Alzheimer\u2019s disease (AD) affects about 5.8 million people in the USA and nearly 400 million people worldwide.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ff5d3a47ea9588d  \n[file]: 35459147 - Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.pdf\n\u003e [evidence]: Background Alzheimer\u2019s disease (AD) affects about 5.8 million people in the USA and nearly 400 mi...", "to": "about 5.8 million people", "value": 1.0, "width": 1.6931471805599454}, {"from": "Alzheimer\u2019s disease amyloid precursor protein", "label": "mediates", "sources": ["{\u0027doc_id\u0027: \u00270d8fbabff4218d22\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"33712570 - Integration of Alzheimer\u0027s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 21, \u0027page\u0027: None, \u0027char_span\u0027: [33, 107], \u0027evidence\u0027: \u0027Burgos, P. et al. Sorting of the Alzheimer\u2019s disease amyloid precursor protein mediated by the AP-4 complex.\u0027, \u0027confidence\u0027: 1.0}"], "title": "mediates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0d8fbabff4218d22  \n[file]: 33712570 - Integration of Alzheimer\u0027s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.pdf\n\u003e [evidence]: Burgos, P. et al. Sorting of the Alzheimer\u2019s disease amyloid precursor protein mediated by the AP...", "to": "AP-4 complex", "value": 1.0, "width": 1.6931471805599454}, {"from": "Angiopoietin-like protein 8 (ANGPTL8)", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00272ab9e10b4b26b7a7\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 1, \u0027page\u0027: None, \u0027char_span\u0027: [11, 117], \u0027evidence\u0027: \u0027Objectives Angiopoietin-like protein 8 (ANGPTL8), a high expression of liver-specific secreted proinflammatory factor, crosses the blood\u2012brain barrier from the bloodstream to abnormally activate microglia and promote AD progression.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ab9e10b4b26b7a7  \n[file]: 40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\n\u003e [evidence]: Objectives Angiopoietin-like protein 8 (ANGPTL8), a high expression of liver-specific secreted pr...", "to": "liver-specific secreted proinflammatory factor", "value": 1.0, "width": 1.6931471805599454}, {"from": "ApoE3", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u002797bab3151172289e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 29, \u0027page\u0027: None, \u0027char_span\u0027: [29, 126], \u0027evidence\u0027: \u0027Interestingly, compared with ApoE3, ApoE4 is associated with greater dysregulation of cholesterol and lipid metabolism in glia [5, 61].\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Interestingly, compared with ApoE3, ApoE4 is associated with greater dysregulation of cholesterol...", "to": "dysregulation of cholesterol and lipid metabolism in glia", "value": 1.0, "width": 1.6931471805599454}, {"from": "ApoE4", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u002797bab3151172289e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 41, \u0027page\u0027: None, \u0027char_span\u0027: [48, 115], \u0027evidence\u0027: \u0027In conclusion, our study provides evidence that ApoE4 induces ER stress and dysregulation of cholesterol metabolism in microglia, leading to increased SREBP2 expression and activation, which in turn promotes neuroinflammation and neurodegeneration in AD.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: In conclusion, our study provides evidence that ApoE4 induces ER stress and dysregulation of chol...", "to": "dysregulation of cholesterol metabolism", "value": 1.0, "width": 1.6931471805599454}, {"from": "ApoE4", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u002797bab3151172289e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 16, \u0027page\u0027: None, \u0027char_span\u0027: [88, 116], \u0027evidence\u0027: \u0027Our observations indicated that MHC II molecules strongly clustered with lipid rafts in BV2 cells treated with ApoE4 in the presence of PHF (Fig. 4e, f ).\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 97bab3151172289e  \n[file]: 39468688 - TRPV1 alleviates APOE4-dependent microglial antigen presentation and T cell infiltration in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Our observations indicated that MHC II molecules strongly clustered with lipid rafts in BV2 cells...", "to": "BV2 cells", "value": 1.0, "width": 1.6931471805599454}, {"from": "Apolipoprotein E \u03b54", "label": "risk for", "sources": ["{\u0027doc_id\u0027: \u00279dd895f2425df710\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 0, \u0027page\u0027: None, \u0027char_span\u0027: [20, 119], \u0027evidence\u0027: \u0027Abstract Background Apolipoprotein E \u03b54 (APOE4) is the strongest genetic risk factor for late-onset Alzheimer\u2019s disease (LOAD).\u0027, \u0027confidence\u0027: 1.0}"], "title": "risk for | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9dd895f2425df710  \n[file]: 39844286 - APOE Christchurch enhances a disease-associated microglial response to plaque but suppresses response to tau pathology.pdf\n\u003e [evidence]: Abstract Background Apolipoprotein E \u03b54 (APOE4) is the strongest genetic risk factor for late-ons...", "to": "late-onset Alzheimer\u2019s disease", "value": 1.0, "width": 1.6931471805599454}, {"from": "Arc mice", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u00276ba9bb6b943017d2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 20, \u0027page\u0027: None, \u0027char_span\u0027: [40, 115], \u0027evidence\u0027: \u0027These \ufb01ndings, that C5aR1 antagonism in Arc mice enhances pathways associated with synaptic plasticity and learning, importantly provide a mechanistic basis for the wide range of human and mouse studies demonstrating that some microglial responses are attempts to protect from injury and should not be inhibited (reviewed in refs. 52,53).\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: These \ufb01ndings, that C5aR1 antagonism in Arc mice enhances pathways associated with synaptic plast...", "to": "synaptic plasticity and learning", "value": 1.0, "width": 1.6931471805599454}, {"from": "Arc mice", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u00276ba9bb6b943017d2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 30, \u0027page\u0027: None, \u0027char_span\u0027: [31, 64], \u0027evidence\u0027: \u0027In a smaller pilot experiment, Arc mice were treated with PMX205 via drinking water for 2, 6, or 12 weeks beginning at 6.5, 5.5 or 4.5 months of age, respectively to detect biomarker changes.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: In a smaller pilot experiment, Arc mice were treated with PMX205 via drinking water for 2, 6, or ...", "to": "PMX205", "value": 1.0, "width": 1.6931471805599454}, {"from": "Arctic model of AD", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 18, \u0027page\u0027: None, \u0027char_span\u0027: [75, 136], \u0027evidence\u0027: \u0027In contrast, the genetic approach to eliminate C5aR1 function used in this Arctic model of AD did not result in reduced fibrillar plaque or microglial accumulation.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: In contrast, the genetic approach to eliminate C5aR1 function used in this Arctic model of AD did...", "to": "fibrillar plaque", "value": 1.0, "width": 1.6931471805599454}, {"from": "Arctic model of AD", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 18, \u0027page\u0027: None, \u0027char_span\u0027: [75, 163], \u0027evidence\u0027: \u0027In contrast, the genetic approach to eliminate C5aR1 function used in this Arctic model of AD did not result in reduced fibrillar plaque or microglial accumulation.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: In contrast, the genetic approach to eliminate C5aR1 function used in this Arctic model of AD did...", "to": "microglial accumulation", "value": 1.0, "width": 1.6931471805599454}, {"from": "Arctic mutation", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 41, \u0027page\u0027: None, \u0027char_span\u0027: [4, 88], \u0027evidence\u0027: \u0027The Arctic mutation results in the increased rate of fibrillar amyloid plaque deposition, initiating as early as 2 months of age in these mice [30, 31].\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: The Arctic mutation results in the increased rate of fibrillar amyloid plaque deposition, initiat...", "to": "fibrillar amyloid plaque deposition", "value": 1.0, "width": 1.6931471805599454}, {"from": "neuronal loss", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u00273b13fd318d8fea14\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [72, 150], \u0027evidence\u0027: \u0027Similar results have been reported in the SOD1-G93A model of ALS, where Cx3cr1 deficiency is associated with increased SOD1 aggregation, neuronal loss and inflammatory microglial activation with impaired autophagy-lysosomal degradation pathways and autophagosome maturation [18, 19].\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Similar results have been reported in the SOD1-G93A model of ALS, where Cx3cr1 deficiency is asso...", "to": "Cx3cr1 deficiency", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 burden", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027215ff893f0c683e8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 33, \u0027page\u0027: None, \u0027char_span\u0027: [135, 192], \u0027evidence\u0027: \u0027The studies by Wang and colleagues [17] show that GV-971 reconditioned gut microbiota dysbiosis, suppressed neuroinflammation, reduced A\u03b2 burden, and lead to a reversal of cognitive impairment.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 215ff893f0c683e8  \n[file]: 38365827 - Sodium oligomannate alters gut microbiota, reduces cerebral amyloidosis and reactive microglia in a sex-specific manner.pdf\n\u003e [evidence]: The studies by Wang and colleagues [17] show that GV-971 reconditioned gut microbiota dysbiosis, ...", "to": "cognitive impairment", "value": 1.0, "width": 1.6931471805599454}, {"from": "cognitive impairment", "label": "correlates with", "sources": ["{\u0027doc_id\u0027: \u00270e0d3b8ebe88e7d8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 11, \u0027page\u0027: None, \u0027char_span\u0027: [36, 100], \u0027evidence\u0027: \u0027Increased levels of serum TNF-\u03b1 and IL-1\u03b2 correlate with an accelerated rate of cognitive impairment in AD patients [80].\u0027, \u0027confidence\u0027: 1.0}"], "title": "correlates with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: Increased levels of serum TNF-\u03b1 and IL-1\u03b2 correlate with an accelerated rate of cognitive impairm...", "to": "IL-1\u03b2", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 deposition along the vasculature", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027e1110680be88d477\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36747024 - Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [44, 140], \u0027evidence\u0027: \u0027Altogether, these and our studies highlight A\u03b2 deposition along the vasculature as a possible trigger for SPP1 upregulation in PVMs and PVFs.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: e1110680be88d477  \n[file]: 36747024 - Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Altogether, these and our studies highlight A\u03b2 deposition along the vasculature as a possible tri...", "to": "PVMs and PVFs", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 fibrils", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 2, \u0027sentence_id\u0027: 3, \u0027page\u0027: None, \u0027char_span\u0027: [0, 30], \u0027evidence\u0027: \u0027A\u03b2 fibrils activate complement resulting in cleavage of C3 and C5.\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: A\u03b2 fibrils activate complement resulting in cleavage of C3 and C5.", "to": "complement", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 load", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u0027af1d54ba089df752\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 9, \u0027page\u0027: None, \u0027char_span\u0027: [11, 76], \u0027evidence\u0027: \u0027It lowered A\u03b2 load in the brain, possibly by inhibiting \u03b2-secretase activity, and increasing the expression of LRP1 and ABCB1 at the blood-brain barrier.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: It lowered A\u03b2 load in the brain, possibly by inhibiting \u03b2-secretase activity, and increasing the ...", "to": "\u03b2-secretase activity", "value": 1.0, "width": 1.6931471805599454}, {"from": "\u03b2-secretase activity", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u00272f3cd755c1b95f07\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 50, \u0027page\u0027: None, \u0027char_span\u0027: [230, 270], \u0027evidence\u0027: \u0027Even though we did not replicate the previously reported effects of THs on APP gene expression, we found that GD induced a significant increase in the levels of both soluble and insoluble A\u03b240 and A\u03b242 with a higher expression of BACE1 and increased \u03b2-secretase activity in AD mice in vivo.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2f3cd755c1b95f07  \n[file]: 37740205 - The effect of hyperthyroidism on cognitive function, neuroinflammation, and necroptosis in APP PS1 mice.pdf\n\u003e [evidence]: Even though we did not replicate the previously reported effects of THs on APP gene expression, w...", "to": "BACE1", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 oligomers", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u002779fca66073e8bfa0\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 14, \u0027page\u0027: None, \u0027char_span\u0027: [13, 88], \u0027evidence\u0027: \u0027For example, A\u03b2 oligomers increase cholesterol concentration at synapses, Ramonet et al.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: For example, A\u03b2 oligomers increase cholesterol concentration at synapses, Ramonet et al.", "to": "Ramonet et al.", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 pathology", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00271f79b999e0214ae2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002736536457 - Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 49, \u0027page\u0027: None, \u0027char_span\u0027: [52, 115], \u0027evidence\u0027: \u0027For example, Siglec-F is upregulated in response to A\u03b2 pathology and is selectively expressed in A\u03b2-associated DAMs, while Siglec-G is upregulated in white-matter-associated LADAM in late-stage AD.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 1f79b999e0214ae2  \n[file]: 36536457 - Amyloid-beta and tau pathologies act synergistically to induce novel disease stage-specific microglia subtypes.pdf\n\u003e [evidence]: For example, Siglec-F is upregulated in response to A\u03b2 pathology and is selectively expressed in ...", "to": "A\u03b2-associated DAMs", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 pathology", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u0027af1d54ba089df752\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 39, \u0027page\u0027: None, \u0027char_span\u0027: [42, 114], \u0027evidence\u0027: \u0027Deletion of Dicer1 in the gut ameliorates A\u03b2 pathology but may also inhibit mitochondrial respiration in the brain of AD mice, and even induce anxiety of mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: Deletion of Dicer1 in the gut ameliorates A\u03b2 pathology but may also inhibit mitochondrial respira...", "to": "mitochondrial respiration in the brain", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 plagues", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00275b4711bead6c11ad\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735706029 - Microglial amyloid beta clearance is driven by PIEZO1 channels.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 33, \u0027page\u0027: None, \u0027char_span\u0027: [89, 155], \u0027evidence\u0027: \u0027Moreover, treatment of the 5xFAD mouse model of AD with Yoda1 recruits microglia towards A\u03b2 plagues and leads to A\u03b2 clearance in the hippocampus and cortex.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 5b4711bead6c11ad  \n[file]: 35706029 - Microglial amyloid beta clearance is driven by PIEZO1 channels.pdf\n\u003e [evidence]: Moreover, treatment of the 5xFAD mouse model of AD with Yoda1 recruits microglia towards A\u03b2 plagu...", "to": "hippocampus and cortex", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 plaques", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027b21810daf417fcbe\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39102080 - Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 17, \u0027page\u0027: None, \u0027char_span\u0027: [59, 131], \u0027evidence\u0027: \u0027In a mouse model of amyloidosis, it has been observed that A\u03b2 plaques create a unique environment that triggers tau phosphorylation within dystrophic neuritis [53].\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b21810daf417fcbe  \n[file]: 39102080 - Enhanced microglial dynamics and a paucity of tau seeding in the amyloid plaque microenvironment contribute to cognitive resilience in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: In a mouse model of amyloidosis, it has been observed that A\u03b2 plaques create a unique environment...", "to": "tau phosphorylation", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 plaques", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00279b1a0347efe392c6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 34, \u0027page\u0027: None, \u0027char_span\u0027: [39, 77], \u0027evidence\u0027: \u0027Our immunochemical results showed that A\u03b2 plaques and the expression of p-Tau were markedly increased in 12-month-old IE2 transgenic mice compared to control mice (Figs. 5 and 6).\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: Our immunochemical results showed that A\u03b2 plaques and the expression of p-Tau were markedly incre...", "to": "p-Tau", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2 plaques", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00270e0d3b8ebe88e7d8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 18, \u0027page\u0027: None, \u0027char_span\u0027: [28, 61], \u0027evidence\u0027: \u0027These results indicate that COX-1 deletion reduces A\u03b2 plaques by reprogramming microglia toward a pro-phagocytic, anti-inflammatory state.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: These results indicate that COX-1 deletion reduces A\u03b2 plaques by reprogramming microglia toward a...", "to": "COX-1 deletion", "value": 1.0, "width": 1.6931471805599454}, {"from": "A\u03b2-exposed microglia", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u00277ec126941318b941\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 15, \u0027page\u0027: None, \u0027char_span\u0027: [63, 129], \u0027evidence\u0027: \u0027d Representative immunoblots showing changes in iNOS levels in A\u03b2-exposed microglia pretreated with a STING agonist or antagonist.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 7ec126941318b941  \n[file]: 39218977 - Blockade of STING activation alleviates microglial dysfunction and a broad spectrum of Alzheimer\u0027s disease pathologies.pdf\n\u003e [evidence]: d Representative immunoblots showing changes in iNOS levels in A\u03b2-exposed microglia pretreated wi...", "to": "STING agonist or antagonist", "value": 1.0, "width": 1.6931471805599454}, {"from": "B cell development", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u00270d8fbabff4218d22\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"33712570 - Integration of Alzheimer\u0027s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 27, \u0027page\u0027: None, \u0027char_span\u0027: [68, 116], \u0027evidence\u0027: \u0027Schneppenheim, J. et al. The intramembrane protease SPPL2a promotes B cell development and controls endosomal traf\ufb01c by cleavage of the invariant chain.\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0d8fbabff4218d22  \n[file]: 33712570 - Integration of Alzheimer\u0027s disease genetics and myeloid genomics identifies disease risk regulatory elements and genes.pdf\n\u003e [evidence]: Schneppenheim, J. et al. The intramembrane protease SPPL2a promotes B cell development and contro...", "to": "endosomal traf\ufb01c", "value": 1.0, "width": 1.6931471805599454}, {"from": "BACE1", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027af1d54ba089df752\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 9, \u0027page\u0027: None, \u0027char_span\u0027: [12, 75], \u0027evidence\u0027: \u0027Deletion of Dicer1 slightly but significantly reduced the activity of BACE1, but not \u03b3-secretase (A and B; two-way ANOVA, n = 5 and 3 for wt and ko groups, respectively).\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: Deletion of Dicer1 slightly but significantly reduced the activity of BACE1, but not \u03b3-secretase ...", "to": "Dicer1", "value": 1.0, "width": 1.6931471805599454}, {"from": "BACE1 activity", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027af1d54ba089df752\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [60, 93], \u0027evidence\u0027: \u00275 Deletion of Dicer1 in intestinal epithelial cells reduces BACE1 activity and increases LRP1 and ABCB1 expression in the brain of App-knock-in mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: 5 Deletion of Dicer1 in intestinal epithelial cells reduces BACE1 activity and increases LRP1 and...", "to": "LRP1", "value": 1.0, "width": 1.6931471805599454}, {"from": "LRP1", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027af1d54ba089df752\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 11, \u0027page\u0027: None, \u0027char_span\u0027: [68, 125], \u0027evidence\u0027: \u0027Quantitative Western blot of vessel lysates showed that deletion of Dicer1 significantly increased the protein levels of LRP1 and ABCB1, but not PDGFR\u03b2 and CD13 (C - H; t test, n = 6\u20138 per group).\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: af1d54ba089df752  \n[file]: 40926280 - Intestinal epithelial Dicer1 regulates gut microbiome and Alzheimer\u0027s pathology in App-knock-in mice.pdf\n\u003e [evidence]: Quantitative Western blot of vessel lysates showed that deletion of Dicer1 significantly increase...", "to": "Dicer1", "value": 1.0, "width": 1.6931471805599454}, {"from": "BACE1 inhibitors", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00273012894074386645\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [6, 58], \u0027evidence\u0027: \u0027While BACE1 inhibitors have been shown to reduce A\u03b2 levels in people with AD, clinical trials targeting BACE1 have failed due to unwanted synaptic deficits.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: While BACE1 inhibitors have been shown to reduce A\u03b2 levels in people with AD, clinical trials tar...", "to": "A\u03b2 levels", "value": 1.0, "width": 1.6931471805599454}, {"from": "BAMs", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027121f7cadde31d785\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737923721 - Dissecting the human leptomeninges at single-cell resolution.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 21, \u0027page\u0027: None, \u0027char_span\u0027: [13, 63], \u0027evidence\u0027: \u0027In addition, BAMs and microglia both express more AD GWAS genes than other cell types, highlighting the important role of the immune component in AD development and the need to investigate BAMs, this understudied immune population.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 121f7cadde31d785  \n[file]: 37923721 - Dissecting the human leptomeninges at single-cell resolution.pdf\n\u003e [evidence]: In addition, BAMs and microglia both express more AD GWAS genes than other cell types, highlighti...", "to": "AD GWAS genes", "value": 1.0, "width": 1.6931471805599454}, {"from": "BAMs", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027121f7cadde31d785\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737923721 - Dissecting the human leptomeninges at single-cell resolution.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 20, \u0027page\u0027: None, \u0027char_span\u0027: [9, 83], \u0027evidence\u0027: \u0027Notably, BAMs display 780 differentially expressed genes from parenchymal microglia, indicating that the local niche signals may shape the gene signatures of BAM versus microglia and instruct their region-speci\ufb01c identities.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 121f7cadde31d785  \n[file]: 37923721 - Dissecting the human leptomeninges at single-cell resolution.pdf\n\u003e [evidence]: Notably, BAMs display 780 differentially expressed genes from parenchymal microglia, indicating t...", "to": "parenchymal microglia", "value": 1.0, "width": 1.6931471805599454}, {"from": "BBB", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u00270dda4f28de06d22f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737907966 - Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer disease.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 1, \u0027page\u0027: None, \u0027char_span\u0027: [26, 74], \u0027evidence\u0027: \u0027A leaky and dysfunctional BBB is linked to many neurodegenerative diseases, including LOAD [5, 37].\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0dda4f28de06d22f  \n[file]: 37907966 - Human isogenic cells of the neurovascular unit exert transcriptomic cell type-specific effects on a blood-brain barrier in vitro model of late-onset Alzheimer disease.pdf\n\u003e [evidence]: A leaky and dysfunctional BBB is linked to many neurodegenerative diseases, including LOAD [5, 37].", "to": "neurodegenerative diseases", "value": 1.0, "width": 1.6931471805599454}, {"from": "BCAT1 gene", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u00274d6afb7163e035aa\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 18, \u0027page\u0027: None, \u0027char_span\u0027: [16, 63], \u0027evidence\u0027: \u0027We validate the BCAT1 gene as downregulated in oligodendrocytes of humans and mice with AD.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4d6afb7163e035aa  \n[file]: 40796563 - Improving reproducibility of differentially expressed genes in single-cell transcriptomic studies of neurodegenerative diseases through meta-analysis.pdf\n\u003e [evidence]: We validate the BCAT1 gene as downregulated in oligodendrocytes of humans and mice with AD.", "to": "oligodendrocytes", "value": 1.0, "width": 1.6931471805599454}, {"from": "oligodendrocytes", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u00271a3720e2622382c1\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 46, \u0027page\u0027: None, \u0027char_span\u0027: [67, 138], \u0027evidence\u0027: \u0027UMAP cluster analysis revealed that the proportions of astrocytes, excitatory neurons, inhibitory neurons, microglia, and oligodendrocytes were similar between the Alzheimer\u2019s and neurological controls brain samples.\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u00271a3720e2622382c1\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [140, 209], \u0027evidence\u0027: \u0027Y axis: Gene count values of cell type marker genes, x axis: 6 cell type marker gene categories (left\u2014astrocytes, endothelial cell markers, excitatory neurons, inhibitory neurons microglia and oligodendrocytes).\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=2.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 1a3720e2622382c1  \n[file]: 36827281 - Single-cell RNA sequencing analysis of human Alzheimer\u0027s disease brain samples reveals neuronal and glial specific cells differential expression.pdf\n\u003e [evidence]: UMAP cluster analysis revealed that the proportions of astrocytes, excitatory neurons, inhibitory...\n\u003e [evidence]: Y axis: Gene count values of cell type marker genes, x axis: 6 cell type marker gene categories (...", "to": "excitatory neurons", "value": 2.0, "width": 2.09861228866811}, {"from": "BDNF signaling pathway", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u0027187cefb34d98d25f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39103533 - Single-cell spatial transcriptomics reveals distinct patterns of dysregulation in non-neuronal and neuronal cells induced by the Trem2(R47H) Alzheimer\u0027s risk gene mutati.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 36, \u0027page\u0027: None, \u0027char_span\u0027: [40, 100], \u0027evidence\u0027: \u0027Nr2f2 and Bdnf are both critical to the BDNF signaling pathway, which activates ERK and Akt pathways to maintain neuronal survival and synaptic plasticity [80].\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 187cefb34d98d25f  \n[file]: 39103533 - Single-cell spatial transcriptomics reveals distinct patterns of dysregulation in non-neuronal and neuronal cells induced by the Trem2(R47H) Alzheimer\u0027s risk gene mutati.pdf\n\u003e [evidence]: Nr2f2 and Bdnf are both critical to the BDNF signaling pathway, which activates ERK and Akt pathw...", "to": "ERK and Akt pathways", "value": 1.0, "width": 1.6931471805599454}, {"from": "BIN1", "label": "binds", "sources": ["{\u0027doc_id\u0027: \u0027749f183524779851\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 33, \u0027page\u0027: None, \u0027char_span\u0027: [14, 58], \u0027evidence\u0027: \u0027Additionally, BIN1 can bind to tau and BIN1 overexpression induces tau-dependent network hyperexcitability in cultured neurons [8, 9]\u0027, \u0027confidence\u0027: 1.0}"], "title": "binds | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: Additionally, BIN1 can bind to tau and BIN1 overexpression induces tau-dependent network hyperexc...", "to": "BIN1 overexpression", "value": 1.0, "width": 1.6931471805599454}, {"from": "BIN1", "label": "binds", "sources": ["{\u0027doc_id\u0027: \u0027749f183524779851\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 33, \u0027page\u0027: None, \u0027char_span\u0027: [14, 34], \u0027evidence\u0027: \u0027Additionally, BIN1 can bind to tau and BIN1 overexpression induces tau-dependent network hyperexcitability in cultured neurons [8, 9]\u0027, \u0027confidence\u0027: 1.0}"], "title": "binds | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: Additionally, BIN1 can bind to tau and BIN1 overexpression induces tau-dependent network hyperexc...", "to": "tau", "value": 1.0, "width": 1.6931471805599454}, {"from": "BIN1", "label": "correlates with", "sources": ["{\u0027doc_id\u0027: \u0027331a8d1a696c0aa5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 1, \u0027page\u0027: None, \u0027char_span\u0027: [0, 53], \u0027evidence\u0027: \u0027BIN1 AD-associated SNPs correlate with Tau deposition as well as with brain atrophy.\u0027, \u0027confidence\u0027: 1.0}"], "title": "correlates with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: BIN1 AD-associated SNPs correlate with Tau deposition as well as with brain atrophy.", "to": "Tau deposition", "value": 1.0, "width": 1.6931471805599454}, {"from": "BIN1", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027331a8d1a696c0aa5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [44, 100], \u0027evidence\u0027: \u0027Furthermore, the level of neuronal-specific BIN1 isoform 1 protein is decreased in sporadic AD cases in parallel with neuronal loss, despite an overall increase in BIN1 total mRNA.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: Furthermore, the level of neuronal-specific BIN1 isoform 1 protein is decreased in sporadic AD ca...", "to": "sporadic AD cases", "value": 1.0, "width": 1.6931471805599454}, {"from": "BIN1", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u0027749f183524779851\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 25, \u0027page\u0027: None, \u0027char_span\u0027: [20, 43], \u0027evidence\u0027: \u0027The requirement for BIN1 to regulate Ifitm3 upregulation during inflammation has important implications for inflammatory responses during the pathogenesis and progression of many neurodegen\u2011 erative diseases.\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: The requirement for BIN1 to regulate Ifitm3 upregulation during inflammation has important implic...", "to": "Ifitm3", "value": 1.0, "width": 1.6931471805599454}, {"from": "BIN1", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u0027749f183524779851\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 48, \u0027page\u0027: None, \u0027char_span\u0027: [26, 68], \u0027evidence\u0027: \u0027Despite the potential for BIN1 to regulate crucial cellular pathways and microglial functions under homeostatic and pathological conditions, studies to date have largely neglected to characterize microglial BIN1 expression.\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: Despite the potential for BIN1 to regulate crucial cellular pathways and microglial functions und...", "to": "cellular pathways", "value": 1.0, "width": 1.6931471805599454}, {"from": "BIN1", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u0027749f183524779851\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 54, \u0027page\u0027: None, \u0027char_span\u0027: [19, 123], \u0027evidence\u0027: \u0027We also found that BIN1 regulates the expression of key genes involved in microglial phagocytosis and inflammatory response, including Cd68, Cx3cr1, and Trem2.\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: We also found that BIN1 regulates the expression of key genes involved in microglial phagocytosis...", "to": "microglial phagocytosis and inflammatory response", "value": 1.0, "width": 1.6931471805599454}, {"from": "BIN1 overexpression", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027749f183524779851\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 33, \u0027page\u0027: None, \u0027char_span\u0027: [39, 126], \u0027evidence\u0027: \u0027Additionally, BIN1 can bind to tau and BIN1 overexpression induces tau-dependent network hyperexcitability in cultured neurons [8, 9]\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: Additionally, BIN1 can bind to tau and BIN1 overexpression induces tau-dependent network hyperexc...", "to": "cultured neurons", "value": 1.0, "width": 1.6931471805599454}, {"from": "BIN1\u2019s ability", "label": "interacts with", "sources": ["{\u0027doc_id\u0027: \u0027749f183524779851\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 31, \u0027page\u0027: None, \u0027char_span\u0027: [111, 173], \u0027evidence\u0027: \u0027A central Clathrin-Associated Protein binding region (CLAP domain), present only in neuronal isoforms, confers BIN1\u2019s ability to interact with the endocytic protein clathrin and its adaptor protein AP-2 [6].\u0027, \u0027confidence\u0027: 1.0}"], "title": "interacts with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: A central Clathrin-Associated Protein binding region (CLAP domain), present only in neuronal isof...", "to": "endocytic protein clathrin", "value": 1.0, "width": 1.6931471805599454}, {"from": "BV2 cell pyroptosis", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u00272ab9e10b4b26b7a7\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [35, 115], \u0027evidence\u0027: \u0027A. To analyse the role of NLRP3 in BV2 cell pyroptosis after treatment with ANGPLT8 and/or A\u03b21-42, a siRNA strategy was used to manipulate the expression of NLRP3 in BV2 cells.\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ab9e10b4b26b7a7  \n[file]: 40634935 - Liver-specific expression of ANGPTL8 promotes Alzheimer\u0027s disease progression through activating microglial pyroptosis.pdf\n\u003e [evidence]: A. To analyse the role of NLRP3 in BV2 cell pyroptosis after treatment with ANGPLT8 and/or A\u03b21-42...", "to": "siRNA strategy", "value": 1.0, "width": 1.6931471805599454}, {"from": "Bace1", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00273012894074386645\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [51, 97], \u0027evidence\u0027: \u0027Our most important finding is that oligodendrocyte Bace1 deletion significantly reduces A\u03b2 plaque load in an AD mouse model.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Our most important finding is that oligodendrocyte Bace1 deletion significantly reduces A\u03b2 plaque...", "to": "A\u03b2 plaque", "value": 1.0, "width": 1.6931471805599454}, {"from": "Bace1fl/fl controls", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00273012894074386645\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 12, \u0027page\u0027: None, \u0027char_span\u0027: [126, 199], \u0027evidence\u0027: \u0027We found that overall BACE1 and APP-fl protein levels in Bace1fl/fl;Olig2-Cre hippocampal tissues were comparable to those of Bace1fl/fl controls, likely due to unaffected Bace1 expression in neurons and other glial cells that masked reduction of Bace1 in oligodendrocytes.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3012894074386645  \n[file]: 39548583 - Contribution of amyloid deposition from oligodendrocytes in a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: We found that overall BACE1 and APP-fl protein levels in Bace1fl/fl;Olig2-Cre hippocampal tissues...", "to": "neurons", "value": 1.0, "width": 1.6931471805599454}, {"from": "neurons", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00279b64c3dd721bd44f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [0, 29], \u0027evidence\u0027: \u0027C3aR1 is expressed by neurons, astrocytes, and microglia in the brain [26\u201328], but the functional consequences of TLQP-21 activation of C3aR1 on microglia are poorly understood [29].\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: C3aR1 is expressed by neurons, astrocytes, and microglia in the brain [26\u201328], but the functional...", "to": "C3aR1", "value": 1.0, "width": 1.6931471805599454}, {"from": "neurons", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027749f183524779851\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 38, \u0027page\u0027: None, \u0027char_span\u0027: [49, 85], \u0027evidence\u0027: \u0027In the CNS, ubiquitous BIN1 isoforms lacking the CLAP domain are expressed in neurons and non-neuronal cells, most prominently in oligodendrocytes within human brain white matter [11, 14, 15].\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: In the CNS, ubiquitous BIN1 isoforms lacking the CLAP domain are expressed in neurons and non-neu...", "to": "CLAP domain", "value": 1.0, "width": 1.6931471805599454}, {"from": "neurons", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00279b1a0347efe392c6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 26, \u0027page\u0027: None, \u0027char_span\u0027: [66, 112], \u0027evidence\u0027: \u0027Previous experiments have demonstrated that overexpression of the IE2 gene can lead to loss of synapses, neurons, and hippocampal volume [10].\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: Previous experiments have demonstrated that overexpression of the IE2 gene can lead to loss of sy...", "to": "IE2 gene", "value": 1.0, "width": 1.6931471805599454}, {"from": "Bayesian approach", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027ab2593c0e43503e8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740074951 - Spotiphy enables single-cell spatial whole transcriptomics across an entire section.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 9, \u0027page\u0027: None, \u0027char_span\u0027: [16, 79], \u0027evidence\u0027: \u0027Spotiphy uses a Bayesian approach to dissect the expression of individual genes and assign them to specific cell types, producing iscRNA data that more accurately reflect expression fluctuations within transcriptomic spots and reveal cellular regional specifications.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: ab2593c0e43503e8  \n[file]: 40074951 - Spotiphy enables single-cell spatial whole transcriptomics across an entire section.pdf\n\u003e [evidence]: Spotiphy uses a Bayesian approach to dissect the expression of individual genes and assign them t...", "to": "individual genes", "value": 1.0, "width": 1.6931471805599454}, {"from": "Bin1", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027331a8d1a696c0aa5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 3, \u0027page\u0027: None, \u0027char_span\u0027: [38, 60], \u0027evidence\u0027: \u0027However, the study found that loss of Bin1 affected behavior in Bin1 c-KO mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: However, the study found that loss of Bin1 affected behavior in Bin1 c-KO mice.", "to": "behavior", "value": 1.0, "width": 1.6931471805599454}, {"from": "Bin1", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027331a8d1a696c0aa5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [34, 74], \u0027evidence\u0027: \u0027The study also found that loss of Bin1 affected neuropathological features in Bin1 c-KO mice, regardless of the expression of human Tau P301S.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The study also found that loss of Bin1 affected neuropathological features in Bin1 c-KO mice, reg...", "to": "neuropathological features", "value": 1.0, "width": 1.6931471805599454}, {"from": "Bin1 c-KO mice", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027331a8d1a696c0aa5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 6, \u0027page\u0027: None, \u0027char_span\u0027: [21, 103], \u0027evidence\u0027: \u0027The study found that Bin1 c-KO mice showed reduced open field exploration and auditory startle response.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The study found that Bin1 c-KO mice showed reduced open field exploration and auditory startle re...", "to": "auditory startle response", "value": 1.0, "width": 1.6931471805599454}, {"from": "Bin1 c-KO mice", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027331a8d1a696c0aa5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [26, 94], \u0027evidence\u0027: \u0027The study also found that Bin1 c-KO mice showed reduced freezing time during fear conditioning.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The study also found that Bin1 c-KO mice showed reduced freezing time during fear conditioning.", "to": "fear conditioning", "value": 1.0, "width": 1.6931471805599454}, {"from": "Bin1 c-KO mice", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027331a8d1a696c0aa5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 6, \u0027page\u0027: None, \u0027char_span\u0027: [21, 73], \u0027evidence\u0027: \u0027The study found that Bin1 c-KO mice showed reduced open field exploration and auditory startle response.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The study found that Bin1 c-KO mice showed reduced open field exploration and auditory startle re...", "to": "open field exploration", "value": 1.0, "width": 1.6931471805599454}, {"from": "Bin1 c-KO mice", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027331a8d1a696c0aa5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 4, \u0027page\u0027: None, \u0027char_span\u0027: [78, 141], \u0027evidence\u0027: \u0027The study also found that loss of Bin1 affected neuropathological features in Bin1 c-KO mice, regardless of the expression of human Tau P301S.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The study also found that loss of Bin1 affected neuropathological features in Bin1 c-KO mice, reg...", "to": "human Tau P301S", "value": 1.0, "width": 1.6931471805599454}, {"from": "Bin1 isoform 1", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027331a8d1a696c0aa5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [12, 78], \u0027evidence\u0027: \u0027The loss of Bin1 isoform 1 resulted in reduced excitability in primary neurons in vitro, reduced neuronal c-fos expression as well as in altered microglia transcriptome in vivo.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 331a8d1a696c0aa5  \n[file]: 31408457 - Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss in vivo.pdf\n\u003e [evidence]: The loss of Bin1 isoform 1 resulted in reduced excitability in primary neurons in vitro, reduced ...", "to": "primary neurons", "value": 1.0, "width": 1.6931471805599454}, {"from": "Black", "label": "mediates", "sources": ["{\u0027doc_id\u0027: \u002719a9292f563b3f37\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"29784049 - Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 15, \u0027page\u0027: None, \u0027char_span\u0027: [169, 203], \u0027evidence\u0027: \u0027Colors represent module membership (Blue: Homeostatic module, Red and Midnightblue: M1-like modules not associated with AD, Cyan: M2-like module not associated with AD, Black: intermediate stages, Yellow: anti-inflammatory DAM module upregulated in AD, Magenta: pro-inflammatory DAM module upregulated in AD).\u0027, \u0027confidence\u0027: 1.0}"], "title": "mediates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 19a9292f563b3f37  \n[file]: 29784049 - Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Colors represent module membership (Blue: Homeostatic module, Red and Midnightblue: M1-like modul...", "to": "Yellow", "value": 1.0, "width": 1.6931471805599454}, {"from": "Black", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u002719a9292f563b3f37\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"29784049 - Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 15, \u0027page\u0027: None, \u0027char_span\u0027: [124, 174], \u0027evidence\u0027: \u0027Colors represent module membership (Blue: Homeostatic module, Red and Midnightblue: M1-like modules not associated with AD, Cyan: M2-like module not associated with AD, Black: intermediate stages, Yellow: anti-inflammatory DAM module upregulated in AD, Magenta: pro-inflammatory DAM module upregulated in AD).\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 19a9292f563b3f37  \n[file]: 29784049 - Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Colors represent module membership (Blue: Homeostatic module, Red and Midnightblue: M1-like modul...", "to": "Cyan", "value": 1.0, "width": 1.6931471805599454}, {"from": "Bone-marrow derived Macrophages", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u002783604f00c2934caf\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"34294785 - Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 12, \u0027page\u0027: None, \u0027char_span\u0027: [0, 68], \u0027evidence\u0027: \u0027Bone-marrow derived Macrophages overexpressing PU.1 increased GM-CSF and M-CSF dependent proliferation and cell number, the opposite was seen in cells transfected with an anti-sense PU.19.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 83604f00c2934caf  \n[file]: 34294785 - Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Bone-marrow derived Macrophages overexpressing PU.1 increased GM-CSF and M-CSF dependent prolifer...", "to": "GM-CSF", "value": 1.0, "width": 1.6931471805599454}, {"from": "Brain", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027f08e8a515e81d795\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 15, \u0027page\u0027: None, \u0027char_span\u0027: [65, 122], \u0027evidence\u0027: \u0027However, aging-associated chronic, low-grade inflammation in the brain can result in dysfunctional microglial phagocytosis of cellular debris and lead to amyloid beta deposition in plaques in the AD brain.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: However, aging-associated chronic, low-grade inflammation in the brain can result in dysfunctiona...", "to": "Microglial phagocytosis", "value": 1.0, "width": 1.6931471805599454}, {"from": "Brown", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u00274531a8781d26732c\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"29954413 - Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer\u0027s disease-related proteins.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 17, \u0027page\u0027: None, \u0027char_span\u0027: [156, 227], \u0027evidence\u0027: \u0027g Immunohistochemistry micrographs from AD and non-disease control post-mortem human brains (frontal cortex) showing increased microglial Cotl1 expression (Brown) in AD as compared to non-disease controls (representative images from n = 4 AD and n = 4 non-AD cases).\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 4531a8781d26732c  \n[file]: 29954413 - Quantitative proteomics of acutely-isolated mouse microglia identifies novel immune Alzheimer\u0027s disease-related proteins.pdf\n\u003e [evidence]: g Immunohistochemistry micrographs from AD and non-disease control post-mortem human brains (fron...", "to": "representative images", "value": 1.0, "width": 1.6931471805599454}, {"from": "C \u00ad D68+/Iba-1+ area", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027efbf7bba620cd8fe\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002736575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 33, \u0027page\u0027: None, \u0027char_span\u0027: [48, 131], \u0027evidence\u0027: \u0027Interestingly, a quantitative assessment of the C \\xad D68+/Iba-1+ area revealed a significant increase in the 5\u00d7FAD + FUS + Adu group Kong et al. Translational Neurodegeneration (2022) 11:57 (Fig. 3e).\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: efbf7bba620cd8fe  \n[file]: 36575534 - Enhanced delivery of a low dose of aducanumab via FUS in 5\u00d7FAD mice, an AD model.pdf\n\u003e [evidence]: Interestingly, a quantitative assessment of the C \u00ad D68+/Iba-1+ area revealed a significant incre...", "to": "5\u00d7FAD + FUS + Adu group", "value": 1.0, "width": 1.6931471805599454}, {"from": "C1q depletion", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u00273a6969ccf167b6e1\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35443751 - Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer\u0027s disease mouse model.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 24, \u0027page\u0027: None, \u0027char_span\u0027: [7, 79], \u0027evidence\u0027: \u0027In AD, C1q depletion is associated with reduced microglia/macrophage activation and AD mice lacking C1q display reduced synapse loss, supporting a role for C1q in mediating synapse removal58.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3a6969ccf167b6e1  \n[file]: 35443751 - Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: In AD, C1q depletion is associated with reduced microglia/macrophage activation and AD mice lacki...", "to": "microglia/macrophage activation", "value": 1.0, "width": 1.6931471805599454}, {"from": "C2C", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u00279f6a04c9a2b37f2c\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38741048 - Characterizing dysregulations via cell-cell communications in Alzheimer\u0027s brains using single-cell transcriptomes.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 20, \u0027page\u0027: None, \u0027char_span\u0027: [98, 143], \u0027evidence\u0027: \u0027Abbreviations AD  Alzheimer\u2019s Disease Astro Astrocytes BICCN BRAIN Initiative Cell Census Network C2C Cell-to-cell Communication CON Control CT Cortico-thalamic Endo Endothelial cells GWAS Genome-Wide Association Studies IT Intra-telencephalic L# Signifies the cortical layer context Micro/PVM Microglia/Perivascular macrophages NP Near-projecting Oligo Oligodendrocytes OPC Oligodendrocyte precursor cells PFC Human prefrontal cortex snRNA-seq Single-nucleus RNA sequencing VLMC Vascular Leptomeningeal cells WES Whole Exome Sequencing\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9f6a04c9a2b37f2c  \n[file]: 38741048 - Characterizing dysregulations via cell-cell communications in Alzheimer\u0027s brains using single-cell transcriptomes.pdf\n\u003e [evidence]: Abbreviations AD Alzheimer\u2019s Disease Astro Astrocytes BICCN BRAIN Initiative Cell Census Network ...", "to": "CT", "value": 1.0, "width": 1.6931471805599454}, {"from": "C2C", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u00279f6a04c9a2b37f2c\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38741048 - Characterizing dysregulations via cell-cell communications in Alzheimer\u0027s brains using single-cell transcriptomes.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 20, \u0027page\u0027: None, \u0027char_span\u0027: [98, 165], \u0027evidence\u0027: \u0027Abbreviations AD  Alzheimer\u2019s Disease Astro Astrocytes BICCN BRAIN Initiative Cell Census Network C2C Cell-to-cell Communication CON Control CT Cortico-thalamic Endo Endothelial cells GWAS Genome-Wide Association Studies IT Intra-telencephalic L# Signifies the cortical layer context Micro/PVM Microglia/Perivascular macrophages NP Near-projecting Oligo Oligodendrocytes OPC Oligodendrocyte precursor cells PFC Human prefrontal cortex snRNA-seq Single-nucleus RNA sequencing VLMC Vascular Leptomeningeal cells WES Whole Exome Sequencing\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9f6a04c9a2b37f2c  \n[file]: 38741048 - Characterizing dysregulations via cell-cell communications in Alzheimer\u0027s brains using single-cell transcriptomes.pdf\n\u003e [evidence]: Abbreviations AD Alzheimer\u2019s Disease Astro Astrocytes BICCN BRAIN Initiative Cell Census Network ...", "to": "Cortico-thalamic Endo", "value": 1.0, "width": 1.6931471805599454}, {"from": "C3 depletion", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00273a6969ccf167b6e1\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35443751 - Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer\u0027s disease mouse model.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 25, \u0027page\u0027: None, \u0027char_span\u0027: [10, 79], \u0027evidence\u0027: \u0027Moreover, C3 depletion in a mouse model of AD signi\ufb01cantly reduces synapse loss and promotes cognition, despite accumulation of the amyloid burden62.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3a6969ccf167b6e1  \n[file]: 35443751 - Stearoyl-CoA Desaturase inhibition reverses immune, synaptic and cognitive impairments in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Moreover, C3 depletion in a mouse model of AD signi\ufb01cantly reduces synapse loss and promotes cogn...", "to": "synapse loss", "value": 1.0, "width": 1.6931471805599454}, {"from": "C3a \u2013 C3aR signaling", "label": "promotes", "sources": ["{\u0027doc_id\u0027: \u0027f08e8a515e81d795\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [13, 53], \u0027evidence\u0027: \u00275 Microglial C3a \u2013 C3aR signaling promotes glycolysis and phagocytosis.\u0027, \u0027confidence\u0027: 1.0}"], "title": "promotes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: 5 Microglial C3a \u2013 C3aR signaling promotes glycolysis and phagocytosis.", "to": "glycolysis", "value": 1.0, "width": 1.6931471805599454}, {"from": "C3a \u2013 C3aR signaling", "label": "promotes", "sources": ["{\u0027doc_id\u0027: \u0027f08e8a515e81d795\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [13, 70], \u0027evidence\u0027: \u00275 Microglial C3a \u2013 C3aR signaling promotes glycolysis and phagocytosis.\u0027, \u0027confidence\u0027: 1.0}"], "title": "promotes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: 5 Microglial C3a \u2013 C3aR signaling promotes glycolysis and phagocytosis.", "to": "phagocytosis", "value": 1.0, "width": 1.6931471805599454}, {"from": "C3aR1-null mice", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u00279b64c3dd721bd44f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 3, \u0027page\u0027: None, \u0027char_span\u0027: [142, 219], \u0027evidence\u0027: \u0027Methods: We performed phagocytic/migration assays and RNA sequencing on BV2 microglial cells and primary microglia isolated from wild-type or C3aR1-null mice following treatment with TLQP-21 or C3a super agonist (C3aSA).\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: Methods: We performed phagocytic/migration assays and RNA sequencing on BV2 microglial cells and ...", "to": "C3a super agonist (C3aSA)", "value": 1.0, "width": 1.6931471805599454}, {"from": "C3aR1-null mice", "label": "treats", "sources": ["{\u0027doc_id\u0027: \u00279b64c3dd721bd44f\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002731924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 3, \u0027page\u0027: None, \u0027char_span\u0027: [142, 190], \u0027evidence\u0027: \u0027Methods: We performed phagocytic/migration assays and RNA sequencing on BV2 microglial cells and primary microglia isolated from wild-type or C3aR1-null mice following treatment with TLQP-21 or C3a super agonist (C3aSA).\u0027, \u0027confidence\u0027: 1.0}"], "title": "treats | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b64c3dd721bd44f  \n[file]: 31924226 - VGF-derived peptide TLQP-21 modulates microglial function through C3aR1 signaling pathways and reduces neuropathology in 5xFAD mice.pdf\n\u003e [evidence]: Methods: We performed phagocytic/migration assays and RNA sequencing on BV2 microglial cells and ...", "to": "TLQP-21", "value": 1.0, "width": 1.6931471805599454}, {"from": "C5a", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 0, \u0027page\u0027: None, \u0027char_span\u0027: [49, 199], \u0027evidence\u0027: \"Abstract Background: Pharmacologic inhibition of C5aR1, a receptor for the complement activation proinflammatory fragment, C5a, suppressed pathology and cognitive deficits in Alzheimer\u0027s disease (AD) mouse models.\", \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Abstract Background: Pharmacologic inhibition of C5aR1, a receptor for the complement activation ...", "to": "Alzheimer\u0027s disease (AD)", "value": 1.0, "width": 1.6931471805599454}, {"from": "C5a", "label": "binds", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 33, \u0027page\u0027: None, \u0027char_span\u0027: [68, 73], \u0027evidence\u0027: \u0027In addition, in vitro cultures of C57BL6/J cortical neurons express C5aR1 and, upon binding, C5a is reported to injure neurons [24, 25].\u0027, \u0027confidence\u0027: 1.0}"], "title": "binds | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: In addition, in vitro cultures of C57BL6/J cortical neurons express C5aR1 and, upon binding, C5a ...", "to": "C5aR1", "value": 1.0, "width": 1.6931471805599454}, {"from": "C5aR1", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [19, 79], \u0027evidence\u0027: \u0027In addition, since C5aR1 is primarily expressed on cells of the myeloid lineage, and only to a lesser extent on endothelial cells and neurons in brain, gene expression in microglia isolated from adult brain at multiple ages was compared across all genotypes.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: In addition, since C5aR1 is primarily expressed on cells of the myeloid lineage, and only to a le...", "to": "myeloid lineage", "value": 1.0, "width": 1.6931471805599454}, {"from": "C5aR1", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 1, \u0027page\u0027: None, \u0027char_span\u0027: [67, 89], \u0027evidence\u0027: \u0027To validate that the effect of the antagonist was specifically via C5aR1 inhibition, mice lacking C5aR1 were generated and compared in behavior and pathology.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: To validate that the effect of the antagonist was specifically via C5aR1 inhibition, mice lacking...", "to": "mice", "value": 1.0, "width": 1.6931471805599454}, {"from": "C5aR1", "label": "prevents", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 5, \u0027page\u0027: None, \u0027char_span\u0027: [19, 52], \u0027evidence\u0027: \u0027Results: A lack of C5aR1 prevented behavior deficits at 10 months, although amyloid plaque load was not altered.\u0027, \u0027confidence\u0027: 1.0}"], "title": "prevents | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Results: A lack of C5aR1 prevented behavior deficits at 10 months, although amyloid plaque load w...", "to": "behavior deficits", "value": 1.0, "width": 1.6931471805599454}, {"from": "C5aR1 inhibition", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00276ba9bb6b943017d2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 13, \u0027page\u0027: None, \u0027char_span\u0027: [25, 79], \u0027evidence\u0027: \u0027However, in those models C5aR1 inhibition decreased amyloid plaque accumulation by 50%.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: However, in those models C5aR1 inhibition decreased amyloid plaque accumulation by 50%.", "to": "amyloid plaque accumulation", "value": 1.0, "width": 1.6931471805599454}, {"from": "C5aR1 signaling", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 16, \u0027page\u0027: None, \u0027char_span\u0027: [86, 154], \u0027evidence\u0027: \u0027Conclusions: These data are consistent with microglial polarization in the absence of C5aR1 signaling reflecting decreased induction of inflammatory genes and enhancement of degradation/clearance pathways, which is accompanied by preservation of CA1 neuronal complexity and hippocampal dependent cognitive function.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Conclusions: These data are consistent with microglial polarization in the absence of C5aR1 signa...", "to": "inflammatory genes", "value": 1.0, "width": 1.6931471805599454}, {"from": "C5aR1 signaling", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 49, \u0027page\u0027: None, \u0027char_span\u0027: [73, 165], \u0027evidence\u0027: \u0027Further studies are needed to determine the specific mechanisms by which C5aR1 signaling regulates these processes and to evaluate the potential of C5aR1 antagonists as a therapeutic strategy for AD.\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Further studies are needed to determine the specific mechanisms by which C5aR1 signaling regulate...", "to": "potential of C5aR1 antagonists", "value": 1.0, "width": 1.6931471805599454}, {"from": "C5aR1-dependent", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u00276ba9bb6b943017d2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 18, \u0027page\u0027: None, \u0027char_span\u0027: [34, 114], \u0027evidence\u0027: \u0027Microglia clusters M4 and M9 were C5aR1-dependent and expressed genes that detrimentally modulated synapse pruning, microglial activation, cognition and cell death, whereas clusters M3 and M8 which had high expression of genes previously characterized as DAM-2 genes were induced in the Arctic without C5aR1 input (C5aR1-independent), and may have repair or restorative functions which are advantageous to maintain, rather than suppressed by more globally targeting strategies.\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6ba9bb6b943017d2  \n[file]: 39147742 - C5aR1 antagonism suppresses inflammatory glial responses and alters cellular signaling in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Microglia clusters M4 and M9 were C5aR1-dependent and expressed genes that detrimentally modulate...", "to": "synapse pruning", "value": 1.0, "width": 1.6931471805599454}, {"from": "CA1 neurons", "label": "prevents", "sources": ["{\u0027doc_id\u0027: \u0027cbcc6ddfa8b90ba6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002728923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 0, \u0027page\u0027: None, \u0027char_span\u0027: [142, 223], \u0027evidence\u0027: \u0027Discussion Genetic deletion of C5aR1 in the Arctic Alzheimer\u2019s disease mouse model resulted in protection from loss of neuronal complexity in CA1 neurons and prevented deficits in a hippocampal dependent spatial memory task relative to the C5aR1 sufficient Arctic animals.\u0027, \u0027confidence\u0027: 1.0}"], "title": "prevents | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: cbcc6ddfa8b90ba6  \n[file]: 28923083 - Prevention of C5aR1 signaling delays microglial inflammatory polarization, favors clearance pathways and suppresses cognitive loss.pdf\n\u003e [evidence]: Discussion Genetic deletion of C5aR1 in the Arctic Alzheimer\u2019s disease mouse model resulted in pr...", "to": "hippocampal dependent spatial memory task", "value": 1.0, "width": 1.6931471805599454}, {"from": "CD33 and TREM2", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u002758164633001be033\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"33081847 - Identification of a dysfunctional microglial population in human Alzheimer\u0027s disease cortex using novel single-cell histology image analysis.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 15, \u0027page\u0027: None, \u0027char_span\u0027: [101, 181], \u0027evidence\u0027: \u0027Genetic risk factors for AD include loss-offunction mutations in microglia-specific genes, including CD33 and TREM2, which are associated with reduced microglial phagocytic capacity [4\u20137].\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 58164633001be033  \n[file]: 33081847 - Identification of a dysfunctional microglial population in human Alzheimer\u0027s disease cortex using novel single-cell histology image analysis.pdf\n\u003e [evidence]: Genetic risk factors for AD include loss-offunction mutations in microglia-specific genes, includ...", "to": "reduced microglial phagocytic capacity", "value": 1.0, "width": 1.6931471805599454}, {"from": "CD8+ cells", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027121f7cadde31d785\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737923721 - Dissecting the human leptomeninges at single-cell resolution.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [84, 121], \u0027evidence\u0027: \u0027For immune cells, we detect diverse T cell subtypes in the leptomeninges, primarily CD8+ cells, expressing TRM core genes.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 121f7cadde31d785  \n[file]: 37923721 - Dissecting the human leptomeninges at single-cell resolution.pdf\n\u003e [evidence]: For immune cells, we detect diverse T cell subtypes in the leptomeninges, primarily CD8+ cells, e...", "to": "TRM core genes", "value": 1.0, "width": 1.6931471805599454}, {"from": "CD83", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u00279b1a0347efe392c6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 14, \u0027page\u0027: None, \u0027char_span\u0027: [83, 129], \u0027evidence\u0027: \u002713 1342 Molecular Neurobiology (2024) 61:1331\u20131345 upregulated genes (ApoE, ISG15, CD83) and downregulated genes (Tmem119, P2ry12), which were associated with disease and homeostasis, respectively.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: 13 1342 Molecular Neurobiology (2024) 61:1331\u20131345 upregulated genes (ApoE, ISG15, CD83) and down...", "to": "P2ry12", "value": 1.0, "width": 1.6931471805599454}, {"from": "CD83", "label": "inhibits", "sources": ["{\u0027doc_id\u0027: \u00279b1a0347efe392c6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 14, \u0027page\u0027: None, \u0027char_span\u0027: [83, 121], \u0027evidence\u0027: \u002713 1342 Molecular Neurobiology (2024) 61:1331\u20131345 upregulated genes (ApoE, ISG15, CD83) and downregulated genes (Tmem119, P2ry12), which were associated with disease and homeostasis, respectively.\u0027, \u0027confidence\u0027: 1.0}"], "title": "inhibits | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9b1a0347efe392c6  \n[file]: 37700217 - Single-Cell RNA Sequencing Transcriptomics Revealed HCMV IE2-Related Microglia Responses in Alzheimer\u0027s-Like Disease in Transgenic Mice.pdf\n\u003e [evidence]: 13 1342 Molecular Neurobiology (2024) 61:1331\u20131345 upregulated genes (ApoE, ISG15, CD83) and down...", "to": "Tmem119", "value": 1.0, "width": 1.6931471805599454}, {"from": "CLAP domain", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027749f183524779851\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002735526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 38, \u0027page\u0027: None, \u0027char_span\u0027: [49, 108], \u0027evidence\u0027: \u0027In the CNS, ubiquitous BIN1 isoforms lacking the CLAP domain are expressed in neurons and non-neuronal cells, most prominently in oligodendrocytes within human brain white matter [11, 14, 15].\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 749f183524779851  \n[file]: 35526014 - BIN1 is a key regulator of proinflammatory and neurodegeneration-related activation in microglia.pdf\n\u003e [evidence]: In the CNS, ubiquitous BIN1 isoforms lacking the CLAP domain are expressed in neurons and non-neu...", "to": "non-neuronal cells", "value": 1.0, "width": 1.6931471805599454}, {"from": "COVID-19-related anosmia", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u0027d6b219e5033d7585\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737620562 - Animal models to study the neurological manifestations of the post-COVID-19 condition.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 5, \u0027page\u0027: None, \u0027char_span\u0027: [0, 61], \u0027evidence\u0027: \u0027COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory epithelium and brain infection in hamsters.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: d6b219e5033d7585  \n[file]: 37620562 - Animal models to study the neurological manifestations of the post-COVID-19 condition.pdf\n\u003e [evidence]: COVID-19-related anosmia is associated with viral persistence and inflammation in human olfactory...", "to": "viral persistence", "value": 1.0, "width": 1.6931471805599454}, {"from": "COX-1", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u00270e0d3b8ebe88e7d8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 2, \u0027page\u0027: None, \u0027char_span\u0027: [0, 51], \u0027evidence\u0027: \u0027COX-1, a target irreversibly inactivated by aspirin, is highly expressed in microglia associated with neuroinflammation [17].\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: COX-1, a target irreversibly inactivated by aspirin, is highly expressed in microglia associated ...", "to": "aspirin", "value": 1.0, "width": 1.6931471805599454}, {"from": "COX-1 deletion", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u00270e0d3b8ebe88e7d8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 22, \u0027page\u0027: None, \u0027char_span\u0027: [0, 59], \u0027evidence\u0027: \u0027COX-1 deletion preferentially enhances microglial clearance of A\u03b242.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: COX-1 deletion preferentially enhances microglial clearance of A\u03b242.", "to": "microglial clearance", "value": 1.0, "width": 1.6931471805599454}, {"from": "CRISPR-ON/OFF system", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u002755563c4d6648408c\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738600587 - An integrated toolkit for human microglia functional genomics.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 49, \u0027page\u0027: None, \u0027char_span\u0027: [14, 82], \u0027evidence\u0027: \u0027The optimized CRISPR-ON/OFF system modulates gene expression with temporal control, and importantly, without inducing DNA double strand breaks.\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 55563c4d6648408c  \n[file]: 38600587 - An integrated toolkit for human microglia functional genomics.pdf\n\u003e [evidence]: The optimized CRISPR-ON/OFF system modulates gene expression with temporal control, and important...", "to": "temporal control", "value": 1.0, "width": 1.6931471805599454}, {"from": "CSF sTREM2", "label": "prevents", "sources": ["{\u0027doc_id\u0027: \u0027bb73bcc13afee4b4\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"34465358 - Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 42, \u0027page\u0027: None, \u0027char_span\u0027: [48, 136], \u0027evidence\u0027: \u0027Another emerging biomarker for assessing DAM is CSF sTREM2, which can induce DAM to protect against amyloid beta-induced neuronal damage [52, 53].\u0027, \u0027confidence\u0027: 1.0}"], "title": "prevents | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: bb73bcc13afee4b4  \n[file]: 34465358 - Hippocampal glucose uptake as a surrogate of metabolic change of microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Another emerging biomarker for assessing DAM is CSF sTREM2, which can induce DAM to protect again...", "to": "amyloid beta-induced neuronal damage", "value": 1.0, "width": 1.6931471805599454}, {"from": "CSF1R", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u0027b075ab080a8658ed\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739294270 - Transcriptional profiling in microglia across physiological and pathological states identifies a transcriptional module associated with neurodegeneration.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [91, 143], \u0027evidence\u0027: \u0027Genes that were previously identi\ufb01ed as microglial markers, such as TREM2, TYROBP, P2RY12, CSF1R, were also upregulated in human microglial set (microglia vs other cells) in our analysis.\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b075ab080a8658ed  \n[file]: 39294270 - Transcriptional profiling in microglia across physiological and pathological states identifies a transcriptional module associated with neurodegeneration.pdf\n\u003e [evidence]: Genes that were previously identi\ufb01ed as microglial markers, such as TREM2, TYROBP, P2RY12, CSF1R,...", "to": "human microglial set", "value": 1.0, "width": 1.6931471805599454}, {"from": "CSF1R", "label": "activates", "sources": ["{\u0027doc_id\u0027: \u0027b075ab080a8658ed\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739294270 - Transcriptional profiling in microglia across physiological and pathological states identifies a transcriptional module associated with neurodegeneration.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [91, 169], \u0027evidence\u0027: \u0027Genes that were previously identi\ufb01ed as microglial markers, such as TREM2, TYROBP, P2RY12, CSF1R, were also upregulated in human microglial set (microglia vs other cells) in our analysis.\u0027, \u0027confidence\u0027: 1.0}"], "title": "activates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: b075ab080a8658ed  \n[file]: 39294270 - Transcriptional profiling in microglia across physiological and pathological states identifies a transcriptional module associated with neurodegeneration.pdf\n\u003e [evidence]: Genes that were previously identi\ufb01ed as microglial markers, such as TREM2, TYROBP, P2RY12, CSF1R,...", "to": "microglia vs other cells", "value": 1.0, "width": 1.6931471805599454}, {"from": "CXCR4", "label": "regulates", "sources": ["{\u0027doc_id\u0027: \u002719a9292f563b3f37\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"29784049 - Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 1, \u0027page\u0027: None, \u0027char_span\u0027: [194, 234], \u0027evidence\u0027: \u0027While pro-inflammatory DAM are characterized by higher expression of CD44, CD45 and Kv1.3 channels and are regulated by NFkB, Stat1 and RelA pathways, anti-inflammatory DAM are characterized by CXCR4 expression and regulated by LXR\u03b1/\u03b2.\u0027, \u0027confidence\u0027: 1.0}"], "title": "regulates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 19a9292f563b3f37  \n[file]: 29784049 - Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: While pro-inflammatory DAM are characterized by higher expression of CD44, CD45 and Kv1.3 channel...", "to": "LXR\u03b1/\u03b2", "value": 1.0, "width": 1.6931471805599454}, {"from": "CXCR4 expression", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00270fafd5f17a2c043e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"33097708 - Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 43, \u0027page\u0027: None, \u0027char_span\u0027: [19, 80], \u0027evidence\u0027: \u0027However, we do see CXCR4 expression highly expressed in the human DAM population and decreased in TREM2 KO microglia (Fig. 5 and Supplementary Data 4), suggesting that TREM2 is required to elicit CXCR4-dependent migration toward plaques and the subsequent adoption of a DAM state.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0fafd5f17a2c043e  \n[file]: 33097708 - Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: However, we do see CXCR4 expression highly expressed in the human DAM population and decreased in...", "to": "human DAM population", "value": 1.0, "width": 1.6931471805599454}, {"from": "CXCR4 signaling", "label": "prevents", "sources": ["{\u0027doc_id\u0027: \u00270fafd5f17a2c043e\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"33097708 - Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 28, \u0027page\u0027: None, \u0027char_span\u0027: [49, 127], \u0027evidence\u0027: \u0027To corroborate these data, we show that blocking CXCR4 signaling with AMD3100 is suf\ufb01cient to prevent migration of WT microglia toward betaamyloid producing neurons and astrocytes (Fig. 5d).\u0027, \u0027confidence\u0027: 1.0}"], "title": "prevents | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0fafd5f17a2c043e  \n[file]: 33097708 - Gene expression and functional deficits underlie TREM2-knockout microglia responses in human models of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: To corroborate these data, we show that blocking CXCR4 signaling with AMD3100 is suf\ufb01cient to pre...", "to": "WT microglia", "value": 1.0, "width": 1.6931471805599454}, {"from": "Cellular debris", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u0027f08e8a515e81d795\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 15, \u0027page\u0027: None, \u0027char_span\u0027: [126, 177], \u0027evidence\u0027: \u0027However, aging-associated chronic, low-grade inflammation in the brain can result in dysfunctional microglial phagocytosis of cellular debris and lead to amyloid beta deposition in plaques in the AD brain.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: However, aging-associated chronic, low-grade inflammation in the brain can result in dysfunctiona...", "to": "Amyloid beta deposition", "value": 1.0, "width": 1.6931471805599454}, {"from": "ChP", "label": "mediates", "sources": ["{\u0027doc_id\u0027: \u00279538f215b7d18baa\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40450296 - Early transcriptional and cellular abnormalities in choroid plexus of a mouse model of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 26, \u0027page\u0027: None, \u0027char_span\u0027: [4, 68], \u0027evidence\u0027: \u0027The ChP also mediates the entry of A\u03b2-activated peripheral monocytes into the brain parenchyma [30, 31].\u0027, \u0027confidence\u0027: 1.0}"], "title": "mediates | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 9538f215b7d18baa  \n[file]: 40450296 - Early transcriptional and cellular abnormalities in choroid plexus of a mouse model of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: The ChP also mediates the entry of A\u03b2-activated peripheral monocytes into the brain parenchyma [3...", "to": "A\u03b2-activated peripheral monocytes", "value": 1.0, "width": 1.6931471805599454}, {"from": "Chen et al.", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u002755563c4d6648408c\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738600587 - An integrated toolkit for human microglia functional genomics.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 26, \u0027page\u0027: None, \u0027char_span\u0027: [0, 79], \u0027evidence\u0027: \u0027Chen et al. induced hiPSCs into iMG in \u003c 20 days with SPI1/CEPBA overexpression.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 55563c4d6648408c  \n[file]: 38600587 - An integrated toolkit for human microglia functional genomics.pdf\n\u003e [evidence]: Chen et al. induced hiPSCs into iMG in \u003c 20 days with SPI1/CEPBA overexpression.", "to": "SPI1/CEPBA overexpression", "value": 1.0, "width": 1.6931471805599454}, {"from": "Choi et al.", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u00270e0d3b8ebe88e7d8\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002740847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 19, \u0027page\u0027: None, \u0027char_span\u0027: [105, 170], \u0027evidence\u0027: \u0027However, a study by Park et al. [81] in APP/PS1 mice showed no A\u03b2 reduction with COX-1 deletion, whereas Choi et al. [26] demonstrated reduced pathology in 3 \u00d7 Tg-AD mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 0e0d3b8ebe88e7d8  \n[file]: 40847374 - Cyclooxygenase-1 deletion in 5 \u00d7 FAD mice protects against microglia-induced neuroinflammation and mitigates cognitive impairment.pdf\n\u003e [evidence]: However, a study by Park et al. [81] in APP/PS1 mice showed no A\u03b2 reduction with COX-1 deletion, ...", "to": "3 \u00d7 Tg-AD mice", "value": 1.0, "width": 1.6931471805599454}, {"from": "Chronic-low level inflammation", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u00272ede31c1d54bcb30\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36199077 - Alzheimer\u0027s disease-related transcriptional sex differences in myeloid cells.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 15, \u0027page\u0027: None, \u0027char_span\u0027: [99, 182], \u0027evidence\u0027: \u0027For example, the transcriptome of peripheral monocytes isolated from individuals with evidence for chronic-low level inflammation found augmented expression of pro-inflammatory genes in women relative to men [55].\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ede31c1d54bcb30  \n[file]: 36199077 - Alzheimer\u0027s disease-related transcriptional sex differences in myeloid cells.pdf\n\u003e [evidence]: For example, the transcriptome of peripheral monocytes isolated from individuals with evidence fo...", "to": "Pro-inflammatory genes", "value": 1.0, "width": 1.6931471805599454}, {"from": "Col25a1", "label": "encodes", "sources": ["{\u0027doc_id\u0027: \u002779fca66073e8bfa0\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 31, \u0027page\u0027: None, \u0027char_span\u0027: [0, 55], \u0027evidence\u0027: \u0027Col25a1 encodes a collagenlike amyloid plaque component, known for forming protease-resistant aggregates.\u0027, \u0027confidence\u0027: 1.0}"], "title": "encodes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 79fca66073e8bfa0  \n[file]: 40931359 - Stabilizing the retromer complex rescues synaptic dysfunction and endosomal trafficking deficits in an Alzheimer\u0027s disease mouse model.pdf\n\u003e [evidence]: Col25a1 encodes a collagenlike amyloid plaque component, known for forming protease-resistant agg...", "to": "collagenlike amyloid plaque component", "value": 1.0, "width": 1.6931471805599454}, {"from": "Combined drop of DA and 5-HT", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u002792ff8f2be96289d7\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"41077614 - Midbrain degeneration triggers astrocyte reactivity and tau pathology in experimental Alzheimer\u0027s Disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 35, \u0027page\u0027: None, \u0027char_span\u0027: [29, 124], \u0027evidence\u0027: \u0027We provide evidence that the combined drop of DA and 5-HT induces significant hippocampal neuroinflammation in C57BL/6N mice, that is characterized by microglia reactivity and interleukin-1\u03b2 (IL-1\u03b2) release mediated by the NOD-, LRR- and Pyrin La Barbera et al.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 92ff8f2be96289d7  \n[file]: 41077614 - Midbrain degeneration triggers astrocyte reactivity and tau pathology in experimental Alzheimer\u0027s Disease.pdf\n\u003e [evidence]: We provide evidence that the combined drop of DA and 5-HT induces significant hippocampal neuroin...", "to": "Hippocampal neuroinflammation in C57BL/6N mice", "value": 1.0, "width": 1.6931471805599454}, {"from": "Computational cell mapping techniques", "label": "predicts", "sources": ["{\u0027doc_id\u0027: \u00272ede31c1d54bcb30\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"36199077 - Alzheimer\u0027s disease-related transcriptional sex differences in myeloid cells.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 20, \u0027page\u0027: None, \u0027char_span\u0027: [6, 81], \u0027evidence\u0027: \u0027Using computational cell mapping techniques to predict microglial gene expression from bulk transcriptomic data, Bonham et al. [33] inferred dysregulation of microglial genes in AD patients in the cerebellum and temporal cortex, and these perturbations were observed to a greater extent in women compared to men.\u0027, \u0027confidence\u0027: 1.0}"], "title": "predicts | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 2ede31c1d54bcb30  \n[file]: 36199077 - Alzheimer\u0027s disease-related transcriptional sex differences in myeloid cells.pdf\n\u003e [evidence]: Using computational cell mapping techniques to predict microglial gene expression from bulk trans...", "to": "Microglial gene expression", "value": 1.0, "width": 1.6931471805599454}, {"from": "Csf1r inhibitors", "label": "prevents", "sources": ["{\u0027doc_id\u0027: \u002783604f00c2934caf\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"34294785 - Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 22, \u0027page\u0027: None, \u0027char_span\u0027: [11, 78], \u0027evidence\u0027: \u0027Given that Csf1r inhibitors have been shown to prevent AD-related microgliosis and partially ameliorate disease pathology in vivo33\u201336 it would be interesting to see if Csf1R protein was affected in Spi1 shRNA infected microglia and if the reduction in PU.1 had a similar impact to Csf1r inhibitors on disease progress.\u0027, \u0027confidence\u0027: 1.0}"], "title": "prevents | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 83604f00c2934caf  \n[file]: 34294785 - Modest changes in Spi1 dosage reveal the potential for altered microglial function as seen in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Given that Csf1r inhibitors have been shown to prevent AD-related microgliosis and partially amel...", "to": "AD-related microgliosis", "value": 1.0, "width": 1.6931471805599454}, {"from": "Cst7", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u002796eb38329566ac36\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 63, \u0027page\u0027: None, \u0027char_span\u0027: [89, 139], \u0027evidence\u0027: \u0027Though this decreased expression may only prove to be beneficial to males as knockout of Cst7 in males decreases pro-inflammatory mediators while females increased pro-inflammatory and endolysosomal expression in microglia [58].\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 96eb38329566ac36  \n[file]: 38385967 - Single-Cell RNA-seq reveals transcriptomic modulation of Alzheimer\u0027s disease by activated protein C.pdf\n\u003e [evidence]: Though this decreased expression may only prove to be beneficial to males as knockout of Cst7 in ...", "to": "pro-inflammatory mediators", "value": 1.0, "width": 1.6931471805599454}, {"from": "Ctsl expression", "label": "decreases", "sources": ["{\u0027doc_id\u0027: \u0027f08e8a515e81d795\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002738840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\u0027}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 26, \u0027page\u0027: None, \u0027char_span\u0027: [22, 93], \u0027evidence\u0027: \u0027We observed increased Ctsl expression by old microglia, but also decreased expression of Cd55, which would be predicted to increase C3 cleavage by the extracellular C3 convertase, so further studies are necessary to determine whether intracellular versus extracellular C3 cleavage and C3aR signaling increase during microglial aging and DAM formation.\u0027, \u0027confidence\u0027: 1.0}"], "title": "decreases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f08e8a515e81d795  \n[file]: 38840206 - Microglia undergo sex-dimorphic transcriptional and metabolic rewiring during aging.pdf\n\u003e [evidence]: We observed increased Ctsl expression by old microglia, but also decreased expression of Cd55, wh...", "to": "Cd55", "value": 1.0, "width": 1.6931471805599454}, {"from": "Cx3cr1 deficiency", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u00273b13fd318d8fea14\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 23, \u0027page\u0027: None, \u0027char_span\u0027: [72, 135], \u0027evidence\u0027: \u0027Similar results have been reported in the SOD1-G93A model of ALS, where Cx3cr1 deficiency is associated with increased SOD1 aggregation, neuronal loss and inflammatory microglial activation with impaired autophagy-lysosomal degradation pathways and autophagosome maturation [18, 19].\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Similar results have been reported in the SOD1-G93A model of ALS, where Cx3cr1 deficiency is asso...", "to": "SOD1 aggregation", "value": 1.0, "width": 1.6931471805599454}, {"from": "Cx3cr1 deficiency", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u00273b13fd318d8fea14\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 19, \u0027page\u0027: None, \u0027char_span\u0027: [0, 80], \u0027evidence\u0027: \u0027Cx3cr1 deficiency is associated with a transient deficit in microglial abundance during early post-natal development [11, 12].\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Cx3cr1 deficiency is associated with a transient deficit in microglial abundance during early pos...", "to": "microglial abundance", "value": 1.0, "width": 1.6931471805599454}, {"from": "Cx3cr1 deficiency", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00273b13fd318d8fea14\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 31, \u0027page\u0027: None, \u0027char_span\u0027: [53, 113], \u0027evidence\u0027: \u0027In the APPPS1 and R1.40 mouse models of amyloidosis, Cx3cr1 deficiency results in a gene-dose dependent reduction in fibrillar A\u03b2 (fA\u03b2) burdens in early disease, suggesting that a loss of CX3CR1 is beneficial in A\u03b2 pathogenesis.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 3b13fd318d8fea14  \n[file]: 35764973 - CX3CR1 deficiency aggravates amyloid driven neuronal pathology and cognitive decline in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: In the APPPS1 and R1.40 mouse models of amyloidosis, Cx3cr1 deficiency results in a gene-dose dep...", "to": "gene-dose dependent reduction", "value": 1.0, "width": 1.6931471805599454}, {"from": "EGFP", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u00275194787e6776a5c5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002737833764 - Chronic neuroinflammation during aging leads to cholinergic neurodegeneration in the mouse medial septum.pdf\u0027}, \u0027chunk_id\u0027: 2, \u0027sentence_id\u0027: 7, \u0027page\u0027: None, \u0027char_span\u0027: [539, 582], \u0027evidence\u0027: \u0027Abbreviations AD Alzheimer\u2019s disease BFCN Basal forebrain cholinergic neuron MS Medial septum BF Basal forebrain VP Ventral pallidum VDB Vertical diagonal band nuclei HDB: Horizontal diagonal band nuclei SI/EA Substantia innominata/extended amygdala ChAT Choline acetyl transferase CA1 Cornu ammonis 1 region REM Rapid eye movement sleep ACh Acetylcholine AChE Enzyme acetylcholinesterase CNS Central nervous system A\u03b2 \u0392-amyloil IL-6 Interleukin-6 GFAP-IL6 Glial fibrillary acidic protein-interleukin 6 BAC Bacterial artificial chromosome EGFP Enhanced green fluorescent protein LPS Lipopolysaccharide TBS Theta-burst stimulation MWM Morris water maze TREM2-DAP12 Triggering receptor expressed on myeloid cells 2-DNAX activation protein 12 Supplementary Information The online version contains supplementary material available at https://\\u200bdoi.\\u200b org/\\u200b10.\\u200b1186/\\u200bs12974-\\u200b023-\\u200b02897-5.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 5194787e6776a5c5  \n[file]: 37833764 - Chronic neuroinflammation during aging leads to cholinergic neurodegeneration in the mouse medial septum.pdf\n\u003e [evidence]: Abbreviations AD Alzheimer\u2019s disease BFCN Basal forebrain cholinergic neuron MS Medial septum BF ...", "to": "LPS", "value": 1.0, "width": 1.6931471805599454}, {"from": "P2RY12", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027128568d9c3e2b7e2\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002739820004 - The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 11, \u0027page\u0027: None, \u0027char_span\u0027: [40, 86], \u0027evidence\u0027: \u0027Special attention must also be given to Homeos2, which expresses high levels of P2RY12 and CX3CR1, and we annotated as \u201chomeostatic\u201d.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 128568d9c3e2b7e2  \n[file]: 39820004 - The Human Microglia Atlas (HuMicA) unravels changes in disease-associated microglia subsets across neurodegenerative conditions.pdf\n\u003e [evidence]: Special attention must also be given to Homeos2, which expresses high levels of P2RY12 and CX3CR1...", "to": "Homeos2", "value": 1.0, "width": 1.6931471805599454}, {"from": "HERV-K RNA", "label": "expresses", "sources": ["{\u0027doc_id\u0027: \u0027f7ba0f60074958f6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002732271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 29, \u0027page\u0027: None, \u0027char_span\u0027: [66, 126], \u0027evidence\u0027: \u0027Although microglia released inflammatory molecules in response to HERV-K RNA and enhanced HERV-K RNA\u2013induced neurodegeneration, they were not required for the observed injurious effects.\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u0027f7ba0f60074958f6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002732271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 28, \u0027page\u0027: None, \u0027char_span\u0027: [101, 176], \u0027evidence\u0027: \u0027Considering the sequence specificity of the LNA-based RNA inhibitor, our data strongly indicate that HERV-K RNA physiologically expressed in humans can induce neurodegeneration.\u0027, \u0027confidence\u0027: 1.0}"], "title": "expresses | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f7ba0f60074958f6  \n[file]: 32271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\n\u003e [evidence]: Although microglia released inflammatory molecules in response to HERV-K RNA and enhanced HERV-K ...\n\u003e [evidence]: Considering the sequence specificity of the LNA-based RNA inhibitor, our data strongly indicate t...", "to": "neurodegeneration", "value": 1.0, "width": 1.6931471805599454}, {"from": "neurodegeneration", "label": "prevents", "sources": ["{\u0027doc_id\u0027: \u0027f7ba0f60074958f6\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \u002732271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\u0027}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 47, \u0027page\u0027: None, \u0027char_span\u0027: [4, 53], \u0027evidence\u0027: \u0027The HERV-K inhibitor also prevented neurodegeneration and microglial activation in response to intrathecal HERV-K in APPPS1 mice.\u0027, \u0027confidence\u0027: 1.0}"], "title": "prevents | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: f7ba0f60074958f6  \n[file]: 32271161 - Human endogenous retrovirus HERV-K(HML-2) RNA causes neurodegeneration through Toll-like receptors.pdf\n\u003e [evidence]: The HERV-K inhibitor also prevented neurodegeneration and microglial activation in response to in...", "to": "HERV-K inhibitor", "value": 1.0, "width": 1.6931471805599454}, {"from": "plaque density", "label": "associated with", "sources": ["{\u0027doc_id\u0027: \u0027a5271e582a6524a5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35180881 - PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 18, \u0027page\u0027: None, \u0027char_span\u0027: [34, 86], \u0027evidence\u0027: \u0027PLCG2 expression was increased in LOAD patients and was associated with plaque density.\u0027, \u0027confidence\u0027: 1.0}"], "title": "associated with | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: a5271e582a6524a5  \n[file]: 35180881 - PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: PLCG2 expression was increased in LOAD patients and was associated with plaque density.", "to": "LOAD patients", "value": 1.0, "width": 1.6931471805599454}, {"from": "LOAD patients", "label": "increases", "sources": ["{\u0027doc_id\u0027: \u0027a5271e582a6524a5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35180881 - PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 3, \u0027page\u0027: None, \u0027char_span\u0027: [151, 208], \u0027evidence\u0027: \u0027Methods: Using bulk RNA-Seq (N=1249) data from the Accelerating Medicines Partnership-Alzheimer\u2019s Disease Consortium (AMP-AD), we investigated whether PLCG2 expression increased in the brains of LOAD patients.\u0027, \u0027confidence\u0027: 1.0}", "{\u0027doc_id\u0027: \u0027a5271e582a6524a5\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"35180881 - PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 1, \u0027sentence_id\u0027: 18, \u0027page\u0027: None, \u0027char_span\u0027: [0, 47], \u0027evidence\u0027: \u0027PLCG2 expression was increased in LOAD patients and was associated with plaque density.\u0027, \u0027confidence\u0027: 1.0}"], "title": "increases | w=2.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: a5271e582a6524a5  \n[file]: 35180881 - PLCG2 is associated with the inflammatory response and is induced by amyloid plaques in Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Methods: Using bulk RNA-Seq (N=1249) data from the Accelerating Medicines Partnership-Alzheimer\u2019s...\n\u003e [evidence]: PLCG2 expression was increased in LOAD patients and was associated with plaque density.", "to": "PLCG2", "value": 2.0, "width": 2.09861228866811}, {"from": "LRP10", "label": "causes", "sources": ["{\u0027doc_id\u0027: \u00276e263da311cc2e11\u0027, \u0027doc_meta\u0027: {\u0027filename\u0027: \"37340466 - Sex specific molecular networks and key drivers of Alzheimer\u0027s disease.pdf\"}, \u0027chunk_id\u0027: 0, \u0027sentence_id\u0027: 10, \u0027page\u0027: None, \u0027char_span\u0027: [69, 117], \u0027evidence\u0027: \u0027Gene perturbation experiments in EFAD mouse models demonstrated that LRP10 differentially affected cognitive function and AD pathology in sex- and APOE genotype-specific manners.\u0027, \u0027confidence\u0027: 1.0}"], "title": "causes | w=1.0\n\n\u2014\u2014 sources \u2014\u2014\n[doc_id]: 6e263da311cc2e11  \n[file]: 37340466 - Sex specific molecular networks and key drivers of Alzheimer\u0027s disease.pdf\n\u003e [evidence]: Gene perturbation experiments in EFAD mouse models demonstrated that LRP10 differentially affecte...", "to": "cognitive function", "value": 1.0, "width": 1.6931471805599454}]);

                  nodeColors = {};
                  allNodes = nodes.get({ returnType: "Object" });
                  for (nodeId in allNodes) {
                    nodeColors[nodeId] = allNodes[nodeId].color;
                  }
                  allEdges = edges.get({ returnType: "Object" });
                  // adding nodes and edges to the graph
                  data = {nodes: nodes, edges: edges};

                  var options = {"physics": {"solver": "barnesHut", "stabilization": {"iterations": 150}, "barnesHut": {"gravitationalConstant": -8000, "springLength": 120, "springConstant": 0.02}}, "interaction": {"hover": true, "tooltipDelay": 100, "multiselect": true, "dragNodes": true}};

                  


                  

                  network = new vis.Network(container, data, options);

                  

                  

                  


                  
                      network.on("stabilizationProgress", function(params) {
                          document.getElementById('loadingBar').removeAttribute("style");
                          var maxWidth = 496;
                          var minWidth = 20;
                          var widthFactor = params.iterations/params.total;
                          var width = Math.max(minWidth,maxWidth * widthFactor);
                          document.getElementById('bar').style.width = width + 'px';
                          document.getElementById('text').innerHTML = Math.round(widthFactor*100) + '%';
                      });
                      network.once("stabilizationIterationsDone", function() {
                          document.getElementById('text').innerHTML = '100%';
                          document.getElementById('bar').style.width = '496px';
                          document.getElementById('loadingBar').style.opacity = 0;
                          // really clean the dom element
                          setTimeout(function () {document.getElementById('loadingBar').style.display = 'none';}, 500);
                      });
                  

                  return network;

              }
              drawGraph();
        </script>
    </body>
</html>